<?xml version="1.0" encoding="UTF-8"?>
<rdf:RDF
   xmlns:ao="http://www.w3.org/ns/oa#"
   xmlns:dailymed="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/"
   xmlns:dct="http://purl.org/dc/terms/"
   xmlns:dikbD2R="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/"
   xmlns:domeo="http://www.w3.org/ns/domeo#"
   xmlns:foafx="http://xmlns.com/foaf/0.1/"
   xmlns:pav="http://purl.org/pav/"
   xmlns:permissions="http://vocab.deri.ie/cpo#"
   xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"
   xmlns:rdfs="http://www.w3.org/2000/01/rdf-schema#"
   xmlns:sio="http://semanticscience.org/resource/"
>
  <rdf:Description rdf:about="urn:domeoclient:uuid:0623A94E-6CBD-441E-92B8-16C280BD8650">
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoserver:annotationset:AAD02A4C-E01E-4C82-BC8A-D0F4639844FA</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:DA8D6B42-B41F-4576-BF10-1285DF3EAB80</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:41D4DAFD-01A3-4F08-82F4-AB8B59CEEB2B"/>
    <pav:lineageUri>urn:domeoserver:annotationset:C8D7FDC6-6816-4BD4-BC7F-88ABDCC37D79</pav:lineageUri>
    <pav:lineageUri>urn:domeoserver:annotation:1D419ED7-58C1-4D42-97B8-92EB462E12B3</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lastSavedOn>2014-07-16 13:20:50 -0400</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoclient:uuid:2F716A41-B68F-48AE-B5C1-E31F1704C565</domeo:belongsToSet>
    <pav:createdOn>2014-07-16 10:20:13 -0700</pav:createdOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:6FFFF211-BFDC-4E16-968C-A296868530C4</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-16 10:20:50 -0700</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:71649D2A-6308-46A5-9322-DFC56F36E8F3">
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoclient:uuid:98DABE9A-9F89-4DF9-9DEE-B6853D1F5CC1</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
    <ao:context rdf:resource="urn:domeoclient:uuid:D4F68DB2-7686-4E60-9A9D-F764E3A0DF93"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lastSavedOn>2014-07-16 18:40:55 -0400</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E3DA2E5E-FC19-4C22-AF6C-A9CB4B450554</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdOn>2014-07-16 15:40:17 -0700</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotation:3427BB2C-A91E-4C2F-9AEF-7451962FB2E7</pav:lineageUri>
    <pav:lastSavedOn>2014-07-16 15:40:55 -0700</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:81CA85AD-8F73-41B9-AEC4-5F2B934C9D93">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid></domeo:uuid>
    <ao:exact>norethindrone</ao:exact>
    <pav:createdOn>2014-07-16 14:03:26 -0700</pav:createdOn>
    <ao:prefix> and </ao:prefix>
    <ao:suffix>. In this placebo-controlled, double-blind, randomized, two-way crossover study carried out over three cycles of oral contraceptive treatment, fluconazole dosing resulted in small increases in the mean AUCs of ethinyl estradiol and norethindrone compared</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:81CA85AD-8F73-41B9-AEC4-5F2B934C9D93"/>
    <domeo:uuid>81CA85AD-8F73-41B9-AEC4-5F2B934C9D93</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-21.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoserver:annotationset:E8194531-C5B3-43AE-BC13-14A252C54824">
    <ao:item rdf:resource="urn:domeoclient:uuid:76E5F11A-7EC2-4412-BCB7-E9B0542040DE"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:920B7836-2155-4EE5-9028-A6274B846CBA"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:C91DD2D9-B8D7-4C80-85A1-EE73345B059A"/>
    <pav:createdOn>2014-07-15 14:02:34 -0700</pav:createdOn>
    <ao:item rdf:resource="urn:domeoclient:uuid:318D970E-E791-465D-B650-869C74523D2C"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:BFCAC108-C978-4C7B-A79A-9887A3CA3C6C"/>
    <domeo:deleted>false</domeo:deleted>
    <ao:item rdf:resource="urn:domeoclient:uuid:3051A76E-96A2-4A70-91F9-A241566DEFD1"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:DDF11329-3CD1-4391-B01E-D821B9E4C7F3"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:BCC5E7E8-854A-4B02-859A-36A9EC807AF5"/>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:annotatesResource>
    <ao:item rdf:resource="urn:domeoclient:uuid:D707EDCF-5B5D-4AB9-9815-32BDDA05721F"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:BED0BB6E-5962-4714-A49A-2DB5A1787334"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:8F11E81F-1EDB-4EA8-8E4A-47D93E06FFF2"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:D1062598-B310-4CF4-8237-5F8F8F74933F"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:E3D4514F-8C2B-4E16-B53E-81B363D7FDBE"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:A252FD3C-4309-4CCB-8491-4B23A2848662"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:274D4FB3-81D3-46CA-BE6A-31286B260E56"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:48E274BA-EE97-464C-9512-861F9207381F"/>
    <pav:previousVersion>urn:domeoserver:annotationset:21B0E479-04F9-4D66-B396-B773EFE53882</pav:previousVersion>
    <ao:item rdf:resource="urn:domeoclient:uuid:52A12616-29C9-4323-A81B-949195D51273"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:ADFEE70E-EDC2-4D08-90AB-0ABAFD52BC6F"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:D2174191-CE1D-4EF2-8DD5-03008A9706DE"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:F87C43FC-DD9B-42FA-953B-C8C25AA48C91"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:07B9E40E-C2A9-41CF-9B91-A2A057E2FB86"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:312701AC-EC1C-4292-B01F-44DD40979EEA"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:99C27DF5-F974-4BCC-AE8D-49CE9212E9D2"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:E2A636FF-8FE8-44E9-B454-573E4E7470FA"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:DA483938-DFFC-4F6C-85C3-FED68E6D4DE8"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:926EB546-FC66-4BEC-B38A-18749E06CCE5"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:52926929-04E3-4243-A2C3-5B9100F9FBE1"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:E0EC9718-8100-4840-9F10-BFE3FC7823F2"/>
    <permissions:permissions rdf:nodeID="Ndfe970a841f44bb49bd85d8289505fc0"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:65047D28-4B70-4701-B243-A146C45926A7"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:14655D75-DC23-4E82-84C9-F40B702E4B69"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:24886D93-A995-41A8-9E66-1BF6DF77E9D2"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:7DF78E91-4010-455D-9300-16EAD7D6AB87"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">8</pav:versionNumber>
    <ao:item rdf:resource="urn:domeoclient:uuid:4CD0874F-AA43-4C04-958D-6CFBFA68EC61"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:A056C491-9BB0-438A-A716-FE909F2281AD"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:914C2061-E547-4CFD-9F3C-C0070F56BF90"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:C4D81A7B-4D7D-4EBA-A2C1-0E5AC4A8CE5C"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:A77ED33E-10B2-43BE-8BC6-D5F14E2FE208"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:34A66F13-B248-4FD8-A3CE-7AAAC40B7ACC"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:24229507-32A8-4A26-89C0-59655390DA1A"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:12D5CA7C-401C-4376-A246-03585C5F9AC0"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:82FFD7F0-AC94-462F-BA86-70CFD849B686"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:6EB13D46-B414-424C-9D7C-BADA59079327"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:4D3BA7C7-A806-41A4-84AC-38A85FF0F9C2"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:0A8134EE-D8E3-447B-9EB9-2CB597651AB4"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:60AE44A7-769C-4774-8E4D-7AF66A2F2EA1"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:AA5B502F-CF57-4C65-81A8-140217111073"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:1453C795-84C1-4C48-AF84-AEEE18ED1682"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:63FB79CC-576B-4FFD-A109-FF63DAE371C0"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:C1A443CA-B8D4-4A28-825B-B97ECDEC88D7"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:2AAEA179-90D2-4661-9105-64A780850DEB"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:A2215D32-FF99-4DC9-90B9-5C350C098EEB"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:12CCDE72-9FC0-4264-A3F2-C533F792F613"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:F8EED65F-31D9-41A0-9BB4-436FCBA969FA"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:8CA72313-3E32-44D6-A336-EDE69F22975A"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:C025BBE5-19A7-4D05-9813-E49F4799CB23"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:A688F7D2-43BF-4838-A9A1-339829ADA43A"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:90386835-AD59-4BAA-A860-3003ABCAF86C"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:A3DBEE5E-C93B-4DBE-A1E3-317DA19FA203"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:C54A1798-BD47-4D4C-89DF-B37F5A3AB9F0"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:785FFE99-34A3-41C7-A3D5-65DC60E0807D"/>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046812afe0146812ce85a0000"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:DC20D454-AAA8-4A81-915D-03526B8FC40B"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:9CAD6283-FE79-428D-A3CE-B664A09583CB"/>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:CA792FCD-C812-49FE-9EDF-15DA0F056A53"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:5C0FAFB3-9734-473A-85E5-980D1051DADD"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:68AD55C4-223A-46C6-896A-87345A781B61"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:76294E1F-52C3-4DC1-BB56-4B5DE633DEA3"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:D1D92634-CB40-4585-8260-1917D2119CC7"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:5415B79F-FEAF-4999-A78E-2C1039116F7C"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:A5A82A3B-FE45-46DE-9048-8E85995D8F43"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:6F7C3F13-3AE2-43EA-93D3-9F0AF79252AC"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:7443907B-C475-4EA4-B081-8C3D55A1EF69"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:A1A5580F-53D7-4F22-824E-5430565EDBF1"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:5CE6135C-97A9-4B21-9915-11E87A1697A5"/>
    <pav:lineageUri>urn:domeoserver:annotationset:75FC1225-8399-469B-AE9D-7F697713E6AC</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
    <ao:item rdf:resource="urn:domeoclient:uuid:7CAB3CEB-53D4-45C0-BDE2-D01D9FD9219C"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:29A7AD86-B18C-409C-86E9-985BFF28A757"/>
    <rdfs:label>Default Set</rdfs:label>
    <ao:item rdf:resource="urn:domeoclient:uuid:BB6F25A1-6FFC-4CE5-8F5F-AD5806D52477"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:A4632682-84C0-4DFD-915D-D1C3B235F095"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:A526C161-102B-469E-9242-8D2CB0C94450"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:797BAFBC-5256-4C7D-9ACC-064403D70DDB"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:71089688-5934-49A8-BBF4-07B4CAD41AA7"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:79C3BE8E-51D8-473A-AC88-0ADB7AE9D239"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:AD757AC1-7E10-42A9-A8ED-0BD21ADA30A7"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:8900088E-395F-4576-960E-1B67ECCA0A65"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:FDDEE9D3-D4C2-40CB-BC92-305777AFD63E"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:6FED0630-F5B3-4A05-892B-CB86D31FD6DF"/>
    <dct:description>The default set is created automatically by Domeo when no other set is existing.</dct:description>
    <ao:item rdf:resource="urn:domeoclient:uuid:DC71B917-C3C7-4475-B462-6525E8CEF601"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:BF8175E8-F52D-4CE3-9DE9-BAE3E2CE04A1"/>
    <pav:lastSavedOn>2014-07-18 18:26:03 -0400</pav:lastSavedOn>
    <ao:item rdf:resource="urn:domeoclient:uuid:7130A96C-7BF2-4DBE-A880-248C420268E9"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:item rdf:resource="urn:domeoclient:uuid:446899E9-2BB7-4629-AA6E-75AF9EC38F08"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:AAA6478C-E7E4-4D30-9F06-AA094434B620"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:C66BBCCE-CA43-44FB-8D97-2084E19C48FF"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:51770B89-7CCF-409A-A2E9-D4576F9DB59A"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:85B5BEBE-D146-414B-A979-B9CEBE9C57E6"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:DA483938-DFFC-4F6C-85C3-FED68E6D4DE8">
    <pav:lastSavedOn>2014-07-15 14:11:14 -0700</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:883587E1-49C1-4EE0-909E-4ADBAE13DD3A</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E8194531-C5B3-43AE-BC13-14A252C54824</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:46636445-93A2-49F0-9E9C-5AEBF17046D2</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9C0B4E8B-9FFE-4E47-9B4C-A6EA4527A384</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:5758DAC0-E1C0-49EB-BE9C-56FFBAF3B6F4</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotation:5F7DE49C-385D-4D24-A536-4D51C78BC17D</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:570DA392-7779-456C-9C18-1FC0E579BBE6</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:9F2162C5-D2E9-42F5-99DE-E7F470A1AD7C"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:21B0E479-04F9-4D66-B396-B773EFE53882</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:2E5CE73B-BFD4-4E35-9A07-D5E37A9E87AE</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E6A1493E-98EE-4FDE-9301-752AB8E3453F</domeo:belongsToSet>
    <pav:createdOn>2014-07-15 14:09:57 -0700</pav:createdOn>
    <pav:lastSavedOn>2014-07-15 17:11:14 -0400</pav:lastSavedOn>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoserver:annotationset:5B6A462D-57EA-4BBD-87E1-A0EC2FAF5196</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:5B73CF3F-C910-4D04-9121-43AA38BE7F2F">
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-28.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:5B73CF3F-C910-4D04-9121-43AA38BE7F2F"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid>5B73CF3F-C910-4D04-9121-43AA38BE7F2F</domeo:uuid>
    <ao:suffix> (6 mg/kg) before and after the oral administration of fluconazole 200 mg daily for 14 days in 16 normal male volunteers. There were significant increases in theophylline AUC, Cmax, and half-life with a corresponding decrease in clearance. The mean ± SD </ao:suffix>
    <pav:createdOn>2014-07-18 14:02:43 -0700</pav:createdOn>
    <ao:exact>aminophylline</ao:exact>
    <ao:prefix> were determined from a single intravenous dose of </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:AEA36B1F-63F1-4CF9-8B5E-4649C4B9F028">
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <ao:suffix>xsd:String</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2014-07-15 14:11:08 -0700</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:AEA36B1F-63F1-4CF9-8B5E-4649C4B9F028"/>
    <domeo:uuid>AEA36B1F-63F1-4CF9-8B5E-4649C4B9F028</domeo:uuid>
    <ao:exact>risperidone</ao:exact>
    <ao:prefix> </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid></domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoserver:annotationset:6DBCB873-26F3-4E6A-9BD4-311369B43736">
    <ao:item rdf:resource="urn:domeoclient:uuid:4BDAA007-22DC-4E1D-8BB3-46728661C2F1"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">2</pav:versionNumber>
    <pav:previousVersion>urn:domeoclient:uuid:E65FF29A-8FE7-4D0E-A93C-4DA8136F4956</pav:previousVersion>
    <ao:item rdf:resource="urn:domeoclient:uuid:95BD0C2B-0FA9-43F6-AC62-608DC7F301DE"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:5280B7DB-AA4C-46FE-AB43-85E58C828264"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:7A5B87F1-0D90-49BD-B71F-1710FF095850"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
    <ao:item rdf:resource="urn:domeoclient:uuid:CFF4DD39-5FB5-46B5-9868-D724A30FB42C"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <pav:createdOn>2014-07-18 14:02:36 -0700</pav:createdOn>
    <permissions:permissions rdf:nodeID="N37196c6fde0647afbdd2b7777de1e363"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:A5A2521E-A463-45F1-BFC8-4843561F5EFD"/>
    <domeo:deleted>false</domeo:deleted>
    <ao:item rdf:resource="urn:domeoclient:uuid:0216B801-6401-4E8A-B678-5222EA6AA098"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdfs:label>Default Set</rdfs:label>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-28.txt.html</ao:annotatesResource>
    <pav:lineageUri>urn:domeoserver:annotationset:9AA0507C-281E-45C8-9719-03E66F12C069</pav:lineageUri>
    <ao:item rdf:resource="urn:domeoclient:uuid:701FB70F-31F1-4E69-B54F-77820E603E4C"/>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046812afe0146812ce85a0000"/>
    <dct:description>The default set is created automatically by Domeo when no other set is existing.</dct:description>
    <pav:lastSavedOn>2014-07-18 17:05:18 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N47b9d4e6b59b4ed4ba29024782538a0f">
    <domeo:sets rdf:resource="urn:pddi:uuid:80054AD6-BA25-42F5-A7DD-E6D78015E9FA"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:1C00DD3B-AD96-4229-AD96-9CFE64EA4677">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046812afe0146812ce85a0000"/>
    <pav:createdOn>2014-07-15 13:56:25 -0700</pav:createdOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotationset:BCA6AE93-8F70-41D6-9D04-EEFEAA82A4A2</pav:lineageUri>
    <pav:lastSavedOn>2014-07-15 16:58:24 -0400</pav:lastSavedOn>
    <rdfs:label>Default Set</rdfs:label>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-4.txt.html</ao:annotatesResource>
    <ao:item rdf:resource="urn:domeoclient:uuid:E38D9228-C97F-4151-9702-C3C8F519D87E"/>
    <dct:description>The default set is created automatically by Domeo when no other set is existing.</dct:description>
    <domeo:deleted>false</domeo:deleted>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <permissions:permissions rdf:nodeID="Nda06508f885044a7aabb745504400d31"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:25F38526-D98C-49CE-873D-4D75248FDE0A">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/83246816-D7FF-44ED-AF9B-04CDD30DDA0F"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/D4B9A038-2770-4F91-9562-10173A7F2D34"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:2B3DD740-D22B-482C-9A75-48DD8B5632A7">
    <ao:exact>risperidone</ao:exact>
    <ao:suffix> occurred at about 1 hour. Peak concentrations of 9-hydroxyrisperidone occurred at about 3 hours in extensive metabolizers, and 17 hours in poor metabolizers. Steady-state concentrations of risperidone are reached in 1 day in extensive metabolizers and w</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid>2B3DD740-D22B-482C-9A75-48DD8B5632A7</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:2B3DD740-D22B-482C-9A75-48DD8B5632A7"/>
    <ao:prefix>xsd:String</ao:prefix>
    <domeo:uuid></domeo:uuid>
    <pav:createdOn>2014-07-16 10:22:55 -0700</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:99C27DF5-F974-4BCC-AE8D-49CE9212E9D2">
    <pav:lastSavedOn>2014-07-15 17:30:45 -0400</pav:lastSavedOn>
    <pav:lastSavedOn>2014-07-15 14:30:47 -0700</pav:lastSavedOn>
    <pav:createdOn>2014-07-15 14:25:37 -0700</pav:createdOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:21B0E479-04F9-4D66-B396-B773EFE53882</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotation:257F96B7-C553-467D-B7B8-F95CCB07173E</pav:lineageUri>
    <ao:body rdf:nodeID="Nd41b5f39f8fb4b7ca07b1f290f829794"/>
    <pav:lastSavedOn>2014-07-15 17:30:47 -0400</pav:lastSavedOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:previousVersion>urn:domeoserver:annotationset:883587E1-49C1-4EE0-909E-4ADBAE13DD3A</pav:previousVersion>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">6</pav:versionNumber>
    <ao:body rdf:nodeID="N82b3173fd9584f64a005d9e4746a9788"/>
    <pav:lineageUri>urn:domeoserver:annotation:BA1A0750-F6A2-4179-B296-393DF4D7CC70</pav:lineageUri>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <ao:body rdf:nodeID="N26aa2427cb2d40bd9d3bae25ca2f6013"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotationset:75FC1225-8399-469B-AE9D-7F697713E6AC</pav:lineageUri>
    <pav:lastSavedOn>2014-07-15 17:30:43 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:46636445-93A2-49F0-9E9C-5AEBF17046D2</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E6A1493E-98EE-4FDE-9301-752AB8E3453F</domeo:belongsToSet>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <ao:body rdf:nodeID="Nd1a93b1bab044f6b83f2066a9ab08fe1"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:5758DAC0-E1C0-49EB-BE9C-56FFBAF3B6F4</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotation:7ED2D152-AC3C-4EDD-A488-E5E09ABC475A</pav:lineageUri>
    <ao:body rdf:nodeID="Ncfd0b85462e544fb81b6acda79f74fc4"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
    <domeo:belongsToSet>urn:domeoserver:annotationset:5B6A462D-57EA-4BBD-87E1-A0EC2FAF5196</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E8194531-C5B3-43AE-BC13-14A252C54824</domeo:belongsToSet>
    <ao:body rdf:nodeID="N96e9e9e77eb543b19ba44ef505150dd6"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <ao:context rdf:resource="urn:domeoclient:uuid:D2EC0D99-6FCE-4978-BE7E-E1C8066C58EF"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:BB6F25A1-6FFC-4CE5-8F5F-AD5806D52477">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoserver:annotationset:21B0E479-04F9-4D66-B396-B773EFE53882</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotation:4CAC7ECA-C790-49F7-B709-B23F96D5F2BA</pav:lineageUri>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdOn>2014-07-15 14:18:35 -0700</pav:createdOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E6A1493E-98EE-4FDE-9301-752AB8E3453F</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-15 14:19:34 -0700</pav:lastSavedOn>
    <pav:lastSavedOn>2014-07-15 17:19:34 -0400</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lastSavedOn>2014-07-15 17:19:32 -0400</pav:lastSavedOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:32BA85DE-7726-48C4-99FF-A828C5E2713A"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
    <domeo:belongsToSet>urn:domeoserver:annotationset:883587E1-49C1-4EE0-909E-4ADBAE13DD3A</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9C0B4E8B-9FFE-4E47-9B4C-A6EA4527A384</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:46636445-93A2-49F0-9E9C-5AEBF17046D2</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E8194531-C5B3-43AE-BC13-14A252C54824</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoserver:annotationset:5758DAC0-E1C0-49EB-BE9C-56FFBAF3B6F4</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:5B6A462D-57EA-4BBD-87E1-A0EC2FAF5196</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotation:521A8518-443B-4C13-B27D-687BA056F54F</pav:lineageUri>
    <pav:previousVersion>xsd:String</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:24229507-32A8-4A26-89C0-59655390DA1A">
    <pav:previousVersion>urn:domeoserver:annotationset:2E5CE73B-BFD4-4E35-9A07-D5E37A9E87AE</pav:previousVersion>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:883587E1-49C1-4EE0-909E-4ADBAE13DD3A</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9C0B4E8B-9FFE-4E47-9B4C-A6EA4527A384</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotationset:75FC1225-8399-469B-AE9D-7F697713E6AC</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:46636445-93A2-49F0-9E9C-5AEBF17046D2</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:5758DAC0-E1C0-49EB-BE9C-56FFBAF3B6F4</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E8194531-C5B3-43AE-BC13-14A252C54824</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E6A1493E-98EE-4FDE-9301-752AB8E3453F</domeo:belongsToSet>
    <pav:createdOn>2014-07-15 14:15:02 -0700</pav:createdOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:21B0E479-04F9-4D66-B396-B773EFE53882</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotation:4F1F10E9-A223-4980-A0E3-66C01265A84D</pav:lineageUri>
    <rdfs:label>Highlight</rdfs:label>
    <ao:context rdf:resource="urn:domeoclient:uuid:0B7730D3-D7F2-4D65-B79F-6DB4ADEC18E6"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:570DA392-7779-456C-9C18-1FC0E579BBE6</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-15 14:17:25 -0700</pav:lastSavedOn>
    <pav:lastSavedOn>2014-07-15 17:17:26 -0400</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">4</pav:versionNumber>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
    <domeo:belongsToSet>urn:domeoserver:annotationset:5B6A462D-57EA-4BBD-87E1-A0EC2FAF5196</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:A8C9B71B-88CF-40BB-B2E7-05BB8108A261">
    <ao:exact>levonorgestrel</ao:exact>
    <pav:createdOn>2014-07-16 15:32:46 -0700</pav:createdOn>
    <ao:prefix> or </ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:A8C9B71B-88CF-40BB-B2E7-05BB8108A261"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-22.txt.html</ao:hasSource>
    <domeo:uuid>A8C9B71B-88CF-40BB-B2E7-05BB8108A261</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix> AUC after the administration of 50 mg of fluconazole. The mean increase in ethinyl estradiol AUC was 6% (range: -47 to 108%) and levonorgestrel AUC increased 17% (range: -33 to 141%).</ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:785FFE99-34A3-41C7-A3D5-65DC60E0807D">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotationset:75FC1225-8399-469B-AE9D-7F697713E6AC</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9C0B4E8B-9FFE-4E47-9B4C-A6EA4527A384</domeo:belongsToSet>
    <pav:createdOn>2014-07-15 14:06:32 -0700</pav:createdOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:46636445-93A2-49F0-9E9C-5AEBF17046D2</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-15 17:07:57 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:21B0E479-04F9-4D66-B396-B773EFE53882</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:5758DAC0-E1C0-49EB-BE9C-56FFBAF3B6F4</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-15 14:07:58 -0700</pav:lastSavedOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:DD78A8D5-89E1-46CD-BC97-037DB330DF6D"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
    <domeo:belongsToSet>urn:domeoserver:annotationset:5B6A462D-57EA-4BBD-87E1-A0EC2FAF5196</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E8194531-C5B3-43AE-BC13-14A252C54824</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:883587E1-49C1-4EE0-909E-4ADBAE13DD3A</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">2</pav:versionNumber>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <rdfs:label>Highlight</rdfs:label>
    <pav:previousVersion>urn:domeoclient:uuid:9B307D8B-D2B0-4795-8850-FAAAAC6B5AF4</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:FA8D1DAC-C616-456C-BB3D-29F18DED21A1</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:570DA392-7779-456C-9C18-1FC0E579BBE6</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:1575950D-32D4-46DE-A44F-8E9E614F997F</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E6A1493E-98EE-4FDE-9301-752AB8E3453F</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotation:3E065066-D4E2-4D26-8036-3DB778564FFB</pav:lineageUri>
    <pav:lineageUri>urn:domeoserver:annotation:B8568ADC-80CF-4A28-8FAE-7E61ECB6613D</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:2E5CE73B-BFD4-4E35-9A07-D5E37A9E87AE</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-15 17:07:58 -0400</pav:lastSavedOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:0409A564-F79B-4C83-9844-E9D65A082622">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/6B3BAFED-E091-412E-B7AB-A9DC8567890B"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/3A85B371-E653-4667-9F67-A08A4188190B"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:9C861997-137E-4C3F-A9A5-BF78640820A1">
    <domeo:belongsToSet>urn:domeoserver:annotationset:A1747CFE-8798-401D-BFC7-1E14B7B3B1B1</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lastSavedOn>2014-07-18 17:23:51 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotation:69AB9248-3F8C-4691-8B3B-22E9D55EAFC7</pav:lineageUri>
    <pav:lineageUri>urn:domeoserver:annotationset:D0F2204E-5148-4A33-AAD0-599FB1F44EFC</pav:lineageUri>
    <pav:createdOn>2014-07-18 14:23:40 -0700</pav:createdOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lastSavedOn>2014-07-18 14:23:49 -0700</pav:lastSavedOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
    <domeo:belongsToSet>urn:domeoclient:uuid:AA2CF58E-6DB1-4267-8DFC-33DE11331D87</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:E3A87903-26B7-471E-B573-E6792F176AFA"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:AB5F4799-5045-4FBD-ACF4-AFCEB256A943">
    <ao:prefix>Administration of a </ao:prefix>
    <pav:createdOn>2014-07-18 13:45:45 -0700</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:AB5F4799-5045-4FBD-ACF4-AFCEB256A943"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix>. (See PRECAUTIONS.</ao:suffix>
    <domeo:uuid>AB5F4799-5045-4FBD-ACF4-AFCEB256A943</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-24.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>single oral 200 mg dose of fluconazole after 15 days of rifampin administered as 600 mg daily in eight healthy male volunteers resulted in a significant decrease in fluconazole AUC and a significant increase in apparent oral clearance of fluconazole. There was a mean ± SD reduction in fluconazole AUC of 23% ± 9% (range: -13 to -42%). Apparent oral clearance of fluconazole increased 32% ± 17% (range: 16 to 72%). Fluconazole half-life decreased from 33.4 ± 4.4 hours to 26.8 ± 3.9 hours</ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:71C7EBFE-DDAD-400D-8A02-566CA152276C">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/F8617FDB-EC1E-432B-A946-4F2CE4A8D3D5"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/10F4138F-8D26-4583-8ACD-216B6C4F221E"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:2FE06202-CAC5-466E-B0DA-E34428ADAEF3">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:2FE06202-CAC5-466E-B0DA-E34428ADAEF3"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2014-07-15 14:07:31 -0700</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <ao:prefix>Distribution: </ao:prefix>
    <ao:suffix> is rapidly distributed. The volume of distribution is 1 to 2 L/kg. In plasma, risperidone is bound to albumin and α1-acid glycoprotein. The plasma protein binding of risperidone is 90%, and that of its major metabolite, 9-hydroxyrisperidone, is 77%. Nei</ao:suffix>
    <domeo:uuid></domeo:uuid>
    <ao:exact>Risperidone</ao:exact>
    <domeo:uuid>2FE06202-CAC5-466E-B0DA-E34428ADAEF3</domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:FDDEE9D3-D4C2-40CB-BC92-305777AFD63E">
    <domeo:belongsToSet>urn:domeoserver:annotationset:46636445-93A2-49F0-9E9C-5AEBF17046D2</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:A61CD8E1-11C9-4016-9EA7-411997F38BC7"/>
    <pav:lastSavedOn>2014-07-15 17:19:34 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:5758DAC0-E1C0-49EB-BE9C-56FFBAF3B6F4</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
    <domeo:belongsToSet>urn:domeoserver:annotationset:5B6A462D-57EA-4BBD-87E1-A0EC2FAF5196</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E8194531-C5B3-43AE-BC13-14A252C54824</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotation:D2DBCC4A-ADA3-42C3-8C46-57DBF12F00B7</pav:lineageUri>
    <pav:lastSavedOn>2014-07-15 14:19:34 -0700</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:883587E1-49C1-4EE0-909E-4ADBAE13DD3A</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-15 17:19:32 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:21B0E479-04F9-4D66-B396-B773EFE53882</domeo:belongsToSet>
    <pav:createdOn>2014-07-15 14:18:29 -0700</pav:createdOn>
    <rdfs:label>Highlight</rdfs:label>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lineageUri>urn:domeoserver:annotation:2CDC8618-5960-4D20-819D-45E18F3FB9E2</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E6A1493E-98EE-4FDE-9301-752AB8E3453F</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9C0B4E8B-9FFE-4E47-9B4C-A6EA4527A384</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/3C3EB772-FD27-4C4F-BAFA-ADD15348B4A5">
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <rdfs:label>carbamazepine</rdfs:label>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/2002</dailymed:activeMoietyRxCUI>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:DAD17BCA-9CFC-4DE8-932B-E68F8A5FAD45">
    <pav:lastSavedOn>2014-07-18 13:56:04 -0700</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:99826AC3-3668-4F74-9E9D-DADD1F7098F0</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
    <ao:context rdf:resource="urn:domeoclient:uuid:58452268-E11A-438D-ACF7-C32BA04261F1"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lastSavedOn>2014-07-18 16:56:04 -0400</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotation:F0DBBACF-FE8B-4884-BCC8-527B11B90A1A</pav:lineageUri>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdOn>2014-07-18 13:55:49 -0700</pav:createdOn>
    <domeo:belongsToSet>urn:domeoclient:uuid:82AC5ADA-B8CE-47A9-AA99-E7187ABEFACA</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoserver:annotationset:7BA312DF-BB65-4A90-8B7D-A54425D7C553">
    <pav:previousVersion>urn:domeoclient:uuid:51A184F8-19CA-4489-AB8F-9AF92E4BE5BE</pav:previousVersion>
    <rdfs:label>Default Set</rdfs:label>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-50.txt.html</ao:annotatesResource>
    <ao:item rdf:resource="urn:domeoclient:uuid:92F5F5C5-9A9C-4B47-AB81-A514809088C8"/>
    <pav:createdOn>2014-07-18 14:20:17 -0700</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotationset:1EE1D64B-EDD4-4170-B797-D8F83B927DCE</pav:lineageUri>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:41E33AFA-32CF-4F33-A475-CBE51A5010FA"/>
    <domeo:deleted>false</domeo:deleted>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
    <ao:item rdf:resource="urn:domeoclient:uuid:3A410142-DDEC-496D-86F6-76E692FBA77E"/>
    <permissions:permissions rdf:nodeID="N124af162555645ef80c102558d0822ea"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">2</pav:versionNumber>
    <pav:lastSavedOn>2014-07-18 17:22:23 -0400</pav:lastSavedOn>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <dct:description>The default set is created automatically by Domeo when no other set is existing.</dct:description>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046812afe0146812ce85a0000"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:17162313-6A55-4157-B495-83AA9CF1A26A"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:item rdf:resource="urn:domeoclient:uuid:844AAE28-6A60-487D-810E-79FA4BF0CAB5"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:24886D93-A995-41A8-9E66-1BF6DF77E9D2">
    <domeo:belongsToSet>urn:domeoserver:annotationset:2E5CE73B-BFD4-4E35-9A07-D5E37A9E87AE</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotation:8FC7533E-98D0-409F-A285-1636EF0EAEA3</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:46636445-93A2-49F0-9E9C-5AEBF17046D2</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-15 14:07:58 -0700</pav:lastSavedOn>
    <pav:lastSavedOn>2014-07-15 17:07:58 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9C0B4E8B-9FFE-4E47-9B4C-A6EA4527A384</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:5758DAC0-E1C0-49EB-BE9C-56FFBAF3B6F4</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotationset:75FC1225-8399-469B-AE9D-7F697713E6AC</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
    <domeo:belongsToSet>urn:domeoserver:annotationset:5B6A462D-57EA-4BBD-87E1-A0EC2FAF5196</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E8194531-C5B3-43AE-BC13-14A252C54824</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:883587E1-49C1-4EE0-909E-4ADBAE13DD3A</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">2</pav:versionNumber>
    <ao:context rdf:resource="urn:domeoclient:uuid:DEA7496B-9CAF-4929-AD2C-2B22EB0C5A6B"/>
    <pav:createdOn>2014-07-15 14:06:27 -0700</pav:createdOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:FA8D1DAC-C616-456C-BB3D-29F18DED21A1</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:570DA392-7779-456C-9C18-1FC0E579BBE6</domeo:belongsToSet>
    <pav:previousVersion>urn:domeoclient:uuid:9B307D8B-D2B0-4795-8850-FAAAAC6B5AF4</pav:previousVersion>
    <rdfs:label>Highlight</rdfs:label>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoserver:annotationset:21B0E479-04F9-4D66-B396-B773EFE53882</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:1575950D-32D4-46DE-A44F-8E9E614F997F</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E6A1493E-98EE-4FDE-9301-752AB8E3453F</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotation:D4B866CB-28CD-4764-94B0-2B0E38EC7F91</pav:lineageUri>
    <pav:lastSavedOn>2014-07-15 17:07:57 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoserver:annotationset:516C333C-B517-4F84-999E-51185DD6E859">
    <pav:lastSavedOn>2014-07-10 14:21:41 -0400</pav:lastSavedOn>
    <ao:item rdf:resource="urn:domeoclient:uuid:31F660CD-C617-4D06-85AD-7A9D8F2EDEEC"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:380253B1-58A2-45B6-B271-96D870E13796"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:702BE5BD-B486-4EEB-9B0C-8C790AAA768A"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:10EA2F12-BD12-4F54-9D90-CD6B3DC5179E"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:F5FD5F49-D620-4FE1-9968-D31A01410DEC"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:5A441D1D-CF1A-4E2D-80CF-F79B9D77D232"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:86ABDA54-6350-41E2-93E1-1353431A082D"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:E5AC3B8B-F69B-4482-815F-54FC3F75312F"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:977A2BC8-0744-472F-9FA2-CCF897431CA1"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:114FB83A-C60C-42F5-AB92-9462558A06FC"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:C820B82D-AF0E-4A71-9E65-5AB73DFE5206"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
    <pav:lineageUri>urn:domeoserver:annotationset:BE290CA3-79BD-411A-BE2E-69AA4D19607D</pav:lineageUri>
    <ao:item rdf:resource="urn:domeoclient:uuid:91E13B1F-608F-46DC-825E-D1031BD8EE6D"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:A30AACD8-E9A8-4B2C-9DB3-7E44F147751F"/>
    <permissions:permissions rdf:nodeID="N6d4d7d940f4c4c0dbe72e196ae29e74b"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:33374D0E-AF28-4161-ACC9-7713697436CB"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:C9D98AB8-FCA0-4A14-92DD-EBD32CC6776E"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:EFED6610-75EB-4165-827C-237B7D245279"/>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046812afe0146812ce85a0000"/>
    <pav:createdOn>2014-07-10 10:59:34 -0700</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:F4E4C204-187C-449E-9023-BF663418A548"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:6C376F0E-D7D6-4846-B8E9-1C50742E0CD2"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:94AD2935-8FE6-4D3D-847A-A1AC66E35692"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:item rdf:resource="urn:domeoclient:uuid:C4DD997B-59E6-4FDF-944E-0E3151C25851"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:665D54F7-737F-4E41-85AF-4DB192AB7A15"/>
    <rdfs:label>Default Set</rdfs:label>
    <ao:item rdf:resource="urn:domeoclient:uuid:3F707B16-9AC0-4A46-A0C5-ED7358D7F764"/>
    <pav:previousVersion>urn:domeoserver:annotationset:2BFC2FB6-6BE9-4822-A245-973533533023</pav:previousVersion>
    <dct:description>The default set is created automatically by Domeo when no other set is existing.</dct:description>
    <ao:item rdf:resource="urn:domeoclient:uuid:C4C14FED-0642-4B44-8AD5-DFA9D02E5B99"/>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:annotatesResource>
    <ao:item rdf:resource="urn:domeoclient:uuid:C70E2E47-3AA5-4F01-A8A1-711E946726F5"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:32208944-92E0-40BE-AA45-03DC0663A09C"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:3E0194D4-524A-4E69-B161-52FB98ED36C2"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">6</pav:versionNumber>
    <ao:item rdf:resource="urn:domeoclient:uuid:B9DE1789-19F9-43BC-B292-659F900EA6EB"/>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:025EF8CC-8100-4ED5-A590-368E009133CC"/>
    <domeo:deleted>false</domeo:deleted>
    <ao:item rdf:resource="urn:domeoclient:uuid:84ED4684-C66A-4CA3-8A17-114128E1557B"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:ABA0CCF3-E252-4C23-B881-D2E2AF418E6C"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoserver:annotationset:15A537D1-5648-41B2-8BFA-0D0BA3DF4393">
    <ao:item rdf:resource="urn:domeoclient:uuid:380253B1-58A2-45B6-B271-96D870E13796"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:CD3E95AA-5887-4E3B-B181-8C84F1A4D6C5"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:F4E4C204-187C-449E-9023-BF663418A548"/>
    <pav:lastSavedOn>2014-07-10 14:25:16 -0400</pav:lastSavedOn>
    <ao:item rdf:resource="urn:domeoclient:uuid:E5AC3B8B-F69B-4482-815F-54FC3F75312F"/>
    <pav:previousVersion>urn:domeoserver:annotationset:970963DF-8BCE-4936-9DFC-328A36014E1B</pav:previousVersion>
    <ao:item rdf:resource="urn:domeoclient:uuid:94AD2935-8FE6-4D3D-847A-A1AC66E35692"/>
    <permissions:permissions rdf:nodeID="N58f3fc48b9604820936f995003155bb8"/>
    <pav:lineageUri>urn:domeoserver:annotationset:BE290CA3-79BD-411A-BE2E-69AA4D19607D</pav:lineageUri>
    <ao:item rdf:resource="urn:domeoclient:uuid:A30AACD8-E9A8-4B2C-9DB3-7E44F147751F"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:F5FD5F49-D620-4FE1-9968-D31A01410DEC"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:43443A66-1162-4BDC-88F9-4CB789CFAF8B"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:31F660CD-C617-4D06-85AD-7A9D8F2EDEEC"/>
    <dct:description>The default set is created automatically by Domeo when no other set is existing.</dct:description>
    <ao:item rdf:resource="urn:domeoclient:uuid:C9D98AB8-FCA0-4A14-92DD-EBD32CC6776E"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:C820B82D-AF0E-4A71-9E65-5AB73DFE5206"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:5A441D1D-CF1A-4E2D-80CF-F79B9D77D232"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:84ED4684-C66A-4CA3-8A17-114128E1557B"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:025EF8CC-8100-4ED5-A590-368E009133CC"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
    <ao:item rdf:resource="urn:domeoclient:uuid:3E0194D4-524A-4E69-B161-52FB98ED36C2"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:91E13B1F-608F-46DC-825E-D1031BD8EE6D"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:32208944-92E0-40BE-AA45-03DC0663A09C"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:702BE5BD-B486-4EEB-9B0C-8C790AAA768A"/>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046812afe0146812ce85a0000"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:B9DE1789-19F9-43BC-B292-659F900EA6EB"/>
    <pav:createdOn>2014-07-10 10:59:34 -0700</pav:createdOn>
    <ao:item rdf:resource="urn:domeoclient:uuid:C4C14FED-0642-4B44-8AD5-DFA9D02E5B99"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:10EA2F12-BD12-4F54-9D90-CD6B3DC5179E"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:C70E2E47-3AA5-4F01-A8A1-711E946726F5"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:86ABDA54-6350-41E2-93E1-1353431A082D"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:EFED6610-75EB-4165-827C-237B7D245279"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:3F707B16-9AC0-4A46-A0C5-ED7358D7F764"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:21180C8D-1095-4E2F-9A46-484DCC01879D"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:977A2BC8-0744-472F-9FA2-CCF897431CA1"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:ABA0CCF3-E252-4C23-B881-D2E2AF418E6C"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:C4DD997B-59E6-4FDF-944E-0E3151C25851"/>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:annotatesResource>
    <ao:item rdf:resource="urn:domeoclient:uuid:6C376F0E-D7D6-4846-B8E9-1C50742E0CD2"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:114FB83A-C60C-42F5-AB92-9462558A06FC"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:665D54F7-737F-4E41-85AF-4DB192AB7A15"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">8</pav:versionNumber>
    <ao:item rdf:resource="urn:domeoclient:uuid:33374D0E-AF28-4161-ACC9-7713697436CB"/>
    <rdfs:label>Default Set</rdfs:label>
    <domeo:deleted>false</domeo:deleted>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:29A7AD86-B18C-409C-86E9-985BFF28A757">
    <pav:previousVersion>urn:domeoserver:annotationset:2E5CE73B-BFD4-4E35-9A07-D5E37A9E87AE</pav:previousVersion>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:883587E1-49C1-4EE0-909E-4ADBAE13DD3A</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9C0B4E8B-9FFE-4E47-9B4C-A6EA4527A384</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotationset:75FC1225-8399-469B-AE9D-7F697713E6AC</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:46636445-93A2-49F0-9E9C-5AEBF17046D2</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:5758DAC0-E1C0-49EB-BE9C-56FFBAF3B6F4</domeo:belongsToSet>
    <pav:createdOn>2014-07-15 14:15:43 -0700</pav:createdOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E8194531-C5B3-43AE-BC13-14A252C54824</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:A60BA1DD-61D6-4A5F-906B-D67F0B3C7692"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:21B0E479-04F9-4D66-B396-B773EFE53882</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoserver:annotationset:570DA392-7779-456C-9C18-1FC0E579BBE6</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-15 14:17:25 -0700</pav:lastSavedOn>
    <pav:lastSavedOn>2014-07-15 17:17:26 -0400</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">4</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotation:7D87CD17-1D6E-401F-B8C4-9F030DA0250E</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:5B6A462D-57EA-4BBD-87E1-A0EC2FAF5196</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E6A1493E-98EE-4FDE-9301-752AB8E3453F</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:891ADA8B-FE3B-424C-BA58-775CE8AC2E75">
    <ao:exact>fluconazole</ao:exact>
    <pav:createdOn>2014-07-18 13:43:23 -0700</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:891ADA8B-FE3B-424C-BA58-775CE8AC2E75"/>
    <ao:suffix>. There was a mean ± SD reduction in fluconazole AUC of 23% ± 9% (range: -13 to -42%). Apparent oral clearance of fluconazole increased 32% ± 17% (range: 16 to 72%). Fluconazole half-life decreased from 33.4 ± 4.4 hours to 26.8 ± 3.9 hours. (See PRECAUTI</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid>891ADA8B-FE3B-424C-BA58-775CE8AC2E75</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-24.txt.html</ao:hasSource>
    <ao:prefix> AUC and a significant increase in apparent oral clearance of </ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:9B307D8B-D2B0-4795-8850-FAAAAC6B5AF4">
    <ao:item rdf:resource="urn:domeoclient:uuid:E2A636FF-8FE8-44E9-B454-573E4E7470FA"/>
    <pav:createdOn>2014-07-15 14:02:34 -0700</pav:createdOn>
    <pav:lastSavedOn>2014-07-15 17:04:05 -0400</pav:lastSavedOn>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046812afe0146812ce85a0000"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:D557988D-572F-43E0-8885-D5BF374D8DDC"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:65047D28-4B70-4701-B243-A146C45926A7"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:312701AC-EC1C-4292-B01F-44DD40979EEA"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:6EB13D46-B414-424C-9D7C-BADA59079327"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:C66BBCCE-CA43-44FB-8D97-2084E19C48FF"/>
    <rdfs:label>Default Set</rdfs:label>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotationset:75FC1225-8399-469B-AE9D-7F697713E6AC</pav:lineageUri>
    <ao:item rdf:resource="urn:domeoclient:uuid:A1A5580F-53D7-4F22-824E-5430565EDBF1"/>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:82FFD7F0-AC94-462F-BA86-70CFD849B686"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <ao:item rdf:resource="urn:domeoclient:uuid:12D5CA7C-401C-4376-A246-03585C5F9AC0"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:12CCDE72-9FC0-4264-A3F2-C533F792F613"/>
    <domeo:deleted>false</domeo:deleted>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:annotatesResource>
    <ao:item rdf:resource="urn:domeoclient:uuid:ADFEE70E-EDC2-4D08-90AB-0ABAFD52BC6F"/>
    <permissions:permissions rdf:nodeID="N4f5f13b2abed4423bd86717d16a5d8f9"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:2AAEA179-90D2-4661-9105-64A780850DEB"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
    <ao:item rdf:resource="urn:domeoclient:uuid:BFCAC108-C978-4C7B-A79A-9887A3CA3C6C"/>
    <dct:description>The default set is created automatically by Domeo when no other set is existing.</dct:description>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:46F1B2A0-76BB-4BB0-9268-81BE8008B192">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>Sildenafil</ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:hasSource>
    <ao:suffix> is an inhibitor of cGMP specific phosphodiesterase type-5 (PDE5) in the smooth muscle of the pulmonary vasculature, where PDE5 is responsible for degradation of cGMP. Sildenafil, therefore, increases cGMP within pulmonary vascular smooth muscle cells re</ao:suffix>
    <domeo:uuid>46F1B2A0-76BB-4BB0-9268-81BE8008B192</domeo:uuid>
    <pav:createdOn>2014-07-10 10:59:34 -0700</pav:createdOn>
    <ao:prefix>xsd:String</ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:46F1B2A0-76BB-4BB0-9268-81BE8008B192"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:BCC5E7E8-854A-4B02-859A-36A9EC807AF5">
    <domeo:belongsToSet>urn:domeoserver:annotationset:5758DAC0-E1C0-49EB-BE9C-56FFBAF3B6F4</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:F5CF7F61-B7F1-4B7C-AF06-558EB0A245B6"/>
    <pav:createdOn>2014-07-15 14:16:25 -0700</pav:createdOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:46636445-93A2-49F0-9E9C-5AEBF17046D2</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:883587E1-49C1-4EE0-909E-4ADBAE13DD3A</domeo:belongsToSet>
    <pav:previousVersion>urn:domeoserver:annotationset:2E5CE73B-BFD4-4E35-9A07-D5E37A9E87AE</pav:previousVersion>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">4</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:5B6A462D-57EA-4BBD-87E1-A0EC2FAF5196</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E8194531-C5B3-43AE-BC13-14A252C54824</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotation:CBA5652C-59BF-4E97-A33A-724DB099169B</pav:lineageUri>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9C0B4E8B-9FFE-4E47-9B4C-A6EA4527A384</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-15 14:17:25 -0700</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotationset:75FC1225-8399-469B-AE9D-7F697713E6AC</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lastSavedOn>2014-07-15 17:17:26 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E6A1493E-98EE-4FDE-9301-752AB8E3453F</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
    <domeo:belongsToSet>urn:domeoserver:annotationset:21B0E479-04F9-4D66-B396-B773EFE53882</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:570DA392-7779-456C-9C18-1FC0E579BBE6</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:A0FB0C6E-5133-4379-A6A1-718CC8383F46">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:A0FB0C6E-5133-4379-A6A1-718CC8383F46"/>
    <ao:prefix> concentrations than poor metabolizers, the pharmacokinetics of </ao:prefix>
    <domeo:uuid>A0FB0C6E-5133-4379-A6A1-718CC8383F46</domeo:uuid>
    <domeo:uuid></domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix> and 9-hydroxyrisperidone combined, after single and multiple doses, are similar in extensive and poor metabolizers.</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>risperidone</ao:exact>
    <pav:createdOn>2014-07-15 14:15:08 -0700</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:8900088E-395F-4576-960E-1B67ECCA0A65">
    <domeo:belongsToSet>urn:domeoserver:annotationset:E8194531-C5B3-43AE-BC13-14A252C54824</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:883587E1-49C1-4EE0-909E-4ADBAE13DD3A</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lastSavedOn>2014-07-15 14:17:25 -0700</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:5B6A462D-57EA-4BBD-87E1-A0EC2FAF5196</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-15 17:17:26 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:5758DAC0-E1C0-49EB-BE9C-56FFBAF3B6F4</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:DB032524-38CD-456B-A44B-C425DFD76D47"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:570DA392-7779-456C-9C18-1FC0E579BBE6</domeo:belongsToSet>
    <pav:createdOn>2014-07-15 14:16:48 -0700</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotationset:75FC1225-8399-469B-AE9D-7F697713E6AC</pav:lineageUri>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">4</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotation:9EA9ACFF-3C30-4274-8DED-CB6A7F54FA96</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:21B0E479-04F9-4D66-B396-B773EFE53882</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:46636445-93A2-49F0-9E9C-5AEBF17046D2</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E6A1493E-98EE-4FDE-9301-752AB8E3453F</domeo:belongsToSet>
    <pav:previousVersion>urn:domeoserver:annotationset:2E5CE73B-BFD4-4E35-9A07-D5E37A9E87AE</pav:previousVersion>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9C0B4E8B-9FFE-4E47-9B4C-A6EA4527A384</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:9DD27DF4-02BD-4CAE-B854-9D4CA6356D04">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdOn>2014-07-16 14:02:20 -0700</pav:createdOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:2CE33325-EF3D-4298-BBCC-82F0A45DA665</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdfs:label>Highlight</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lastSavedOn>2014-07-16 17:02:25 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
    <pav:lineageUri>urn:domeoserver:annotation:EDB609C2-D0B7-41E7-83D5-9E2646CB8E4E</pav:lineageUri>
    <ao:context rdf:resource="urn:domeoclient:uuid:E9DA4784-7755-4859-B2A0-96322779CF59"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:831D0F3D-639E-4B91-A3ED-AE0F362D5CE0">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2014-07-16 14:03:59 -0700</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:831D0F3D-639E-4B91-A3ED-AE0F362D5CE0"/>
    <ao:suffix> and norethindrone increased by 24% (95% C.I. range 18 to 31%) and 13% (95% C.I. range 8 to 18%), respectively relative to placebo. Fluconazole treatment did not cause a decrease in the ethinyl estradiol AUC of any individual subject in this study compar</ao:suffix>
    <domeo:uuid></domeo:uuid>
    <ao:prefix>compared to similar placebo dosing. The mean AUCs of </ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-21.txt.html</ao:hasSource>
    <domeo:uuid>831D0F3D-639E-4B91-A3ED-AE0F362D5CE0</domeo:uuid>
    <ao:exact>ethinyl estradiol</ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:2F716A41-B68F-48AE-B5C1-E31F1704C565">
    <pav:createdOn>2014-07-16 10:18:37 -0700</pav:createdOn>
    <ao:item rdf:resource="urn:domeoclient:uuid:81DA2C24-D202-4991-9DC6-FFA54776B4D2"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdfs:label>Default Set</rdfs:label>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046812afe0146812ce85a0000"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:75261373-1FF5-4BA4-8887-FD4548F77DE6"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:18EE2CB9-3D4F-42B6-A49D-245BF6C564CA"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:F89E37D5-CA53-4C58-B4D2-AE8F0A3FBCE2"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:785FC8A2-DE5D-4084-8BEC-107690A111CB"/>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:annotatesResource>
    <ao:item rdf:resource="urn:domeoclient:uuid:0623A94E-6CBD-441E-92B8-16C280BD8650"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:34BFAD74-FE4D-4E30-8ACE-10002901EAA2"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:8D0FBEEE-F2C5-4EBC-892B-1E8DE2D584AE"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:069D387B-708F-4C78-BA75-2E62415C81C9"/>
    <pav:lastSavedOn>2014-07-16 13:20:50 -0400</pav:lastSavedOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:11B78A9D-1251-420C-8AE2-B343DD8F857F"/>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <dct:description>The default set is created automatically by Domeo when no other set is existing.</dct:description>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:item rdf:resource="urn:domeoclient:uuid:ADF2DC89-FCCE-47DE-8493-BEC599C898E4"/>
    <domeo:deleted>false</domeo:deleted>
    <permissions:permissions rdf:nodeID="N8926cf7098424227b45f3e1e11d321ec"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:06A59058-E7B5-4A71-9D10-07FD98051EBF"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <ao:item rdf:resource="urn:domeoclient:uuid:6395774E-A61F-4CC3-AC03-4A9A97F402CB"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:EDA5CCDC-B45B-4C9D-9286-2C6331B0DC2E"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:6B42267E-6924-4453-B105-2F66C330186C"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:50B64AB9-5E00-4F5D-BE7F-9B8CE91BCF2A"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:AC4605E1-BB47-46C6-87EA-F8DDE5BC9868"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
    <ao:item rdf:resource="urn:domeoclient:uuid:F2AF7A08-3EE5-4851-BC7F-4DF99BFE382A"/>
    <pav:lineageUri>urn:domeoserver:annotationset:C8D7FDC6-6816-4BD4-BC7F-88ABDCC37D79</pav:lineageUri>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:DC71B917-C3C7-4475-B462-6525E8CEF601">
    <pav:lastSavedOn>2014-07-15 14:17:25 -0700</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:21B0E479-04F9-4D66-B396-B773EFE53882</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E8194531-C5B3-43AE-BC13-14A252C54824</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
    <pav:lineageUri>urn:domeoserver:annotationset:75FC1225-8399-469B-AE9D-7F697713E6AC</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E6A1493E-98EE-4FDE-9301-752AB8E3453F</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">4</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:570DA392-7779-456C-9C18-1FC0E579BBE6</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-15 17:17:26 -0400</pav:lastSavedOn>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoserver:annotationset:5B6A462D-57EA-4BBD-87E1-A0EC2FAF5196</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:883587E1-49C1-4EE0-909E-4ADBAE13DD3A</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdOn>2014-07-15 14:14:54 -0700</pav:createdOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:46636445-93A2-49F0-9E9C-5AEBF17046D2</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9C0B4E8B-9FFE-4E47-9B4C-A6EA4527A384</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotation:08564D31-FC27-45D9-AB14-DB6431082C8B</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:5758DAC0-E1C0-49EB-BE9C-56FFBAF3B6F4</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:14470CEA-E989-4566-A704-AC9CEFD39B6E"/>
    <pav:previousVersion>urn:domeoserver:annotationset:2E5CE73B-BFD4-4E35-9A07-D5E37A9E87AE</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoserver:annotationset:570DA392-7779-456C-9C18-1FC0E579BBE6">
    <ao:item rdf:resource="urn:domeoclient:uuid:BFCAC108-C978-4C7B-A79A-9887A3CA3C6C"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:A4632682-84C0-4DFD-915D-D1C3B235F095"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:85B5BEBE-D146-414B-A979-B9CEBE9C57E6"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:318D970E-E791-465D-B650-869C74523D2C"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:6FED0630-F5B3-4A05-892B-CB86D31FD6DF"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:4D3BA7C7-A806-41A4-84AC-38A85FF0F9C2"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:7CAB3CEB-53D4-45C0-BDE2-D01D9FD9219C"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:926EB546-FC66-4BEC-B38A-18749E06CCE5"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:A77ED33E-10B2-43BE-8BC6-D5F14E2FE208"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:A526C161-102B-469E-9242-8D2CB0C94450"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:797BAFBC-5256-4C7D-9ACC-064403D70DDB"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:BCC5E7E8-854A-4B02-859A-36A9EC807AF5"/>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:8900088E-395F-4576-960E-1B67ECCA0A65"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:5415B79F-FEAF-4999-A78E-2C1039116F7C"/>
    <domeo:deleted>false</domeo:deleted>
    <ao:item rdf:resource="urn:domeoclient:uuid:D2174191-CE1D-4EF2-8DD5-03008A9706DE"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:F87C43FC-DD9B-42FA-953B-C8C25AA48C91"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:51770B89-7CCF-409A-A2E9-D4576F9DB59A"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:A1A5580F-53D7-4F22-824E-5430565EDBF1"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:DA483938-DFFC-4F6C-85C3-FED68E6D4DE8"/>
    <permissions:permissions rdf:nodeID="Nd38c8439574849118ab636eefec731ef"/>
    <dct:description>The default set is created automatically by Domeo when no other set is existing.</dct:description>
    <ao:item rdf:resource="urn:domeoclient:uuid:65047D28-4B70-4701-B243-A146C45926A7"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:A2215D32-FF99-4DC9-90B9-5C350C098EEB"/>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046812afe0146812ce85a0000"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:A252FD3C-4309-4CCB-8491-4B23A2848662"/>
    <pav:previousVersion>urn:domeoserver:annotationset:2E5CE73B-BFD4-4E35-9A07-D5E37A9E87AE</pav:previousVersion>
    <ao:item rdf:resource="urn:domeoclient:uuid:7130A96C-7BF2-4DBE-A880-248C420268E9"/>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:annotatesResource>
    <ao:item rdf:resource="urn:domeoclient:uuid:D707EDCF-5B5D-4AB9-9815-32BDDA05721F"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:ADFEE70E-EDC2-4D08-90AB-0ABAFD52BC6F"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:E2A636FF-8FE8-44E9-B454-573E4E7470FA"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:82FFD7F0-AC94-462F-BA86-70CFD849B686"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:D1062598-B310-4CF4-8237-5F8F8F74933F"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:AAA6478C-E7E4-4D30-9F06-AA094434B620"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:71089688-5934-49A8-BBF4-07B4CAD41AA7"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:0A8134EE-D8E3-447B-9EB9-2CB597651AB4"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:A056C491-9BB0-438A-A716-FE909F2281AD"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:12D5CA7C-401C-4376-A246-03585C5F9AC0"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:34A66F13-B248-4FD8-A3CE-7AAAC40B7ACC"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:446899E9-2BB7-4629-AA6E-75AF9EC38F08"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:C1A443CA-B8D4-4A28-825B-B97ECDEC88D7"/>
    <rdfs:label>Default Set</rdfs:label>
    <ao:item rdf:resource="urn:domeoclient:uuid:274D4FB3-81D3-46CA-BE6A-31286B260E56"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:7DF78E91-4010-455D-9300-16EAD7D6AB87"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:60AE44A7-769C-4774-8E4D-7AF66A2F2EA1"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:1453C795-84C1-4C48-AF84-AEEE18ED1682"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:914C2061-E547-4CFD-9F3C-C0070F56BF90"/>
    <pav:lineageUri>urn:domeoserver:annotationset:75FC1225-8399-469B-AE9D-7F697713E6AC</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
    <ao:item rdf:resource="urn:domeoclient:uuid:DC71B917-C3C7-4475-B462-6525E8CEF601"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:8F11E81F-1EDB-4EA8-8E4A-47D93E06FFF2"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:6EB13D46-B414-424C-9D7C-BADA59079327"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:item rdf:resource="urn:domeoclient:uuid:312701AC-EC1C-4292-B01F-44DD40979EEA"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:68AD55C4-223A-46C6-896A-87345A781B61"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:A5A82A3B-FE45-46DE-9048-8E85995D8F43"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:C4D81A7B-4D7D-4EBA-A2C1-0E5AC4A8CE5C"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:E0EC9718-8100-4840-9F10-BFE3FC7823F2"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:24886D93-A995-41A8-9E66-1BF6DF77E9D2"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:C54A1798-BD47-4D4C-89DF-B37F5A3AB9F0"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:6F7C3F13-3AE2-43EA-93D3-9F0AF79252AC"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:CA792FCD-C812-49FE-9EDF-15DA0F056A53"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:12CCDE72-9FC0-4264-A3F2-C533F792F613"/>
    <pav:lastSavedOn>2014-07-15 17:17:25 -0400</pav:lastSavedOn>
    <ao:item rdf:resource="urn:domeoclient:uuid:DC20D454-AAA8-4A81-915D-03526B8FC40B"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:D1D92634-CB40-4585-8260-1917D2119CC7"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:29A7AD86-B18C-409C-86E9-985BFF28A757"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:BED0BB6E-5962-4714-A49A-2DB5A1787334"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:7443907B-C475-4EA4-B081-8C3D55A1EF69"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:14655D75-DC23-4E82-84C9-F40B702E4B69"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:2AAEA179-90D2-4661-9105-64A780850DEB"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:9CAD6283-FE79-428D-A3CE-B664A09583CB"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:3051A76E-96A2-4A70-91F9-A241566DEFD1"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:24229507-32A8-4A26-89C0-59655390DA1A"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:A3DBEE5E-C93B-4DBE-A1E3-317DA19FA203"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:52A12616-29C9-4323-A81B-949195D51273"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:A688F7D2-43BF-4838-A9A1-339829ADA43A"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:90386835-AD59-4BAA-A860-3003ABCAF86C"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:76E5F11A-7EC2-4412-BCB7-E9B0542040DE"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:AD757AC1-7E10-42A9-A8ED-0BD21ADA30A7"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:C66BBCCE-CA43-44FB-8D97-2084E19C48FF"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:785FFE99-34A3-41C7-A3D5-65DC60E0807D"/>
    <pav:createdOn>2014-07-15 14:02:34 -0700</pav:createdOn>
    <ao:item rdf:resource="urn:domeoclient:uuid:5C0FAFB3-9734-473A-85E5-980D1051DADD"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">4</pav:versionNumber>
    <ao:item rdf:resource="urn:domeoclient:uuid:BF8175E8-F52D-4CE3-9DE9-BAE3E2CE04A1"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/2902A8BF-91ED-45A1-915C-39CB68D197C6">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <rdfs:label>sildenafil</rdfs:label>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/136411</dailymed:activeMoietyRxCUI>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <dct:description>Referred to the drug in the interaction.</dct:description>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:7838B265-7A04-40B9-A395-37C612A69AEA">
    <pav:lineageUri>urn:domeoserver:annotation:92855478-6BBF-4E59-B790-71252579DF43</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:0F87EEF0-40A6-43E2-8222-95E7D1335A0B</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdOn>2014-07-16 15:35:39 -0700</pav:createdOn>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <ao:body rdf:nodeID="N9690a7dc558e4518abc3a25d9569abd0"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:4DC7A7E5-5253-4EB7-AEC1-2FD55FEF5068"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lastSavedOn>2014-07-16 18:38:32 -0400</pav:lastSavedOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:CC119E59-51D3-4AAE-87A1-B3FF2D690F31">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:CC119E59-51D3-4AAE-87A1-B3FF2D690F31"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <domeo:uuid></domeo:uuid>
    <pav:createdOn>2014-07-15 14:18:41 -0700</pav:createdOn>
    <domeo:uuid>CC119E59-51D3-4AAE-87A1-B3FF2D690F31</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>Risperidone</ao:exact>
    <ao:suffix> doses should be reduced in patients with liver disease [see 2 DOSAGE AND ADMINISTRATION and 5 WARNINGS AND PRECAUTIONS].</ao:suffix>
    <ao:prefix> in plasma was increased by about 35% because of the diminished concentration of both albumin and α1-acid glycoprotein. </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoserver:annotationset:0F87EEF0-40A6-43E2-8222-95E7D1335A0B">
    <domeo:agents rdf:resource="urn:person:uuid:080e143046812afe0146812ce85a0000"/>
    <pav:createdOn>2014-07-16 15:32:30 -0700</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotationset:7AE68AC7-9B47-4954-8C65-45A6F0DC80C2</pav:lineageUri>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-22.txt.html</ao:annotatesResource>
    <ao:item rdf:resource="urn:domeoclient:uuid:51D42CFA-4CB2-4B55-9EFE-A1109484AC25"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">2</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:item rdf:resource="urn:domeoclient:uuid:33ED9F46-26DA-4463-B66D-77E2995BE5C0"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
    <ao:item rdf:resource="urn:domeoclient:uuid:787C8DA7-E4FF-4344-8E03-827399F78206"/>
    <dct:description>The default set is created automatically by Domeo when no other set is existing.</dct:description>
    <permissions:permissions rdf:nodeID="Nedc4ff23db304cd084af415e92951fd4"/>
    <pav:lastSavedOn>2014-07-16 18:38:32 -0400</pav:lastSavedOn>
    <pav:previousVersion>urn:domeoclient:uuid:5C7A7116-C174-4EB1-933E-3A46CEE71709</pav:previousVersion>
    <ao:item rdf:resource="urn:domeoclient:uuid:7D975807-A259-49EC-97EB-1E0EC9EB112C"/>
    <domeo:deleted>false</domeo:deleted>
    <ao:item rdf:resource="urn:domeoclient:uuid:8A82BF7D-FCE6-4985-9C4B-E950C1124476"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:5153D183-17EE-480B-9FF3-A9FB70E3CB26"/>
    <rdfs:label>Default Set</rdfs:label>
    <ao:item rdf:resource="urn:domeoclient:uuid:7838B265-7A04-40B9-A395-37C612A69AEA"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:5A671621-83D0-48B3-B249-7E1ECC849539"/>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:977A2BC8-0744-472F-9FA2-CCF897431CA1">
    <pav:lastSavedOn>2014-07-10 11:15:41 -0700</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotation:3477E78B-51FA-46A4-B752-9494D4A66F96</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:239B4C6D-1110-4B65-AC66-F8A394187814</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:15A537D1-5648-41B2-8BFA-0D0BA3DF4393</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:DBBBAD55-D12B-4890-A2AF-85D3C85A7BEF</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:516C333C-B517-4F84-999E-51185DD6E859</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:D7826928-4C32-427A-B946-D947EB2451B5"/>
    <pav:lastSavedOn>2014-07-10 14:15:41 -0400</pav:lastSavedOn>
    <pav:createdOn>2014-07-10 11:15:15 -0700</pav:createdOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:970963DF-8BCE-4936-9DFC-328A36014E1B</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">4</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:2BFC2FB6-6BE9-4822-A245-973533533023</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotationset:BE290CA3-79BD-411A-BE2E-69AA4D19607D</pav:lineageUri>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <rdfs:label>Highlight</rdfs:label>
    <pav:previousVersion>urn:domeoserver:annotationset:3F81414E-B149-4B05-925B-18735B554A13</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoserver:annotationset:9C0B4E8B-9FFE-4E47-9B4C-A6EA4527A384">
    <ao:item rdf:resource="urn:domeoclient:uuid:C4D81A7B-4D7D-4EBA-A2C1-0E5AC4A8CE5C"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:5415B79F-FEAF-4999-A78E-2C1039116F7C"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:A1A5580F-53D7-4F22-824E-5430565EDBF1"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:8F11E81F-1EDB-4EA8-8E4A-47D93E06FFF2"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:7443907B-C475-4EA4-B081-8C3D55A1EF69"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:E2A636FF-8FE8-44E9-B454-573E4E7470FA"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:2AAEA179-90D2-4661-9105-64A780850DEB"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:A3DBEE5E-C93B-4DBE-A1E3-317DA19FA203"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:F8EED65F-31D9-41A0-9BB4-436FCBA969FA"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:D707EDCF-5B5D-4AB9-9815-32BDDA05721F"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:7130A96C-7BF2-4DBE-A880-248C420268E9"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:D1062598-B310-4CF4-8237-5F8F8F74933F"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:90386835-AD59-4BAA-A860-3003ABCAF86C"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:BED0BB6E-5962-4714-A49A-2DB5A1787334"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:785FFE99-34A3-41C7-A3D5-65DC60E0807D"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:BF8175E8-F52D-4CE3-9DE9-BAE3E2CE04A1"/>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <dct:description>The default set is created automatically by Domeo when no other set is existing.</dct:description>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046812afe0146812ce85a0000"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:446899E9-2BB7-4629-AA6E-75AF9EC38F08"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:E0EC9718-8100-4840-9F10-BFE3FC7823F2"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:1453C795-84C1-4C48-AF84-AEEE18ED1682"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:920B7836-2155-4EE5-9028-A6274B846CBA"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:BFCAC108-C978-4C7B-A79A-9887A3CA3C6C"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:C1A443CA-B8D4-4A28-825B-B97ECDEC88D7"/>
    <rdfs:label>Default Set</rdfs:label>
    <ao:item rdf:resource="urn:domeoclient:uuid:914C2061-E547-4CFD-9F3C-C0070F56BF90"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:BCC5E7E8-854A-4B02-859A-36A9EC807AF5"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:797BAFBC-5256-4C7D-9ACC-064403D70DDB"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:BB6F25A1-6FFC-4CE5-8F5F-AD5806D52477"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:7DF78E91-4010-455D-9300-16EAD7D6AB87"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:8900088E-395F-4576-960E-1B67ECCA0A65"/>
    <domeo:deleted>false</domeo:deleted>
    <pav:lastSavedOn>2014-07-15 17:19:32 -0400</pav:lastSavedOn>
    <ao:item rdf:resource="urn:domeoclient:uuid:AAA6478C-E7E4-4D30-9F06-AA094434B620"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:6FED0630-F5B3-4A05-892B-CB86D31FD6DF"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:274D4FB3-81D3-46CA-BE6A-31286B260E56"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:4CD0874F-AA43-4C04-958D-6CFBFA68EC61"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:C54A1798-BD47-4D4C-89DF-B37F5A3AB9F0"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:6EB13D46-B414-424C-9D7C-BADA59079327"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:65047D28-4B70-4701-B243-A146C45926A7"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:24886D93-A995-41A8-9E66-1BF6DF77E9D2"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:68AD55C4-223A-46C6-896A-87345A781B61"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:A5A82A3B-FE45-46DE-9048-8E85995D8F43"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:F87C43FC-DD9B-42FA-953B-C8C25AA48C91"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:6F7C3F13-3AE2-43EA-93D3-9F0AF79252AC"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:29A7AD86-B18C-409C-86E9-985BFF28A757"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:DA483938-DFFC-4F6C-85C3-FED68E6D4DE8"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:3051A76E-96A2-4A70-91F9-A241566DEFD1"/>
    <pav:createdOn>2014-07-15 14:02:34 -0700</pav:createdOn>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:annotatesResource>
    <ao:item rdf:resource="urn:domeoclient:uuid:8CA72313-3E32-44D6-A336-EDE69F22975A"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:24229507-32A8-4A26-89C0-59655390DA1A"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:A2215D32-FF99-4DC9-90B9-5C350C098EEB"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:A688F7D2-43BF-4838-A9A1-339829ADA43A"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:C025BBE5-19A7-4D05-9813-E49F4799CB23"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:71089688-5934-49A8-BBF4-07B4CAD41AA7"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:A252FD3C-4309-4CCB-8491-4B23A2848662"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:A056C491-9BB0-438A-A716-FE909F2281AD"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:9CAD6283-FE79-428D-A3CE-B664A09583CB"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:12D5CA7C-401C-4376-A246-03585C5F9AC0"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:5CE6135C-97A9-4B21-9915-11E87A1697A5"/>
    <pav:previousVersion>urn:domeoserver:annotationset:570DA392-7779-456C-9C18-1FC0E579BBE6</pav:previousVersion>
    <ao:item rdf:resource="urn:domeoclient:uuid:34A66F13-B248-4FD8-A3CE-7AAAC40B7ACC"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:ADFEE70E-EDC2-4D08-90AB-0ABAFD52BC6F"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">5</pav:versionNumber>
    <ao:item rdf:resource="urn:domeoclient:uuid:79C3BE8E-51D8-473A-AC88-0ADB7AE9D239"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:52A12616-29C9-4323-A81B-949195D51273"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:82FFD7F0-AC94-462F-BA86-70CFD849B686"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:60AE44A7-769C-4774-8E4D-7AF66A2F2EA1"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:76E5F11A-7EC2-4412-BCB7-E9B0542040DE"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:AA5B502F-CF57-4C65-81A8-140217111073"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:0A8134EE-D8E3-447B-9EB9-2CB597651AB4"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:C66BBCCE-CA43-44FB-8D97-2084E19C48FF"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:85B5BEBE-D146-414B-A979-B9CEBE9C57E6"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:318D970E-E791-465D-B650-869C74523D2C"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:C91DD2D9-B8D7-4C80-85A1-EE73345B059A"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:AD757AC1-7E10-42A9-A8ED-0BD21ADA30A7"/>
    <permissions:permissions rdf:nodeID="Nd1f535489f10490faa3c8931af14d98f"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:63FB79CC-576B-4FFD-A109-FF63DAE371C0"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
    <ao:item rdf:resource="urn:domeoclient:uuid:7CAB3CEB-53D4-45C0-BDE2-D01D9FD9219C"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:14655D75-DC23-4E82-84C9-F40B702E4B69"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:12CCDE72-9FC0-4264-A3F2-C533F792F613"/>
    <pav:lineageUri>urn:domeoserver:annotationset:75FC1225-8399-469B-AE9D-7F697713E6AC</pav:lineageUri>
    <ao:item rdf:resource="urn:domeoclient:uuid:A526C161-102B-469E-9242-8D2CB0C94450"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:51770B89-7CCF-409A-A2E9-D4576F9DB59A"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:926EB546-FC66-4BEC-B38A-18749E06CCE5"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:FDDEE9D3-D4C2-40CB-BC92-305777AFD63E"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:CA792FCD-C812-49FE-9EDF-15DA0F056A53"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:A77ED33E-10B2-43BE-8BC6-D5F14E2FE208"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:DC71B917-C3C7-4475-B462-6525E8CEF601"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:DC20D454-AAA8-4A81-915D-03526B8FC40B"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:D1D92634-CB40-4585-8260-1917D2119CC7"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:item rdf:resource="urn:domeoclient:uuid:5C0FAFB3-9734-473A-85E5-980D1051DADD"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:312701AC-EC1C-4292-B01F-44DD40979EEA"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:A4632682-84C0-4DFD-915D-D1C3B235F095"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:D2174191-CE1D-4EF2-8DD5-03008A9706DE"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:4D3BA7C7-A806-41A4-84AC-38A85FF0F9C2"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:8F4A61A4-B256-44BA-A917-3B5D6CDEEC4F">
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:32A0FE11-022B-463B-8705-7B1DFD8D84DC"/>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoserver:annotationset:5B6A462D-57EA-4BBD-87E1-A0EC2FAF5196">
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:CA792FCD-C812-49FE-9EDF-15DA0F056A53"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:29A7AD86-B18C-409C-86E9-985BFF28A757"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:D1D92634-CB40-4585-8260-1917D2119CC7"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:797BAFBC-5256-4C7D-9ACC-064403D70DDB"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:D2174191-CE1D-4EF2-8DD5-03008A9706DE"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:C4D81A7B-4D7D-4EBA-A2C1-0E5AC4A8CE5C"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:07B9E40E-C2A9-41CF-9B91-A2A057E2FB86"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:8900088E-395F-4576-960E-1B67ECCA0A65"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">8</pav:versionNumber>
    <ao:item rdf:resource="urn:domeoclient:uuid:7130A96C-7BF2-4DBE-A880-248C420268E9"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:24886D93-A995-41A8-9E66-1BF6DF77E9D2"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:A1A5580F-53D7-4F22-824E-5430565EDBF1"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:6FED0630-F5B3-4A05-892B-CB86D31FD6DF"/>
    <dct:description>The default set is created automatically by Domeo when no other set is existing.</dct:description>
    <ao:item rdf:resource="urn:domeoclient:uuid:DC71B917-C3C7-4475-B462-6525E8CEF601"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:926EB546-FC66-4BEC-B38A-18749E06CCE5"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:71089688-5934-49A8-BBF4-07B4CAD41AA7"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:5C0FAFB3-9734-473A-85E5-980D1051DADD"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:24229507-32A8-4A26-89C0-59655390DA1A"/>
    <rdfs:label>Default Set</rdfs:label>
    <ao:item rdf:resource="urn:domeoclient:uuid:A3DBEE5E-C93B-4DBE-A1E3-317DA19FA203"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:5CE6135C-97A9-4B21-9915-11E87A1697A5"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:BCC5E7E8-854A-4B02-859A-36A9EC807AF5"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:item rdf:resource="urn:domeoclient:uuid:7DF78E91-4010-455D-9300-16EAD7D6AB87"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:920B7836-2155-4EE5-9028-A6274B846CBA"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:914C2061-E547-4CFD-9F3C-C0070F56BF90"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:1453C795-84C1-4C48-AF84-AEEE18ED1682"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:BFCAC108-C978-4C7B-A79A-9887A3CA3C6C"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:C1A443CA-B8D4-4A28-825B-B97ECDEC88D7"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:BF8175E8-F52D-4CE3-9DE9-BAE3E2CE04A1"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:274D4FB3-81D3-46CA-BE6A-31286B260E56"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:446899E9-2BB7-4629-AA6E-75AF9EC38F08"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:5415B79F-FEAF-4999-A78E-2C1039116F7C"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:8CA72313-3E32-44D6-A336-EDE69F22975A"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:A688F7D2-43BF-4838-A9A1-339829ADA43A"/>
    <pav:previousVersion>urn:domeoserver:annotationset:21B0E479-04F9-4D66-B396-B773EFE53882</pav:previousVersion>
    <ao:item rdf:resource="urn:domeoclient:uuid:E3D4514F-8C2B-4E16-B53E-81B363D7FDBE"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:318D970E-E791-465D-B650-869C74523D2C"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:9CAD6283-FE79-428D-A3CE-B664A09583CB"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:ADFEE70E-EDC2-4D08-90AB-0ABAFD52BC6F"/>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:annotatesResource>
    <ao:item rdf:resource="urn:domeoclient:uuid:BED0BB6E-5962-4714-A49A-2DB5A1787334"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:34A66F13-B248-4FD8-A3CE-7AAAC40B7ACC"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:FDDEE9D3-D4C2-40CB-BC92-305777AFD63E"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:C54A1798-BD47-4D4C-89DF-B37F5A3AB9F0"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:A252FD3C-4309-4CCB-8491-4B23A2848662"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:99C27DF5-F974-4BCC-AE8D-49CE9212E9D2"/>
    <pav:lineageUri>urn:domeoserver:annotationset:75FC1225-8399-469B-AE9D-7F697713E6AC</pav:lineageUri>
    <ao:item rdf:resource="urn:domeoclient:uuid:12CCDE72-9FC0-4264-A3F2-C533F792F613"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:65047D28-4B70-4701-B243-A146C45926A7"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:68AD55C4-223A-46C6-896A-87345A781B61"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:AD757AC1-7E10-42A9-A8ED-0BD21ADA30A7"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:76294E1F-52C3-4DC1-BB56-4B5DE633DEA3"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:8F11E81F-1EDB-4EA8-8E4A-47D93E06FFF2"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:F87C43FC-DD9B-42FA-953B-C8C25AA48C91"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:A5A82A3B-FE45-46DE-9048-8E85995D8F43"/>
    <domeo:deleted>false</domeo:deleted>
    <ao:item rdf:resource="urn:domeoclient:uuid:4CD0874F-AA43-4C04-958D-6CFBFA68EC61"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:E2A636FF-8FE8-44E9-B454-573E4E7470FA"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
    <ao:item rdf:resource="urn:domeoclient:uuid:52926929-04E3-4243-A2C3-5B9100F9FBE1"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:7CAB3CEB-53D4-45C0-BDE2-D01D9FD9219C"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:A77ED33E-10B2-43BE-8BC6-D5F14E2FE208"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:A526C161-102B-469E-9242-8D2CB0C94450"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:79C3BE8E-51D8-473A-AC88-0ADB7AE9D239"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:85B5BEBE-D146-414B-A979-B9CEBE9C57E6"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:AA5B502F-CF57-4C65-81A8-140217111073"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:C91DD2D9-B8D7-4C80-85A1-EE73345B059A"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:A056C491-9BB0-438A-A716-FE909F2281AD"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:6F7C3F13-3AE2-43EA-93D3-9F0AF79252AC"/>
    <permissions:permissions rdf:nodeID="Ndbecb8efe3064bab80577ec3baa2893d"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:312701AC-EC1C-4292-B01F-44DD40979EEA"/>
    <pav:lastSavedOn>2014-07-18 18:26:08 -0400</pav:lastSavedOn>
    <ao:item rdf:resource="urn:domeoclient:uuid:DDF11329-3CD1-4391-B01E-D821B9E4C7F3"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:12D5CA7C-401C-4376-A246-03585C5F9AC0"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:82FFD7F0-AC94-462F-BA86-70CFD849B686"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:DA483938-DFFC-4F6C-85C3-FED68E6D4DE8"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:D707EDCF-5B5D-4AB9-9815-32BDDA05721F"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:0A8134EE-D8E3-447B-9EB9-2CB597651AB4"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:C66BBCCE-CA43-44FB-8D97-2084E19C48FF"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:C025BBE5-19A7-4D05-9813-E49F4799CB23"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:14655D75-DC23-4E82-84C9-F40B702E4B69"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:60AE44A7-769C-4774-8E4D-7AF66A2F2EA1"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:76E5F11A-7EC2-4412-BCB7-E9B0542040DE"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:D1062598-B310-4CF4-8237-5F8F8F74933F"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:90386835-AD59-4BAA-A860-3003ABCAF86C"/>
    <pav:createdOn>2014-07-15 14:02:34 -0700</pav:createdOn>
    <ao:item rdf:resource="urn:domeoclient:uuid:785FFE99-34A3-41C7-A3D5-65DC60E0807D"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:AAA6478C-E7E4-4D30-9F06-AA094434B620"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:48E274BA-EE97-464C-9512-861F9207381F"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:3051A76E-96A2-4A70-91F9-A241566DEFD1"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:2AAEA179-90D2-4661-9105-64A780850DEB"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:52A12616-29C9-4323-A81B-949195D51273"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:A2215D32-FF99-4DC9-90B9-5C350C098EEB"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:E0EC9718-8100-4840-9F10-BFE3FC7823F2"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:F8EED65F-31D9-41A0-9BB4-436FCBA969FA"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:6EB13D46-B414-424C-9D7C-BADA59079327"/>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046812afe0146812ce85a0000"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:A4632682-84C0-4DFD-915D-D1C3B235F095"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:7443907B-C475-4EA4-B081-8C3D55A1EF69"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:BB6F25A1-6FFC-4CE5-8F5F-AD5806D52477"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:51770B89-7CCF-409A-A2E9-D4576F9DB59A"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:63FB79CC-576B-4FFD-A109-FF63DAE371C0"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:4D3BA7C7-A806-41A4-84AC-38A85FF0F9C2"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:DC20D454-AAA8-4A81-915D-03526B8FC40B"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:25FC3270-77CF-4552-800B-3A6E31592E33">
    <ao:exact>Risperidone</ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:25FC3270-77CF-4552-800B-3A6E31592E33"/>
    <pav:createdOn>2014-07-15 14:02:44 -0700</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid></domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix> is a selective monoaminergic antagonist with high affinity (Ki of 0.12 to 7.3 nM) for the serotonin Type 2 (5HT2), dopamine Type 2 (D2), α1 and α2 adrenergic, and H1 histaminergic receptors. Risperidone acts as an antagonist at other receptors, but with</ao:suffix>
    <domeo:uuid>25FC3270-77CF-4552-800B-3A6E31592E33</domeo:uuid>
    <ao:prefix>xsd:String</ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoserver:annotationset:5758DAC0-E1C0-49EB-BE9C-56FFBAF3B6F4">
    <ao:item rdf:resource="urn:domeoclient:uuid:920B7836-2155-4EE5-9028-A6274B846CBA"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:76E5F11A-7EC2-4412-BCB7-E9B0542040DE"/>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:BFCAC108-C978-4C7B-A79A-9887A3CA3C6C"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:C66BBCCE-CA43-44FB-8D97-2084E19C48FF"/>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046812afe0146812ce85a0000"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:446899E9-2BB7-4629-AA6E-75AF9EC38F08"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:797BAFBC-5256-4C7D-9ACC-064403D70DDB"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:24886D93-A995-41A8-9E66-1BF6DF77E9D2"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:AD757AC1-7E10-42A9-A8ED-0BD21ADA30A7"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:8900088E-395F-4576-960E-1B67ECCA0A65"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:312701AC-EC1C-4292-B01F-44DD40979EEA"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:A4632682-84C0-4DFD-915D-D1C3B235F095"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:DC71B917-C3C7-4475-B462-6525E8CEF601"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:6FED0630-F5B3-4A05-892B-CB86D31FD6DF"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:A526C161-102B-469E-9242-8D2CB0C94450"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:5C0FAFB3-9734-473A-85E5-980D1051DADD"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:ADFEE70E-EDC2-4D08-90AB-0ABAFD52BC6F"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:4D3BA7C7-A806-41A4-84AC-38A85FF0F9C2"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:14655D75-DC23-4E82-84C9-F40B702E4B69"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:BCC5E7E8-854A-4B02-859A-36A9EC807AF5"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:7443907B-C475-4EA4-B081-8C3D55A1EF69"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:E2A636FF-8FE8-44E9-B454-573E4E7470FA"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:CA792FCD-C812-49FE-9EDF-15DA0F056A53"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:BF8175E8-F52D-4CE3-9DE9-BAE3E2CE04A1"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:DC20D454-AAA8-4A81-915D-03526B8FC40B"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:52A12616-29C9-4323-A81B-949195D51273"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:60AE44A7-769C-4774-8E4D-7AF66A2F2EA1"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:D1D92634-CB40-4585-8260-1917D2119CC7"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:7130A96C-7BF2-4DBE-A880-248C420268E9"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:6F7C3F13-3AE2-43EA-93D3-9F0AF79252AC"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:C54A1798-BD47-4D4C-89DF-B37F5A3AB9F0"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:12CCDE72-9FC0-4264-A3F2-C533F792F613"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:90386835-AD59-4BAA-A860-3003ABCAF86C"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:C4D81A7B-4D7D-4EBA-A2C1-0E5AC4A8CE5C"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:A1A5580F-53D7-4F22-824E-5430565EDBF1"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:785FFE99-34A3-41C7-A3D5-65DC60E0807D"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:B71CF81C-58B7-42D8-94AA-D3DE86C41757"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:68AD55C4-223A-46C6-896A-87345A781B61"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:A5A82A3B-FE45-46DE-9048-8E85995D8F43"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:A688F7D2-43BF-4838-A9A1-339829ADA43A"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:2AAEA179-90D2-4661-9105-64A780850DEB"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:C025BBE5-19A7-4D05-9813-E49F4799CB23"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:F8EED65F-31D9-41A0-9BB4-436FCBA969FA"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:29A7AD86-B18C-409C-86E9-985BFF28A757"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:9CAD6283-FE79-428D-A3CE-B664A09583CB"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:FDDEE9D3-D4C2-40CB-BC92-305777AFD63E"/>
    <pav:previousVersion>urn:domeoserver:annotationset:883587E1-49C1-4EE0-909E-4ADBAE13DD3A</pav:previousVersion>
    <ao:item rdf:resource="urn:domeoclient:uuid:BB6F25A1-6FFC-4CE5-8F5F-AD5806D52477"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:274D4FB3-81D3-46CA-BE6A-31286B260E56"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:A2215D32-FF99-4DC9-90B9-5C350C098EEB"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:AAA6478C-E7E4-4D30-9F06-AA094434B620"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:AA5B502F-CF57-4C65-81A8-140217111073"/>
    <pav:lineageUri>urn:domeoserver:annotationset:75FC1225-8399-469B-AE9D-7F697713E6AC</pav:lineageUri>
    <ao:item rdf:resource="urn:domeoclient:uuid:65047D28-4B70-4701-B243-A146C45926A7"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:926EB546-FC66-4BEC-B38A-18749E06CCE5"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:A056C491-9BB0-438A-A716-FE909F2281AD"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:12D5CA7C-401C-4376-A246-03585C5F9AC0"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:34A66F13-B248-4FD8-A3CE-7AAAC40B7ACC"/>
    <pav:createdOn>2014-07-15 14:02:34 -0700</pav:createdOn>
    <pav:lastSavedOn>2014-07-15 17:30:45 -0400</pav:lastSavedOn>
    <ao:item rdf:resource="urn:domeoclient:uuid:8F11E81F-1EDB-4EA8-8E4A-47D93E06FFF2"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:1453C795-84C1-4C48-AF84-AEEE18ED1682"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:82FFD7F0-AC94-462F-BA86-70CFD849B686"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:4CD0874F-AA43-4C04-958D-6CFBFA68EC61"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:E0EC9718-8100-4840-9F10-BFE3FC7823F2"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:79C3BE8E-51D8-473A-AC88-0ADB7AE9D239"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:0A8134EE-D8E3-447B-9EB9-2CB597651AB4"/>
    <rdfs:label>Default Set</rdfs:label>
    <ao:item rdf:resource="urn:domeoclient:uuid:52926929-04E3-4243-A2C3-5B9100F9FBE1"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:6EB13D46-B414-424C-9D7C-BADA59079327"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:5CE6135C-97A9-4B21-9915-11E87A1697A5"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:8CA72313-3E32-44D6-A336-EDE69F22975A"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:A77ED33E-10B2-43BE-8BC6-D5F14E2FE208"/>
    <domeo:deleted>false</domeo:deleted>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
    <ao:item rdf:resource="urn:domeoclient:uuid:914C2061-E547-4CFD-9F3C-C0070F56BF90"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:99C27DF5-F974-4BCC-AE8D-49CE9212E9D2"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:item rdf:resource="urn:domeoclient:uuid:5415B79F-FEAF-4999-A78E-2C1039116F7C"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:7CAB3CEB-53D4-45C0-BDE2-D01D9FD9219C"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:DA483938-DFFC-4F6C-85C3-FED68E6D4DE8"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:51770B89-7CCF-409A-A2E9-D4576F9DB59A"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:24229507-32A8-4A26-89C0-59655390DA1A"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:63FB79CC-576B-4FFD-A109-FF63DAE371C0"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:71089688-5934-49A8-BBF4-07B4CAD41AA7"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:F87C43FC-DD9B-42FA-953B-C8C25AA48C91"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:BED0BB6E-5962-4714-A49A-2DB5A1787334"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:D707EDCF-5B5D-4AB9-9815-32BDDA05721F"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:48E274BA-EE97-464C-9512-861F9207381F"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:C1A443CA-B8D4-4A28-825B-B97ECDEC88D7"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:07B9E40E-C2A9-41CF-9B91-A2A057E2FB86"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:D1062598-B310-4CF4-8237-5F8F8F74933F"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:D2174191-CE1D-4EF2-8DD5-03008A9706DE"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:7DF78E91-4010-455D-9300-16EAD7D6AB87"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:3051A76E-96A2-4A70-91F9-A241566DEFD1"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">6</pav:versionNumber>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:annotatesResource>
    <permissions:permissions rdf:nodeID="Nb2b03e5f5afb44e9aa000e94df07b912"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:E3D4514F-8C2B-4E16-B53E-81B363D7FDBE"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <dct:description>The default set is created automatically by Domeo when no other set is existing.</dct:description>
    <ao:item rdf:resource="urn:domeoclient:uuid:85B5BEBE-D146-414B-A979-B9CEBE9C57E6"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:A252FD3C-4309-4CCB-8491-4B23A2848662"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:318D970E-E791-465D-B650-869C74523D2C"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:C91DD2D9-B8D7-4C80-85A1-EE73345B059A"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:DDF11329-3CD1-4391-B01E-D821B9E4C7F3"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:A3DBEE5E-C93B-4DBE-A1E3-317DA19FA203"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:21394BF5-9EBD-45B5-A3E3-29F92CC4E65F">
    <domeo:belongsToSet>urn:domeoserver:annotationset:8DEBE5AF-B171-4BE8-880B-76A2BEE742A6</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotation:4E053C86-6FA4-447F-9766-589AB6BD0573</pav:lineageUri>
    <pav:lastSavedOn>2014-07-17 18:59:36 -0400</pav:lastSavedOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
    <pav:lastSavedOn>2014-07-17 15:59:35 -0700</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoclient:uuid:83B2E87D-3732-4699-AA3D-363A6EB95959</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:E0676820-4037-444B-AE4D-9C1ED43E28D9"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdOn>2014-07-17 15:59:21 -0700</pav:createdOn>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotationset:B716A719-3E66-4B72-87E0-370D90F3B8F7</pav:lineageUri>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:5692BCB9-DDA3-438D-9E49-F80218BB67C8">
    <domeo:belongsToSet>urn:domeoclient:uuid:83B2E87D-3732-4699-AA3D-363A6EB95959</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotationset:B716A719-3E66-4B72-87E0-370D90F3B8F7</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:8DEBE5AF-B171-4BE8-880B-76A2BEE742A6</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotation:016C3172-A9B7-430B-9EF7-92BF6E0867A5</pav:lineageUri>
    <pav:lastSavedOn>2014-07-17 18:59:36 -0400</pav:lastSavedOn>
    <pav:createdOn>2014-07-17 15:59:16 -0700</pav:createdOn>
    <pav:lastSavedOn>2014-07-17 15:59:35 -0700</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:2FC3C7A5-C738-4ED9-8908-673E98D7C9CB"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoserver:annotationset:80304B91-FB8B-4EF5-87EC-80F59A689F2A">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <pav:previousVersion>urn:domeoserver:annotationset:88784842-2713-4D3B-A293-A9498ACCA54A</pav:previousVersion>
    <ao:item rdf:resource="urn:domeoclient:uuid:1FD70F7A-986E-48F8-93F4-DA3377C3E107"/>
    <rdfs:label>Default Set</rdfs:label>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-13.txt.html</ao:annotatesResource>
    <ao:item rdf:resource="urn:domeoclient:uuid:05BFE4D9-CD9B-4F44-B4A5-28A1E4F90000"/>
    <permissions:permissions rdf:nodeID="N0d649a3d31fb487a9e4a022b6c3336d5"/>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">3</pav:versionNumber>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046812afe0146812ce85a0000"/>
    <pav:lastSavedOn>2014-07-09 16:57:52 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
    <pav:lineageUri>urn:domeoserver:annotationset:2C25A7F3-8A42-4060-A64C-5C2AB24D4675</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:deleted>false</domeo:deleted>
    <ao:item rdf:resource="urn:domeoclient:uuid:52C23FEF-CB29-459B-934E-EDA40F63DD1E"/>
    <dct:description>The default set is created automatically by Domeo when no other set is existing.</dct:description>
    <pav:createdOn>2014-07-09 13:36:31 -0700</pav:createdOn>
    <ao:item rdf:resource="urn:domeoclient:uuid:BE8D3AAD-5714-40E9-8521-B30676F883D5"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:E0EC9718-8100-4840-9F10-BFE3FC7823F2">
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E8194531-C5B3-43AE-BC13-14A252C54824</domeo:belongsToSet>
    <pav:previousVersion>urn:domeoserver:annotationset:2E5CE73B-BFD4-4E35-9A07-D5E37A9E87AE</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:0846F768-2376-4051-A905-427746D087A6"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">4</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotationset:75FC1225-8399-469B-AE9D-7F697713E6AC</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoserver:annotationset:46636445-93A2-49F0-9E9C-5AEBF17046D2</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:570DA392-7779-456C-9C18-1FC0E579BBE6</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:5758DAC0-E1C0-49EB-BE9C-56FFBAF3B6F4</domeo:belongsToSet>
    <pav:createdOn>2014-07-15 14:15:37 -0700</pav:createdOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
    <domeo:belongsToSet>urn:domeoserver:annotationset:5B6A462D-57EA-4BBD-87E1-A0EC2FAF5196</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E6A1493E-98EE-4FDE-9301-752AB8E3453F</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:883587E1-49C1-4EE0-909E-4ADBAE13DD3A</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-15 17:17:26 -0400</pav:lastSavedOn>
    <pav:lastSavedOn>2014-07-15 14:17:25 -0700</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9C0B4E8B-9FFE-4E47-9B4C-A6EA4527A384</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotation:91A94FFA-DA30-4BA1-95DC-9FE583CF190E</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:21B0E479-04F9-4D66-B396-B773EFE53882</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:3776F388-42AA-4941-B8F9-416DFC230546">
    <pav:lineageUri>urn:domeoserver:annotation:036BDAF2-5EB1-43A8-9A15-54EECB844D12</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E3DA2E5E-FC19-4C22-AF6C-A9CB4B450554</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lastSavedOn>2014-07-16 18:40:55 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
    <pav:lastSavedOn>2014-07-16 15:40:55 -0700</pav:lastSavedOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoclient:uuid:98DABE9A-9F89-4DF9-9DEE-B6853D1F5CC1</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <ao:context rdf:resource="urn:domeoclient:uuid:6501B61D-9F1D-47DB-B93C-A2B799BFACF1"/>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdOn>2014-07-16 15:39:46 -0700</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:F77BE7E4-398E-4B73-9848-3A5055B88BD4">
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
    <pav:createdOn>2014-07-16 14:03:22 -0700</pav:createdOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:316356DA-5EB5-42EB-9878-F3A3E1BDA4E9"/>
    <domeo:belongsToSet>urn:domeoclient:uuid:8C39EA63-3E52-40B4-8935-6ADC75CCA74D</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotation:172620B0-F20C-491D-A7F8-F2C65B3B75A5</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:AD2FD8CD-1032-462E-833D-451021CE67B2</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-16 14:06:30 -0700</pav:lastSavedOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lastSavedOn>2014-07-16 17:06:30 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:C2A39432-076D-421D-8007-22690EDA5A0C</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:B3F0B84F-756D-4724-B177-98D0D290D00D</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:0E27FBCC-C6F8-42FB-A7DC-B9AA486D3D4F">
    <ao:prefix> rapidly into </ao:prefix>
    <ao:exact>9-hydroxyrisperidone</ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2014-07-15 14:14:47 -0700</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix>, whereas poor CYP 2D6 metabolizers convert it much more slowly. Although extensive metabolizers have lower risperidone and higher 9-hydroxyrisperidone concentrations than poor metabolizers, the pharmacokinetics of risperidone and 9-hydroxyrisperidone co</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:0E27FBCC-C6F8-42FB-A7DC-B9AA486D3D4F"/>
    <domeo:uuid></domeo:uuid>
    <domeo:uuid>0E27FBCC-C6F8-42FB-A7DC-B9AA486D3D4F</domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:6F7C3F13-3AE2-43EA-93D3-9F0AF79252AC">
    <rdfs:label>Highlight</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotationset:75FC1225-8399-469B-AE9D-7F697713E6AC</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">2</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9C0B4E8B-9FFE-4E47-9B4C-A6EA4527A384</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-15 17:07:57 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotation:AE493A1B-E5A5-43D2-B401-59B7DE1A6723</pav:lineageUri>
    <pav:lineageUri>urn:domeoserver:annotation:6134D218-52FE-43B8-B2E4-27FF38188FD3</pav:lineageUri>
    <pav:lastSavedOn>2014-07-15 17:07:58 -0400</pav:lastSavedOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoserver:annotationset:2E5CE73B-BFD4-4E35-9A07-D5E37A9E87AE</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E6A1493E-98EE-4FDE-9301-752AB8E3453F</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:1575950D-32D4-46DE-A44F-8E9E614F997F</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:570DA392-7779-456C-9C18-1FC0E579BBE6</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:5758DAC0-E1C0-49EB-BE9C-56FFBAF3B6F4</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:previousVersion>urn:domeoclient:uuid:9B307D8B-D2B0-4795-8850-FAAAAC6B5AF4</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:21B0E479-04F9-4D66-B396-B773EFE53882</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:46636445-93A2-49F0-9E9C-5AEBF17046D2</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:D4B04F76-068F-4446-8605-4EDC1E4CB4F3"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:883587E1-49C1-4EE0-909E-4ADBAE13DD3A</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:5B6A462D-57EA-4BBD-87E1-A0EC2FAF5196</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E8194531-C5B3-43AE-BC13-14A252C54824</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-15 14:07:58 -0700</pav:lastSavedOn>
    <pav:createdOn>2014-07-15 14:07:21 -0700</pav:createdOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:FA8D1DAC-C616-456C-BB3D-29F18DED21A1</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:882C3E53-3401-4418-9864-3D34134F9C86">
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-13.txt.html</ao:hasSource>
    <ao:exact>In a placebo-controlled trial in normal volunteers, the administration of two doses of sertraline did not significantly alter steady-state lithium levels or the renal clearance of lithium</ao:exact>
    <domeo:uuid>882C3E53-3401-4418-9864-3D34134F9C86</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:882C3E53-3401-4418-9864-3D34134F9C86"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2014-07-09 13:57:34 -0700</pav:createdOn>
    <ao:suffix>xsd:String</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix>xsd:String</ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/838C89BB-67FF-4BA3-AE73-A11A7721AFAE">
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <rdfs:label>warfarin</rdfs:label>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/11289</dailymed:activeMoietyRxCUI>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:5D12662E-B4E8-4D82-82D8-C7038995144A">
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-50.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:5D12662E-B4E8-4D82-82D8-C7038995144A"/>
    <domeo:uuid>5D12662E-B4E8-4D82-82D8-C7038995144A</domeo:uuid>
    <ao:suffix>. If anticholinergic effects are seen, the dose of</ao:suffix>
    <ao:exact>Daily oral dosing of immediate-release paroxetine (30 mg once daily) increased steady-state AUC0-24, Cmax, and Cmin values of procyclidine (5 mg oral once daily) by 35%, 37%, and 67%, respectively, compared to procyclidine alone at steady state</ao:exact>
    <pav:createdOn>2014-07-18 14:22:23 -0700</pav:createdOn>
    <ao:prefix>xsd:String</ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoserver:annotationset:E6A1493E-98EE-4FDE-9301-752AB8E3453F">
    <ao:item rdf:resource="urn:domeoclient:uuid:312701AC-EC1C-4292-B01F-44DD40979EEA"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:C1A443CA-B8D4-4A28-825B-B97ECDEC88D7"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:AA5B502F-CF57-4C65-81A8-140217111073"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:A2215D32-FF99-4DC9-90B9-5C350C098EEB"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:4D3BA7C7-A806-41A4-84AC-38A85FF0F9C2"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:1453C795-84C1-4C48-AF84-AEEE18ED1682"/>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046812afe0146812ce85a0000"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:9CAD6283-FE79-428D-A3CE-B664A09583CB"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:B71CF81C-58B7-42D8-94AA-D3DE86C41757"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:F8EED65F-31D9-41A0-9BB4-436FCBA969FA"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:C025BBE5-19A7-4D05-9813-E49F4799CB23"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:BED0BB6E-5962-4714-A49A-2DB5A1787334"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:2AAEA179-90D2-4661-9105-64A780850DEB"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:A688F7D2-43BF-4838-A9A1-339829ADA43A"/>
    <pav:lineageUri>urn:domeoserver:annotationset:75FC1225-8399-469B-AE9D-7F697713E6AC</pav:lineageUri>
    <ao:item rdf:resource="urn:domeoclient:uuid:A5A82A3B-FE45-46DE-9048-8E85995D8F43"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:68AD55C4-223A-46C6-896A-87345A781B61"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:8CA72313-3E32-44D6-A336-EDE69F22975A"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:785FFE99-34A3-41C7-A3D5-65DC60E0807D"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:A1A5580F-53D7-4F22-824E-5430565EDBF1"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:5415B79F-FEAF-4999-A78E-2C1039116F7C"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:90386835-AD59-4BAA-A860-3003ABCAF86C"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:12CCDE72-9FC0-4264-A3F2-C533F792F613"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:C54A1798-BD47-4D4C-89DF-B37F5A3AB9F0"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:6F7C3F13-3AE2-43EA-93D3-9F0AF79252AC"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:7130A96C-7BF2-4DBE-A880-248C420268E9"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:65047D28-4B70-4701-B243-A146C45926A7"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:D1D92634-CB40-4585-8260-1917D2119CC7"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:DC20D454-AAA8-4A81-915D-03526B8FC40B"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:CA792FCD-C812-49FE-9EDF-15DA0F056A53"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:7443907B-C475-4EA4-B081-8C3D55A1EF69"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:6EB13D46-B414-424C-9D7C-BADA59079327"/>
    <pav:createdOn>2014-07-15 14:02:34 -0700</pav:createdOn>
    <ao:item rdf:resource="urn:domeoclient:uuid:A4632682-84C0-4DFD-915D-D1C3B235F095"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">6</pav:versionNumber>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <domeo:deleted>false</domeo:deleted>
    <ao:item rdf:resource="urn:domeoclient:uuid:274D4FB3-81D3-46CA-BE6A-31286B260E56"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:E2A636FF-8FE8-44E9-B454-573E4E7470FA"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:5C0FAFB3-9734-473A-85E5-980D1051DADD"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:A526C161-102B-469E-9242-8D2CB0C94450"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:6FED0630-F5B3-4A05-892B-CB86D31FD6DF"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:DC71B917-C3C7-4475-B462-6525E8CEF601"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:7CAB3CEB-53D4-45C0-BDE2-D01D9FD9219C"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:8900088E-395F-4576-960E-1B67ECCA0A65"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:BB6F25A1-6FFC-4CE5-8F5F-AD5806D52477"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:24886D93-A995-41A8-9E66-1BF6DF77E9D2"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:797BAFBC-5256-4C7D-9ACC-064403D70DDB"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:446899E9-2BB7-4629-AA6E-75AF9EC38F08"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:29A7AD86-B18C-409C-86E9-985BFF28A757"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:BF8175E8-F52D-4CE3-9DE9-BAE3E2CE04A1"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:C66BBCCE-CA43-44FB-8D97-2084E19C48FF"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:BFCAC108-C978-4C7B-A79A-9887A3CA3C6C"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:76E5F11A-7EC2-4412-BCB7-E9B0542040DE"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:51770B89-7CCF-409A-A2E9-D4576F9DB59A"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:920B7836-2155-4EE5-9028-A6274B846CBA"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:item rdf:resource="urn:domeoclient:uuid:A3DBEE5E-C93B-4DBE-A1E3-317DA19FA203"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:DDF11329-3CD1-4391-B01E-D821B9E4C7F3"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:AD757AC1-7E10-42A9-A8ED-0BD21ADA30A7"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:C91DD2D9-B8D7-4C80-85A1-EE73345B059A"/>
    <dct:description>The default set is created automatically by Domeo when no other set is existing.</dct:description>
    <ao:item rdf:resource="urn:domeoclient:uuid:318D970E-E791-465D-B650-869C74523D2C"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:A252FD3C-4309-4CCB-8491-4B23A2848662"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:85B5BEBE-D146-414B-A979-B9CEBE9C57E6"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:60AE44A7-769C-4774-8E4D-7AF66A2F2EA1"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:14655D75-DC23-4E82-84C9-F40B702E4B69"/>
    <rdfs:label>Default Set</rdfs:label>
    <ao:item rdf:resource="urn:domeoclient:uuid:E3D4514F-8C2B-4E16-B53E-81B363D7FDBE"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:52A12616-29C9-4323-A81B-949195D51273"/>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:annotatesResource>
    <ao:item rdf:resource="urn:domeoclient:uuid:ADFEE70E-EDC2-4D08-90AB-0ABAFD52BC6F"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:3051A76E-96A2-4A70-91F9-A241566DEFD1"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:D2174191-CE1D-4EF2-8DD5-03008A9706DE"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:D1062598-B310-4CF4-8237-5F8F8F74933F"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:07B9E40E-C2A9-41CF-9B91-A2A057E2FB86"/>
    <pav:lastSavedOn>2014-07-15 17:30:43 -0400</pav:lastSavedOn>
    <ao:item rdf:resource="urn:domeoclient:uuid:D707EDCF-5B5D-4AB9-9815-32BDDA05721F"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:F87C43FC-DD9B-42FA-953B-C8C25AA48C91"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
    <ao:item rdf:resource="urn:domeoclient:uuid:E0EC9718-8100-4840-9F10-BFE3FC7823F2"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:79C3BE8E-51D8-473A-AC88-0ADB7AE9D239"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:24229507-32A8-4A26-89C0-59655390DA1A"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:48E274BA-EE97-464C-9512-861F9207381F"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:914C2061-E547-4CFD-9F3C-C0070F56BF90"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:DA483938-DFFC-4F6C-85C3-FED68E6D4DE8"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:63FB79CC-576B-4FFD-A109-FF63DAE371C0"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:99C27DF5-F974-4BCC-AE8D-49CE9212E9D2"/>
    <permissions:permissions rdf:nodeID="Nccb0c3ea034845dd966c4f33629f76a6"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:926EB546-FC66-4BEC-B38A-18749E06CCE5"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:C4D81A7B-4D7D-4EBA-A2C1-0E5AC4A8CE5C"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:A77ED33E-10B2-43BE-8BC6-D5F14E2FE208"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:7DF78E91-4010-455D-9300-16EAD7D6AB87"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:5CE6135C-97A9-4B21-9915-11E87A1697A5"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:52926929-04E3-4243-A2C3-5B9100F9FBE1"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:0A8134EE-D8E3-447B-9EB9-2CB597651AB4"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:BCC5E7E8-854A-4B02-859A-36A9EC807AF5"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:FDDEE9D3-D4C2-40CB-BC92-305777AFD63E"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:AAA6478C-E7E4-4D30-9F06-AA094434B620"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:4CD0874F-AA43-4C04-958D-6CFBFA68EC61"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:82FFD7F0-AC94-462F-BA86-70CFD849B686"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:8F11E81F-1EDB-4EA8-8E4A-47D93E06FFF2"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:34A66F13-B248-4FD8-A3CE-7AAAC40B7ACC"/>
    <pav:previousVersion>urn:domeoserver:annotationset:883587E1-49C1-4EE0-909E-4ADBAE13DD3A</pav:previousVersion>
    <ao:item rdf:resource="urn:domeoclient:uuid:12D5CA7C-401C-4376-A246-03585C5F9AC0"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:A056C491-9BB0-438A-A716-FE909F2281AD"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:71089688-5934-49A8-BBF4-07B4CAD41AA7"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:69BEBC8E-741D-4841-BCB0-771651B22677">
    <domeo:uuid></domeo:uuid>
    <ao:suffix>could be subject to two kinds of drug-drug interactions. First, inhibitors of CYP 2D6 interfere with conversion of risperidone to 9-hydroxyrisperidone [see 7 DRUG INTERACTIONS]. This occurs with quinidine, giving essentially all recipients a risperidone </ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:69BEBC8E-741D-4841-BCB0-771651B22677"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2014-07-15 14:15:18 -0700</pav:createdOn>
    <ao:prefix>xsd:String</ao:prefix>
    <ao:exact>Risperidone </ao:exact>
    <domeo:uuid>69BEBC8E-741D-4841-BCB0-771651B22677</domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:D166220A-E6E2-4ECF-B03B-AF573EEAE31B">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:D166220A-E6E2-4ECF-B03B-AF573EEAE31B"/>
    <ao:exact>sildenafil</ao:exact>
    <pav:createdOn>2014-07-10 11:20:24 -0700</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix> (80 mg tid) bioavailability due to co-administration of epoprostenol was 28%, resulting in about 22% lower mean average steady state concentrations. Therefore, the slight decrease of sildenafil exposure in the presence of epoprostenol is not considered </ao:suffix>
    <domeo:uuid>D166220A-E6E2-4ECF-B03B-AF573EEAE31B</domeo:uuid>
    <ao:prefix>The mean reduction of </ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:7F8B9524-4C64-4996-BBA7-9A2CED8F6A99">
    <ao:prefix> to</ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:7F8B9524-4C64-4996-BBA7-9A2CED8F6A99"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix> [see 7 DRUG INTERACTIONS]. This occurs with quinidine, giving essentially all recipients a risperidone pharmacokinetic profile typical of poor metabolizers. The therapeutic benefits and adverse effects of risperidone in patients receiving quinidine have</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <ao:exact> 9-hydroxyrisperidone</ao:exact>
    <domeo:uuid></domeo:uuid>
    <pav:createdOn>2014-07-15 14:15:32 -0700</pav:createdOn>
    <domeo:uuid>7F8B9524-4C64-4996-BBA7-9A2CED8F6A99</domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoserver:annotationset:21B0E479-04F9-4D66-B396-B773EFE53882">
    <ao:item rdf:resource="urn:domeoclient:uuid:797BAFBC-5256-4C7D-9ACC-064403D70DDB"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:14655D75-DC23-4E82-84C9-F40B702E4B69"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:BCC5E7E8-854A-4B02-859A-36A9EC807AF5"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:3051A76E-96A2-4A70-91F9-A241566DEFD1"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:BED0BB6E-5962-4714-A49A-2DB5A1787334"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:8900088E-395F-4576-960E-1B67ECCA0A65"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:312701AC-EC1C-4292-B01F-44DD40979EEA"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:A4632682-84C0-4DFD-915D-D1C3B235F095"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:920B7836-2155-4EE5-9028-A6274B846CBA"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:A526C161-102B-469E-9242-8D2CB0C94450"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">7</pav:versionNumber>
    <ao:item rdf:resource="urn:domeoclient:uuid:85B5BEBE-D146-414B-A979-B9CEBE9C57E6"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:BFCAC108-C978-4C7B-A79A-9887A3CA3C6C"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:C66BBCCE-CA43-44FB-8D97-2084E19C48FF"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:12CCDE72-9FC0-4264-A3F2-C533F792F613"/>
    <domeo:deleted>false</domeo:deleted>
    <ao:item rdf:resource="urn:domeoclient:uuid:C91DD2D9-B8D7-4C80-85A1-EE73345B059A"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:A3DBEE5E-C93B-4DBE-A1E3-317DA19FA203"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:51770B89-7CCF-409A-A2E9-D4576F9DB59A"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:76294E1F-52C3-4DC1-BB56-4B5DE633DEA3"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:DC71B917-C3C7-4475-B462-6525E8CEF601"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:ADFEE70E-EDC2-4D08-90AB-0ABAFD52BC6F"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:CA792FCD-C812-49FE-9EDF-15DA0F056A53"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:A5A82A3B-FE45-46DE-9048-8E85995D8F43"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:5C0FAFB3-9734-473A-85E5-980D1051DADD"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:D1D92634-CB40-4585-8260-1917D2119CC7"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:8CA72313-3E32-44D6-A336-EDE69F22975A"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:7CAB3CEB-53D4-45C0-BDE2-D01D9FD9219C"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:BF8175E8-F52D-4CE3-9DE9-BAE3E2CE04A1"/>
    <permissions:permissions rdf:nodeID="N6f77e491b4c042cfb1923d40cdb14b9a"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:90386835-AD59-4BAA-A860-3003ABCAF86C"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:9CAD6283-FE79-428D-A3CE-B664A09583CB"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:24886D93-A995-41A8-9E66-1BF6DF77E9D2"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:AD757AC1-7E10-42A9-A8ED-0BD21ADA30A7"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:785FFE99-34A3-41C7-A3D5-65DC60E0807D"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:B71CF81C-58B7-42D8-94AA-D3DE86C41757"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:79C3BE8E-51D8-473A-AC88-0ADB7AE9D239"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:A688F7D2-43BF-4838-A9A1-339829ADA43A"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:2AAEA179-90D2-4661-9105-64A780850DEB"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:29A7AD86-B18C-409C-86E9-985BFF28A757"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:6F7C3F13-3AE2-43EA-93D3-9F0AF79252AC"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:F8EED65F-31D9-41A0-9BB4-436FCBA969FA"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:C4D81A7B-4D7D-4EBA-A2C1-0E5AC4A8CE5C"/>
    <dct:description>The default set is created automatically by Domeo when no other set is existing.</dct:description>
    <ao:item rdf:resource="urn:domeoclient:uuid:7443907B-C475-4EA4-B081-8C3D55A1EF69"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:68AD55C4-223A-46C6-896A-87345A781B61"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:1453C795-84C1-4C48-AF84-AEEE18ED1682"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:274D4FB3-81D3-46CA-BE6A-31286B260E56"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:FDDEE9D3-D4C2-40CB-BC92-305777AFD63E"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:item rdf:resource="urn:domeoclient:uuid:AA5B502F-CF57-4C65-81A8-140217111073"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:AAA6478C-E7E4-4D30-9F06-AA094434B620"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:D2174191-CE1D-4EF2-8DD5-03008A9706DE"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:C54A1798-BD47-4D4C-89DF-B37F5A3AB9F0"/>
    <pav:previousVersion>urn:domeoserver:annotationset:46636445-93A2-49F0-9E9C-5AEBF17046D2</pav:previousVersion>
    <ao:item rdf:resource="urn:domeoclient:uuid:5CE6135C-97A9-4B21-9915-11E87A1697A5"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:12D5CA7C-401C-4376-A246-03585C5F9AC0"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:7DF78E91-4010-455D-9300-16EAD7D6AB87"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:A1A5580F-53D7-4F22-824E-5430565EDBF1"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:A2215D32-FF99-4DC9-90B9-5C350C098EEB"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:8F11E81F-1EDB-4EA8-8E4A-47D93E06FFF2"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:914C2061-E547-4CFD-9F3C-C0070F56BF90"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:C025BBE5-19A7-4D05-9813-E49F4799CB23"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:C1A443CA-B8D4-4A28-825B-B97ECDEC88D7"/>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046812afe0146812ce85a0000"/>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:63FB79CC-576B-4FFD-A109-FF63DAE371C0"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:82FFD7F0-AC94-462F-BA86-70CFD849B686"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:99C27DF5-F974-4BCC-AE8D-49CE9212E9D2"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:E0EC9718-8100-4840-9F10-BFE3FC7823F2"/>
    <pav:lineageUri>urn:domeoserver:annotationset:75FC1225-8399-469B-AE9D-7F697713E6AC</pav:lineageUri>
    <pav:lastSavedOn>2014-07-15 17:32:08 -0400</pav:lastSavedOn>
    <ao:item rdf:resource="urn:domeoclient:uuid:0A8134EE-D8E3-447B-9EB9-2CB597651AB4"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:7130A96C-7BF2-4DBE-A880-248C420268E9"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:6EB13D46-B414-424C-9D7C-BADA59079327"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:07B9E40E-C2A9-41CF-9B91-A2A057E2FB86"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:A056C491-9BB0-438A-A716-FE909F2281AD"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:48E274BA-EE97-464C-9512-861F9207381F"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:4D3BA7C7-A806-41A4-84AC-38A85FF0F9C2"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:34A66F13-B248-4FD8-A3CE-7AAAC40B7ACC"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:A77ED33E-10B2-43BE-8BC6-D5F14E2FE208"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:4CD0874F-AA43-4C04-958D-6CFBFA68EC61"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:D707EDCF-5B5D-4AB9-9815-32BDDA05721F"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:A252FD3C-4309-4CCB-8491-4B23A2848662"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:52926929-04E3-4243-A2C3-5B9100F9FBE1"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:DA483938-DFFC-4F6C-85C3-FED68E6D4DE8"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:D1062598-B310-4CF4-8237-5F8F8F74933F"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:DC20D454-AAA8-4A81-915D-03526B8FC40B"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:DDF11329-3CD1-4391-B01E-D821B9E4C7F3"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:65047D28-4B70-4701-B243-A146C45926A7"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:24229507-32A8-4A26-89C0-59655390DA1A"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
    <ao:item rdf:resource="urn:domeoclient:uuid:F87C43FC-DD9B-42FA-953B-C8C25AA48C91"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:76E5F11A-7EC2-4412-BCB7-E9B0542040DE"/>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:annotatesResource>
    <ao:item rdf:resource="urn:domeoclient:uuid:60AE44A7-769C-4774-8E4D-7AF66A2F2EA1"/>
    <pav:createdOn>2014-07-15 14:02:34 -0700</pav:createdOn>
    <ao:item rdf:resource="urn:domeoclient:uuid:446899E9-2BB7-4629-AA6E-75AF9EC38F08"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:5415B79F-FEAF-4999-A78E-2C1039116F7C"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:71089688-5934-49A8-BBF4-07B4CAD41AA7"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:52A12616-29C9-4323-A81B-949195D51273"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:E3D4514F-8C2B-4E16-B53E-81B363D7FDBE"/>
    <rdfs:label>Default Set</rdfs:label>
    <ao:item rdf:resource="urn:domeoclient:uuid:E2A636FF-8FE8-44E9-B454-573E4E7470FA"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:6FED0630-F5B3-4A05-892B-CB86D31FD6DF"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:926EB546-FC66-4BEC-B38A-18749E06CCE5"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:318D970E-E791-465D-B650-869C74523D2C"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:BB6F25A1-6FFC-4CE5-8F5F-AD5806D52477"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:A96A53F5-6219-428F-A3F8-43699BB234C3">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:A96A53F5-6219-428F-A3F8-43699BB234C3"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>tolbutamide</ao:exact>
    <ao:prefix>In 13 normal male volunteers, there was significant increase in </ao:prefix>
    <domeo:uuid>A96A53F5-6219-428F-A3F8-43699BB234C3</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2014-07-18 14:07:10 -0700</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-29.txt.html</ao:hasSource>
    <ao:suffix> (500 mg single dose) AUC and Cmax following the administration of fluconazole. There was a mean ± SD increase in tolbutamide AUC of 26% ± 9% (range: 12 to 39%). Tolbutamide Cmax increased 11% ± 9% (range: -6 to 27%). (See PRECAUTIONS.)</ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:ABA0CCF3-E252-4C23-B881-D2E2AF418E6C">
    <pav:lineageUri>urn:domeoserver:annotation:950496C8-FA45-45AE-88FA-D996FB45EC0A</pav:lineageUri>
    <pav:createdOn>2014-07-10 11:20:15 -0700</pav:createdOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
    <domeo:belongsToSet>urn:domeoserver:annotationset:15A537D1-5648-41B2-8BFA-0D0BA3DF4393</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lastSavedOn>2014-07-10 11:21:41 -0700</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:970963DF-8BCE-4936-9DFC-328A36014E1B</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">6</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:516C333C-B517-4F84-999E-51185DD6E859</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:540A603C-5624-405F-9660-D636865AE01B"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:239B4C6D-1110-4B65-AC66-F8A394187814</domeo:belongsToSet>
    <pav:previousVersion>urn:domeoserver:annotationset:2BFC2FB6-6BE9-4822-A245-973533533023</pav:previousVersion>
    <pav:lastSavedOn>2014-07-10 14:21:41 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotationset:BE290CA3-79BD-411A-BE2E-69AA4D19607D</pav:lineageUri>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/971F6D08-1DD4-4857-AFE6-8AC2A827166E">
    <rdfs:label>sulfamethazine</rdfs:label>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:34A66F13-B248-4FD8-A3CE-7AAAC40B7ACC">
    <domeo:belongsToSet>urn:domeoserver:annotationset:1575950D-32D4-46DE-A44F-8E9E614F997F</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:5758DAC0-E1C0-49EB-BE9C-56FFBAF3B6F4</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
    <domeo:belongsToSet>urn:domeoserver:annotationset:46636445-93A2-49F0-9E9C-5AEBF17046D2</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E8194531-C5B3-43AE-BC13-14A252C54824</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotation:721C9E88-0020-4AC2-A50B-73CE1E69EED9</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9C0B4E8B-9FFE-4E47-9B4C-A6EA4527A384</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:883587E1-49C1-4EE0-909E-4ADBAE13DD3A</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-15 17:07:57 -0400</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">2</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotationset:75FC1225-8399-469B-AE9D-7F697713E6AC</pav:lineageUri>
    <ao:context rdf:resource="urn:domeoclient:uuid:75D8DE94-F5D4-4DC6-BC3F-9344C057C003"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:5B6A462D-57EA-4BBD-87E1-A0EC2FAF5196</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:570DA392-7779-456C-9C18-1FC0E579BBE6</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-15 17:07:58 -0400</pav:lastSavedOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdOn>2014-07-15 14:07:26 -0700</pav:createdOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E6A1493E-98EE-4FDE-9301-752AB8E3453F</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:FA8D1DAC-C616-456C-BB3D-29F18DED21A1</domeo:belongsToSet>
    <pav:previousVersion>urn:domeoclient:uuid:9B307D8B-D2B0-4795-8850-FAAAAC6B5AF4</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:2E5CE73B-BFD4-4E35-9A07-D5E37A9E87AE</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:21B0E479-04F9-4D66-B396-B773EFE53882</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lastSavedOn>2014-07-15 14:07:58 -0700</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotation:CAF52307-F302-4111-A840-507254115DAB</pav:lineageUri>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:32208944-92E0-40BE-AA45-03DC0663A09C">
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
    <domeo:belongsToSet>urn:domeoserver:annotationset:970963DF-8BCE-4936-9DFC-328A36014E1B</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:3F81414E-B149-4B05-925B-18735B554A13</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:DBBBAD55-D12B-4890-A2AF-85D3C85A7BEF</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:3A31AA07-7919-4161-9DEB-01C06D730BF5"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:2BFC2FB6-6BE9-4822-A245-973533533023</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:239B4C6D-1110-4B65-AC66-F8A394187814</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:516C333C-B517-4F84-999E-51185DD6E859</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-10 11:14:30 -0700</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:15A537D1-5648-41B2-8BFA-0D0BA3DF4393</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lastSavedOn>2014-07-10 14:14:30 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotation:7BF5554D-4C3C-4CBD-A76D-4F6E34BF997A</pav:lineageUri>
    <pav:createdOn>2014-07-10 11:10:53 -0700</pav:createdOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N7f0784cce2494edfa265d44e58e5bbd2">
    <domeo:sets rdf:resource="urn:pddi:uuid:49AC02A4-8391-4B23-ADA4-A757C853CF17"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:6395774E-A61F-4CC3-AC03-4A9A97F402CB">
    <ao:context rdf:resource="urn:domeoclient:uuid:1EC63B9B-4ECA-4533-97EA-FF3CFF05DB75"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lineageUri>urn:domeoserver:annotationset:C8D7FDC6-6816-4BD4-BC7F-88ABDCC37D79</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoserver:annotationset:DA8D6B42-B41F-4576-BF10-1285DF3EAB80</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoserver:annotationset:6FFFF211-BFDC-4E16-968C-A296868530C4</domeo:belongsToSet>
    <pav:createdOn>2014-07-16 10:18:44 -0700</pav:createdOn>
    <pav:lastSavedOn>2014-07-16 10:20:50 -0700</pav:lastSavedOn>
    <pav:lastSavedOn>2014-07-16 13:20:50 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:AAD02A4C-E01E-4C82-BC8A-D0F4639844FA</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoclient:uuid:2F716A41-B68F-48AE-B5C1-E31F1704C565</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
    <pav:lineageUri>urn:domeoserver:annotation:1022E548-5EB9-4235-83BA-8461C493CCC9</pav:lineageUri>
    <pav:previousVersion>xsd:String</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N56feba46f95c4035af532037d678420d">
    <permissions:isLocked>false</permissions:isLocked>
    <permissions:accessType>urn:domeo:access:public</permissions:accessType>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:75FA9873-2FCB-4682-B059-2B0DDAB0A8C0">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2014-07-17 15:59:27 -0700</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>			http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-24.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:75FA9873-2FCB-4682-B059-2B0DDAB0A8C0"/>
    <ao:suffix> increased 32% ± 17% (range: 16 to 72%). Fluconazole half-life decreased from 33.4 ± 4.4 hours to 26.8 ± 3.9 hours. (See PRECAUTIONS.)</ao:suffix>
    <domeo:uuid>75FA9873-2FCB-4682-B059-2B0DDAB0A8C0</domeo:uuid>
    <ao:prefix> AUC of 23% ± 9% (range: -13 to -42%). Apparent oral clearance of </ao:prefix>
    <ao:exact>fluconazole</ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:17162313-6A55-4157-B495-83AA9CF1A26A">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:7BA312DF-BB65-4A90-8B7D-A54425D7C553</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lastSavedOn>2014-07-18 17:20:41 -0400</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
    <pav:createdOn>2014-07-18 14:20:39 -0700</pav:createdOn>
    <rdfs:label>Highlight</rdfs:label>
    <ao:context rdf:resource="urn:domeoclient:uuid:11E6A1FA-CF90-4170-B074-E4E3C8C8288D"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoclient:uuid:51A184F8-19CA-4489-AB8F-9AF92E4BE5BE</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotation:EA8D5F54-A19D-4740-9097-EC5D5ED348F2</pav:lineageUri>
    <pav:lastSavedOn>2014-07-18 14:20:41 -0700</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotationset:1EE1D64B-EDD4-4170-B797-D8F83B927DCE</pav:lineageUri>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:CB645A75-8C80-4DBE-A619-BDD15DFC4DF3">
    <domeo:belongsToSet>urn:domeoclient:uuid:98DABE9A-9F89-4DF9-9DEE-B6853D1F5CC1</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-16 15:40:55 -0700</pav:lastSavedOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
    <ao:context rdf:resource="urn:domeoclient:uuid:719101C7-4FC8-4E56-81FA-58D7AC021659"/>
    <pav:lineageUri>urn:domeoserver:annotation:389FC9FC-6B0A-4B9D-BFD4-2042659879DF</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lastSavedOn>2014-07-16 18:40:55 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E3DA2E5E-FC19-4C22-AF6C-A9CB4B450554</domeo:belongsToSet>
    <pav:createdOn>2014-07-16 15:40:24 -0700</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:07B9E40E-C2A9-41CF-9B91-A2A057E2FB86">
    <pav:createdOn>2014-07-15 14:26:27 -0700</pav:createdOn>
    <ao:body rdf:nodeID="N81442154b0614b38834e53fe09f8a316"/>
    <pav:lineageUri>urn:domeoserver:annotation:1A3B028E-646E-4459-BECE-B2E8BD3A8104</pav:lineageUri>
    <ao:body rdf:nodeID="N1fd5325f3fff46beaeb1c3ec92e92735"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:21B0E479-04F9-4D66-B396-B773EFE53882</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotation:B2B1B26D-3D3F-4F55-AF64-5012AFAC26FD</pav:lineageUri>
    <pav:lastSavedOn>2014-07-15 14:30:47 -0700</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
    <domeo:belongsToSet>urn:domeoserver:annotationset:5B6A462D-57EA-4BBD-87E1-A0EC2FAF5196</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lastSavedOn>2014-07-15 17:30:45 -0400</pav:lastSavedOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">6</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E8194531-C5B3-43AE-BC13-14A252C54824</domeo:belongsToSet>
    <ao:body rdf:nodeID="Ne6567c736ac14792a2b0be3721c09907"/>
    <pav:lineageUri>urn:domeoserver:annotationset:75FC1225-8399-469B-AE9D-7F697713E6AC</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotation:A0DB6DA3-F8EE-4160-A518-BBC713DBCEC9</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:46636445-93A2-49F0-9E9C-5AEBF17046D2</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-15 17:30:43 -0400</pav:lastSavedOn>
    <pav:lastSavedOn>2014-07-15 17:30:48 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:5758DAC0-E1C0-49EB-BE9C-56FFBAF3B6F4</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E6A1493E-98EE-4FDE-9301-752AB8E3453F</domeo:belongsToSet>
    <ao:body rdf:nodeID="Nded6cab7b2cb4cf1baa747a776609218"/>
    <ao:body rdf:nodeID="Ne856021d8a7f43319d62e2b149ab919a"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:ED25013C-406F-45E7-817A-38F31C1C84A1"/>
    <pav:previousVersion>urn:domeoserver:annotationset:883587E1-49C1-4EE0-909E-4ADBAE13DD3A</pav:previousVersion>
    <ao:body rdf:nodeID="Ndea203f3f0f341ffa9558d67b3e517b9"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdfs:label>expertstudy Annotation</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:8F11E81F-1EDB-4EA8-8E4A-47D93E06FFF2">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lineageUri>urn:domeoserver:annotationset:75FC1225-8399-469B-AE9D-7F697713E6AC</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E8194531-C5B3-43AE-BC13-14A252C54824</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9C0B4E8B-9FFE-4E47-9B4C-A6EA4527A384</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotation:FDA119AE-EB8A-4E3E-9CB0-141996428B76</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:883587E1-49C1-4EE0-909E-4ADBAE13DD3A</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">4</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:5B6A462D-57EA-4BBD-87E1-A0EC2FAF5196</domeo:belongsToSet>
    <pav:previousVersion>urn:domeoserver:annotationset:2E5CE73B-BFD4-4E35-9A07-D5E37A9E87AE</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E6A1493E-98EE-4FDE-9301-752AB8E3453F</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:5758DAC0-E1C0-49EB-BE9C-56FFBAF3B6F4</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:570DA392-7779-456C-9C18-1FC0E579BBE6</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:7F8B9524-4C64-4996-BBA7-9A2CED8F6A99"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:21B0E479-04F9-4D66-B396-B773EFE53882</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:46636445-93A2-49F0-9E9C-5AEBF17046D2</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-15 14:17:25 -0700</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lastSavedOn>2014-07-15 17:17:26 -0400</pav:lastSavedOn>
    <pav:createdOn>2014-07-15 14:15:32 -0700</pav:createdOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
    <rdfs:label>Highlight</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:C51A06F1-DF50-4438-A801-D1307CBA609A">
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-25.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:C51A06F1-DF50-4438-A801-D1307CBA609A"/>
    <domeo:uuid>C51A06F1-DF50-4438-A801-D1307CBA609A</domeo:uuid>
    <pav:createdOn>2014-07-18 13:49:30 -0700</pav:createdOn>
    <ao:exact>Phenytoin AUC was determined after 4 days of phenytoin dosing (200 mg daily, orally for 3 days followed by 250 mg intravenously for one dose) both with and without the administration of fluconazole (oral fluconazole 200 mg daily for 16 days) in 10 normal male volunteers. There was a significant increase in phenytoin AUC. The mean ± SD increase in phenytoin AUC was 88% ± 68% (range: 16 to 247%)</ao:exact>
    <ao:suffix>. The absolute magnitude of this interaction is unknown because of the intrinsically nonlinear disposition of phenytoin. (See PRECAUTIONS.</ao:suffix>
    <ao:prefix>xsd:String</ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:701FB70F-31F1-4E69-B54F-77820E603E4C">
    <domeo:belongsToSet>urn:domeoserver:annotationset:6DBCB873-26F3-4E6A-9BD4-311369B43736</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
    <pav:createdOn>2014-07-18 14:02:49 -0700</pav:createdOn>
    <rdfs:label>Highlight</rdfs:label>
    <ao:context rdf:resource="urn:domeoclient:uuid:A3A3ADF6-73D6-48FB-AF10-EC6590D40ED9"/>
    <pav:lastSavedOn>2014-07-18 17:03:19 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotationset:9AA0507C-281E-45C8-9719-03E66F12C069</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoclient:uuid:E65FF29A-8FE7-4D0E-A93C-4DA8136F4956</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lineageUri>urn:domeoserver:annotation:1A5A0EF3-36AE-4BBC-9E24-A64F0B58DF7E</pav:lineageUri>
    <pav:lastSavedOn>2014-07-18 14:03:19 -0700</pav:lastSavedOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoserver:annotationset:46636445-93A2-49F0-9E9C-5AEBF17046D2">
    <ao:item rdf:resource="urn:domeoclient:uuid:BED0BB6E-5962-4714-A49A-2DB5A1787334"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:797BAFBC-5256-4C7D-9ACC-064403D70DDB"/>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046812afe0146812ce85a0000"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:BCC5E7E8-854A-4B02-859A-36A9EC807AF5"/>
    <dct:description>The default set is created automatically by Domeo when no other set is existing.</dct:description>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:7130A96C-7BF2-4DBE-A880-248C420268E9"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:312701AC-EC1C-4292-B01F-44DD40979EEA"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:DDF11329-3CD1-4391-B01E-D821B9E4C7F3"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:3051A76E-96A2-4A70-91F9-A241566DEFD1"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:14655D75-DC23-4E82-84C9-F40B702E4B69"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:318D970E-E791-465D-B650-869C74523D2C"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:7443907B-C475-4EA4-B081-8C3D55A1EF69"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:A526C161-102B-469E-9242-8D2CB0C94450"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:76E5F11A-7EC2-4412-BCB7-E9B0542040DE"/>
    <pav:lastSavedOn>2014-07-15 17:30:47 -0400</pav:lastSavedOn>
    <ao:item rdf:resource="urn:domeoclient:uuid:C4D81A7B-4D7D-4EBA-A2C1-0E5AC4A8CE5C"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:926EB546-FC66-4BEC-B38A-18749E06CCE5"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:446899E9-2BB7-4629-AA6E-75AF9EC38F08"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:68AD55C4-223A-46C6-896A-87345A781B61"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:5C0FAFB3-9734-473A-85E5-980D1051DADD"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:9CAD6283-FE79-428D-A3CE-B664A09583CB"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:DC20D454-AAA8-4A81-915D-03526B8FC40B"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:DC71B917-C3C7-4475-B462-6525E8CEF601"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:785FFE99-34A3-41C7-A3D5-65DC60E0807D"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:C54A1798-BD47-4D4C-89DF-B37F5A3AB9F0"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:24886D93-A995-41A8-9E66-1BF6DF77E9D2"/>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:annotatesResource>
    <ao:item rdf:resource="urn:domeoclient:uuid:90386835-AD59-4BAA-A860-3003ABCAF86C"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:A688F7D2-43BF-4838-A9A1-339829ADA43A"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:29A7AD86-B18C-409C-86E9-985BFF28A757"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">6</pav:versionNumber>
    <ao:item rdf:resource="urn:domeoclient:uuid:E0EC9718-8100-4840-9F10-BFE3FC7823F2"/>
    <pav:previousVersion>urn:domeoserver:annotationset:883587E1-49C1-4EE0-909E-4ADBAE13DD3A</pav:previousVersion>
    <ao:item rdf:resource="urn:domeoclient:uuid:B71CF81C-58B7-42D8-94AA-D3DE86C41757"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:F8EED65F-31D9-41A0-9BB4-436FCBA969FA"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:AD757AC1-7E10-42A9-A8ED-0BD21ADA30A7"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:2AAEA179-90D2-4661-9105-64A780850DEB"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:12CCDE72-9FC0-4264-A3F2-C533F792F613"/>
    <rdfs:label>Default Set</rdfs:label>
    <ao:item rdf:resource="urn:domeoclient:uuid:FDDEE9D3-D4C2-40CB-BC92-305777AFD63E"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:A1A5580F-53D7-4F22-824E-5430565EDBF1"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:A5A82A3B-FE45-46DE-9048-8E85995D8F43"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:0A8134EE-D8E3-447B-9EB9-2CB597651AB4"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:D1D92634-CB40-4585-8260-1917D2119CC7"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:6EB13D46-B414-424C-9D7C-BADA59079327"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:5CE6135C-97A9-4B21-9915-11E87A1697A5"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:82FFD7F0-AC94-462F-BA86-70CFD849B686"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:CA792FCD-C812-49FE-9EDF-15DA0F056A53"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:34A66F13-B248-4FD8-A3CE-7AAAC40B7ACC"/>
    <pav:lineageUri>urn:domeoserver:annotationset:75FC1225-8399-469B-AE9D-7F697713E6AC</pav:lineageUri>
    <ao:item rdf:resource="urn:domeoclient:uuid:914C2061-E547-4CFD-9F3C-C0070F56BF90"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:A056C491-9BB0-438A-A716-FE909F2281AD"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:1453C795-84C1-4C48-AF84-AEEE18ED1682"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:7DF78E91-4010-455D-9300-16EAD7D6AB87"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:item rdf:resource="urn:domeoclient:uuid:C025BBE5-19A7-4D05-9813-E49F4799CB23"/>
    <pav:createdOn>2014-07-15 14:02:34 -0700</pav:createdOn>
    <ao:item rdf:resource="urn:domeoclient:uuid:8F11E81F-1EDB-4EA8-8E4A-47D93E06FFF2"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:274D4FB3-81D3-46CA-BE6A-31286B260E56"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:E2A636FF-8FE8-44E9-B454-573E4E7470FA"/>
    <domeo:deleted>false</domeo:deleted>
    <ao:item rdf:resource="urn:domeoclient:uuid:65047D28-4B70-4701-B243-A146C45926A7"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:DA483938-DFFC-4F6C-85C3-FED68E6D4DE8"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:8CA72313-3E32-44D6-A336-EDE69F22975A"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:A4632682-84C0-4DFD-915D-D1C3B235F095"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:24229507-32A8-4A26-89C0-59655390DA1A"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:6F7C3F13-3AE2-43EA-93D3-9F0AF79252AC"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:AA5B502F-CF57-4C65-81A8-140217111073"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:AAA6478C-E7E4-4D30-9F06-AA094434B620"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:F87C43FC-DD9B-42FA-953B-C8C25AA48C91"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:D2174191-CE1D-4EF2-8DD5-03008A9706DE"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:79C3BE8E-51D8-473A-AC88-0ADB7AE9D239"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
    <ao:item rdf:resource="urn:domeoclient:uuid:ADFEE70E-EDC2-4D08-90AB-0ABAFD52BC6F"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:BB6F25A1-6FFC-4CE5-8F5F-AD5806D52477"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:12D5CA7C-401C-4376-A246-03585C5F9AC0"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:A77ED33E-10B2-43BE-8BC6-D5F14E2FE208"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:48E274BA-EE97-464C-9512-861F9207381F"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:60AE44A7-769C-4774-8E4D-7AF66A2F2EA1"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:A252FD3C-4309-4CCB-8491-4B23A2848662"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:4CD0874F-AA43-4C04-958D-6CFBFA68EC61"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:D1062598-B310-4CF4-8237-5F8F8F74933F"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:D707EDCF-5B5D-4AB9-9815-32BDDA05721F"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:5415B79F-FEAF-4999-A78E-2C1039116F7C"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:63FB79CC-576B-4FFD-A109-FF63DAE371C0"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:52926929-04E3-4243-A2C3-5B9100F9FBE1"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:A2215D32-FF99-4DC9-90B9-5C350C098EEB"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:BFCAC108-C978-4C7B-A79A-9887A3CA3C6C"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:4D3BA7C7-A806-41A4-84AC-38A85FF0F9C2"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:99C27DF5-F974-4BCC-AE8D-49CE9212E9D2"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:71089688-5934-49A8-BBF4-07B4CAD41AA7"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:E3D4514F-8C2B-4E16-B53E-81B363D7FDBE"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:C91DD2D9-B8D7-4C80-85A1-EE73345B059A"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:920B7836-2155-4EE5-9028-A6274B846CBA"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:07B9E40E-C2A9-41CF-9B91-A2A057E2FB86"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:85B5BEBE-D146-414B-A979-B9CEBE9C57E6"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:C66BBCCE-CA43-44FB-8D97-2084E19C48FF"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:C1A443CA-B8D4-4A28-825B-B97ECDEC88D7"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:52A12616-29C9-4323-A81B-949195D51273"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:BF8175E8-F52D-4CE3-9DE9-BAE3E2CE04A1"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:51770B89-7CCF-409A-A2E9-D4576F9DB59A"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:6FED0630-F5B3-4A05-892B-CB86D31FD6DF"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:7CAB3CEB-53D4-45C0-BDE2-D01D9FD9219C"/>
    <permissions:permissions rdf:nodeID="N8c3413f915c841d1b41279d4bb037e73"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:A3DBEE5E-C93B-4DBE-A1E3-317DA19FA203"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:8900088E-395F-4576-960E-1B67ECCA0A65"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:12D5CA7C-401C-4376-A246-03585C5F9AC0">
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:5758DAC0-E1C0-49EB-BE9C-56FFBAF3B6F4</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoclient:uuid:9B307D8B-D2B0-4795-8850-FAAAAC6B5AF4</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9C0B4E8B-9FFE-4E47-9B4C-A6EA4527A384</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-15 17:04:06 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:46636445-93A2-49F0-9E9C-5AEBF17046D2</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E8194531-C5B3-43AE-BC13-14A252C54824</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:883587E1-49C1-4EE0-909E-4ADBAE13DD3A</domeo:belongsToSet>
    <pav:createdOn>2014-07-15 14:03:32 -0700</pav:createdOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:5B6A462D-57EA-4BBD-87E1-A0EC2FAF5196</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lastSavedOn>2014-07-15 14:04:06 -0700</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:570DA392-7779-456C-9C18-1FC0E579BBE6</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E6A1493E-98EE-4FDE-9301-752AB8E3453F</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:2E5CE73B-BFD4-4E35-9A07-D5E37A9E87AE</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotation:C731C2A5-DBEA-4B3B-ADC8-9CA0828BC185</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:FA8D1DAC-C616-456C-BB3D-29F18DED21A1</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoserver:annotationset:1575950D-32D4-46DE-A44F-8E9E614F997F</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:3AF5AF5B-6498-4C88-94AC-716E8168CCAC"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:21B0E479-04F9-4D66-B396-B773EFE53882</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:9C730C18-D51E-4ABD-B037-60F8C4579F49">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact> ethinyl estradio</ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:9C730C18-D51E-4ABD-B037-60F8C4579F49"/>
    <pav:createdOn>2014-07-16 15:32:56 -0700</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid>9C730C18-D51E-4ABD-B037-60F8C4579F49</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-22.txt.html</ao:hasSource>
    <ao:suffix>l AUC was 6% (range: -47 to 108%) and levonorgestrel AUC increased 17% (range: -33 to 141%).</ao:suffix>
    <ao:prefix> AUC after the administration of 50 mg of fluconazole. The mean increase in</ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:A81A4371-A756-421B-8B30-D10382A032D4">
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:A81A4371-A756-421B-8B30-D10382A032D4"/>
    <domeo:uuid></domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix>. Extensive CYP 2D6 metabolizers convert </ao:prefix>
    <domeo:uuid>A81A4371-A756-421B-8B30-D10382A032D4</domeo:uuid>
    <ao:suffix> rapidly into 9-hydroxyrisperidone, whereas poor CYP 2D6 metabolizers convert it much more slowly. Although extensive metabolizers have lower risperidone and higher 9-hydroxyrisperidone concentrations than poor metabolizers, the pharmacokinetics of rispe</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>risperidone</ao:exact>
    <pav:createdOn>2014-07-15 14:14:40 -0700</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:069D387B-708F-4C78-BA75-2E62415C81C9">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lastSavedOn>2014-07-16 10:20:50 -0700</pav:lastSavedOn>
    <pav:lastSavedOn>2014-07-16 13:20:50 -0400</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <ao:context rdf:resource="urn:domeoclient:uuid:9DF202FF-7B27-4079-825C-68963E1927BA"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:DA8D6B42-B41F-4576-BF10-1285DF3EAB80</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotation:6F76C929-6A41-4C7C-BA61-6609B4A880E6</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:AAD02A4C-E01E-4C82-BC8A-D0F4639844FA</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoserver:annotationset:6FFFF211-BFDC-4E16-968C-A296868530C4</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoclient:uuid:2F716A41-B68F-48AE-B5C1-E31F1704C565</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
    <pav:lineageUri>urn:domeoserver:annotationset:C8D7FDC6-6816-4BD4-BC7F-88ABDCC37D79</pav:lineageUri>
    <pav:createdOn>2014-07-16 10:20:36 -0700</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:6FE3E0C7-BFF1-4C33-8E1B-DDF1CDB00784">
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:7A2CAFDF-C49B-4054-971B-E8074913A461"/>
    <dikbD2R:modality>ncit:negative</dikbD2R:modality>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:53F2EA0B-B02F-4D15-A55E-843D837795E4">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>53F2EA0B-B02F-4D15-A55E-843D837795E4</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid></domeo:uuid>
    <ao:exact>9-hydroxyrisperidone</ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:53F2EA0B-B02F-4D15-A55E-843D837795E4"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <ao:suffix> are dose proportional over the dosing range of 1 to 16 mg daily (0.5 to 8 mg twice daily). Following oral administration of solution or tablet, mean peak plasma concentrations of risperidone occurred at about 1 hour. Peak concentrations of 9-hydroxyrisp</ao:suffix>
    <pav:createdOn>2014-07-15 14:06:41 -0700</pav:createdOn>
    <ao:prefix> plus </ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:523A8E6B-6F7F-4807-9852-CFA0940BB6CC">
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:3E222580-6163-4407-B0C4-D0FC6BC85172"/>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:FE1313C3-E1E7-419F-9B99-0AFA7CE149F5">
    <ao:exact>fluconazole</ao:exact>
    <domeo:uuid>FE1313C3-E1E7-419F-9B99-0AFA7CE149F5</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-23.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:FE1313C3-E1E7-419F-9B99-0AFA7CE149F5"/>
    <ao:prefix> </ao:prefix>
    <domeo:uuid></domeo:uuid>
    <pav:createdOn>2014-07-16 15:40:52 -0700</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix> in 24 healthy male volunteers</ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoserver:annotationset:AAD02A4C-E01E-4C82-BC8A-D0F4639844FA">
    <ao:item rdf:resource="urn:domeoclient:uuid:ADF2DC89-FCCE-47DE-8493-BEC599C898E4"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:8D0FBEEE-F2C5-4EBC-892B-1E8DE2D584AE"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:069D387B-708F-4C78-BA75-2E62415C81C9"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">3</pav:versionNumber>
    <rdfs:label>Default Set</rdfs:label>
    <ao:item rdf:resource="urn:domeoclient:uuid:EDA5CCDC-B45B-4C9D-9286-2C6331B0DC2E"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:F89E37D5-CA53-4C58-B4D2-AE8F0A3FBCE2"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:34BFAD74-FE4D-4E30-8ACE-10002901EAA2"/>
    <dct:description>The default set is created automatically by Domeo when no other set is existing.</dct:description>
    <ao:item rdf:resource="urn:domeoclient:uuid:987C60C7-6D1F-4118-A362-4E5E00057318"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:18EE2CB9-3D4F-42B6-A49D-245BF6C564CA"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:076F37CF-3229-400A-A6F6-EBE2A8FC2F4C"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:81DA2C24-D202-4991-9DC6-FFA54776B4D2"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:785FC8A2-DE5D-4084-8BEC-107690A111CB"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:75261373-1FF5-4BA4-8887-FD4548F77DE6"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:AD7753FF-D1E8-489F-B53D-1F96A5C7118D"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:A9E905EC-FD3B-44E6-9603-8C4B7B645A61"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:item rdf:resource="urn:domeoclient:uuid:A216BADD-014F-4644-9641-24F03B40257D"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:41134D12-A312-4FDD-ADEA-5285A0740BFA"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:0623A94E-6CBD-441E-92B8-16C280BD8650"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:AC4605E1-BB47-46C6-87EA-F8DDE5BC9868"/>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <domeo:deleted>false</domeo:deleted>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046812afe0146812ce85a0000"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:F2AF7A08-3EE5-4851-BC7F-4DF99BFE382A"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:6B42267E-6924-4453-B105-2F66C330186C"/>
    <pav:previousVersion>urn:domeoserver:annotationset:DA8D6B42-B41F-4576-BF10-1285DF3EAB80</pav:previousVersion>
    <ao:item rdf:resource="urn:domeoclient:uuid:6395774E-A61F-4CC3-AC03-4A9A97F402CB"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:50B64AB9-5E00-4F5D-BE7F-9B8CE91BCF2A"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:0C20AD1B-8F9C-472D-A102-E6A1F85BDC4E"/>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:annotatesResource>
    <pav:lastSavedOn>2014-07-16 13:23:07 -0400</pav:lastSavedOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:06A59058-E7B5-4A71-9D10-07FD98051EBF"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
    <pav:lineageUri>urn:domeoserver:annotationset:C8D7FDC6-6816-4BD4-BC7F-88ABDCC37D79</pav:lineageUri>
    <pav:createdOn>2014-07-16 10:18:37 -0700</pav:createdOn>
    <permissions:permissions rdf:nodeID="N22b27ddb6cef4d4892aa72cae76c4d0f"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:318D970E-E791-465D-B650-869C74523D2C">
    <domeo:belongsToSet>urn:domeoserver:annotationset:883587E1-49C1-4EE0-909E-4ADBAE13DD3A</domeo:belongsToSet>
    <pav:createdOn>2014-07-15 14:14:47 -0700</pav:createdOn>
    <pav:lastSavedOn>2014-07-15 14:17:25 -0700</pav:lastSavedOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoserver:annotationset:21B0E479-04F9-4D66-B396-B773EFE53882</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotation:FBFD98AB-C116-495B-B6CF-C7C99F3F4882</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:570DA392-7779-456C-9C18-1FC0E579BBE6</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E6A1493E-98EE-4FDE-9301-752AB8E3453F</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:0E27FBCC-C6F8-42FB-A7DC-B9AA486D3D4F"/>
    <pav:lastSavedOn>2014-07-15 17:17:26 -0400</pav:lastSavedOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotationset:75FC1225-8399-469B-AE9D-7F697713E6AC</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9C0B4E8B-9FFE-4E47-9B4C-A6EA4527A384</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:46636445-93A2-49F0-9E9C-5AEBF17046D2</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:5758DAC0-E1C0-49EB-BE9C-56FFBAF3B6F4</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">4</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:5B6A462D-57EA-4BBD-87E1-A0EC2FAF5196</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E8194531-C5B3-43AE-BC13-14A252C54824</domeo:belongsToSet>
    <pav:previousVersion>urn:domeoserver:annotationset:2E5CE73B-BFD4-4E35-9A07-D5E37A9E87AE</pav:previousVersion>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:previousVersion>xsd:String</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/10F4138F-8D26-4583-8ACD-216B6C4F221E">
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/2002</dailymed:activeMoietyRxCUI>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <rdfs:label>carbamazepine</rdfs:label>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <dct:description>Referred to the drug in the interaction.</dct:description>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:C70E2E47-3AA5-4F01-A8A1-711E946726F5">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:2BFC2FB6-6BE9-4822-A245-973533533023</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoserver:annotationset:DBBBAD55-D12B-4890-A2AF-85D3C85A7BEF</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:EF537613-8BA0-4920-9501-06EA08F94E71"/>
    <pav:lastSavedOn>2014-07-10 11:14:30 -0700</pav:lastSavedOn>
    <pav:lastSavedOn>2014-07-10 14:14:30 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:239B4C6D-1110-4B65-AC66-F8A394187814</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:3F81414E-B149-4B05-925B-18735B554A13</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:970963DF-8BCE-4936-9DFC-328A36014E1B</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotation:A4A573A6-4DD9-4D71-9C8C-FC03B750BDC0</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:15A537D1-5648-41B2-8BFA-0D0BA3DF4393</domeo:belongsToSet>
    <pav:createdOn>2014-07-10 11:09:23 -0700</pav:createdOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:516C333C-B517-4F84-999E-51185DD6E859</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:E03B1442-AB3D-475E-AEE8-EFD5DC37D96C">
    <pav:createdOn>2014-07-17 15:53:41 -0700</pav:createdOn>
    <ao:suffix> 400 mg to six healthy male volunteers. After the administration of cimetidine, there was a significant decrease in fluconazole AUC and Cmax. There was a mean ± SD decrease in fluconazole AUC of 13% ± 11% (range: -3.4 to -31%) and Cmax decreased 19% ± 14</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:E03B1442-AB3D-475E-AEE8-EFD5DC37D96C"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix> 100 mg was administered as a single oral dose alone and two hours after a single dose of </ao:prefix>
    <ao:hasSource>				http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-23.txt.html																													</ao:hasSource>
    <domeo:uuid>E03B1442-AB3D-475E-AEE8-EFD5DC37D96C</domeo:uuid>
    <ao:exact>cimetidine</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoserver:annotationset:FF76049E-6B2C-46A9-ACF7-CA565C8087F3">
    <ao:item rdf:resource="urn:domeoclient:uuid:30DE360C-B631-4F35-8C09-DC4BC562543A"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:ECE81054-6CF5-460C-88CE-88C1E5F148ED"/>
    <pav:lineageUri>urn:domeoserver:annotationset:C00C2C3C-0648-4779-A135-09D440F1CEA8</pav:lineageUri>
    <ao:item rdf:resource="urn:domeoclient:uuid:B372AAFD-51DF-43D9-B838-0F98E9692F16"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <domeo:deleted>false</domeo:deleted>
    <rdfs:label>Default Set</rdfs:label>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046812afe0146812ce85a0000"/>
    <pav:createdOn>2014-07-18 13:43:09 -0700</pav:createdOn>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:31737AE9-0835-48DB-82BD-A713405999A3"/>
    <pav:lastSavedOn>2014-07-18 16:46:22 -0400</pav:lastSavedOn>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-24.txt.html</ao:annotatesResource>
    <ao:item rdf:resource="urn:domeoclient:uuid:548F8E3A-F3DF-41D2-B65F-5C14C8EE8007"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:E7893705-3CF7-42B9-9C7F-93F25693DB84"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">2</pav:versionNumber>
    <ao:item rdf:resource="urn:domeoclient:uuid:E68A8F1A-49B1-485B-9508-70DEE10CB0DB"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:previousVersion>urn:domeoclient:uuid:23AC741A-2236-437C-90AA-82B2E00E875C</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
    <permissions:permissions rdf:nodeID="Nf8561cb33604467ea02ef2ac6183824e"/>
    <dct:description>The default set is created automatically by Domeo when no other set is existing.</dct:description>
    <ao:item rdf:resource="urn:domeoclient:uuid:16CA4CDD-75E6-4B6B-8392-4CE5B648D48E"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/F5B727AA-1FE7-4EF4-9422-5C712EBAD08C">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <rdfs:label>aminophylline</rdfs:label>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/689</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoserver:annotationset:2CE33325-EF3D-4298-BBCC-82F0A45DA665">
    <pav:createdOn>2014-07-16 10:36:03 -0700</pav:createdOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">2</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:item rdf:resource="urn:domeoclient:uuid:C039DC79-C2B3-4581-A409-2060854712D2"/>
    <pav:lineageUri>urn:domeoserver:annotationset:8ABB5677-3B0A-44AC-B5F0-95374283E66A</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
    <dct:description>The default set is created automatically by Domeo when no other set is existing.</dct:description>
    <ao:item rdf:resource="urn:domeoclient:uuid:C966BEAA-709F-4F5C-9638-F94D75B69135"/>
    <pav:previousVersion>urn:domeoclient:uuid:C5D9EC69-52E2-48F5-B3D8-867DE23DEC96</pav:previousVersion>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-20.txt.html</ao:annotatesResource>
    <permissions:permissions rdf:nodeID="N87e6a4a5863445ab9cbc02ba28422c66"/>
    <pav:lastSavedOn>2014-07-16 17:02:24 -0400</pav:lastSavedOn>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <domeo:deleted>false</domeo:deleted>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046812afe0146812ce85a0000"/>
    <rdfs:label>Default Set</rdfs:label>
    <ao:item rdf:resource="urn:domeoclient:uuid:9DD27DF4-02BD-4CAE-B854-9D4CA6356D04"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/2CB7BD6B-AF06-43CD-9905-C06E37B34FC9">
    <rdfs:label>risperidone</rdfs:label>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/35636</dailymed:activeMoietyRxCUI>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:4CE762A1-3B91-4B51-861E-7CFEE91439CF">
    <domeo:uuid>4CE762A1-3B91-4B51-861E-7CFEE91439CF</domeo:uuid>
    <pav:createdOn>2014-07-09 13:36:31 -0700</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:4CE762A1-3B91-4B51-861E-7CFEE91439CF"/>
    <ao:prefix>In a placebo-controlled trial in normal volunteers, the administration of two doses of </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>sertraline</ao:exact>
    <ao:suffix> did not significantly alter steady-state lithium levels or the renal clearance of lithium.</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-13.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:4E109C84-6323-418A-9404-5FBE487E6AA2">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2014-07-18 13:51:28 -0700</pav:createdOn>
    <domeo:uuid>4E109C84-6323-418A-9404-5FBE487E6AA2</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:4E109C84-6323-418A-9404-5FBE487E6AA2"/>
    <ao:suffix> dose for at least 6 weeks. There was a significant increase in cyclosporine AUC, Cmax, Cmin (24-hour concentration), and a significant reduction in apparent oral clearance following the administration of fluconazole. The mean ± SD increase in AUC was 92</ao:suffix>
    <ao:prefix> therapy for at least 6 months and on a stable </ao:prefix>
    <ao:exact>cyclosporine</ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-26.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:A526C161-102B-469E-9242-8D2CB0C94450">
    <ao:context rdf:resource="urn:domeoclient:uuid:27E8BA7E-57CC-48C7-86F6-BFF286EBA6E0"/>
    <pav:lastSavedOn>2014-07-15 17:11:14 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
    <domeo:belongsToSet>urn:domeoserver:annotationset:5B6A462D-57EA-4BBD-87E1-A0EC2FAF5196</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E8194531-C5B3-43AE-BC13-14A252C54824</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotation:40507A83-879B-47E6-8AFE-8BF8A6380190</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:883587E1-49C1-4EE0-909E-4ADBAE13DD3A</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdOn>2014-07-15 14:10:12 -0700</pav:createdOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:46636445-93A2-49F0-9E9C-5AEBF17046D2</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:21B0E479-04F9-4D66-B396-B773EFE53882</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:5758DAC0-E1C0-49EB-BE9C-56FFBAF3B6F4</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:570DA392-7779-456C-9C18-1FC0E579BBE6</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E6A1493E-98EE-4FDE-9301-752AB8E3453F</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:2E5CE73B-BFD4-4E35-9A07-D5E37A9E87AE</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9C0B4E8B-9FFE-4E47-9B4C-A6EA4527A384</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-15 14:11:14 -0700</pav:lastSavedOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <rdfs:label>Highlight</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:E7E6B698-CDF9-4B67-A4F6-CC3D84C50315">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2014-07-15 14:15:56 -0700</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:E7E6B698-CDF9-4B67-A4F6-CC3D84C50315"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <ao:suffix> have not been evaluated, but observations in a modest number (N≅70) of poor metabolizers given risperidone do not suggest important differences between poor and extensive metabolizers. Second, co-administration of known enzyme inducers (e.g., carbamazep</ao:suffix>
    <domeo:uuid></domeo:uuid>
    <ao:prefix> in patients receiving </ao:prefix>
    <domeo:uuid>E7E6B698-CDF9-4B67-A4F6-CC3D84C50315</domeo:uuid>
    <ao:exact>quinidine</ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/6B86F899-B737-4700-BD45-A7A2D76ED9A5">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <rdfs:label>warfarin</rdfs:label>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/11289</dailymed:activeMoietyRxCUI>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <dct:description>Referred to the drug in the interaction.</dct:description>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:A21EC03A-3C43-4CAE-9D75-32F08D9599AA">
    <ao:prefix> </ao:prefix>
    <ao:suffix>dosing resulted in small increases in the mean AUCs of ethinyl estradiol and norethindrone compared to similar placebo dosing. The mean AUCs of ethinyl estradiol and norethindrone increased by 24% (95% C.I. range 18 to 31%) and 13% (95% C.I. range 8 to 1</ao:suffix>
    <domeo:uuid></domeo:uuid>
    <pav:createdOn>2014-07-16 14:03:39 -0700</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:A21EC03A-3C43-4CAE-9D75-32F08D9599AA"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>A21EC03A-3C43-4CAE-9D75-32F08D9599AA</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-21.txt.html</ao:hasSource>
    <ao:exact>fluconazole </ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:3B501E10-7673-4F8E-889F-7048994F6D90">
    <pav:createdOn>2014-07-18 14:23:45 -0700</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:3B501E10-7673-4F8E-889F-7048994F6D90"/>
    <ao:exact>paroxetine</ao:exact>
    <domeo:uuid>3B501E10-7673-4F8E-889F-7048994F6D90</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-51.txt.html</ao:hasSource>
    <ao:suffix>. Any dose adjustment should be guided by clinical effect (tolerability and efficacy). </ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix> significantly decreased plasma levels of </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:C820B82D-AF0E-4A71-9E65-5AB73DFE5206">
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
    <pav:lastSavedOn>2014-07-10 14:14:30 -0400</pav:lastSavedOn>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoserver:annotationset:970963DF-8BCE-4936-9DFC-328A36014E1B</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:15A537D1-5648-41B2-8BFA-0D0BA3DF4393</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotation:B06DA6C0-E42B-45A0-999E-F9ABDA68454E</pav:lineageUri>
    <pav:lastSavedOn>2014-07-10 11:14:30 -0700</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:DBBBAD55-D12B-4890-A2AF-85D3C85A7BEF</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:C69466D9-4AD4-4863-ABBC-AEF76AEF11D6"/>
    <pav:createdOn>2014-07-10 11:08:09 -0700</pav:createdOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:3F81414E-B149-4B05-925B-18735B554A13</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:516C333C-B517-4F84-999E-51185DD6E859</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:239B4C6D-1110-4B65-AC66-F8A394187814</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:2BFC2FB6-6BE9-4822-A245-973533533023</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:F247102D-970B-4569-BFF9-4021B0D33CE0">
    <ao:suffix> Cmax. Co-administration resulted in a 50% increase in AUC of bosentan. The combination of both drugs did not lead to clinically significant changes in blood pressure (supine or standing). Concomitant administration of potent CYP3A inducers is expected t</ao:suffix>
    <pav:createdOn>2014-07-10 11:20:13 -0700</pav:createdOn>
    <ao:prefix> AUC and a 55% decrease in </ao:prefix>
    <ao:exact>sildenafil</ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:F247102D-970B-4569-BFF9-4021B0D33CE0"/>
    <domeo:uuid>F247102D-970B-4569-BFF9-4021B0D33CE0</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:FCAC7AB3-7719-4C9B-8378-64BF0D2B4AD2">
    <domeo:belongsToSet>urn:domeoclient:uuid:53775C4C-7CC4-46EB-9EFC-EDF9D3D264ED</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A7F21A3D-50B3-495E-884A-2C707B40C763</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:4148B6C7-21F7-44D9-9466-BC519FF61DF1"/>
    <pav:createdOn>2014-07-18 13:48:11 -0700</pav:createdOn>
    <pav:lastSavedOn>2014-07-18 16:48:39 -0400</pav:lastSavedOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lineageUri>urn:domeoserver:annotation:EB1F37FB-63FD-4FB9-A232-E2134E06E60D</pav:lineageUri>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
    <pav:lineageUri>urn:domeoserver:annotationset:748BB253-1066-4977-91B2-35D8C6906790</pav:lineageUri>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lastSavedOn>2014-07-18 13:48:39 -0700</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:5280B7DB-AA4C-46FE-AB43-85E58C828264">
    <domeo:belongsToSet>urn:domeoclient:uuid:E65FF29A-8FE7-4D0E-A93C-4DA8136F4956</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:6DBCB873-26F3-4E6A-9BD4-311369B43736</domeo:belongsToSet>
    <pav:createdOn>2014-07-18 14:02:36 -0700</pav:createdOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotation:B5442226-85CF-407D-A5FE-78FAB7226273</pav:lineageUri>
    <pav:lineageUri>urn:domeoserver:annotationset:9AA0507C-281E-45C8-9719-03E66F12C069</pav:lineageUri>
    <pav:lastSavedOn>2014-07-18 17:03:19 -0400</pav:lastSavedOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:A7527009-01DC-4E9A-8438-D89D172BDEAA"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lastSavedOn>2014-07-18 14:03:19 -0700</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:587BEAE7-8AE9-4452-8478-FF400284EBF7">
    <pav:createdOn>2014-07-10 11:10:42 -0700</pav:createdOn>
    <ao:exact>sildenafil</ao:exact>
    <ao:prefix>xsd:String</ao:prefix>
    <ao:suffix> was co-administered with erythromycin, a CYP3A inhibitor, at steady state (500 mg BID for 5 days), there was a 182% increase in sildenafil systemic exposure (AUC).</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:587BEAE7-8AE9-4452-8478-FF400284EBF7"/>
    <domeo:uuid></domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>587BEAE7-8AE9-4452-8478-FF400284EBF7</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoserver:annotationset:6FFFF211-BFDC-4E16-968C-A296868530C4">
    <ao:item rdf:resource="urn:domeoclient:uuid:50B64AB9-5E00-4F5D-BE7F-9B8CE91BCF2A"/>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046812afe0146812ce85a0000"/>
    <pav:createdOn>2014-07-16 10:18:37 -0700</pav:createdOn>
    <ao:item rdf:resource="urn:domeoclient:uuid:785FC8A2-DE5D-4084-8BEC-107690A111CB"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:18EE2CB9-3D4F-42B6-A49D-245BF6C564CA"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:A9E905EC-FD3B-44E6-9603-8C4B7B645A61"/>
    <pav:lastSavedOn>2014-07-18 18:26:38 -0400</pav:lastSavedOn>
    <ao:item rdf:resource="urn:domeoclient:uuid:8D0FBEEE-F2C5-4EBC-892B-1E8DE2D584AE"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:75261373-1FF5-4BA4-8887-FD4548F77DE6"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:076F37CF-3229-400A-A6F6-EBE2A8FC2F4C"/>
    <rdfs:label>Default Set</rdfs:label>
    <ao:item rdf:resource="urn:domeoclient:uuid:81DA2C24-D202-4991-9DC6-FFA54776B4D2"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:item rdf:resource="urn:domeoclient:uuid:0623A94E-6CBD-441E-92B8-16C280BD8650"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:287EB7AD-1FB2-4E91-A01C-FFE1A2CB547D"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:F2AF7A08-3EE5-4851-BC7F-4DF99BFE382A"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:D3E83240-5B88-4E8A-9F52-DF6E195AAF5D"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:06A59058-E7B5-4A71-9D10-07FD98051EBF"/>
    <pav:lineageUri>urn:domeoserver:annotationset:C8D7FDC6-6816-4BD4-BC7F-88ABDCC37D79</pav:lineageUri>
    <ao:item rdf:resource="urn:domeoclient:uuid:AC4605E1-BB47-46C6-87EA-F8DDE5BC9868"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:6B42267E-6924-4453-B105-2F66C330186C"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">4</pav:versionNumber>
    <ao:item rdf:resource="urn:domeoclient:uuid:6395774E-A61F-4CC3-AC03-4A9A97F402CB"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
    <ao:item rdf:resource="urn:domeoclient:uuid:F89E37D5-CA53-4C58-B4D2-AE8F0A3FBCE2"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:AD7753FF-D1E8-489F-B53D-1F96A5C7118D"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:34BFAD74-FE4D-4E30-8ACE-10002901EAA2"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:A216BADD-014F-4644-9641-24F03B40257D"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:EDA5CCDC-B45B-4C9D-9286-2C6331B0DC2E"/>
    <dct:description>The default set is created automatically by Domeo when no other set is existing.</dct:description>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:069D387B-708F-4C78-BA75-2E62415C81C9"/>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:annotatesResource>
    <domeo:deleted>false</domeo:deleted>
    <ao:item rdf:resource="urn:domeoclient:uuid:41134D12-A312-4FDD-ADEA-5285A0740BFA"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:987C60C7-6D1F-4118-A362-4E5E00057318"/>
    <permissions:permissions rdf:nodeID="N6be5e5a7447c475695953a4666d8ca69"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:ADF2DC89-FCCE-47DE-8493-BEC599C898E4"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:94220E4B-2D94-4374-8F09-2F8CAACF7723"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:0C20AD1B-8F9C-472D-A102-E6A1F85BDC4E"/>
    <pav:previousVersion>urn:domeoserver:annotationset:AAD02A4C-E01E-4C82-BC8A-D0F4639844FA</pav:previousVersion>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:0ABB2266-B2C7-44A9-8367-C5FE4916C02B">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:0ABB2266-B2C7-44A9-8367-C5FE4916C02B"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>risperidone</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix> pharmacokinetic profile typical of poor metabolizers. The therapeutic benefits and adverse effects of </ao:prefix>
    <domeo:uuid>0ABB2266-B2C7-44A9-8367-C5FE4916C02B</domeo:uuid>
    <pav:createdOn>2014-07-15 14:15:52 -0700</pav:createdOn>
    <ao:suffix> in patients receiving quinidine have not been evaluated, but observations in a modest number (N≅70) of poor metabolizers given risperidone do not suggest important differences between poor and extensive metabolizers. Second, co-administration of known e</ao:suffix>
    <domeo:uuid></domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:E68A8F1A-49B1-485B-9508-70DEE10CB0DB">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoclient:uuid:23AC741A-2236-437C-90AA-82B2E00E875C</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
    <pav:createdOn>2014-07-18 13:43:30 -0700</pav:createdOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:FF76049E-6B2C-46A9-ACF7-CA565C8087F3</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotationset:C00C2C3C-0648-4779-A135-09D440F1CEA8</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotation:DF4D5610-6F7F-4372-B205-AB01D06FDAF9</pav:lineageUri>
    <ao:context rdf:resource="urn:domeoclient:uuid:616A7F11-F942-4085-A069-8C230D26C0CF"/>
    <pav:lastSavedOn>2014-07-18 16:43:48 -0400</pav:lastSavedOn>
    <pav:lastSavedOn>2014-07-18 13:43:48 -0700</pav:lastSavedOn>
    <rdfs:label>Highlight</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:AA5B502F-CF57-4C65-81A8-140217111073">
    <domeo:belongsToSet>urn:domeoserver:annotationset:46636445-93A2-49F0-9E9C-5AEBF17046D2</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:21B0E479-04F9-4D66-B396-B773EFE53882</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotation:A21596A1-B9A7-434C-AAFD-8F103C78CFE7</pav:lineageUri>
    <pav:lastSavedOn>2014-07-15 17:19:32 -0400</pav:lastSavedOn>
    <pav:lastSavedOn>2014-07-15 14:19:34 -0700</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotation:F31130A8-92DE-4A3D-BCA1-C17226A873C5</pav:lineageUri>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lastSavedOn>2014-07-15 17:19:34 -0400</pav:lastSavedOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:A42DE598-1DBE-4AFF-81B2-08991620AD5B"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9C0B4E8B-9FFE-4E47-9B4C-A6EA4527A384</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E8194531-C5B3-43AE-BC13-14A252C54824</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:883587E1-49C1-4EE0-909E-4ADBAE13DD3A</domeo:belongsToSet>
    <pav:createdOn>2014-07-15 14:17:37 -0700</pav:createdOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E6A1493E-98EE-4FDE-9301-752AB8E3453F</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:5B6A462D-57EA-4BBD-87E1-A0EC2FAF5196</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
    <domeo:belongsToSet>urn:domeoserver:annotationset:5758DAC0-E1C0-49EB-BE9C-56FFBAF3B6F4</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/0E178A5B-0ACA-4567-B955-2FBD97EA282B">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/</dailymed:activeMoietyRxCUI>
    <rdfs:label>sulfamethazine</rdfs:label>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:312701AC-EC1C-4292-B01F-44DD40979EEA">
    <pav:lastSavedOn>2014-07-15 17:04:06 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9C0B4E8B-9FFE-4E47-9B4C-A6EA4527A384</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
    <rdfs:label>Highlight</rdfs:label>
    <ao:context rdf:resource="urn:domeoclient:uuid:6684B979-BD2C-446B-B807-178AE44EB6F8"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:5B6A462D-57EA-4BBD-87E1-A0EC2FAF5196</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:883587E1-49C1-4EE0-909E-4ADBAE13DD3A</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotation:FB36FF68-03E9-4628-8F83-9796F15BD779</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:21B0E479-04F9-4D66-B396-B773EFE53882</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:46636445-93A2-49F0-9E9C-5AEBF17046D2</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoclient:uuid:9B307D8B-D2B0-4795-8850-FAAAAC6B5AF4</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E6A1493E-98EE-4FDE-9301-752AB8E3453F</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:5758DAC0-E1C0-49EB-BE9C-56FFBAF3B6F4</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:570DA392-7779-456C-9C18-1FC0E579BBE6</domeo:belongsToSet>
    <pav:createdOn>2014-07-15 14:03:26 -0700</pav:createdOn>
    <pav:lastSavedOn>2014-07-15 14:04:06 -0700</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:1575950D-32D4-46DE-A44F-8E9E614F997F</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:FA8D1DAC-C616-456C-BB3D-29F18DED21A1</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:2E5CE73B-BFD4-4E35-9A07-D5E37A9E87AE</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E8194531-C5B3-43AE-BC13-14A252C54824</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:8F5BD518-01AA-46D8-B893-6470B014CC3B">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2014-07-15 14:17:13 -0700</pav:createdOn>
    <domeo:uuid>8F5BD518-01AA-46D8-B893-6470B014CC3B</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:8F5BD518-01AA-46D8-B893-6470B014CC3B"/>
    <domeo:uuid></domeo:uuid>
    <ao:prefix>The apparent half-life of </ao:prefix>
    <ao:suffix> was 3 hours (CV=30%) in extensive metabolizers and 20 hours (CV=40%) in poor metabolizers. The apparent half-life of 9-hydroxyrisperidone was about 21 hours (CV=20%) in extensive metabolizers and 30 hours (CV=25%) in poor metabolizers. The pharmacokinet</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <ao:exact>risperidone</ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:D9907CFF-B778-4B29-8773-70DE74FE7759">
    <pav:createdOn>2014-07-15 14:09:46 -0700</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>9-hydroxyrisperidone</ao:exact>
    <domeo:uuid></domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:D9907CFF-B778-4B29-8773-70DE74FE7759"/>
    <ao:prefix> at 10 ng/mL and </ao:prefix>
    <domeo:uuid>D9907CFF-B778-4B29-8773-70DE74FE7759</domeo:uuid>
    <ao:suffix> at 50 ng/mL, changes of unknown clinical significance.</ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoserver:annotationset:C2A39432-076D-421D-8007-22690EDA5A0C">
    <ao:item rdf:resource="urn:domeoclient:uuid:A9B54FB4-D4A5-4FA0-ABB3-A05CFA1F5934"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:DCA6DB56-8ED4-4BF0-9368-16ACBA6F82AE"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:C8EE5491-20E0-446F-BE4F-48D8F8CDCAB9"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:CA979FCE-441A-47D4-9797-5CC727F01663"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:A2FA427B-9D1C-4042-8796-682C2C547E30"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:B7CDA6B5-18B6-4EB0-A176-5FA6DF4BD169"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:EB1F59F5-F04B-4836-B1C9-90E20E62B91E"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:9B234C79-AB11-4626-BB32-A29D819B57BA"/>
    <domeo:deleted>false</domeo:deleted>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">3</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotationset:03DD4E8D-1756-4822-B979-A160AAF90F82</pav:lineageUri>
    <rdfs:label>Default Set</rdfs:label>
    <ao:item rdf:resource="urn:domeoclient:uuid:5DCE0D50-99F3-4301-8B36-DE5F9A87ECDD"/>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046812afe0146812ce85a0000"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:05F3AC40-8EB1-409A-9E01-317E8C07400C"/>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <pav:previousVersion>urn:domeoserver:annotationset:B3F0B84F-756D-4724-B177-98D0D290D00D</pav:previousVersion>
    <ao:item rdf:resource="urn:domeoclient:uuid:F77BE7E4-398E-4B73-9848-3A5055B88BD4"/>
    <pav:lastSavedOn>2014-07-16 17:10:58 -0400</pav:lastSavedOn>
    <ao:item rdf:resource="urn:domeoclient:uuid:7EF340BC-FC51-443A-B404-48D9728F2E15"/>
    <permissions:permissions rdf:nodeID="N43f8f8c529d64181827d8af0ede55d07"/>
    <pav:createdOn>2014-07-16 14:03:15 -0700</pav:createdOn>
    <ao:item rdf:resource="urn:domeoclient:uuid:0C9C3F3B-D652-4BC5-8BE9-2D01F09D0D62"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-21.txt.html</ao:annotatesResource>
    <dct:description>The default set is created automatically by Domeo when no other set is existing.</dct:description>
    <ao:item rdf:resource="urn:domeoclient:uuid:73C19DFA-F31A-4286-BFC2-5C8757F59492"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:844AAE28-6A60-487D-810E-79FA4BF0CAB5">
    <domeo:belongsToSet>urn:domeoclient:uuid:51A184F8-19CA-4489-AB8F-9AF92E4BE5BE</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotationset:1EE1D64B-EDD4-4170-B797-D8F83B927DCE</pav:lineageUri>
    <pav:lastSavedOn>2014-07-18 14:20:41 -0700</pav:lastSavedOn>
    <pav:createdOn>2014-07-18 14:20:30 -0700</pav:createdOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:7BA312DF-BB65-4A90-8B7D-A54425D7C553</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-18 17:20:41 -0400</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotation:18A893DA-4C4B-4AF8-833C-C9A6F6962271</pav:lineageUri>
    <ao:context rdf:resource="urn:domeoclient:uuid:C0577481-DCD6-4058-A293-BB8EFDB9B578"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoserver:annotationset:FA8D1DAC-C616-456C-BB3D-29F18DED21A1">
    <ao:item rdf:resource="urn:domeoclient:uuid:312701AC-EC1C-4292-B01F-44DD40979EEA"/>
    <rdfs:label>Default Set</rdfs:label>
    <ao:item rdf:resource="urn:domeoclient:uuid:6EB13D46-B414-424C-9D7C-BADA59079327"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:F87C43FC-DD9B-42FA-953B-C8C25AA48C91"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lastSavedOn>2014-07-15 17:07:58 -0400</pav:lastSavedOn>
    <ao:item rdf:resource="urn:domeoclient:uuid:A056C491-9BB0-438A-A716-FE909F2281AD"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:BFCAC108-C978-4C7B-A79A-9887A3CA3C6C"/>
    <pav:lineageUri>urn:domeoserver:annotationset:75FC1225-8399-469B-AE9D-7F697713E6AC</pav:lineageUri>
    <ao:item rdf:resource="urn:domeoclient:uuid:34A66F13-B248-4FD8-A3CE-7AAAC40B7ACC"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:12CCDE72-9FC0-4264-A3F2-C533F792F613"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:82FFD7F0-AC94-462F-BA86-70CFD849B686"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:D1D92634-CB40-4585-8260-1917D2119CC7"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:0A8134EE-D8E3-447B-9EB9-2CB597651AB4"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:C66BBCCE-CA43-44FB-8D97-2084E19C48FF"/>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046812afe0146812ce85a0000"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:D1062598-B310-4CF4-8237-5F8F8F74933F"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:90386835-AD59-4BAA-A860-3003ABCAF86C"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:24886D93-A995-41A8-9E66-1BF6DF77E9D2"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:A1A5580F-53D7-4F22-824E-5430565EDBF1"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:785FFE99-34A3-41C7-A3D5-65DC60E0807D"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
    <ao:item rdf:resource="urn:domeoclient:uuid:2AAEA179-90D2-4661-9105-64A780850DEB"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:ADFEE70E-EDC2-4D08-90AB-0ABAFD52BC6F"/>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:annotatesResource>
    <ao:item rdf:resource="urn:domeoclient:uuid:4D3BA7C7-A806-41A4-84AC-38A85FF0F9C2"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">2</pav:versionNumber>
    <ao:item rdf:resource="urn:domeoclient:uuid:E2A636FF-8FE8-44E9-B454-573E4E7470FA"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:6F7C3F13-3AE2-43EA-93D3-9F0AF79252AC"/>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:65047D28-4B70-4701-B243-A146C45926A7"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:D2174191-CE1D-4EF2-8DD5-03008A9706DE"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:5415B79F-FEAF-4999-A78E-2C1039116F7C"/>
    <permissions:permissions rdf:nodeID="N415318f07c154292bae45e2099521a0c"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:12D5CA7C-401C-4376-A246-03585C5F9AC0"/>
    <domeo:deleted>false</domeo:deleted>
    <pav:createdOn>2014-07-15 14:02:34 -0700</pav:createdOn>
    <pav:previousVersion>urn:domeoclient:uuid:9B307D8B-D2B0-4795-8850-FAAAAC6B5AF4</pav:previousVersion>
    <dct:description>The default set is created automatically by Domeo when no other set is existing.</dct:description>
    <ao:item rdf:resource="urn:domeoclient:uuid:199E47E3-ECB3-4CC4-AF72-217C37FF517C"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:95BD0C2B-0FA9-43F6-AC62-608DC7F301DE">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:6DBCB873-26F3-4E6A-9BD4-311369B43736</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotation:F8282F99-351D-45A5-87BE-3CB2CADBE643</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
    <pav:lastSavedOn>2014-07-18 17:03:19 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotationset:9AA0507C-281E-45C8-9719-03E66F12C069</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoclient:uuid:E65FF29A-8FE7-4D0E-A93C-4DA8136F4956</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdOn>2014-07-18 14:02:56 -0700</pav:createdOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:FC34EFC8-BB07-4B83-AD21-D8DD09AB286D"/>
    <pav:lastSavedOn>2014-07-18 14:03:19 -0700</pav:lastSavedOn>
    <rdfs:label>Highlight</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:6684B979-BD2C-446B-B807-178AE44EB6F8">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid>6684B979-BD2C-446B-B807-178AE44EB6F8</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:6684B979-BD2C-446B-B807-178AE44EB6F8"/>
    <pav:createdOn>2014-07-15 14:03:26 -0700</pav:createdOn>
    <ao:prefix>Absorption: </ao:prefix>
    <ao:exact>Risperidone</ao:exact>
    <domeo:uuid></domeo:uuid>
    <ao:suffix> is well absorbed. The absolute oral bioavailability of risperidone is 70% (CV=25%). The relative oral bioavailability of risperidone from a tablet is 94% (CV=10%) when compared to a solution.</ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:BEAE7606-F223-4295-A5D4-C1A750C28439">
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:92A39181-37D0-41C9-B1A9-CE76BFF02C6F"/>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoserver:annotationset:2E5CE73B-BFD4-4E35-9A07-D5E37A9E87AE">
    <ao:item rdf:resource="urn:domeoclient:uuid:7DF78E91-4010-455D-9300-16EAD7D6AB87"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:A056C491-9BB0-438A-A716-FE909F2281AD"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:C1A443CA-B8D4-4A28-825B-B97ECDEC88D7"/>
    <dct:description>The default set is created automatically by Domeo when no other set is existing.</dct:description>
    <ao:item rdf:resource="urn:domeoclient:uuid:BF8175E8-F52D-4CE3-9DE9-BAE3E2CE04A1"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:34A66F13-B248-4FD8-A3CE-7AAAC40B7ACC"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:446899E9-2BB7-4629-AA6E-75AF9EC38F08"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:CA792FCD-C812-49FE-9EDF-15DA0F056A53"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:4D3BA7C7-A806-41A4-84AC-38A85FF0F9C2"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:82FFD7F0-AC94-462F-BA86-70CFD849B686"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:6EB13D46-B414-424C-9D7C-BADA59079327"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:D1D92634-CB40-4585-8260-1917D2119CC7"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:item rdf:resource="urn:domeoclient:uuid:0A8134EE-D8E3-447B-9EB9-2CB597651AB4"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:C66BBCCE-CA43-44FB-8D97-2084E19C48FF"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:12CCDE72-9FC0-4264-A3F2-C533F792F613"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:A5A82A3B-FE45-46DE-9048-8E85995D8F43"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:A1A5580F-53D7-4F22-824E-5430565EDBF1"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:F87C43FC-DD9B-42FA-953B-C8C25AA48C91"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:BFCAC108-C978-4C7B-A79A-9887A3CA3C6C"/>
    <pav:lineageUri>urn:domeoserver:annotationset:75FC1225-8399-469B-AE9D-7F697713E6AC</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:2AAEA179-90D2-4661-9105-64A780850DEB"/>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:annotatesResource>
    <ao:item rdf:resource="urn:domeoclient:uuid:D1062598-B310-4CF4-8237-5F8F8F74933F"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:90386835-AD59-4BAA-A860-3003ABCAF86C"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:24886D93-A995-41A8-9E66-1BF6DF77E9D2"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:785FFE99-34A3-41C7-A3D5-65DC60E0807D"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">3</pav:versionNumber>
    <ao:item rdf:resource="urn:domeoclient:uuid:DC20D454-AAA8-4A81-915D-03526B8FC40B"/>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046812afe0146812ce85a0000"/>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:68AD55C4-223A-46C6-896A-87345A781B61"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:ADFEE70E-EDC2-4D08-90AB-0ABAFD52BC6F"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:E2A636FF-8FE8-44E9-B454-573E4E7470FA"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:6F7C3F13-3AE2-43EA-93D3-9F0AF79252AC"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:274D4FB3-81D3-46CA-BE6A-31286B260E56"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:D2174191-CE1D-4EF2-8DD5-03008A9706DE"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:5415B79F-FEAF-4999-A78E-2C1039116F7C"/>
    <permissions:permissions rdf:nodeID="Ncdc9507dadc748aebfb4babe734b11c0"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:76E5F11A-7EC2-4412-BCB7-E9B0542040DE"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:A3DBEE5E-C93B-4DBE-A1E3-317DA19FA203"/>
    <domeo:deleted>false</domeo:deleted>
    <ao:item rdf:resource="urn:domeoclient:uuid:7443907B-C475-4EA4-B081-8C3D55A1EF69"/>
    <pav:previousVersion>urn:domeoserver:annotationset:FA8D1DAC-C616-456C-BB3D-29F18DED21A1</pav:previousVersion>
    <ao:item rdf:resource="urn:domeoclient:uuid:12D5CA7C-401C-4376-A246-03585C5F9AC0"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:1453C795-84C1-4C48-AF84-AEEE18ED1682"/>
    <pav:lastSavedOn>2014-07-15 17:11:14 -0400</pav:lastSavedOn>
    <pav:createdOn>2014-07-15 14:02:34 -0700</pav:createdOn>
    <ao:item rdf:resource="urn:domeoclient:uuid:DA483938-DFFC-4F6C-85C3-FED68E6D4DE8"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:312701AC-EC1C-4292-B01F-44DD40979EEA"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:65047D28-4B70-4701-B243-A146C45926A7"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:A2215D32-FF99-4DC9-90B9-5C350C098EEB"/>
    <rdfs:label>Default Set</rdfs:label>
    <ao:item rdf:resource="urn:domeoclient:uuid:A526C161-102B-469E-9242-8D2CB0C94450"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:797BAFBC-5256-4C7D-9ACC-064403D70DDB"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:BED0BB6E-5962-4714-A49A-2DB5A1787334"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:EB1F59F5-F04B-4836-B1C9-90E20E62B91E">
    <ao:context rdf:resource="urn:domeoclient:uuid:B419ACAE-832E-406D-9427-D88D93B6A405"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:C2A39432-076D-421D-8007-22690EDA5A0C</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lastSavedOn>2014-07-16 14:07:53 -0700</pav:lastSavedOn>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lastSavedOn>2014-07-16 17:07:51 -0400</pav:lastSavedOn>
    <pav:createdOn>2014-07-16 14:07:45 -0700</pav:createdOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:AD2FD8CD-1032-462E-833D-451021CE67B2</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:B3F0B84F-756D-4724-B177-98D0D290D00D</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-16 17:07:53 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotation:AF88B107-1B45-4CD4-A63F-0DC626B375A8</pav:lineageUri>
    <pav:lineageUri>urn:domeoserver:annotation:657A398B-E79F-46DD-A0A7-D82ADD011110</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
    <pav:previousVersion>xsd:String</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:32BA85DE-7726-48C4-99FF-A828C5E2713A">
    <domeo:uuid></domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:32BA85DE-7726-48C4-99FF-A828C5E2713A"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>32BA85DE-7726-48C4-99FF-A828C5E2713A</domeo:uuid>
    <pav:createdOn>2014-07-15 14:18:35 -0700</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix> in plasma was increased by about 35% because of the diminished concentration of both albumin and α1-acid glycoprotein. Risperidone doses should be reduced in patients with liver disease [see 2 DOSAGE AND ADMINISTRATION and 5 WARNINGS AND PRECAUTIONS].</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <ao:prefix> in subjects with liver disease were comparable to those in young healthy subjects, the mean free fraction of </ao:prefix>
    <ao:exact>risperidone</ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoserver:annotationset:B480EE53-5881-4650-9D82-D1F972071243">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">2</pav:versionNumber>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:3564DC3A-4069-432B-A29D-98AB86C42DF6"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:547CD07E-3BE0-408B-82B7-99021E41003B"/>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046812afe0146812ce85a0000"/>
    <dct:description>The default set is created automatically by Domeo when no other set is existing.</dct:description>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:8C676DD4-0D35-4578-AF3F-F66853FF712A"/>
    <pav:lastSavedOn>2014-07-18 17:08:08 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
    <domeo:deleted>false</domeo:deleted>
    <ao:item rdf:resource="urn:domeoclient:uuid:9E954CE3-F61D-4171-A4FE-6FAE429FF615"/>
    <pav:createdOn>2014-07-18 14:07:10 -0700</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotationset:B136901C-38A0-4F12-B35D-BF814374DB34</pav:lineageUri>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-29.txt.html</ao:annotatesResource>
    <pav:previousVersion>urn:domeoclient:uuid:346C4DA6-A4F5-4B6F-AADB-4E76B1FDE36F</pav:previousVersion>
    <rdfs:label>Default Set</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:item rdf:resource="urn:domeoclient:uuid:1B6D54E8-D781-4B59-A1BC-6120E5CF9015"/>
    <permissions:permissions rdf:nodeID="Ncb4832c4e4724406a354f03e0fe85ae0"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:D1D04FEE-3479-4F04-B0D6-9FC8F29285CE">
    <pav:createdOn>2014-07-17 15:54:16 -0700</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:D1D04FEE-3479-4F04-B0D6-9FC8F29285CE"/>
    <ao:prefix> AUC of 13% ± 11% (range: -3.4 to -31%) and Cmax decreased 19% ± 14% (range: -5 to -40%). However, the administration of </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>cimetidine</ao:exact>
    <ao:hasSource>				http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-23.txt.html																													</ao:hasSource>
    <domeo:uuid>D1D04FEE-3479-4F04-B0D6-9FC8F29285CE</domeo:uuid>
    <ao:suffix> 600 mg to 900 mg intravenously over a four-hour period (from one hour before to 3 hours after a single oral dose of fluconazole 200 mg) did not affect the bioavailability or pharmacokinetics of fluconazole in 24 healthy male volunteers.</ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:2AA708F1-622C-4D5D-9D25-2946E06DCDDB">
    <ao:exact>pharmacokinetics of theophylline were determined from a single intravenous dose of aminophylline (6 mg/kg) before and after the oral administration of fluconazole 200 mg daily for 14 days in 16 normal male volunteers. There were significant increases in theophylline AUC, Cmax, and half-life with a corresponding decrease in clearance. The mean ± SD theophylline AUC increased 21% ± 16% (range: -5 to 48%). The Cmax increased 13% ± 17% (range: -13 to 40%). Theophylline clearance decreased 16% ± 11 % (range: -32 to 5%). The half-life of theophylline increased from 6.6 ± 1.7 hours to 7.9 ± 1.5 hours</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix>The </ao:prefix>
    <domeo:uuid>2AA708F1-622C-4D5D-9D25-2946E06DCDDB</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:2AA708F1-622C-4D5D-9D25-2946E06DCDDB"/>
    <pav:createdOn>2014-07-18 14:05:17 -0700</pav:createdOn>
    <ao:suffix>. (See PRECAUTIONS.</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-28.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:C1AC6F60-3C7C-4BEB-9095-25D25890AC79">
    <ao:exact>sildenafil</ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:C1AC6F60-3C7C-4BEB-9095-25D25890AC79"/>
    <ao:prefix> was 28%, resulting in about 22% lower mean average steady state concentrations. Therefore, the slight decrease of </ao:prefix>
    <domeo:uuid>C1AC6F60-3C7C-4BEB-9095-25D25890AC79</domeo:uuid>
    <ao:suffix> exposure in the presence of epoprostenol is not considered clinically relevant. The effect of sildenafil on epoprostenol pharmacokinetics is not known.</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2014-07-10 11:20:29 -0700</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:EE1BA765-A716-44E9-BE81-971BDF21154E">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoclient:uuid:B8452517-26D0-419F-88FD-A818925FDE06</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdOn>2014-07-18 13:51:15 -0700</pav:createdOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
    <pav:lineageUri>urn:domeoserver:annotation:A333DBF9-EA93-491F-AA00-B054BE6A4C4E</pav:lineageUri>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lastSavedOn>2014-07-18 16:51:47 -0400</pav:lastSavedOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:EEA8D937-1DA8-4F98-9D1E-B48786184636"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:3E2E0F2D-3281-4126-8A9C-921B0A849990">
    <ao:suffix> and norethindrone compared to similar placebo dosing. The mean AUCs of ethinyl estradiol and norethindrone increased by 24% (95% C.I. range 18 to 31%) and 13% (95% C.I. range 8 to 18%), respectively relative to placebo. Fluconazole treatment did not cau</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-21.txt.html</ao:hasSource>
    <ao:prefix>dosing resulted in small increases in the mean AUCs of </ao:prefix>
    <ao:exact>ethinyl estradiol</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:3E2E0F2D-3281-4126-8A9C-921B0A849990"/>
    <pav:createdOn>2014-07-16 14:03:46 -0700</pav:createdOn>
    <domeo:uuid>3E2E0F2D-3281-4126-8A9C-921B0A849990</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid></domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:D75527AE-44F3-49BF-B7AB-31C1D6E91722">
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lastSavedOn>2014-07-18 13:48:39 -0700</pav:lastSavedOn>
    <pav:lastSavedOn>2014-07-18 16:48:39 -0400</pav:lastSavedOn>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoclient:uuid:53775C4C-7CC4-46EB-9EFC-EDF9D3D264ED</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:2C01868C-4CA4-41F7-878B-4BF3487A2B98"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A7F21A3D-50B3-495E-884A-2C707B40C763</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lineageUri>urn:domeoserver:annotation:B9529634-6409-4BA9-BC03-9656D0B66443</pav:lineageUri>
    <pav:createdOn>2014-07-18 13:48:05 -0700</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotationset:748BB253-1066-4977-91B2-35D8C6906790</pav:lineageUri>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:60698783-AF86-402C-ADB4-1162CCD89EBA">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid>60698783-AF86-402C-ADB4-1162CCD89EBA</domeo:uuid>
    <ao:exact>study evaluated the potential interaction of once weekly dosing of fluconazole 300 mg to 21 normal females taking an oral contraceptive containing ethinyl estradiol and norethindrone. In this placebo-controlled, double-blind, randomized, two-way crossover study carried out over three cycles of oral contraceptive treatment, fluconazole dosing resulted in small increases in the mean AUCs of ethinyl estradiol and norethindrone compared to similar placebo dosing. The mean AUCs of ethinyl estradiol and norethindrone increased by 24% (95% C.I. range 18 to 31%) and 13% (95% C.I. range 8 to 18%), respectively relative to placebo. Fluconazole treatment did not cause a decrease in the ethinyl estradiol AUC of any individual subject in this study compared to placebo dosing. The individual AUC values of norethindrone decreased very slightly (&lt;5%) in 3 of the 21 subjects after fluconazole treatment</ao:exact>
    <ao:prefix>A third </ao:prefix>
    <ao:suffix>xsd:String</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:60698783-AF86-402C-ADB4-1162CCD89EBA"/>
    <pav:createdOn>2014-07-16 14:09:37 -0700</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-21.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:23BAF555-C96E-4707-8EBA-34BCE14B71F5">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:23BAF555-C96E-4707-8EBA-34BCE14B71F5"/>
    <ao:exact>rifampin</ao:exact>
    <ao:prefix> after 15 days of </ao:prefix>
    <pav:createdOn>2014-07-18 13:43:13 -0700</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid>23BAF555-C96E-4707-8EBA-34BCE14B71F5</domeo:uuid>
    <ao:suffix> administered as 600 mg daily in eight healthy male volunteers resulted in a significant decrease in fluconazole AUC and a significant increase in apparent oral clearance of fluconazole. There was a mean ± SD reduction in fluconazole AUC of 23% ± 9% (ran</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-24.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:4E57D817-C3D5-47E5-AECC-169C5A1EF60D">
    <pav:lineageUri>urn:domeoserver:annotationset:C94BECCE-E3E9-4B70-AC23-F715B9D3EEFF</pav:lineageUri>
    <ao:item rdf:resource="urn:domeoclient:uuid:B2690ED3-4A3B-4FA6-84FF-6800464F3D50"/>
    <domeo:deleted>false</domeo:deleted>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <permissions:permissions rdf:nodeID="N6d28ced8003844fea33c1556745360c5"/>
    <rdfs:label>Default Set</rdfs:label>
    <ao:item rdf:resource="urn:domeoclient:uuid:D590AF4F-FC05-41EA-8CBC-29156060B437"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:6F6FACEE-5C35-4020-BE6D-26958BA10CA6"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:B230469B-00AA-4A73-A839-6D9826213D36"/>
    <pav:createdOn>2014-07-17 15:53:34 -0700</pav:createdOn>
    <pav:lastSavedOn>2014-07-17 18:54:46 -0400</pav:lastSavedOn>
    <ao:annotatesResource>				http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-23.txt.html																													</ao:annotatesResource>
    <dct:description>The default set is created automatically by Domeo when no other set is existing.</dct:description>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046812afe0146812ce85a0000"/>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:BD319A5A-0B87-457E-BF99-76BC4728CC77"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:95E933E3-09F5-4362-96D4-CF14B045A370"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:item rdf:resource="urn:domeoclient:uuid:079A4E14-C541-4AC8-B876-063FC489849B"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:C5D9EC69-52E2-48F5-B3D8-867DE23DEC96">
    <pav:lineageUri>urn:domeoserver:annotationset:8ABB5677-3B0A-44AC-B5F0-95374283E66A</pav:lineageUri>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-20.txt.html</ao:annotatesResource>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lastSavedOn>2014-07-16 13:36:37 -0400</pav:lastSavedOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdfs:label>Default Set</rdfs:label>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
    <ao:item rdf:resource="urn:domeoclient:uuid:C966BEAA-709F-4F5C-9638-F94D75B69135"/>
    <permissions:permissions rdf:nodeID="N80221a75a9164b95951a0153fd8ac4b3"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:C039DC79-C2B3-4581-A409-2060854712D2"/>
    <domeo:deleted>false</domeo:deleted>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046812afe0146812ce85a0000"/>
    <pav:createdOn>2014-07-16 10:36:03 -0700</pav:createdOn>
    <dct:description>The default set is created automatically by Domeo when no other set is existing.</dct:description>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:7A6A4F43-E19F-4F5E-BBA6-D0937A988F58">
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <dikbD2R:modality>ncit:negative</dikbD2R:modality>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:71C7EBFE-DDAD-400D-8A02-566CA152276C"/>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:8C39EA63-3E52-40B4-8935-6ADC75CCA74D">
    <domeo:agents rdf:resource="urn:person:uuid:080e143046812afe0146812ce85a0000"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:5DCE0D50-99F3-4301-8B36-DE5F9A87ECDD"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:7EF340BC-FC51-443A-B404-48D9728F2E15"/>
    <pav:lastSavedOn>2014-07-16 17:06:30 -0400</pav:lastSavedOn>
    <ao:item rdf:resource="urn:domeoclient:uuid:0C9C3F3B-D652-4BC5-8BE9-2D01F09D0D62"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotationset:03DD4E8D-1756-4822-B979-A160AAF90F82</pav:lineageUri>
    <ao:item rdf:resource="urn:domeoclient:uuid:CA979FCE-441A-47D4-9797-5CC727F01663"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:F77BE7E4-398E-4B73-9848-3A5055B88BD4"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-21.txt.html</ao:annotatesResource>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <domeo:deleted>false</domeo:deleted>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:73C19DFA-F31A-4286-BFC2-5C8757F59492"/>
    <rdfs:label>Default Set</rdfs:label>
    <ao:item rdf:resource="urn:domeoclient:uuid:A2FA427B-9D1C-4042-8796-682C2C547E30"/>
    <permissions:permissions rdf:nodeID="N38ce0769c3e6448788fb649cd2cfa456"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:4D132ADB-A976-4F25-A18F-56BA89AC252A"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
    <ao:item rdf:resource="urn:domeoclient:uuid:05F3AC40-8EB1-409A-9E01-317E8C07400C"/>
    <dct:description>The default set is created automatically by Domeo when no other set is existing.</dct:description>
    <ao:item rdf:resource="urn:domeoclient:uuid:B7CDA6B5-18B6-4EB0-A176-5FA6DF4BD169"/>
    <pav:createdOn>2014-07-16 14:03:15 -0700</pav:createdOn>
    <ao:item rdf:resource="urn:domeoclient:uuid:C8EE5491-20E0-446F-BE4F-48D8F8CDCAB9"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:B8F6DECD-B84A-439C-AB5B-FD0E059E3FAC">
    <pav:createdOn>2014-07-15 14:31:21 -0700</pav:createdOn>
    <domeo:uuid></domeo:uuid>
    <ao:prefix>xsd:String</ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:B8F6DECD-B84A-439C-AB5B-FD0E059E3FAC"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid>B8F6DECD-B84A-439C-AB5B-FD0E059E3FAC</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <ao:exact>carbamazepine</ao:exact>
    <ao:suffix>xsd:String</ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:3E0194D4-524A-4E69-B161-52FB98ED36C2">
    <pav:lineageUri>urn:domeoserver:annotationset:BE290CA3-79BD-411A-BE2E-69AA4D19607D</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">6</pav:versionNumber>
    <ao:context rdf:resource="urn:domeoclient:uuid:46F4178C-1487-4F57-A6D9-06D0CE8BE565"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
    <domeo:belongsToSet>urn:domeoserver:annotationset:239B4C6D-1110-4B65-AC66-F8A394187814</domeo:belongsToSet>
    <pav:previousVersion>urn:domeoserver:annotationset:2BFC2FB6-6BE9-4822-A245-973533533023</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:516C333C-B517-4F84-999E-51185DD6E859</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lastSavedOn>2014-07-10 11:21:41 -0700</pav:lastSavedOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdOn>2014-07-10 11:20:21 -0700</pav:createdOn>
    <pav:lastSavedOn>2014-07-10 14:21:41 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:970963DF-8BCE-4936-9DFC-328A36014E1B</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotation:DAEB03B6-4208-448B-BFFF-F0154B8F673F</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:15A537D1-5648-41B2-8BFA-0D0BA3DF4393</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/EDAB886F-D798-49C1-A0C4-ED5754179815">
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <rdfs:label>risperidone</rdfs:label>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/35636</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:E65FF29A-8FE7-4D0E-A93C-4DA8136F4956">
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046812afe0146812ce85a0000"/>
    <dct:description>The default set is created automatically by Domeo when no other set is existing.</dct:description>
    <ao:item rdf:resource="urn:domeoclient:uuid:A5A2521E-A463-45F1-BFC8-4843561F5EFD"/>
    <domeo:deleted>false</domeo:deleted>
    <pav:lineageUri>urn:domeoserver:annotationset:9AA0507C-281E-45C8-9719-03E66F12C069</pav:lineageUri>
    <ao:item rdf:resource="urn:domeoclient:uuid:0216B801-6401-4E8A-B678-5222EA6AA098"/>
    <rdfs:label>Default Set</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:7A5B87F1-0D90-49BD-B71F-1710FF095850"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:701FB70F-31F1-4E69-B54F-77820E603E4C"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:item rdf:resource="urn:domeoclient:uuid:CFF4DD39-5FB5-46B5-9868-D724A30FB42C"/>
    <pav:createdOn>2014-07-18 14:02:36 -0700</pav:createdOn>
    <permissions:permissions rdf:nodeID="Nbe9b47c3a0ec4d5bb46340cdbeb7d951"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:95BD0C2B-0FA9-43F6-AC62-608DC7F301DE"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:5280B7DB-AA4C-46FE-AB43-85E58C828264"/>
    <pav:lastSavedOn>2014-07-18 17:03:19 -0400</pav:lastSavedOn>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-28.txt.html</ao:annotatesResource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:9B234C79-AB11-4626-BB32-A29D819B57BA">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:C2A39432-076D-421D-8007-22690EDA5A0C</domeo:belongsToSet>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotation:A7878F85-BB08-493B-BAC8-A9CE6B2E5167</pav:lineageUri>
    <pav:createdOn>2014-07-16 14:10:22 -0700</pav:createdOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:body rdf:nodeID="N47b9d4e6b59b4ed4ba29024782538a0f"/>
    <pav:lastSavedOn>2014-07-16 17:10:58 -0400</pav:lastSavedOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:F11CBAD8-E220-415C-81B8-EC30E7A34762"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:ADF2DC89-FCCE-47DE-8493-BEC599C898E4">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lastSavedOn>2014-07-16 10:20:50 -0700</pav:lastSavedOn>
    <pav:lastSavedOn>2014-07-16 13:20:50 -0400</pav:lastSavedOn>
    <pav:createdOn>2014-07-16 10:19:32 -0700</pav:createdOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:DA8D6B42-B41F-4576-BF10-1285DF3EAB80</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:F5EA08DB-0874-466C-8ADD-16FB922B834F"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:AAD02A4C-E01E-4C82-BC8A-D0F4639844FA</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotation:A08BB6C9-21B5-4D9C-BA66-1DD976AB3E41</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:6FFFF211-BFDC-4E16-968C-A296868530C4</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoclient:uuid:2F716A41-B68F-48AE-B5C1-E31F1704C565</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
    <pav:lineageUri>urn:domeoserver:annotationset:C8D7FDC6-6816-4BD4-BC7F-88ABDCC37D79</pav:lineageUri>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:A4CB337C-2A42-4BB9-AADC-A7635FC3DAA5">
    <domeo:uuid>A4CB337C-2A42-4BB9-AADC-A7635FC3DAA5</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:A4CB337C-2A42-4BB9-AADC-A7635FC3DAA5"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix>ridone is 90%, and that of its major metabolite, 9-hydroxyrisperidone, is 77%. Neither risperidone nor 9-hydroxyrisperidone displaces each other from plasma binding sites. High therapeutic concentrations of sulfamethazine (100 mcg/mL), warfarin (10 mcg/m</ao:suffix>
    <ao:exact> rispe</ao:exact>
    <pav:createdOn>2014-07-15 14:07:44 -0700</pav:createdOn>
    <ao:prefix> is bound to albumin and α1-acid glycoprotein. The plasma protein binding of</ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:5D7443E0-0C82-47A0-A810-6FF473FEFEEF">
    <ao:suffix>e oral solution is bioequivalent to risperidone tablets.</ao:suffix>
    <domeo:uuid>5D7443E0-0C82-47A0-A810-6FF473FEFEEF</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix>Pharmacokinetic studies showed that </ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:5D7443E0-0C82-47A0-A810-6FF473FEFEEF"/>
    <pav:createdOn>2014-07-15 14:03:52 -0700</pav:createdOn>
    <ao:exact>risperidon</ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:3F6F9929-F258-49DD-AEE9-BEC5C27775EF">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix> 200 mg) did not affect the bioavailability or pharmacokinetics of fluconazole in 24 healthy male volunteers.</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-23.txt.html</ao:hasSource>
    <ao:prefix> 600 mg to 900 mg intravenously over a four-hour period (from one hour before to 3 hours after a single oral dose of </ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:3F6F9929-F258-49DD-AEE9-BEC5C27775EF"/>
    <pav:createdOn>2014-07-16 15:40:36 -0700</pav:createdOn>
    <domeo:uuid></domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>fluconazole</ao:exact>
    <domeo:uuid>3F6F9929-F258-49DD-AEE9-BEC5C27775EF</domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:6293CB80-DCD6-4620-8C0D-569FB4C95073">
    <pav:createdOn>2014-07-16 10:18:56 -0700</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <domeo:uuid></domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>Risperidone</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix> acts as an antagonist at other receptors, but with lower potency. Risperidone has low to moderate affinity (Ki of 47 to 253 nM) for the serotonin 5HT1C, 5HT1D, and 5HT1A receptors, weak affinity (Ki of 620 to 800 nM) for the dopamine D1 and haloperidol-</ao:suffix>
    <ao:prefix> is a selective monoaminergic antagonist with high affinity (Ki of 0.12 to 7.3 nM) for the serotonin Type 2 (5HT2), dopamine Type 2 (D2), α1 and α2 adrenergic, and H1 histaminergic receptors. </ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:6293CB80-DCD6-4620-8C0D-569FB4C95073"/>
    <domeo:uuid>6293CB80-DCD6-4620-8C0D-569FB4C95073</domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:A056C491-9BB0-438A-A716-FE909F2281AD">
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdOn>2014-07-15 14:06:41 -0700</pav:createdOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">2</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E8194531-C5B3-43AE-BC13-14A252C54824</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:5B6A462D-57EA-4BBD-87E1-A0EC2FAF5196</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:21B0E479-04F9-4D66-B396-B773EFE53882</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:883587E1-49C1-4EE0-909E-4ADBAE13DD3A</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:53F2EA0B-B02F-4D15-A55E-843D837795E4"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E6A1493E-98EE-4FDE-9301-752AB8E3453F</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:46636445-93A2-49F0-9E9C-5AEBF17046D2</domeo:belongsToSet>
    <pav:previousVersion>urn:domeoclient:uuid:9B307D8B-D2B0-4795-8850-FAAAAC6B5AF4</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:5758DAC0-E1C0-49EB-BE9C-56FFBAF3B6F4</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:570DA392-7779-456C-9C18-1FC0E579BBE6</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-15 17:07:58 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:1575950D-32D4-46DE-A44F-8E9E614F997F</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-15 17:07:57 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:2E5CE73B-BFD4-4E35-9A07-D5E37A9E87AE</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
    <pav:lastSavedOn>2014-07-15 14:07:58 -0700</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:FA8D1DAC-C616-456C-BB3D-29F18DED21A1</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotation:C2D00ABD-F3D8-4CAF-B9E3-93477FF3BA0F</pav:lineageUri>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9C0B4E8B-9FFE-4E47-9B4C-A6EA4527A384</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotation:A629C3E1-D942-4E4E-B01A-1BA3AB97BC58</pav:lineageUri>
    <pav:lineageUri>urn:domeoserver:annotationset:75FC1225-8399-469B-AE9D-7F697713E6AC</pav:lineageUri>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:547CD07E-3BE0-408B-82B7-99021E41003B">
    <ao:context rdf:resource="urn:domeoclient:uuid:A420EA3F-BB84-4220-A684-2224CB4B6C3D"/>
    <pav:lastSavedOn>2014-07-18 14:07:26 -0700</pav:lastSavedOn>
    <rdfs:label>Highlight</rdfs:label>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotation:B81F7688-83C9-4AFB-998C-B3DB99A2D1D4</pav:lineageUri>
    <pav:lineageUri>urn:domeoserver:annotationset:B136901C-38A0-4F12-B35D-BF814374DB34</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdOn>2014-07-18 14:07:15 -0700</pav:createdOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:B480EE53-5881-4650-9D82-D1F972071243</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
    <domeo:belongsToSet>urn:domeoclient:uuid:346C4DA6-A4F5-4B6F-AADB-4E76B1FDE36F</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lastSavedOn>2014-07-18 17:07:27 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:6B42267E-6924-4453-B105-2F66C330186C">
    <pav:lineageUri>urn:domeoserver:annotationset:C8D7FDC6-6816-4BD4-BC7F-88ABDCC37D79</pav:lineageUri>
    <pav:lastSavedOn>2014-07-16 13:20:50 -0400</pav:lastSavedOn>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoclient:uuid:2F716A41-B68F-48AE-B5C1-E31F1704C565</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotation:144A8F9C-6A69-42D9-8217-86B363E9039F</pav:lineageUri>
    <ao:context rdf:resource="urn:domeoclient:uuid:6293CB80-DCD6-4620-8C0D-569FB4C95073"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:DA8D6B42-B41F-4576-BF10-1285DF3EAB80</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:6FFFF211-BFDC-4E16-968C-A296868530C4</domeo:belongsToSet>
    <pav:createdOn>2014-07-16 10:18:56 -0700</pav:createdOn>
    <pav:lastSavedOn>2014-07-16 10:20:50 -0700</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:AAD02A4C-E01E-4C82-BC8A-D0F4639844FA</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:91E13B1F-608F-46DC-825E-D1031BD8EE6D">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lineageUri>urn:domeoserver:annotation:CE26CA94-E51C-4CCC-B7E0-646CFB7F6C15</pav:lineageUri>
    <ao:context rdf:resource="urn:domeoclient:uuid:8AD0A979-32CC-4AB1-A507-37A7920B4725"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lastSavedOn>2014-07-10 11:21:41 -0700</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">6</pav:versionNumber>
    <pav:lastSavedOn>2014-07-10 14:21:41 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:239B4C6D-1110-4B65-AC66-F8A394187814</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoserver:annotationset:516C333C-B517-4F84-999E-51185DD6E859</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:15A537D1-5648-41B2-8BFA-0D0BA3DF4393</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
    <pav:createdOn>2014-07-10 11:20:05 -0700</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotationset:BE290CA3-79BD-411A-BE2E-69AA4D19607D</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:970963DF-8BCE-4936-9DFC-328A36014E1B</domeo:belongsToSet>
    <pav:previousVersion>urn:domeoserver:annotationset:2BFC2FB6-6BE9-4822-A245-973533533023</pav:previousVersion>
    <pav:previousVersion>xsd:String</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:18F0C730-DDF2-4F8F-842E-A969F966577E">
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:146409FD-1622-4B3D-BC72-24835C4FD699"/>
    <dikbD2R:modality>ncit:negative</dikbD2R:modality>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:C91DD2D9-B8D7-4C80-85A1-EE73345B059A">
    <pav:lastSavedOn>2014-07-15 17:19:32 -0400</pav:lastSavedOn>
    <rdfs:label>Highlight</rdfs:label>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotation:F6A08558-747B-4489-8846-8F2B5DE155ED</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:46636445-93A2-49F0-9E9C-5AEBF17046D2</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotation:E905D145-BD9A-448D-B5A6-A6ADEE130A3F</pav:lineageUri>
    <pav:lastSavedOn>2014-07-15 14:19:34 -0700</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:21B0E479-04F9-4D66-B396-B773EFE53882</domeo:belongsToSet>
    <pav:createdOn>2014-07-15 14:17:31 -0700</pav:createdOn>
    <pav:lastSavedOn>2014-07-15 17:19:34 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:5758DAC0-E1C0-49EB-BE9C-56FFBAF3B6F4</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
    <domeo:belongsToSet>urn:domeoserver:annotationset:5B6A462D-57EA-4BBD-87E1-A0EC2FAF5196</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E8194531-C5B3-43AE-BC13-14A252C54824</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:7B656CB9-304A-4F35-9AAE-0A055011F03C"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:883587E1-49C1-4EE0-909E-4ADBAE13DD3A</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9C0B4E8B-9FFE-4E47-9B4C-A6EA4527A384</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E6A1493E-98EE-4FDE-9301-752AB8E3453F</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:6EB13D46-B414-424C-9D7C-BADA59079327">
    <domeo:belongsToSet>urn:domeoserver:annotationset:9C0B4E8B-9FFE-4E47-9B4C-A6EA4527A384</domeo:belongsToSet>
    <pav:createdOn>2014-07-15 14:04:04 -0700</pav:createdOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:FA8D1DAC-C616-456C-BB3D-29F18DED21A1</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:2E5CE73B-BFD4-4E35-9A07-D5E37A9E87AE</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:1575950D-32D4-46DE-A44F-8E9E614F997F</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:570DA392-7779-456C-9C18-1FC0E579BBE6</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:5758DAC0-E1C0-49EB-BE9C-56FFBAF3B6F4</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
    <pav:lastSavedOn>2014-07-15 17:04:06 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:46636445-93A2-49F0-9E9C-5AEBF17046D2</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoclient:uuid:9B307D8B-D2B0-4795-8850-FAAAAC6B5AF4</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E8194531-C5B3-43AE-BC13-14A252C54824</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:883587E1-49C1-4EE0-909E-4ADBAE13DD3A</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:21B0E479-04F9-4D66-B396-B773EFE53882</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotation:ECCDA999-8E58-4BD8-9384-5A00E79F147E</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:21EAE98A-5FE8-4364-AD53-F77A42DFEE51"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:5B6A462D-57EA-4BBD-87E1-A0EC2FAF5196</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-15 14:04:06 -0700</pav:lastSavedOn>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E6A1493E-98EE-4FDE-9301-752AB8E3453F</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoserver:annotationset:AD2FD8CD-1032-462E-833D-451021CE67B2">
    <dct:description>The default set is created automatically by Domeo when no other set is existing.</dct:description>
    <permissions:permissions rdf:nodeID="N7603ab6d050d4a819ee99357e7ac3fd6"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:A2FA427B-9D1C-4042-8796-682C2C547E30"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
    <ao:item rdf:resource="urn:domeoclient:uuid:EB1F59F5-F04B-4836-B1C9-90E20E62B91E"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdfs:label>Default Set</rdfs:label>
    <ao:item rdf:resource="urn:domeoclient:uuid:0C9C3F3B-D652-4BC5-8BE9-2D01F09D0D62"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:C8EE5491-20E0-446F-BE4F-48D8F8CDCAB9"/>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:5DCE0D50-99F3-4301-8B36-DE5F9A87ECDD"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:CA979FCE-441A-47D4-9797-5CC727F01663"/>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046812afe0146812ce85a0000"/>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-21.txt.html</ao:annotatesResource>
    <ao:item rdf:resource="urn:domeoclient:uuid:7EF340BC-FC51-443A-B404-48D9728F2E15"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:F77BE7E4-398E-4B73-9848-3A5055B88BD4"/>
    <domeo:deleted>false</domeo:deleted>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">2</pav:versionNumber>
    <ao:item rdf:resource="urn:domeoclient:uuid:DCA6DB56-8ED4-4BF0-9368-16ACBA6F82AE"/>
    <pav:createdOn>2014-07-16 14:03:15 -0700</pav:createdOn>
    <ao:item rdf:resource="urn:domeoclient:uuid:05F3AC40-8EB1-409A-9E01-317E8C07400C"/>
    <pav:previousVersion>urn:domeoclient:uuid:8C39EA63-3E52-40B4-8935-6ADC75CCA74D</pav:previousVersion>
    <ao:item rdf:resource="urn:domeoclient:uuid:B7CDA6B5-18B6-4EB0-A176-5FA6DF4BD169"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:73C19DFA-F31A-4286-BFC2-5C8757F59492"/>
    <pav:lastSavedOn>2014-07-16 17:07:51 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotationset:03DD4E8D-1756-4822-B979-A160AAF90F82</pav:lineageUri>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:ADFEE70E-EDC2-4D08-90AB-0ABAFD52BC6F">
    <domeo:belongsToSet>urn:domeoserver:annotationset:9C0B4E8B-9FFE-4E47-9B4C-A6EA4527A384</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:FA8D1DAC-C616-456C-BB3D-29F18DED21A1</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:2E5CE73B-BFD4-4E35-9A07-D5E37A9E87AE</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:1575950D-32D4-46DE-A44F-8E9E614F997F</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:570DA392-7779-456C-9C18-1FC0E579BBE6</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:5758DAC0-E1C0-49EB-BE9C-56FFBAF3B6F4</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
    <pav:lastSavedOn>2014-07-15 17:04:06 -0400</pav:lastSavedOn>
    <pav:createdOn>2014-07-15 14:04:00 -0700</pav:createdOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E6A1493E-98EE-4FDE-9301-752AB8E3453F</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoclient:uuid:9B307D8B-D2B0-4795-8850-FAAAAC6B5AF4</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:883587E1-49C1-4EE0-909E-4ADBAE13DD3A</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:21B0E479-04F9-4D66-B396-B773EFE53882</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotation:8E83F562-4A5B-4C25-9BBD-C2D4037787C2</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:5B6A462D-57EA-4BBD-87E1-A0EC2FAF5196</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:46636445-93A2-49F0-9E9C-5AEBF17046D2</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E8194531-C5B3-43AE-BC13-14A252C54824</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:CC9D7EB3-FEB5-450C-959B-F7BCBAC26F3C"/>
    <pav:lastSavedOn>2014-07-15 14:04:06 -0700</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:029204D1-F9E2-49AE-8BBC-4F278A048EBD">
    <ao:prefix> and its major metabolite, </ao:prefix>
    <ao:suffix> [see 12 CLINICAL PHARMACOLOGY]. Antagonism at receptors other than D2 and 5HT2 [see 12 CLINICAL PHARMACOLOGY] may explain some of the other effects of risperidone.</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:029204D1-F9E2-49AE-8BBC-4F278A048EBD"/>
    <domeo:uuid></domeo:uuid>
    <domeo:uuid>029204D1-F9E2-49AE-8BBC-4F278A048EBD</domeo:uuid>
    <pav:createdOn>2014-07-16 10:19:19 -0700</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>9-hydroxyrisperidone </ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:C52DDDDD-59AD-4D62-94B9-F53565B2D800">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix>xsd:String</ao:prefix>
    <pav:createdOn>2014-07-16 15:39:34 -0700</pav:createdOn>
    <domeo:uuid></domeo:uuid>
    <ao:exact>Fluconazole</ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:C52DDDDD-59AD-4D62-94B9-F53565B2D800"/>
    <domeo:uuid>C52DDDDD-59AD-4D62-94B9-F53565B2D800</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-23.txt.html</ao:hasSource>
    <ao:suffix> 100 mg was administered as a single oral dose alone and two hours after a single dose of cimetidine 400 mg to six healthy male volunteers. After the administration of cimetidine, there was a significant decrease in fluconazole AUC and Cmax. There was a </ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:5415B79F-FEAF-4999-A78E-2C1039116F7C">
    <pav:lineageUri>urn:domeoserver:annotation:23FCEEEE-A25C-4FE7-B309-62599BB17E6C</pav:lineageUri>
    <pav:lastSavedOn>2014-07-15 17:07:58 -0400</pav:lastSavedOn>
    <rdfs:label>Highlight</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">2</pav:versionNumber>
    <pav:lastSavedOn>2014-07-15 17:07:57 -0400</pav:lastSavedOn>
    <pav:createdOn>2014-07-15 14:07:38 -0700</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoserver:annotationset:21B0E479-04F9-4D66-B396-B773EFE53882</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:2E5CE73B-BFD4-4E35-9A07-D5E37A9E87AE</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
    <domeo:belongsToSet>urn:domeoserver:annotationset:46636445-93A2-49F0-9E9C-5AEBF17046D2</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E6A1493E-98EE-4FDE-9301-752AB8E3453F</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:570DA392-7779-456C-9C18-1FC0E579BBE6</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:5758DAC0-E1C0-49EB-BE9C-56FFBAF3B6F4</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:D0A91F52-6752-4FEC-A801-601958619292"/>
    <pav:lastSavedOn>2014-07-15 14:07:58 -0700</pav:lastSavedOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:previousVersion>urn:domeoclient:uuid:9B307D8B-D2B0-4795-8850-FAAAAC6B5AF4</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotation:EE581232-8A02-4DFF-AF7D-37B91AE11AB0</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:5B6A462D-57EA-4BBD-87E1-A0EC2FAF5196</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:1575950D-32D4-46DE-A44F-8E9E614F997F</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:883587E1-49C1-4EE0-909E-4ADBAE13DD3A</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:FA8D1DAC-C616-456C-BB3D-29F18DED21A1</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E8194531-C5B3-43AE-BC13-14A252C54824</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotationset:75FC1225-8399-469B-AE9D-7F697713E6AC</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9C0B4E8B-9FFE-4E47-9B4C-A6EA4527A384</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N345cd2b584764af3a6b3f342ec8a2d6e">
    <permissions:isLocked>false</permissions:isLocked>
    <permissions:accessType>urn:domeo:access:public</permissions:accessType>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:6DC754D9-968C-4DBC-BC8E-28DCC1DD36A3">
    <domeo:uuid>6DC754D9-968C-4DBC-BC8E-28DCC1DD36A3</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:hasSource>
    <ao:suffix>, both of which are CYP3A substrates.</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:6DC754D9-968C-4DBC-BC8E-28DCC1DD36A3"/>
    <ao:exact>ritonavir</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2014-07-10 11:20:46 -0700</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix> and </ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:82FFD7F0-AC94-462F-BA86-70CFD849B686">
    <domeo:belongsToSet>urn:domeoserver:annotationset:2E5CE73B-BFD4-4E35-9A07-D5E37A9E87AE</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-15 14:04:06 -0700</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E6A1493E-98EE-4FDE-9301-752AB8E3453F</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:1575950D-32D4-46DE-A44F-8E9E614F997F</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-15 17:04:06 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:570DA392-7779-456C-9C18-1FC0E579BBE6</domeo:belongsToSet>
    <pav:createdOn>2014-07-15 14:03:20 -0700</pav:createdOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:FA8D1DAC-C616-456C-BB3D-29F18DED21A1</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:21B0E479-04F9-4D66-B396-B773EFE53882</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotation:73404969-6C7F-414E-BB3E-BABBFAA2C784</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E8194531-C5B3-43AE-BC13-14A252C54824</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:883587E1-49C1-4EE0-909E-4ADBAE13DD3A</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:5B6A462D-57EA-4BBD-87E1-A0EC2FAF5196</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:5758DAC0-E1C0-49EB-BE9C-56FFBAF3B6F4</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:46636445-93A2-49F0-9E9C-5AEBF17046D2</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9C0B4E8B-9FFE-4E47-9B4C-A6EA4527A384</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoclient:uuid:9B307D8B-D2B0-4795-8850-FAAAAC6B5AF4</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <ao:context rdf:resource="urn:domeoclient:uuid:54821DEB-AB64-414E-803A-23F9B9CF1CE7"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:F89E37D5-CA53-4C58-B4D2-AE8F0A3FBCE2">
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoclient:uuid:2F716A41-B68F-48AE-B5C1-E31F1704C565</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-16 10:20:50 -0700</pav:lastSavedOn>
    <pav:createdOn>2014-07-16 10:19:38 -0700</pav:createdOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoserver:annotationset:6FFFF211-BFDC-4E16-968C-A296868530C4</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:EEAF2259-5093-4FDA-A5B5-9FB724127DB0"/>
    <pav:lineageUri>urn:domeoserver:annotationset:C8D7FDC6-6816-4BD4-BC7F-88ABDCC37D79</pav:lineageUri>
    <pav:lastSavedOn>2014-07-16 13:20:50 -0400</pav:lastSavedOn>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoserver:annotationset:DA8D6B42-B41F-4576-BF10-1285DF3EAB80</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotation:8FE9D16E-6A32-4BB8-915E-2A13242AE7C9</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:AAD02A4C-E01E-4C82-BC8A-D0F4639844FA</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:71327EBC-8F62-4995-B5BE-B26C486DD473">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/3C3EB772-FD27-4C4F-BAFA-ADD15348B4A5"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/296C3432-7AB8-4E8A-B177-4F9932029F26"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:68AD55C4-223A-46C6-896A-87345A781B61">
    <domeo:belongsToSet>urn:domeoserver:annotationset:2E5CE73B-BFD4-4E35-9A07-D5E37A9E87AE</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E6A1493E-98EE-4FDE-9301-752AB8E3453F</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:570DA392-7779-456C-9C18-1FC0E579BBE6</domeo:belongsToSet>
    <pav:createdOn>2014-07-15 14:08:20 -0700</pav:createdOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:21B0E479-04F9-4D66-B396-B773EFE53882</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lastSavedOn>2014-07-15 14:11:14 -0700</pav:lastSavedOn>
    <pav:lastSavedOn>2014-07-15 17:11:14 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:883587E1-49C1-4EE0-909E-4ADBAE13DD3A</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E8194531-C5B3-43AE-BC13-14A252C54824</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:5B6A462D-57EA-4BBD-87E1-A0EC2FAF5196</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:5758DAC0-E1C0-49EB-BE9C-56FFBAF3B6F4</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:46636445-93A2-49F0-9E9C-5AEBF17046D2</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9C0B4E8B-9FFE-4E47-9B4C-A6EA4527A384</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotation:9D72DC80-EDD2-4049-A453-1997284CCF0D</pav:lineageUri>
    <ao:context rdf:resource="urn:domeoclient:uuid:46A0754E-C451-439B-B685-374909D4C42D"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:7B06A286-D3FC-41A8-A621-60C6E027265C">
    <ao:prefix>, is 77%. Neither </ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:7B06A286-D3FC-41A8-A621-60C6E027265C"/>
    <domeo:uuid>7B06A286-D3FC-41A8-A621-60C6E027265C</domeo:uuid>
    <domeo:uuid></domeo:uuid>
    <ao:suffix> nor 9-hydroxyrisperidone displaces each other from plasma binding sites. High therapeutic concentrations of sulfamethazine (100 mcg/mL), warfarin (10 mcg/mL), and carbamazepine (10 mcg/mL) caused only a slight increase in the free fraction of risperidon</ao:suffix>
    <pav:createdOn>2014-07-15 14:08:46 -0700</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>risperidone</ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:2808EA87-CFD9-497E-B3D4-336DDC2CF6FF">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:2808EA87-CFD9-497E-B3D4-336DDC2CF6FF"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix> </ao:prefix>
    <ao:exact>sildenafil</ao:exact>
    <pav:createdOn>2014-07-10 11:08:45 -0700</pav:createdOn>
    <domeo:uuid></domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:hasSource>
    <ao:suffix> concentrations when co-administered with sildenafil (50 mg) to healthy volunteers</ao:suffix>
    <domeo:uuid>2808EA87-CFD9-497E-B3D4-336DDC2CF6FF</domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:52C23FEF-CB29-459B-934E-EDA40F63DD1E">
    <domeo:belongsToSet>urn:domeoserver:annotationset:88784842-2713-4D3B-A293-A9498ACCA54A</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:E4FC0A1A-8003-4267-9EC8-5C1F467D2F5F"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
    <domeo:belongsToSet>urn:domeoserver:annotationset:80304B91-FB8B-4EF5-87EC-80F59A689F2A</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotation:A61EA487-DD48-423C-ADE1-0C7F92875628</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoclient:uuid:8B8B88D4-5E42-47CB-9E37-EED59C74FD96</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-09 16:39:37 -0400</pav:lastSavedOn>
    <pav:createdOn>2014-07-09 13:36:40 -0700</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotationset:2C25A7F3-8A42-4060-A64C-5C2AB24D4675</pav:lineageUri>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lastSavedOn>2014-07-09 13:39:37 -0700</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:B8452517-26D0-419F-88FD-A818925FDE06">
    <domeo:agents rdf:resource="urn:person:uuid:080e143046812afe0146812ce85a0000"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:F9B8EE58-CE38-4918-9802-C2CBECEEA050"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:item rdf:resource="urn:domeoclient:uuid:05FDCD78-BAF2-46D7-9D0F-0636684A6834"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <ao:item rdf:resource="urn:domeoclient:uuid:0ED8918B-EAC0-44B8-AA42-B78AD724F7BE"/>
    <pav:createdOn>2014-07-18 13:51:09 -0700</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotationset:5D9E9387-63D8-470C-8657-CFD191EF7563</pav:lineageUri>
    <dct:description>The default set is created automatically by Domeo when no other set is existing.</dct:description>
    <rdfs:label>Default Set</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:item rdf:resource="urn:domeoclient:uuid:F69E5920-13F7-4233-8E5C-355591D43752"/>
    <permissions:permissions rdf:nodeID="N6c201c50ed164a088486a4794032ccb0"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:EE1BA765-A716-44E9-BE81-971BDF21154E"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:5975A18C-9750-49AF-9CBD-E13C8DFBA413"/>
    <domeo:deleted>false</domeo:deleted>
    <pav:lastSavedOn>2014-07-18 16:51:47 -0400</pav:lastSavedOn>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-26.txt.html</ao:annotatesResource>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/4AF09D72-39A6-4BC4-A512-26DBDD3392E4">
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <rdfs:label>sildenafil</rdfs:label>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/136411</dailymed:activeMoietyRxCUI>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:79C3BE8E-51D8-473A-AC88-0ADB7AE9D239">
    <domeo:belongsToSet>urn:domeoserver:annotationset:21B0E479-04F9-4D66-B396-B773EFE53882</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:46636445-93A2-49F0-9E9C-5AEBF17046D2</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E8194531-C5B3-43AE-BC13-14A252C54824</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
    <pav:lastSavedOn>2014-07-15 14:19:34 -0700</pav:lastSavedOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9C0B4E8B-9FFE-4E47-9B4C-A6EA4527A384</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:883587E1-49C1-4EE0-909E-4ADBAE13DD3A</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotation:2C59DE50-E2FD-45B0-BBB1-D747D1309DA4</pav:lineageUri>
    <ao:context rdf:resource="urn:domeoclient:uuid:70E10DEB-A12F-401E-803F-F6734EDD7985"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:5B6A462D-57EA-4BBD-87E1-A0EC2FAF5196</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotation:D3256BE2-E89D-49FD-813F-D726CC19F915</pav:lineageUri>
    <pav:lastSavedOn>2014-07-15 17:19:32 -0400</pav:lastSavedOn>
    <pav:createdOn>2014-07-15 14:18:14 -0700</pav:createdOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E6A1493E-98EE-4FDE-9301-752AB8E3453F</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:5758DAC0-E1C0-49EB-BE9C-56FFBAF3B6F4</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-15 17:19:34 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:D2EC0D99-6FCE-4978-BE7E-E1C8066C58EF">
    <pav:createdOn>2014-07-15 14:26:58 -0700</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:D2EC0D99-6FCE-4978-BE7E-E1C8066C58EF"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid></domeo:uuid>
    <ao:suffix>t 50 ng/m</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <domeo:uuid>D2EC0D99-6FCE-4978-BE7E-E1C8066C58EF</domeo:uuid>
    <ao:prefix>xsd:String</ao:prefix>
    <ao:exact>warfarin (10 mcg/mL), and carbamazepine (10 mcg/mL) caused only a slight increase in the free fraction of risperidone at 10 ng/mL and 9-hydroxyrisperidone a</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:A3A3ADF6-73D6-48FB-AF10-EC6590D40ED9">
    <ao:prefix> (6 mg/kg) before and after the oral administration of </ao:prefix>
    <ao:exact>fluconazole</ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-28.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix> 200 mg daily for 14 days in 16 normal male volunteers. There were significant increases in theophylline AUC, Cmax, and half-life with a corresponding decrease in clearance. The mean ± SD theophylline AUC increased 21% ± 16% (range: -5 to 48%). The Cmax </ao:suffix>
    <domeo:uuid>A3A3ADF6-73D6-48FB-AF10-EC6590D40ED9</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:A3A3ADF6-73D6-48FB-AF10-EC6590D40ED9"/>
    <pav:createdOn>2014-07-18 14:02:49 -0700</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:70E10DEB-A12F-401E-803F-F6734EDD7985">
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <domeo:uuid></domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix> and its </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>active metabolite</ao:exact>
    <pav:createdOn>2014-07-15 14:18:14 -0700</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:70E10DEB-A12F-401E-803F-F6734EDD7985"/>
    <ao:suffix> decreased by 60% compared to young healthy subjects. Risperidone doses should be reduced in patients with renal disease [see 2 DOSAGE AND ADMINISTRATION and 5 WARNINGS AND PRECAUTIONS].</ao:suffix>
    <domeo:uuid>70E10DEB-A12F-401E-803F-F6734EDD7985</domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:DD78A8D5-89E1-46CD-BC97-037DB330DF6D">
    <ao:prefix>, its major metabolite, </ao:prefix>
    <domeo:uuid></domeo:uuid>
    <pav:createdOn>2014-07-15 14:06:32 -0700</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>DD78A8D5-89E1-46CD-BC97-037DB330DF6D</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>9-hydroxyrisperidone</ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:DD78A8D5-89E1-46CD-BC97-037DB330DF6D"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <ao:suffix>, and risperidone plus 9-hydroxyrisperidone are dose proportional over the dosing range of 1 to 16 mg daily (0.5 to 8 mg twice daily). Following oral administration of solution or tablet, mean peak plasma concentrations of risperidone occurred at about 1</ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:84ED4684-C66A-4CA3-8A17-114128E1557B">
    <pav:lastSavedOn>2014-07-10 14:21:41 -0400</pav:lastSavedOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lineageUri>urn:domeoserver:annotation:C800444F-0B75-4CBF-9D67-E9E258B2C11A</pav:lineageUri>
    <rdfs:label>Highlight</rdfs:label>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdOn>2014-07-10 11:20:31 -0700</pav:createdOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:970963DF-8BCE-4936-9DFC-328A36014E1B</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoserver:annotationset:15A537D1-5648-41B2-8BFA-0D0BA3DF4393</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:239B4C6D-1110-4B65-AC66-F8A394187814</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-10 11:21:41 -0700</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">6</pav:versionNumber>
    <pav:previousVersion>urn:domeoserver:annotationset:2BFC2FB6-6BE9-4822-A245-973533533023</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
    <ao:context rdf:resource="urn:domeoclient:uuid:B8AA7B02-72B4-4632-9BDA-34C02C628D9A"/>
    <pav:lineageUri>urn:domeoserver:annotationset:BE290CA3-79BD-411A-BE2E-69AA4D19607D</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:516C333C-B517-4F84-999E-51185DD6E859</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:455E5E9F-232E-451B-8C43-9687045AD008">
    <ao:prefix>xsd:String</ao:prefix>
    <ao:exact>Cyclosporine</ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-26.txt.html</ao:hasSource>
    <domeo:uuid>455E5E9F-232E-451B-8C43-9687045AD008</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:455E5E9F-232E-451B-8C43-9687045AD008"/>
    <ao:suffix> AUC and Cmax were determined before and after the administration of fluconazole 200 mg daily for 14 days in eight renal transplant patients who had been on cyclosporine therapy for at least 6 months and on a stable cyclosporine dose for at least 6 weeks</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2014-07-18 13:51:09 -0700</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:076F37CF-3229-400A-A6F6-EBE2A8FC2F4C">
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
    <pav:lastSavedOn>2014-07-16 13:23:07 -0400</pav:lastSavedOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lineageUri>urn:domeoserver:annotation:F4C204C3-294D-408E-8ABD-F4E69A7A6099</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoserver:annotationset:6FFFF211-BFDC-4E16-968C-A296868530C4</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-16 10:23:07 -0700</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:AAD02A4C-E01E-4C82-BC8A-D0F4639844FA</domeo:belongsToSet>
    <pav:createdOn>2014-07-16 10:22:41 -0700</pav:createdOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:13602CFC-088D-4008-B42C-EA497E316CB4"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:F1D1B89D-DB23-4CCB-9037-CD647F4B2A5F">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/A241CF77-D66D-4D63-803F-85B041DD2240"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/824BF6A0-F3B4-4249-BFA7-C700B01561D9"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:3051A76E-96A2-4A70-91F9-A241566DEFD1">
    <domeo:belongsToSet>urn:domeoserver:annotationset:9C0B4E8B-9FFE-4E47-9B4C-A6EA4527A384</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotationset:75FC1225-8399-469B-AE9D-7F697713E6AC</pav:lineageUri>
    <pav:createdOn>2014-07-15 14:15:18 -0700</pav:createdOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:883587E1-49C1-4EE0-909E-4ADBAE13DD3A</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:69BEBC8E-741D-4841-BCB0-771651B22677"/>
    <pav:previousVersion>urn:domeoserver:annotationset:2E5CE73B-BFD4-4E35-9A07-D5E37A9E87AE</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E6A1493E-98EE-4FDE-9301-752AB8E3453F</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:5B6A462D-57EA-4BBD-87E1-A0EC2FAF5196</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">4</pav:versionNumber>
    <pav:lastSavedOn>2014-07-15 14:17:25 -0700</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E8194531-C5B3-43AE-BC13-14A252C54824</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:21B0E479-04F9-4D66-B396-B773EFE53882</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:5758DAC0-E1C0-49EB-BE9C-56FFBAF3B6F4</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:570DA392-7779-456C-9C18-1FC0E579BBE6</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:46636445-93A2-49F0-9E9C-5AEBF17046D2</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
    <pav:lastSavedOn>2014-07-15 17:17:26 -0400</pav:lastSavedOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotation:EF20B30D-5084-4471-B3CA-B0715BCBFEE2</pav:lineageUri>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdfs:label>Highlight</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:C4E9DA8F-91C3-4A6F-9726-C8A51040AAC3">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:C4E9DA8F-91C3-4A6F-9726-C8A51040AAC3"/>
    <domeo:uuid>C4E9DA8F-91C3-4A6F-9726-C8A51040AAC3</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>9-hydroxyrisperidone</ao:exact>
    <domeo:uuid></domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2014-07-16 10:21:01 -0700</pav:createdOn>
    <ao:suffix> </ao:suffix>
    <ao:prefix>xsd:String</ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:8D0FBEEE-F2C5-4EBC-892B-1E8DE2D584AE">
    <pav:lineageUri>urn:domeoserver:annotationset:C8D7FDC6-6816-4BD4-BC7F-88ABDCC37D79</pav:lineageUri>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:AAD02A4C-E01E-4C82-BC8A-D0F4639844FA</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lastSavedOn>2014-07-16 10:20:50 -0700</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:DA8D6B42-B41F-4576-BF10-1285DF3EAB80</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotation:0B8F5480-BD9E-4C28-A32B-FD0F14FF7D04</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdOn>2014-07-16 10:20:06 -0700</pav:createdOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:6FFFF211-BFDC-4E16-968C-A296868530C4</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:10C3FD12-EB69-4E8A-9C52-BB5ED70A7565"/>
    <domeo:belongsToSet>urn:domeoclient:uuid:2F716A41-B68F-48AE-B5C1-E31F1704C565</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-16 13:20:50 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:5A441D1D-CF1A-4E2D-80CF-F79B9D77D232">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <ao:context rdf:resource="urn:domeoclient:uuid:1C30B0B1-5EC7-4866-B5F3-AA2CB04C9143"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:239B4C6D-1110-4B65-AC66-F8A394187814</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">6</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotationset:BE290CA3-79BD-411A-BE2E-69AA4D19607D</pav:lineageUri>
    <pav:lineageUri>urn:domeoserver:annotation:F063DBC5-9EC9-475A-856D-246053E77CAC</pav:lineageUri>
    <pav:createdOn>2014-07-10 11:20:26 -0700</pav:createdOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:516C333C-B517-4F84-999E-51185DD6E859</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:15A537D1-5648-41B2-8BFA-0D0BA3DF4393</domeo:belongsToSet>
    <pav:previousVersion>urn:domeoserver:annotationset:2BFC2FB6-6BE9-4822-A245-973533533023</pav:previousVersion>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lastSavedOn>2014-07-10 11:21:41 -0700</pav:lastSavedOn>
    <pav:lastSavedOn>2014-07-10 14:21:41 -0400</pav:lastSavedOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoserver:annotationset:970963DF-8BCE-4936-9DFC-328A36014E1B</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:1FD70F7A-986E-48F8-93F4-DA3377C3E107">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <ao:context rdf:resource="urn:domeoclient:uuid:4CE762A1-3B91-4B51-861E-7CFEE91439CF"/>
    <pav:lastSavedOn>2014-07-09 16:39:37 -0400</pav:lastSavedOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lastSavedOn>2014-07-09 13:39:37 -0700</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotation:52693E55-26B8-43BB-931D-E525F2D667AE</pav:lineageUri>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoserver:annotationset:88784842-2713-4D3B-A293-A9498ACCA54A</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
    <pav:createdOn>2014-07-09 13:36:31 -0700</pav:createdOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:80304B91-FB8B-4EF5-87EC-80F59A689F2A</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotationset:2C25A7F3-8A42-4060-A64C-5C2AB24D4675</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoclient:uuid:8B8B88D4-5E42-47CB-9E37-EED59C74FD96</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:7CAB3CEB-53D4-45C0-BDE2-D01D9FD9219C">
    <domeo:belongsToSet>urn:domeoserver:annotationset:9C0B4E8B-9FFE-4E47-9B4C-A6EA4527A384</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoserver:annotationset:5B6A462D-57EA-4BBD-87E1-A0EC2FAF5196</domeo:belongsToSet>
    <pav:previousVersion>urn:domeoserver:annotationset:2E5CE73B-BFD4-4E35-9A07-D5E37A9E87AE</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:883587E1-49C1-4EE0-909E-4ADBAE13DD3A</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">4</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:21B0E479-04F9-4D66-B396-B773EFE53882</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:46636445-93A2-49F0-9E9C-5AEBF17046D2</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotation:A1069958-2F3D-4AD6-B33E-47125F69271F</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E6A1493E-98EE-4FDE-9301-752AB8E3453F</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:5758DAC0-E1C0-49EB-BE9C-56FFBAF3B6F4</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:570DA392-7779-456C-9C18-1FC0E579BBE6</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-15 17:17:26 -0400</pav:lastSavedOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:03498850-C0AC-4682-B3F3-91FD27180D38"/>
    <pav:createdOn>2014-07-15 14:17:20 -0700</pav:createdOn>
    <pav:lastSavedOn>2014-07-15 14:17:25 -0700</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotationset:75FC1225-8399-469B-AE9D-7F697713E6AC</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E8194531-C5B3-43AE-BC13-14A252C54824</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:CC9D7EB3-FEB5-450C-959B-F7BCBAC26F3C">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:CC9D7EB3-FEB5-450C-959B-F7BCBAC26F3C"/>
    <domeo:uuid></domeo:uuid>
    <ao:prefix>e oral solution is bioequivalent to </ao:prefix>
    <pav:createdOn>2014-07-15 14:04:00 -0700</pav:createdOn>
    <domeo:uuid>CC9D7EB3-FEB5-450C-959B-F7BCBAC26F3C</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <ao:suffix> tablets.</ao:suffix>
    <ao:exact>risperidone</ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:7EF340BC-FC51-443A-B404-48D9728F2E15">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lastSavedOn>2014-07-16 14:06:30 -0700</pav:lastSavedOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:92E5C2B0-A019-4BC5-BDC7-295AFBB9DF17"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
    <pav:createdOn>2014-07-16 14:04:04 -0700</pav:createdOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:C2A39432-076D-421D-8007-22690EDA5A0C</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:B3F0B84F-756D-4724-B177-98D0D290D00D</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotation:857E22AD-F64E-4FA6-B3BC-CE9046AD4CDA</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoclient:uuid:8C39EA63-3E52-40B4-8935-6ADC75CCA74D</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-16 17:06:30 -0400</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:AD2FD8CD-1032-462E-833D-451021CE67B2</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:52A12616-29C9-4323-A81B-949195D51273">
    <ao:context rdf:resource="urn:domeoclient:uuid:E455E1D2-B393-4131-81F1-25CAC07249AA"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:21B0E479-04F9-4D66-B396-B773EFE53882</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoserver:annotationset:570DA392-7779-456C-9C18-1FC0E579BBE6</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-15 14:17:25 -0700</pav:lastSavedOn>
    <pav:lastSavedOn>2014-07-15 17:17:26 -0400</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">4</pav:versionNumber>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
    <pav:lineageUri>urn:domeoserver:annotation:86FDCE7E-D5EF-4E78-ADD1-7AD3F3DD7744</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:5B6A462D-57EA-4BBD-87E1-A0EC2FAF5196</domeo:belongsToSet>
    <pav:previousVersion>urn:domeoserver:annotationset:2E5CE73B-BFD4-4E35-9A07-D5E37A9E87AE</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:883587E1-49C1-4EE0-909E-4ADBAE13DD3A</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9C0B4E8B-9FFE-4E47-9B4C-A6EA4527A384</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotationset:75FC1225-8399-469B-AE9D-7F697713E6AC</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:46636445-93A2-49F0-9E9C-5AEBF17046D2</domeo:belongsToSet>
    <pav:createdOn>2014-07-15 14:15:27 -0700</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:5758DAC0-E1C0-49EB-BE9C-56FFBAF3B6F4</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E6A1493E-98EE-4FDE-9301-752AB8E3453F</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E8194531-C5B3-43AE-BC13-14A252C54824</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:55703ACD-B978-421D-82AE-69E7022573D6">
    <ao:suffix> is extensively metabolized in the liver. The main metabolic pathway is through hydroxylation of risperidone to 9-hydroxyrisperidone by the enzyme, CYP 2D6. A minor metabolic pathway is through N-dealkylation. The main metabolite, 9-hydroxyrisperidone, h</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>Risperidone</ao:exact>
    <domeo:uuid></domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:55703ACD-B978-421D-82AE-69E7022573D6"/>
    <pav:createdOn>2014-07-15 14:09:52 -0700</pav:createdOn>
    <ao:prefix>Metabolism and Drug Interactions: </ao:prefix>
    <domeo:uuid>55703ACD-B978-421D-82AE-69E7022573D6</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:C54A1798-BD47-4D4C-89DF-B37F5A3AB9F0">
    <domeo:belongsToSet>urn:domeoserver:annotationset:E8194531-C5B3-43AE-BC13-14A252C54824</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
    <pav:lineageUri>urn:domeoserver:annotation:3015D7F6-AF64-4360-8A75-C570D293D4C8</pav:lineageUri>
    <ao:context rdf:resource="urn:domeoclient:uuid:3F3050AD-E886-4649-8017-65F649BAA9E7"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:5B6A462D-57EA-4BBD-87E1-A0EC2FAF5196</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:21B0E479-04F9-4D66-B396-B773EFE53882</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:883587E1-49C1-4EE0-909E-4ADBAE13DD3A</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E6A1493E-98EE-4FDE-9301-752AB8E3453F</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:46636445-93A2-49F0-9E9C-5AEBF17046D2</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">4</pav:versionNumber>
    <pav:createdOn>2014-07-15 14:15:13 -0700</pav:createdOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:5758DAC0-E1C0-49EB-BE9C-56FFBAF3B6F4</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:570DA392-7779-456C-9C18-1FC0E579BBE6</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-15 17:17:26 -0400</pav:lastSavedOn>
    <pav:lastSavedOn>2014-07-15 14:17:25 -0700</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:previousVersion>urn:domeoserver:annotationset:2E5CE73B-BFD4-4E35-9A07-D5E37A9E87AE</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotationset:75FC1225-8399-469B-AE9D-7F697713E6AC</pav:lineageUri>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9C0B4E8B-9FFE-4E47-9B4C-A6EA4527A384</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:BA399F23-8D58-4471-8517-AC275675E0F0">
    <domeo:uuid>BA399F23-8D58-4471-8517-AC275675E0F0</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>Administration of a single oral 200 mg dose of fluconazole after 15 days of rifampin administered as 600 mg daily in eight healthy male volunteers resulted in a significant decrease in fluconazole AUC and a significant increase in apparent oral clearance of fluconazole. There was a mean ± SD reduction in fluconazole AUC of 23% ± 9% (range: -13 to -42%). Apparent oral clearance of fluconazole increased 32% ± 17% (range: 16 to 72%). Fluconazole half-life decreased from 33.4 ± 4.4 hours to 26.8 ± 3.9 hours</ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:BA399F23-8D58-4471-8517-AC275675E0F0"/>
    <pav:createdOn>2014-07-17 16:00:10 -0700</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>			http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-24.txt.html</ao:hasSource>
    <ao:suffix>. (See PRECAUTIONS.</ao:suffix>
    <ao:prefix>xsd:String</ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:63FB79CC-576B-4FFD-A109-FF63DAE371C0">
    <pav:lastSavedOn>2014-07-15 17:19:34 -0400</pav:lastSavedOn>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E8194531-C5B3-43AE-BC13-14A252C54824</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotation:DE64D465-1597-4221-A9B1-89F08D7235B8</pav:lineageUri>
    <pav:lastSavedOn>2014-07-15 17:19:32 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotation:D18513E9-C8CC-44F5-97CD-54C950FF557B</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoserver:annotationset:46636445-93A2-49F0-9E9C-5AEBF17046D2</domeo:belongsToSet>
    <pav:createdOn>2014-07-15 14:18:48 -0700</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lastSavedOn>2014-07-15 14:19:34 -0700</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:21B0E479-04F9-4D66-B396-B773EFE53882</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
    <domeo:belongsToSet>urn:domeoserver:annotationset:5B6A462D-57EA-4BBD-87E1-A0EC2FAF5196</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E6A1493E-98EE-4FDE-9301-752AB8E3453F</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:883587E1-49C1-4EE0-909E-4ADBAE13DD3A</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:5758DAC0-E1C0-49EB-BE9C-56FFBAF3B6F4</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:B0997699-FE17-48DB-97D8-9BA9ABDD0C90"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9C0B4E8B-9FFE-4E47-9B4C-A6EA4527A384</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:1C30B0B1-5EC7-4866-B5F3-AA2CB04C9143">
    <ao:prefix> (80 mg tid) bioavailability due to co-administration of </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>epoprostenol</ao:exact>
    <ao:suffix> was 28%, resulting in about 22% lower mean average steady state concentrations. Therefore, the slight decrease of sildenafil exposure in the presence of epoprostenol is not considered clinically relevant. The effect of sildenafil on epoprostenol pharmac</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:1C30B0B1-5EC7-4866-B5F3-AA2CB04C9143"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:hasSource>
    <pav:createdOn>2014-07-10 11:20:26 -0700</pav:createdOn>
    <domeo:uuid>1C30B0B1-5EC7-4866-B5F3-AA2CB04C9143</domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:ECDDC20F-1C2B-469E-98F0-C0EB9DA754E2">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:ECDDC20F-1C2B-469E-98F0-C0EB9DA754E2"/>
    <domeo:uuid>ECDDC20F-1C2B-469E-98F0-C0EB9DA754E2</domeo:uuid>
    <ao:suffix> estradiol or levonorgestrel AUC after the administration of 50 mg of fluconazole. The mean increase in ethinyl estradiol AUC was 6% (range: -47 to 108%) and levonorgestrel AUC increased 17% (range: -33 to 141%).</ao:suffix>
    <ao:prefix> 50 mg once daily for 10 days in 10 healthy women. There was no significant difference in </ao:prefix>
    <pav:createdOn>2014-07-16 15:32:37 -0700</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-22.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>ethinyl </ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:0A8134EE-D8E3-447B-9EB9-2CB597651AB4">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">2</pav:versionNumber>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lastSavedOn>2014-07-15 17:07:57 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:570DA392-7779-456C-9C18-1FC0E579BBE6</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E6A1493E-98EE-4FDE-9301-752AB8E3453F</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoserver:annotationset:21B0E479-04F9-4D66-B396-B773EFE53882</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:FA8D1DAC-C616-456C-BB3D-29F18DED21A1</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:883587E1-49C1-4EE0-909E-4ADBAE13DD3A</domeo:belongsToSet>
    <pav:previousVersion>urn:domeoclient:uuid:9B307D8B-D2B0-4795-8850-FAAAAC6B5AF4</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:5B6A462D-57EA-4BBD-87E1-A0EC2FAF5196</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotation:14BDF874-EC19-466B-8549-7CB28212736F</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9C0B4E8B-9FFE-4E47-9B4C-A6EA4527A384</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotationset:75FC1225-8399-469B-AE9D-7F697713E6AC</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E8194531-C5B3-43AE-BC13-14A252C54824</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-15 14:07:58 -0700</pav:lastSavedOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:FC5E4603-2CB7-4D28-ABE9-54E9294FD8DC"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:46636445-93A2-49F0-9E9C-5AEBF17046D2</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotation:D52D7739-6567-4D67-B379-D8C6A3BAEC24</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:2E5CE73B-BFD4-4E35-9A07-D5E37A9E87AE</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lastSavedOn>2014-07-15 17:07:58 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:5758DAC0-E1C0-49EB-BE9C-56FFBAF3B6F4</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:1575950D-32D4-46DE-A44F-8E9E614F997F</domeo:belongsToSet>
    <pav:createdOn>2014-07-15 14:06:47 -0700</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:387A1EFC-40FD-4ED2-A90C-E9AE2D14E77B">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:387A1EFC-40FD-4ED2-A90C-E9AE2D14E77B"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix>l AUC was 6% (range: -47 to 108%) and </ao:prefix>
    <pav:createdOn>2014-07-16 15:33:03 -0700</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-22.txt.html</ao:hasSource>
    <domeo:uuid>387A1EFC-40FD-4ED2-A90C-E9AE2D14E77B</domeo:uuid>
    <ao:exact>levonorgestrel</ao:exact>
    <ao:suffix> AUC increased 17% (range: -33 to 141%).</ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:90386835-AD59-4BAA-A860-3003ABCAF86C">
    <pav:createdOn>2014-07-15 14:06:21 -0700</pav:createdOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:2E5CE73B-BFD4-4E35-9A07-D5E37A9E87AE</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:46636445-93A2-49F0-9E9C-5AEBF17046D2</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9C0B4E8B-9FFE-4E47-9B4C-A6EA4527A384</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
    <domeo:belongsToSet>urn:domeoserver:annotationset:5758DAC0-E1C0-49EB-BE9C-56FFBAF3B6F4</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E8194531-C5B3-43AE-BC13-14A252C54824</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-15 17:07:58 -0400</pav:lastSavedOn>
    <pav:previousVersion>urn:domeoclient:uuid:9B307D8B-D2B0-4795-8850-FAAAAC6B5AF4</pav:previousVersion>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">2</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:5B6A462D-57EA-4BBD-87E1-A0EC2FAF5196</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lastSavedOn>2014-07-15 17:07:57 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:883587E1-49C1-4EE0-909E-4ADBAE13DD3A</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:FA8D1DAC-C616-456C-BB3D-29F18DED21A1</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotation:4FD1B79C-CFF4-4CEC-A8FA-8BA5D67B909F</pav:lineageUri>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoserver:annotationset:21B0E479-04F9-4D66-B396-B773EFE53882</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotationset:75FC1225-8399-469B-AE9D-7F697713E6AC</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E6A1493E-98EE-4FDE-9301-752AB8E3453F</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:570DA392-7779-456C-9C18-1FC0E579BBE6</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lastSavedOn>2014-07-15 14:07:58 -0700</pav:lastSavedOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:ADE68C3A-6684-4E35-B3C0-F519065A2D66"/>
    <pav:lineageUri>urn:domeoserver:annotation:78BB9E8D-8AB6-4B9C-AEE8-66B2BE02A34B</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:1575950D-32D4-46DE-A44F-8E9E614F997F</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoserver:annotationset:239B4C6D-1110-4B65-AC66-F8A394187814">
    <pav:createdOn>2014-07-10 10:59:34 -0700</pav:createdOn>
    <ao:item rdf:resource="urn:domeoclient:uuid:F4E4C204-187C-449E-9023-BF663418A548"/>
    <domeo:deleted>false</domeo:deleted>
    <ao:item rdf:resource="urn:domeoclient:uuid:114FB83A-C60C-42F5-AB92-9462558A06FC"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:380253B1-58A2-45B6-B271-96D870E13796"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:91E13B1F-608F-46DC-825E-D1031BD8EE6D"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:annotatesResource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <rdfs:label>Default Set</rdfs:label>
    <ao:item rdf:resource="urn:domeoclient:uuid:33374D0E-AF28-4161-ACC9-7713697436CB"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:977A2BC8-0744-472F-9FA2-CCF897431CA1"/>
    <pav:lineageUri>urn:domeoserver:annotationset:BE290CA3-79BD-411A-BE2E-69AA4D19607D</pav:lineageUri>
    <ao:item rdf:resource="urn:domeoclient:uuid:C70E2E47-3AA5-4F01-A8A1-711E946726F5"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:6C376F0E-D7D6-4846-B8E9-1C50742E0CD2"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:C4DD997B-59E6-4FDF-944E-0E3151C25851"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:702BE5BD-B486-4EEB-9B0C-8C790AAA768A"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:665D54F7-737F-4E41-85AF-4DB192AB7A15"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:ABA0CCF3-E252-4C23-B881-D2E2AF418E6C"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:3F707B16-9AC0-4A46-A0C5-ED7358D7F764"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <permissions:permissions rdf:nodeID="N784a56c4988e43998f54bd4b168e8ee9"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:10EA2F12-BD12-4F54-9D90-CD6B3DC5179E"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:C4C14FED-0642-4B44-8AD5-DFA9D02E5B99"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:025EF8CC-8100-4ED5-A590-368E009133CC"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:84ED4684-C66A-4CA3-8A17-114128E1557B"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:B9DE1789-19F9-43BC-B292-659F900EA6EB"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">7</pav:versionNumber>
    <ao:item rdf:resource="urn:domeoclient:uuid:C9D98AB8-FCA0-4A14-92DD-EBD32CC6776E"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:32208944-92E0-40BE-AA45-03DC0663A09C"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:3E0194D4-524A-4E69-B161-52FB98ED36C2"/>
    <pav:lastSavedOn>2014-07-10 14:23:56 -0400</pav:lastSavedOn>
    <ao:item rdf:resource="urn:domeoclient:uuid:A30AACD8-E9A8-4B2C-9DB3-7E44F147751F"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:F5FD5F49-D620-4FE1-9968-D31A01410DEC"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:E5AC3B8B-F69B-4482-815F-54FC3F75312F"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:5A441D1D-CF1A-4E2D-80CF-F79B9D77D232"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:C820B82D-AF0E-4A71-9E65-5AB73DFE5206"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:CD3E95AA-5887-4E3B-B181-8C84F1A4D6C5"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:31F660CD-C617-4D06-85AD-7A9D8F2EDEEC"/>
    <dct:description>The default set is created automatically by Domeo when no other set is existing.</dct:description>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:86ABDA54-6350-41E2-93E1-1353431A082D"/>
    <pav:previousVersion>urn:domeoserver:annotationset:516C333C-B517-4F84-999E-51185DD6E859</pav:previousVersion>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046812afe0146812ce85a0000"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:94AD2935-8FE6-4D3D-847A-A1AC66E35692"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:EFED6610-75EB-4165-827C-237B7D245279"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/52C813E5-0F7C-4C85-B289-60F729DEBDA0">
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/85762</dailymed:activeMoietyRxCUI>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdfs:label>ritonavir</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:D557988D-572F-43E0-8885-D5BF374D8DDC">
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoclient:uuid:9B307D8B-D2B0-4795-8850-FAAAAC6B5AF4</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
    <ao:context rdf:resource="urn:domeoclient:uuid:5D7443E0-0C82-47A0-A810-6FF473FEFEEF"/>
    <pav:createdOn>2014-07-15 14:03:52 -0700</pav:createdOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lastSavedOn>2014-07-15 17:04:06 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotation:7BE0B8DB-17FF-43E6-8FA0-592F765846C3</pav:lineageUri>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:CD3E95AA-5887-4E3B-B181-8C84F1A4D6C5">
    <pav:lineageUri>urn:domeoserver:annotationset:BE290CA3-79BD-411A-BE2E-69AA4D19607D</pav:lineageUri>
    <ao:body rdf:nodeID="Nef3809c30def40ceb3a3debf303d7643"/>
    <pav:lineageUri>urn:domeoserver:annotation:55AA5346-06AA-45BF-B9FA-FC83DDD8E8F0</pav:lineageUri>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <ao:body rdf:nodeID="N7e3f621adfe64aa792e6f3f20ad0f31c"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
    <pav:createdOn>2014-07-10 11:22:24 -0700</pav:createdOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">7</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotation:32E08EA2-2E4E-4C12-A873-5187F47C1C86</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:body rdf:nodeID="N0c3808b9ed5843e9a43ee26b718ac1af"/>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <domeo:belongsToSet>urn:domeoserver:annotationset:970963DF-8BCE-4936-9DFC-328A36014E1B</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:15A537D1-5648-41B2-8BFA-0D0BA3DF4393</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-10 11:23:57 -0700</pav:lastSavedOn>
    <pav:lastSavedOn>2014-07-10 14:23:56 -0400</pav:lastSavedOn>
    <pav:previousVersion>urn:domeoserver:annotationset:516C333C-B517-4F84-999E-51185DD6E859</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:D779518E-9AC6-475E-AE81-120556E044A3"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:239B4C6D-1110-4B65-AC66-F8A394187814</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-10 14:23:57 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:76E5F11A-7EC2-4412-BCB7-E9B0542040DE">
    <domeo:belongsToSet>urn:domeoserver:annotationset:5B6A462D-57EA-4BBD-87E1-A0EC2FAF5196</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotation:AF2632B4-B087-439E-B33B-C14D3A0BCF9B</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoserver:annotationset:883587E1-49C1-4EE0-909E-4ADBAE13DD3A</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9C0B4E8B-9FFE-4E47-9B4C-A6EA4527A384</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:46636445-93A2-49F0-9E9C-5AEBF17046D2</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:CB5A75B5-09F1-40D7-97B6-D21EA870EF66"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:5758DAC0-E1C0-49EB-BE9C-56FFBAF3B6F4</domeo:belongsToSet>
    <pav:createdOn>2014-07-15 14:09:12 -0700</pav:createdOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E8194531-C5B3-43AE-BC13-14A252C54824</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:21B0E479-04F9-4D66-B396-B773EFE53882</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:2E5CE73B-BFD4-4E35-9A07-D5E37A9E87AE</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E6A1493E-98EE-4FDE-9301-752AB8E3453F</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
    <pav:lastSavedOn>2014-07-15 17:11:14 -0400</pav:lastSavedOn>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoserver:annotationset:570DA392-7779-456C-9C18-1FC0E579BBE6</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-15 14:11:14 -0700</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N43f8f8c529d64181827d8af0ede55d07">
    <permissions:accessType>urn:domeo:access:public</permissions:accessType>
    <permissions:isLocked>false</permissions:isLocked>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/B26407E4-88EB-4192-AB48-8E81668A0F5A">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/4053</dailymed:activeMoietyRxCUI>
    <rdfs:label>erythromycin</rdfs:label>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:7DF78E91-4010-455D-9300-16EAD7D6AB87">
    <domeo:belongsToSet>urn:domeoserver:annotationset:21B0E479-04F9-4D66-B396-B773EFE53882</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:2E5CE73B-BFD4-4E35-9A07-D5E37A9E87AE</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E8194531-C5B3-43AE-BC13-14A252C54824</domeo:belongsToSet>
    <pav:createdOn>2014-07-15 14:08:33 -0700</pav:createdOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E6A1493E-98EE-4FDE-9301-752AB8E3453F</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
    <pav:lineageUri>urn:domeoserver:annotation:9A4FDA77-AC39-4F85-8AE8-81F4B016A81D</pav:lineageUri>
    <pav:lastSavedOn>2014-07-15 17:11:14 -0400</pav:lastSavedOn>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoserver:annotationset:570DA392-7779-456C-9C18-1FC0E579BBE6</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-15 14:11:14 -0700</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:5B6A462D-57EA-4BBD-87E1-A0EC2FAF5196</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoserver:annotationset:883587E1-49C1-4EE0-909E-4ADBAE13DD3A</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9C0B4E8B-9FFE-4E47-9B4C-A6EA4527A384</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:46636445-93A2-49F0-9E9C-5AEBF17046D2</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:5758DAC0-E1C0-49EB-BE9C-56FFBAF3B6F4</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:7A0209F9-EA1A-4BBA-865A-0A0F6CCAF57E"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoserver:annotationset:970963DF-8BCE-4936-9DFC-328A36014E1B">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <rdfs:label>Default Set</rdfs:label>
    <ao:item rdf:resource="urn:domeoclient:uuid:91E13B1F-608F-46DC-825E-D1031BD8EE6D"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:EFED6610-75EB-4165-827C-237B7D245279"/>
    <pav:createdOn>2014-07-10 10:59:34 -0700</pav:createdOn>
    <dct:description>The default set is created automatically by Domeo when no other set is existing.</dct:description>
    <pav:lastSavedOn>2014-07-10 14:23:57 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:annotatesResource>
    <ao:item rdf:resource="urn:domeoclient:uuid:C4DD997B-59E6-4FDF-944E-0E3151C25851"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:3E0194D4-524A-4E69-B161-52FB98ED36C2"/>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <pav:previousVersion>urn:domeoserver:annotationset:516C333C-B517-4F84-999E-51185DD6E859</pav:previousVersion>
    <ao:item rdf:resource="urn:domeoclient:uuid:ABA0CCF3-E252-4C23-B881-D2E2AF418E6C"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:977A2BC8-0744-472F-9FA2-CCF897431CA1"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:3F707B16-9AC0-4A46-A0C5-ED7358D7F764"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:item rdf:resource="urn:domeoclient:uuid:C4C14FED-0642-4B44-8AD5-DFA9D02E5B99"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:C70E2E47-3AA5-4F01-A8A1-711E946726F5"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:10EA2F12-BD12-4F54-9D90-CD6B3DC5179E"/>
    <domeo:deleted>false</domeo:deleted>
    <ao:item rdf:resource="urn:domeoclient:uuid:114FB83A-C60C-42F5-AB92-9462558A06FC"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:33374D0E-AF28-4161-ACC9-7713697436CB"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:B9DE1789-19F9-43BC-B292-659F900EA6EB"/>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046812afe0146812ce85a0000"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:702BE5BD-B486-4EEB-9B0C-8C790AAA768A"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:32208944-92E0-40BE-AA45-03DC0663A09C"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:86ABDA54-6350-41E2-93E1-1353431A082D"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">7</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotationset:BE290CA3-79BD-411A-BE2E-69AA4D19607D</pav:lineageUri>
    <ao:item rdf:resource="urn:domeoclient:uuid:025EF8CC-8100-4ED5-A590-368E009133CC"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:84ED4684-C66A-4CA3-8A17-114128E1557B"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:5A441D1D-CF1A-4E2D-80CF-F79B9D77D232"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:380253B1-58A2-45B6-B271-96D870E13796"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:C820B82D-AF0E-4A71-9E65-5AB73DFE5206"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:C9D98AB8-FCA0-4A14-92DD-EBD32CC6776E"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:31F660CD-C617-4D06-85AD-7A9D8F2EDEEC"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:665D54F7-737F-4E41-85AF-4DB192AB7A15"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:A30AACD8-E9A8-4B2C-9DB3-7E44F147751F"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:F5FD5F49-D620-4FE1-9968-D31A01410DEC"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:94AD2935-8FE6-4D3D-847A-A1AC66E35692"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:E5AC3B8B-F69B-4482-815F-54FC3F75312F"/>
    <permissions:permissions rdf:nodeID="N3f501a665880439c80efc0356eaced0c"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:F4E4C204-187C-449E-9023-BF663418A548"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:CD3E95AA-5887-4E3B-B181-8C84F1A4D6C5"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:6C376F0E-D7D6-4846-B8E9-1C50742E0CD2"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:787C8DA7-E4FF-4344-8E03-827399F78206">
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:0F87EEF0-40A6-43E2-8222-95E7D1335A0B</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotation:95B80454-C9C1-41A7-A25D-A14B814D136B</pav:lineageUri>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lastSavedOn>2014-07-16 18:33:07 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotationset:7AE68AC7-9B47-4954-8C65-45A6F0DC80C2</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoclient:uuid:5C7A7116-C174-4EB1-933E-3A46CEE71709</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lastSavedOn>2014-07-16 15:33:06 -0700</pav:lastSavedOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:085B00A2-6C6B-488C-9382-36A86ADDE1DE"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdOn>2014-07-16 15:32:41 -0700</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:3AF5AF5B-6498-4C88-94AC-716E8168CCAC">
    <domeo:uuid>3AF5AF5B-6498-4C88-94AC-716E8168CCAC</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:3AF5AF5B-6498-4C88-94AC-716E8168CCAC"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix> is 70% (CV=25%). The relative oral bioavailability of risperidone from a tablet is 94% (CV=10%) when compared to a solution.</ao:suffix>
    <ao:exact> risperidone</ao:exact>
    <pav:createdOn>2014-07-15 14:03:32 -0700</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid></domeo:uuid>
    <ao:prefix> is well absorbed. The absolute oral bioavailability of</ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:0AE1727A-ACA3-43E1-8A12-B8F0F479A3DF">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
    <pav:lineageUri>urn:domeoserver:annotation:97255696-57A7-4674-B6CC-7D97B9150434</pav:lineageUri>
    <ao:context rdf:resource="urn:domeoclient:uuid:75FA9873-2FCB-4682-B059-2B0DDAB0A8C0"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:8DEBE5AF-B171-4BE8-880B-76A2BEE742A6</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lineageUri>urn:domeoserver:annotationset:B716A719-3E66-4B72-87E0-370D90F3B8F7</pav:lineageUri>
    <pav:lastSavedOn>2014-07-17 15:59:35 -0700</pav:lastSavedOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdOn>2014-07-17 15:59:27 -0700</pav:createdOn>
    <pav:lastSavedOn>2014-07-17 18:59:36 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoclient:uuid:83B2E87D-3732-4699-AA3D-363A6EB95959</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:C4DD997B-59E6-4FDF-944E-0E3151C25851">
    <pav:lineageUri>urn:domeoserver:annotation:8789E383-9738-4346-A502-B1ABDC068E30</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:previousVersion>urn:domeoserver:annotationset:3F81414E-B149-4B05-925B-18735B554A13</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotationset:BE290CA3-79BD-411A-BE2E-69AA4D19607D</pav:lineageUri>
    <ao:context rdf:resource="urn:domeoclient:uuid:A4BD01D1-8101-4C58-92D8-CF144E1497B9"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
    <domeo:belongsToSet>urn:domeoserver:annotationset:970963DF-8BCE-4936-9DFC-328A36014E1B</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:15A537D1-5648-41B2-8BFA-0D0BA3DF4393</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:239B4C6D-1110-4B65-AC66-F8A394187814</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoserver:annotationset:DBBBAD55-D12B-4890-A2AF-85D3C85A7BEF</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoserver:annotationset:2BFC2FB6-6BE9-4822-A245-973533533023</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">4</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:516C333C-B517-4F84-999E-51185DD6E859</domeo:belongsToSet>
    <pav:createdOn>2014-07-10 11:15:31 -0700</pav:createdOn>
    <pav:lastSavedOn>2014-07-10 11:15:41 -0700</pav:lastSavedOn>
    <pav:lastSavedOn>2014-07-10 14:15:41 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:06A59058-E7B5-4A71-9D10-07FD98051EBF">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoserver:annotationset:6FFFF211-BFDC-4E16-968C-A296868530C4</domeo:belongsToSet>
    <pav:createdOn>2014-07-16 10:19:19 -0700</pav:createdOn>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoclient:uuid:2F716A41-B68F-48AE-B5C1-E31F1704C565</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotationset:C8D7FDC6-6816-4BD4-BC7F-88ABDCC37D79</pav:lineageUri>
    <pav:lastSavedOn>2014-07-16 13:20:50 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:AAD02A4C-E01E-4C82-BC8A-D0F4639844FA</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-16 10:20:50 -0700</pav:lastSavedOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:029204D1-F9E2-49AE-8BBC-4F278A048EBD"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
    <domeo:belongsToSet>urn:domeoserver:annotationset:DA8D6B42-B41F-4576-BF10-1285DF3EAB80</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotation:53F23D59-D3F8-4534-84E8-1668AD77AFF5</pav:lineageUri>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:C8EE5491-20E0-446F-BE4F-48D8F8CDCAB9">
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
    <pav:lineageUri>urn:domeoserver:annotation:026B20A4-1022-4C15-ACEE-79151F28992D</pav:lineageUri>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lastSavedOn>2014-07-16 14:06:30 -0700</pav:lastSavedOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:A21EC03A-3C43-4CAE-9D75-32F08D9599AA"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:AD2FD8CD-1032-462E-833D-451021CE67B2</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdOn>2014-07-16 14:03:39 -0700</pav:createdOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lastSavedOn>2014-07-16 17:06:30 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:C2A39432-076D-421D-8007-22690EDA5A0C</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoclient:uuid:8C39EA63-3E52-40B4-8935-6ADC75CCA74D</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:B3F0B84F-756D-4724-B177-98D0D290D00D</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:785FC8A2-DE5D-4084-8BEC-107690A111CB">
    <ao:context rdf:resource="urn:domeoclient:uuid:DADF82D0-0BE9-4691-8522-E52C0C20266C"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoclient:uuid:2F716A41-B68F-48AE-B5C1-E31F1704C565</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lastSavedOn>2014-07-16 13:20:50 -0400</pav:lastSavedOn>
    <pav:lastSavedOn>2014-07-16 10:20:50 -0700</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:6FFFF211-BFDC-4E16-968C-A296868530C4</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotationset:C8D7FDC6-6816-4BD4-BC7F-88ABDCC37D79</pav:lineageUri>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoserver:annotationset:AAD02A4C-E01E-4C82-BC8A-D0F4639844FA</domeo:belongsToSet>
    <pav:createdOn>2014-07-16 10:19:02 -0700</pav:createdOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
    <pav:lineageUri>urn:domeoserver:annotation:2ECAC9C7-DF17-436D-854A-4EAC4494AC29</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:DA8D6B42-B41F-4576-BF10-1285DF3EAB80</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:EDA5CCDC-B45B-4C9D-9286-2C6331B0DC2E">
    <ao:context rdf:resource="urn:domeoclient:uuid:433EA64F-D83C-4038-880E-456719321D8E"/>
    <pav:lineageUri>urn:domeoserver:annotationset:C8D7FDC6-6816-4BD4-BC7F-88ABDCC37D79</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
    <domeo:belongsToSet>urn:domeoserver:annotationset:DA8D6B42-B41F-4576-BF10-1285DF3EAB80</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdOn>2014-07-16 10:20:45 -0700</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotation:A0B2D702-DF25-4C7A-875A-BA765F06D196</pav:lineageUri>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoclient:uuid:2F716A41-B68F-48AE-B5C1-E31F1704C565</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lastSavedOn>2014-07-16 13:20:50 -0400</pav:lastSavedOn>
    <pav:lastSavedOn>2014-07-16 10:20:50 -0700</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:6FFFF211-BFDC-4E16-968C-A296868530C4</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoserver:annotationset:AAD02A4C-E01E-4C82-BC8A-D0F4639844FA</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:316356DA-5EB5-42EB-9878-F3A3E1BDA4E9">
    <ao:exact>ethinyl estradiol</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2014-07-16 14:03:22 -0700</pav:createdOn>
    <domeo:uuid>316356DA-5EB5-42EB-9878-F3A3E1BDA4E9</domeo:uuid>
    <ao:prefix> 300 mg to 21 normal females taking an oral contraceptive containing </ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:316356DA-5EB5-42EB-9878-F3A3E1BDA4E9"/>
    <ao:suffix> and norethindrone. In this placebo-controlled, double-blind, randomized, two-way crossover study carried out over three cycles of oral contraceptive treatment, fluconazole dosing resulted in small increases in the mean AUCs of ethinyl estradiol and nore</ao:suffix>
    <domeo:uuid></domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-21.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:025EF8CC-8100-4ED5-A590-368E009133CC">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <ao:body rdf:nodeID="N77d0f1c1a62043cf858346777fcbe67b"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotation:F930ACB0-4682-4B67-AC74-854CDD0499D4</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:970963DF-8BCE-4936-9DFC-328A36014E1B</domeo:belongsToSet>
    <pav:previousVersion>urn:domeoserver:annotationset:2BFC2FB6-6BE9-4822-A245-973533533023</pav:previousVersion>
    <pav:lastSavedOn>2014-07-10 14:21:41 -0400</pav:lastSavedOn>
    <pav:createdOn>2014-07-10 11:21:39 -0700</pav:createdOn>
    <ao:body rdf:nodeID="N07254ea8d76c49b29d7bad60b95d19e6"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">6</pav:versionNumber>
    <ao:body rdf:nodeID="N134abbc44e9d49cc998663bcaa643749"/>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <domeo:belongsToSet>urn:domeoserver:annotationset:239B4C6D-1110-4B65-AC66-F8A394187814</domeo:belongsToSet>
    <ao:body rdf:nodeID="N28a19dd2e0fe4529b1e00a3cd0eb7374"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:3443022F-68AE-4016-8363-C6C96EE0AE69"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:516C333C-B517-4F84-999E-51185DD6E859</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:15A537D1-5648-41B2-8BFA-0D0BA3DF4393</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotationset:BE290CA3-79BD-411A-BE2E-69AA4D19607D</pav:lineageUri>
    <pav:lastSavedOn>2014-07-10 11:21:41 -0700</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:D0DA49DD-64B6-4DB4-8411-726DBD8A6893">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:D0DA49DD-64B6-4DB4-8411-726DBD8A6893"/>
    <ao:prefix> (oral </ao:prefix>
    <ao:exact>fluconazole </ao:exact>
    <ao:suffix> 200 mg daily for 16 days) in 10 normal male volunteers. There was a significant increase in phenytoin AUC. The mean ± SD increase in phenytoin AUC was 88% ± 68% (range: 16 to 247%). The absolute magnitude of this interaction is unknown because of the in</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-25.txt.html</ao:hasSource>
    <pav:createdOn>2014-07-18 13:48:22 -0700</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>D0DA49DD-64B6-4DB4-8411-726DBD8A6893</domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:920B7836-2155-4EE5-9028-A6274B846CBA">
    <rdfs:label>Highlight</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lastSavedOn>2014-07-15 14:19:34 -0700</pav:lastSavedOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E6A1493E-98EE-4FDE-9301-752AB8E3453F</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9C0B4E8B-9FFE-4E47-9B4C-A6EA4527A384</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-15 17:19:34 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:5758DAC0-E1C0-49EB-BE9C-56FFBAF3B6F4</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdOn>2014-07-15 14:17:46 -0700</pav:createdOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:46636445-93A2-49F0-9E9C-5AEBF17046D2</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:15C80BDC-57FE-49D1-830F-1A9F2C7BCA2C"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:883587E1-49C1-4EE0-909E-4ADBAE13DD3A</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:21B0E479-04F9-4D66-B396-B773EFE53882</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-15 17:19:32 -0400</pav:lastSavedOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:5B6A462D-57EA-4BBD-87E1-A0EC2FAF5196</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotation:38E5099A-2116-42B9-B051-715C68299A81</pav:lineageUri>
    <pav:lineageUri>urn:domeoserver:annotation:6B035BA6-E470-4F95-8C92-A00364BFCC56</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E8194531-C5B3-43AE-BC13-14A252C54824</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:ED6E68B4-D2C7-419B-A740-99C70A25F570">
    <pav:createdOn>2014-07-15 13:56:25 -0700</pav:createdOn>
    <ao:suffix>l is 400 mg daily given as 200 mg b.i.d. Dosage should be increased gradually until an optimal clinical response is obtained, generally at 600 to 1200 mg per day. If treatment is to be discontinued, the dosage should be reduced gradually over a period of</ao:suffix>
    <ao:prefix>The usual initial dosage of </ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:ED6E68B4-D2C7-419B-A740-99C70A25F570"/>
    <domeo:uuid>ED6E68B4-D2C7-419B-A740-99C70A25F570</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-4.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>acebutolo</ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:82C41618-75F7-4A21-9E13-4028DB75BB70">
    <pav:createdOn>2014-07-17 15:59:32 -0700</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:82C41618-75F7-4A21-9E13-4028DB75BB70"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>Fluconazole</ao:exact>
    <domeo:uuid>82C41618-75F7-4A21-9E13-4028DB75BB70</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix> increased 32% ± 17% (range: 16 to 72%). </ao:prefix>
    <ao:hasSource>			http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-24.txt.html</ao:hasSource>
    <ao:suffix> half-life decreased from 33.4 ± 4.4 hours to 26.8 ± 3.9 hours. (See PRECAUTIONS.)</ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:76294E1F-52C3-4DC1-BB56-4B5DE633DEA3">
    <ao:context rdf:resource="urn:domeoclient:uuid:B8F6DECD-B84A-439C-AB5B-FD0E059E3FAC"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdOn>2014-07-15 14:31:21 -0700</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotation:3B7D16AF-4F8C-446D-AE7D-C284C5835FAC</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lastSavedOn>2014-07-15 17:32:08 -0400</pav:lastSavedOn>
    <pav:lastSavedOn>2014-07-15 14:32:08 -0700</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E8194531-C5B3-43AE-BC13-14A252C54824</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:5B6A462D-57EA-4BBD-87E1-A0EC2FAF5196</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:21B0E479-04F9-4D66-B396-B773EFE53882</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:A3DBEE5E-C93B-4DBE-A1E3-317DA19FA203">
    <pav:createdOn>2014-07-15 14:09:05 -0700</pav:createdOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:5B6A462D-57EA-4BBD-87E1-A0EC2FAF5196</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:0C912224-9ADC-4466-B8BD-9A0D37DB3F64"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:5758DAC0-E1C0-49EB-BE9C-56FFBAF3B6F4</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9C0B4E8B-9FFE-4E47-9B4C-A6EA4527A384</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E8194531-C5B3-43AE-BC13-14A252C54824</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-15 17:11:14 -0400</pav:lastSavedOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoserver:annotationset:46636445-93A2-49F0-9E9C-5AEBF17046D2</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:2E5CE73B-BFD4-4E35-9A07-D5E37A9E87AE</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotation:08F50372-771E-460E-BD76-88F11A77AEF6</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:570DA392-7779-456C-9C18-1FC0E579BBE6</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-15 14:11:14 -0700</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E6A1493E-98EE-4FDE-9301-752AB8E3453F</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
    <domeo:belongsToSet>urn:domeoserver:annotationset:21B0E479-04F9-4D66-B396-B773EFE53882</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:883587E1-49C1-4EE0-909E-4ADBAE13DD3A</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:9533CE02-6E66-4E86-A2D3-E8EB0BF5E6A2">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/B647582C-D9C5-493D-9D1E-21B820C9FB2B"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/88F80C49-1D15-4DDF-86BB-BC4D3583608D"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:FE6DEC5A-2EFB-4D44-817D-5B910C9A906D">
    <ao:exact>epoprostenol</ao:exact>
    <pav:createdOn>2014-07-10 11:20:35 -0700</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:hasSource>
    <ao:suffix> pharmacokinetics is not known.</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:FE6DEC5A-2EFB-4D44-817D-5B910C9A906D"/>
    <ao:prefix> on </ao:prefix>
    <domeo:uuid>FE6DEC5A-2EFB-4D44-817D-5B910C9A906D</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:719101C7-4FC8-4E56-81FA-58D7AC021659">
    <pav:createdOn>2014-07-16 15:40:24 -0700</pav:createdOn>
    <domeo:uuid>719101C7-4FC8-4E56-81FA-58D7AC021659</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid></domeo:uuid>
    <ao:suffix> 600 mg to 900 mg intravenously over a four-hour period (from one hour before to 3 hours after a single oral dose of fluconazole 200 mg) did not affect the bioavailability or pharmacokinetics of fluconazole in 24 healthy male volunteers.</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-23.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:719101C7-4FC8-4E56-81FA-58D7AC021659"/>
    <ao:exact>cimetidine</ao:exact>
    <ao:prefix> AUC of 13% ± 11% (range: -3.4 to -31%) and Cmax decreased 19% ± 14% (range: -5 to -40%). However, the administration of </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:C69466D9-4AD4-4863-ABBC-AEF76AEF11D6">
    <domeo:uuid></domeo:uuid>
    <ao:exact>Cimetidine</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2014-07-10 11:08:09 -0700</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:hasSource>
    <ao:suffix> (800 mg), a nonspecific CYP inhibitor, caused a 56% increase in plasma sildenafil concentrations when co-administered with sildenafil (50 mg) to healthy volunteers.</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:C69466D9-4AD4-4863-ABBC-AEF76AEF11D6"/>
    <ao:prefix>xsd:String</ao:prefix>
    <domeo:uuid>C69466D9-4AD4-4863-ABBC-AEF76AEF11D6</domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:36A89B29-F675-4E00-B50E-A68B59055C9F">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/F87C05D6-DDC3-4EA8-9B34-3C2D17DDAE87"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/E5665B96-F57B-4E5D-A279-724307FF4350"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:987C60C7-6D1F-4118-A362-4E5E00057318">
    <domeo:belongsToSet>urn:domeoserver:annotationset:6FFFF211-BFDC-4E16-968C-A296868530C4</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:AAD02A4C-E01E-4C82-BC8A-D0F4639844FA</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotation:FE963564-3A50-43BC-A700-CA59A1CF8371</pav:lineageUri>
    <pav:lastSavedOn>2014-07-16 13:23:07 -0400</pav:lastSavedOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:2B3DD740-D22B-482C-9A75-48DD8B5632A7"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lastSavedOn>2014-07-16 10:23:07 -0700</pav:lastSavedOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdfs:label>Highlight</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdOn>2014-07-16 10:22:55 -0700</pav:createdOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:2C01868C-4CA4-41F7-878B-4BF3487A2B98">
    <pav:createdOn>2014-07-18 13:48:05 -0700</pav:createdOn>
    <ao:suffix> AUC was determined after 4 days of phenytoin dosing (200 mg daily, orally for 3 days followed by 250 mg intravenously for one dose) both with and without the administration of fluconazole (oral fluconazole 200 mg daily for 16 days) in 10 normal male vol</ao:suffix>
    <ao:prefix>xsd:String</ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:2C01868C-4CA4-41F7-878B-4BF3487A2B98"/>
    <domeo:uuid>2C01868C-4CA4-41F7-878B-4BF3487A2B98</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-25.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>Phenytoin</ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:94AD2935-8FE6-4D3D-847A-A1AC66E35692">
    <ao:context rdf:resource="urn:domeoclient:uuid:2808EA87-CFD9-497E-B3D4-336DDC2CF6FF"/>
    <pav:createdOn>2014-07-10 11:08:45 -0700</pav:createdOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lastSavedOn>2014-07-10 11:14:30 -0700</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
    <domeo:belongsToSet>urn:domeoserver:annotationset:970963DF-8BCE-4936-9DFC-328A36014E1B</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:3F81414E-B149-4B05-925B-18735B554A13</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotation:F1857E03-2545-40CD-AA96-12B6719617BF</pav:lineageUri>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:DBBBAD55-D12B-4890-A2AF-85D3C85A7BEF</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:239B4C6D-1110-4B65-AC66-F8A394187814</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:516C333C-B517-4F84-999E-51185DD6E859</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:15A537D1-5648-41B2-8BFA-0D0BA3DF4393</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:2BFC2FB6-6BE9-4822-A245-973533533023</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lastSavedOn>2014-07-10 14:14:30 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:97152B9D-CEAA-4BF5-BCF3-8D56F516DD36">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/00222986-6A7D-42B7-950C-C9A90060EA28"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/165E87BD-01D4-4D78-8A0D-F6089ECEF3AA"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:665D54F7-737F-4E41-85AF-4DB192AB7A15">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoserver:annotationset:239B4C6D-1110-4B65-AC66-F8A394187814</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-10 11:21:41 -0700</pav:lastSavedOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdOn>2014-07-10 11:20:46 -0700</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotation:DFC20B56-EF35-4D2E-9FF4-1C23E197E179</pav:lineageUri>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoserver:annotationset:15A537D1-5648-41B2-8BFA-0D0BA3DF4393</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
    <ao:context rdf:resource="urn:domeoclient:uuid:6DC754D9-968C-4DBC-BC8E-28DCC1DD36A3"/>
    <pav:lineageUri>urn:domeoserver:annotationset:BE290CA3-79BD-411A-BE2E-69AA4D19607D</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">6</pav:versionNumber>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:previousVersion>urn:domeoserver:annotationset:2BFC2FB6-6BE9-4822-A245-973533533023</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:516C333C-B517-4F84-999E-51185DD6E859</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:970963DF-8BCE-4936-9DFC-328A36014E1B</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-10 14:21:41 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/9E074531-245B-46FE-9C5E-1F5147C63ABC">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <rdfs:label>risperidone</rdfs:label>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/35636</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:51D42CFA-4CB2-4B55-9EFE-A1109484AC25">
    <domeo:belongsToSet>urn:domeoclient:uuid:5C7A7116-C174-4EB1-933E-3A46CEE71709</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdOn>2014-07-16 15:32:30 -0700</pav:createdOn>
    <pav:lastSavedOn>2014-07-16 15:33:06 -0700</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lineageUri>urn:domeoserver:annotation:D446C1BE-0A11-41D4-BBD8-35A843FA44BD</pav:lineageUri>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:0F87EEF0-40A6-43E2-8222-95E7D1335A0B</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lastSavedOn>2014-07-16 18:33:07 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotationset:7AE68AC7-9B47-4954-8C65-45A6F0DC80C2</pav:lineageUri>
    <ao:context rdf:resource="urn:domeoclient:uuid:DE86A623-45C7-446E-BC44-389610395DA9"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:64D0C269-01F6-4340-8315-A41DCAE1D199">
    <domeo:uuid></domeo:uuid>
    <domeo:uuid>64D0C269-01F6-4340-8315-A41DCAE1D199</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:64D0C269-01F6-4340-8315-A41DCAE1D199"/>
    <ao:exact>9-hydroxyrisperidone</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2014-07-15 14:14:03 -0700</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix>.</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <ao:prefix> plus </ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/00222986-6A7D-42B7-950C-C9A90060EA28">
    <rdfs:label>tolbutamide</rdfs:label>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/10635</dailymed:activeMoietyRxCUI>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:1F34CC8F-6DA9-47CE-AD8A-A80AB8D1E0F8">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/3786B2EC-7B7E-486B-9D91-E1B956AA357E"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/14DF06A5-FE87-442F-A9ED-BDE176C70C7C"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:6FED0630-F5B3-4A05-892B-CB86D31FD6DF">
    <pav:lineageUri>urn:domeoserver:annotation:C0A93109-AAC3-40ED-96A6-E40A91DE0BF5</pav:lineageUri>
    <pav:previousVersion>urn:domeoserver:annotationset:2E5CE73B-BFD4-4E35-9A07-D5E37A9E87AE</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E6A1493E-98EE-4FDE-9301-752AB8E3453F</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">4</pav:versionNumber>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
    <domeo:belongsToSet>urn:domeoserver:annotationset:21B0E479-04F9-4D66-B396-B773EFE53882</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoserver:annotationset:570DA392-7779-456C-9C18-1FC0E579BBE6</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:541CB376-3C80-4099-9753-CC9C70F09426"/>
    <pav:lineageUri>urn:domeoserver:annotationset:75FC1225-8399-469B-AE9D-7F697713E6AC</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lastSavedOn>2014-07-15 17:17:26 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:883587E1-49C1-4EE0-909E-4ADBAE13DD3A</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E8194531-C5B3-43AE-BC13-14A252C54824</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:5B6A462D-57EA-4BBD-87E1-A0EC2FAF5196</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:5758DAC0-E1C0-49EB-BE9C-56FFBAF3B6F4</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9C0B4E8B-9FFE-4E47-9B4C-A6EA4527A384</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lastSavedOn>2014-07-15 14:17:25 -0700</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:46636445-93A2-49F0-9E9C-5AEBF17046D2</domeo:belongsToSet>
    <pav:createdOn>2014-07-15 14:16:16 -0700</pav:createdOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/37773057-2593-4F89-A721-5933D9C73741">
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/136411</dailymed:activeMoietyRxCUI>
    <rdfs:label>sildenafil</rdfs:label>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:C025BBE5-19A7-4D05-9813-E49F4799CB23">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:883587E1-49C1-4EE0-909E-4ADBAE13DD3A</domeo:belongsToSet>
    <pav:createdOn>2014-07-15 14:18:41 -0700</pav:createdOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:5B6A462D-57EA-4BBD-87E1-A0EC2FAF5196</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9C0B4E8B-9FFE-4E47-9B4C-A6EA4527A384</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:5758DAC0-E1C0-49EB-BE9C-56FFBAF3B6F4</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotation:21913A08-CEC4-4A35-8091-FB341A1A3AFF</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:46636445-93A2-49F0-9E9C-5AEBF17046D2</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotation:2BCCD145-6E75-4F42-8F21-C96F2FF41685</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E6A1493E-98EE-4FDE-9301-752AB8E3453F</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:21B0E479-04F9-4D66-B396-B773EFE53882</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-15 14:19:34 -0700</pav:lastSavedOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:CC119E59-51D3-4AAE-87A1-B3FF2D690F31"/>
    <pav:lastSavedOn>2014-07-15 17:19:34 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
    <pav:lastSavedOn>2014-07-15 17:19:32 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E8194531-C5B3-43AE-BC13-14A252C54824</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:701B3F36-4375-4CB6-A9F8-C942C7D5632E">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:701B3F36-4375-4CB6-A9F8-C942C7D5632E"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid></domeo:uuid>
    <ao:suffix> 400 mg to six healthy male volunteers. After the administration of cimetidine, there was a significant decrease in fluconazole AUC and Cmax. There was a mean ± SD decrease in fluconazole AUC of 13% ± 11% (range: -3.4 to -31%) and Cmax decreased 19% ± 14</ao:suffix>
    <domeo:uuid>701B3F36-4375-4CB6-A9F8-C942C7D5632E</domeo:uuid>
    <ao:prefix> 100 mg was administered as a single oral dose alone and two hours after a single dose of </ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-23.txt.html</ao:hasSource>
    <pav:createdOn>2014-07-16 15:39:41 -0700</pav:createdOn>
    <ao:exact>cimetidine</ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:B7CDA6B5-18B6-4EB0-A176-5FA6DF4BD169">
    <pav:createdOn>2014-07-16 14:03:59 -0700</pav:createdOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:C2A39432-076D-421D-8007-22690EDA5A0C</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoclient:uuid:8C39EA63-3E52-40B4-8935-6ADC75CCA74D</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lastSavedOn>2014-07-16 14:06:30 -0700</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotation:E3BDCAAC-7613-4A30-B9AE-3E150C9C0E1D</pav:lineageUri>
    <ao:context rdf:resource="urn:domeoclient:uuid:831D0F3D-639E-4B91-A3ED-AE0F362D5CE0"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:AD2FD8CD-1032-462E-833D-451021CE67B2</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lastSavedOn>2014-07-16 17:06:30 -0400</pav:lastSavedOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoserver:annotationset:B3F0B84F-756D-4724-B177-98D0D290D00D</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:F9B8EE58-CE38-4918-9802-C2CBECEEA050">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:4E109C84-6323-418A-9404-5FBE487E6AA2"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdOn>2014-07-18 13:51:28 -0700</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotation:8F049889-04A8-49FD-BB22-5FC8DE315EE3</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lastSavedOn>2014-07-18 16:51:47 -0400</pav:lastSavedOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
    <domeo:belongsToSet>urn:domeoclient:uuid:B8452517-26D0-419F-88FD-A818925FDE06</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:433EA64F-D83C-4038-880E-456719321D8E">
    <ao:exact>9-hydroxyrisperidone</ao:exact>
    <ao:suffix> </ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix>xsd:String</ao:prefix>
    <pav:createdOn>2014-07-16 10:20:45 -0700</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:433EA64F-D83C-4038-880E-456719321D8E"/>
    <domeo:uuid>433EA64F-D83C-4038-880E-456719321D8E</domeo:uuid>
    <domeo:uuid></domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:5C0FAFB3-9734-473A-85E5-980D1051DADD">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdOn>2014-07-15 14:16:36 -0700</pav:createdOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:21B0E479-04F9-4D66-B396-B773EFE53882</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoserver:annotationset:570DA392-7779-456C-9C18-1FC0E579BBE6</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-15 14:17:25 -0700</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E6A1493E-98EE-4FDE-9301-752AB8E3453F</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">4</pav:versionNumber>
    <ao:context rdf:resource="urn:domeoclient:uuid:47F91319-FBBC-4D96-B4A4-0705F95D9E7C"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
    <domeo:belongsToSet>urn:domeoserver:annotationset:5B6A462D-57EA-4BBD-87E1-A0EC2FAF5196</domeo:belongsToSet>
    <pav:previousVersion>urn:domeoserver:annotationset:2E5CE73B-BFD4-4E35-9A07-D5E37A9E87AE</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:883587E1-49C1-4EE0-909E-4ADBAE13DD3A</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9C0B4E8B-9FFE-4E47-9B4C-A6EA4527A384</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotationset:75FC1225-8399-469B-AE9D-7F697713E6AC</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:46636445-93A2-49F0-9E9C-5AEBF17046D2</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:5758DAC0-E1C0-49EB-BE9C-56FFBAF3B6F4</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lineageUri>urn:domeoserver:annotation:F842EBB7-093B-4914-B91F-508CB6F38688</pav:lineageUri>
    <pav:lastSavedOn>2014-07-15 17:17:26 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E8194531-C5B3-43AE-BC13-14A252C54824</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:4ACE7F4B-F57E-4417-9D3D-B18148E82D1E">
    <pav:lastSavedOn>2014-07-18 16:48:39 -0400</pav:lastSavedOn>
    <pav:createdOn>2014-07-18 13:48:18 -0700</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotation:2FB686A9-E8A4-4059-9887-71838B315434</pav:lineageUri>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
    <pav:lineageUri>urn:domeoserver:annotationset:748BB253-1066-4977-91B2-35D8C6906790</pav:lineageUri>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lastSavedOn>2014-07-18 13:48:39 -0700</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoclient:uuid:53775C4C-7CC4-46EB-9EFC-EDF9D3D264ED</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A7F21A3D-50B3-495E-884A-2C707B40C763</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:BAF30A3C-A239-441C-8B34-9AC0EFD5ED8E"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:7D975807-A259-49EC-97EB-1E0EC9EB112C">
    <pav:lastSavedOn>2014-07-16 18:33:07 -0400</pav:lastSavedOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoserver:annotationset:0F87EEF0-40A6-43E2-8222-95E7D1335A0B</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lineageUri>urn:domeoserver:annotationset:7AE68AC7-9B47-4954-8C65-45A6F0DC80C2</pav:lineageUri>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdOn>2014-07-16 15:33:03 -0700</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotation:FE3C213F-82E3-4A38-BABE-CFD93E98B984</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoclient:uuid:5C7A7116-C174-4EB1-933E-3A46CEE71709</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:387A1EFC-40FD-4ED2-A90C-E9AE2D14E77B"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lastSavedOn>2014-07-16 15:33:06 -0700</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:53775C4C-7CC4-46EB-9EFC-EDF9D3D264ED">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <ao:item rdf:resource="urn:domeoclient:uuid:D75527AE-44F3-49BF-B7AB-31C1D6E91722"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:4ACE7F4B-F57E-4417-9D3D-B18148E82D1E"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:E960B89C-B215-4093-9AF7-C100D8D48511"/>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-25.txt.html</ao:annotatesResource>
    <permissions:permissions rdf:nodeID="N486967aed5194782a3de45510624653e"/>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <dct:description>The default set is created automatically by Domeo when no other set is existing.</dct:description>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046812afe0146812ce85a0000"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:item rdf:resource="urn:domeoclient:uuid:862041D3-5963-4DC0-966F-207E3A62BA47"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:item rdf:resource="urn:domeoclient:uuid:FCAC7AB3-7719-4C9B-8378-64BF0D2B4AD2"/>
    <rdfs:label>Default Set</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotationset:748BB253-1066-4977-91B2-35D8C6906790</pav:lineageUri>
    <pav:lastSavedOn>2014-07-18 16:48:39 -0400</pav:lastSavedOn>
    <pav:createdOn>2014-07-18 13:48:05 -0700</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <domeo:deleted>false</domeo:deleted>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
    <ao:item rdf:resource="urn:domeoclient:uuid:D8773E33-77FB-4402-ABAD-8048CB22BB84"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:BFCAC108-C978-4C7B-A79A-9887A3CA3C6C">
    <pav:lineageUri>urn:domeoserver:annotation:382E18F6-8A13-40D6-8859-AAB418548244</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:2E5CE73B-BFD4-4E35-9A07-D5E37A9E87AE</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:FA8D1DAC-C616-456C-BB3D-29F18DED21A1</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:1575950D-32D4-46DE-A44F-8E9E614F997F</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:CFD4FFA0-934F-4003-A721-60AFD1521572"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:570DA392-7779-456C-9C18-1FC0E579BBE6</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:5758DAC0-E1C0-49EB-BE9C-56FFBAF3B6F4</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E6A1493E-98EE-4FDE-9301-752AB8E3453F</domeo:belongsToSet>
    <pav:createdOn>2014-07-15 14:03:43 -0700</pav:createdOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
    <domeo:belongsToSet>urn:domeoserver:annotationset:46636445-93A2-49F0-9E9C-5AEBF17046D2</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:21B0E479-04F9-4D66-B396-B773EFE53882</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-15 14:04:06 -0700</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:883587E1-49C1-4EE0-909E-4ADBAE13DD3A</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoserver:annotationset:5B6A462D-57EA-4BBD-87E1-A0EC2FAF5196</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoclient:uuid:9B307D8B-D2B0-4795-8850-FAAAAC6B5AF4</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lastSavedOn>2014-07-15 17:04:06 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9C0B4E8B-9FFE-4E47-9B4C-A6EA4527A384</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E8194531-C5B3-43AE-BC13-14A252C54824</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:A42DE598-1DBE-4AFF-81B2-08991620AD5B">
    <ao:exact>9-hydroxyrisperidone</ao:exact>
    <pav:createdOn>2014-07-15 14:17:37 -0700</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:A42DE598-1DBE-4AFF-81B2-08991620AD5B"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid></domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <ao:prefix> and </ao:prefix>
    <ao:suffix> combined, after single and multiple doses, were similar in extensive and poor metabolizers, with an overall mean elimination half-life of about 20 hours.</ao:suffix>
    <domeo:uuid>A42DE598-1DBE-4AFF-81B2-08991620AD5B</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:86ABDA54-6350-41E2-93E1-1353431A082D">
    <pav:lineageUri>urn:domeoserver:annotationset:BE290CA3-79BD-411A-BE2E-69AA4D19607D</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">6</pav:versionNumber>
    <pav:lastSavedOn>2014-07-10 11:21:41 -0700</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
    <pav:previousVersion>urn:domeoserver:annotationset:2BFC2FB6-6BE9-4822-A245-973533533023</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:516C333C-B517-4F84-999E-51185DD6E859</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:C1AC6F60-3C7C-4BEB-9095-25D25890AC79"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:239B4C6D-1110-4B65-AC66-F8A394187814</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotation:EA81F5F0-CB21-4238-92BA-886594EB656F</pav:lineageUri>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoserver:annotationset:15A537D1-5648-41B2-8BFA-0D0BA3DF4393</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:970963DF-8BCE-4936-9DFC-328A36014E1B</domeo:belongsToSet>
    <pav:createdOn>2014-07-10 11:20:29 -0700</pav:createdOn>
    <pav:lastSavedOn>2014-07-10 14:21:41 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:438EE2CD-205C-4FF7-85D9-5CA19DA48F3F">
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:AA24DC3C-1B9F-4AFC-BD77-237EC620A97C"/>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:98DABE9A-9F89-4DF9-9DEE-B6853D1F5CC1">
    <ao:item rdf:resource="urn:domeoclient:uuid:9AF357DC-FE46-4BA4-BC30-1C0C4232273D"/>
    <domeo:deleted>false</domeo:deleted>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
    <pav:lineageUri>urn:domeoserver:annotationset:E97673F8-7E4F-465A-9DDA-320EE8E031C1</pav:lineageUri>
    <ao:item rdf:resource="urn:domeoclient:uuid:F7888D3F-B736-44E1-8FF0-7C578EEDD97E"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:71649D2A-6308-46A5-9322-DFC56F36E8F3"/>
    <rdfs:label>Default Set</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lastSavedOn>2014-07-16 18:40:55 -0400</pav:lastSavedOn>
    <pav:createdOn>2014-07-16 15:39:34 -0700</pav:createdOn>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-23.txt.html</ao:annotatesResource>
    <permissions:permissions rdf:nodeID="Nc6efe70c0f5f4e2c8de4fdc6f738cecb"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:B2C03A2F-0DF1-4E82-B58C-1909B3460EAA"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:CB645A75-8C80-4DBE-A619-BDD15DFC4DF3"/>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046812afe0146812ce85a0000"/>
    <dct:description>The default set is created automatically by Domeo when no other set is existing.</dct:description>
    <ao:item rdf:resource="urn:domeoclient:uuid:3776F388-42AA-4941-B8F9-416DFC230546"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:item rdf:resource="urn:domeoclient:uuid:ABA94567-EA53-40B6-AF02-E6FC02E40AD6"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/A5BD11F1-3771-4A48-8EB4-641010611616">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <rdfs:label>risperidone</rdfs:label>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/35636</dailymed:activeMoietyRxCUI>
    <dct:description>Referred to the drug in the interaction.</dct:description>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/AC9A1D27-44BD-40B7-A83D-E484627AE823">
    <rdfs:label>sildenafil</rdfs:label>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/136411</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:12CCDE72-9FC0-4264-A3F2-C533F792F613">
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E8194531-C5B3-43AE-BC13-14A252C54824</domeo:belongsToSet>
    <pav:createdOn>2014-07-15 14:02:53 -0700</pav:createdOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:1575950D-32D4-46DE-A44F-8E9E614F997F</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:2E5CE73B-BFD4-4E35-9A07-D5E37A9E87AE</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoserver:annotationset:46636445-93A2-49F0-9E9C-5AEBF17046D2</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotation:A853DC31-3688-4537-B866-1E714F554B83</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:570DA392-7779-456C-9C18-1FC0E579BBE6</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:5758DAC0-E1C0-49EB-BE9C-56FFBAF3B6F4</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:A7E2E6B0-6F82-4961-8B6D-923A4E0BC5E9"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
    <pav:lastSavedOn>2014-07-15 17:04:06 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:5B6A462D-57EA-4BBD-87E1-A0EC2FAF5196</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E6A1493E-98EE-4FDE-9301-752AB8E3453F</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lastSavedOn>2014-07-15 14:04:06 -0700</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:883587E1-49C1-4EE0-909E-4ADBAE13DD3A</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9C0B4E8B-9FFE-4E47-9B4C-A6EA4527A384</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:21B0E479-04F9-4D66-B396-B773EFE53882</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoclient:uuid:9B307D8B-D2B0-4795-8850-FAAAAC6B5AF4</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:FA8D1DAC-C616-456C-BB3D-29F18DED21A1</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoserver:annotationset:96BAB4C7-6F7A-4EBA-BAC1-134F746F11FA">
    <rdfs:label>Default Set</rdfs:label>
    <ao:item rdf:resource="urn:domeoclient:uuid:B230469B-00AA-4A73-A839-6D9826213D36"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:6F6FACEE-5C35-4020-BE6D-26958BA10CA6"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
    <domeo:deleted>false</domeo:deleted>
    <ao:item rdf:resource="urn:domeoclient:uuid:079A4E14-C541-4AC8-B876-063FC489849B"/>
    <pav:createdOn>2014-07-17 15:53:34 -0700</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:BD319A5A-0B87-457E-BF99-76BC4728CC77"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:0FE2C318-FF67-459F-9092-2EF6E04B1472"/>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046812afe0146812ce85a0000"/>
    <permissions:permissions rdf:nodeID="N627916f651634fcf86d85a92cc8ae545"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:046CE425-7371-402F-A18F-6913B0C03124"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:95E933E3-09F5-4362-96D4-CF14B045A370"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:D590AF4F-FC05-41EA-8CBC-29156060B437"/>
    <pav:lineageUri>urn:domeoserver:annotationset:C94BECCE-E3E9-4B70-AC23-F715B9D3EEFF</pav:lineageUri>
    <pav:previousVersion>urn:domeoserver:annotationset:2D3D9594-163C-4299-854D-3987A43B7DCF</pav:previousVersion>
    <ao:annotatesResource>				http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-23.txt.html																													</ao:annotatesResource>
    <ao:item rdf:resource="urn:domeoclient:uuid:B2690ED3-4A3B-4FA6-84FF-6800464F3D50"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">3</pav:versionNumber>
    <pav:lastSavedOn>2014-07-17 18:56:48 -0400</pav:lastSavedOn>
    <dct:description>The default set is created automatically by Domeo when no other set is existing.</dct:description>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:D38AF6AA-4E2D-418F-9389-D56A758CE615">
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:632CBF5A-9363-46AA-BF07-49466689FFD1"/>
    <dikbD2R:modality>ncit:negative</dikbD2R:modality>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:C4D81A7B-4D7D-4EBA-A2C1-0E5AC4A8CE5C">
    <pav:createdOn>2014-07-15 14:17:07 -0700</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotation:85D60B7C-4035-4031-B794-2D22E3F45094</pav:lineageUri>
    <pav:lastSavedOn>2014-07-15 17:17:26 -0400</pav:lastSavedOn>
    <rdfs:label>Highlight</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">4</pav:versionNumber>
    <pav:lastSavedOn>2014-07-15 14:17:25 -0700</pav:lastSavedOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoserver:annotationset:21B0E479-04F9-4D66-B396-B773EFE53882</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
    <domeo:belongsToSet>urn:domeoserver:annotationset:46636445-93A2-49F0-9E9C-5AEBF17046D2</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:7AB175A5-BD20-41A8-91C0-16D5DF981557"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E6A1493E-98EE-4FDE-9301-752AB8E3453F</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:570DA392-7779-456C-9C18-1FC0E579BBE6</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:5758DAC0-E1C0-49EB-BE9C-56FFBAF3B6F4</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:5B6A462D-57EA-4BBD-87E1-A0EC2FAF5196</domeo:belongsToSet>
    <pav:previousVersion>urn:domeoserver:annotationset:2E5CE73B-BFD4-4E35-9A07-D5E37A9E87AE</pav:previousVersion>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:883587E1-49C1-4EE0-909E-4ADBAE13DD3A</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E8194531-C5B3-43AE-BC13-14A252C54824</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotationset:75FC1225-8399-469B-AE9D-7F697713E6AC</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9C0B4E8B-9FFE-4E47-9B4C-A6EA4527A384</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:0261AF60-9879-4F43-A258-63443FAFA74D">
    <dikbD2R:modality>ncit:negative</dikbD2R:modality>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:D0B55215-1EBF-494D-B824-11B81E6480B8"/>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:9DF202FF-7B27-4079-825C-68963E1927BA">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:9DF202FF-7B27-4079-825C-68963E1927BA"/>
    <domeo:uuid>9DF202FF-7B27-4079-825C-68963E1927BA</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>9-hydroxyrisperidone</ao:exact>
    <domeo:uuid></domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2014-07-16 10:20:36 -0700</pav:createdOn>
    <ao:suffix> </ao:suffix>
    <ao:prefix>xsd:String</ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:A7E2E6B0-6F82-4961-8B6D-923A4E0BC5E9">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:A7E2E6B0-6F82-4961-8B6D-923A4E0BC5E9"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid></domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <ao:suffix>e acts as an antagonist at other receptors, but with lower potency. Risperidone has low to moderate affinity (Ki of 47 to 253 nM) for the serotonin 5HT1C, 5HT1D, and 5HT1A receptors, weak affinity (Ki of 620 to 800 nM) for the dopamine D1 and haloperidol</ao:suffix>
    <ao:exact>Risperidon</ao:exact>
    <ao:prefix> is a selective monoaminergic antagonist with high affinity (Ki of 0.12 to 7.3 nM) for the serotonin Type 2 (5HT2), dopamine Type 2 (D2), α1 and α2 adrenergic, and H1 histaminergic receptors. </ao:prefix>
    <pav:createdOn>2014-07-15 14:02:53 -0700</pav:createdOn>
    <domeo:uuid>A7E2E6B0-6F82-4961-8B6D-923A4E0BC5E9</domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:6501B61D-9F1D-47DB-B93C-A2B799BFACF1">
    <ao:prefix> 400 mg to six healthy male volunteers. After the administration of </ao:prefix>
    <domeo:uuid>6501B61D-9F1D-47DB-B93C-A2B799BFACF1</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid></domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-23.txt.html</ao:hasSource>
    <pav:createdOn>2014-07-16 15:39:46 -0700</pav:createdOn>
    <ao:suffix>, there was a significant decrease in fluconazole AUC and Cmax. There was a mean ± SD decrease in fluconazole AUC of 13% ± 11% (range: -3.4 to -31%) and Cmax decreased 19% ± 14% (range: -5 to -40%). However, the administration of cimetidine 600 mg to 900</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:6501B61D-9F1D-47DB-B93C-A2B799BFACF1"/>
    <ao:exact>cimetidine</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:570B84EB-A83D-4275-82DA-1B306C0F0E33">
    <ao:exact>risperidone</ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:570B84EB-A83D-4275-82DA-1B306C0F0E33"/>
    <domeo:uuid></domeo:uuid>
    <ao:prefix> to interfere with metabolism of other drugs metabolized by CYP 2D6. Relatively weak binding of </ao:prefix>
    <pav:createdOn>2014-07-15 14:16:55 -0700</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix> to the enzyme suggests this is unlikely [see 7 DRUG INTERACTIONS].</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>570B84EB-A83D-4275-82DA-1B306C0F0E33</domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:11E6A1FA-CF90-4170-B074-E4E3C8C8288D">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix> alone at steady state. If anticholinergic effects are seen, the dose of </ao:prefix>
    <pav:createdOn>2014-07-18 14:20:39 -0700</pav:createdOn>
    <ao:suffix> should be reduced.</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-50.txt.html</ao:hasSource>
    <ao:exact>procyclidine</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>11E6A1FA-CF90-4170-B074-E4E3C8C8288D</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:11E6A1FA-CF90-4170-B074-E4E3C8C8288D"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:EFD26771-2076-4B50-83F1-3C5592306D86">
    <ao:prefix> AUC of 23% ± 9% (range: -13 to -42%). Apparent oral clearance of </ao:prefix>
    <ao:exact>fluconazole</ao:exact>
    <ao:suffix> increased 32% ± 17% (range: 16 to 72%). Fluconazole half-life decreased from 33.4 ± 4.4 hours to 26.8 ± 3.9 hours. (See PRECAUTIONS.)</ao:suffix>
    <domeo:uuid>EFD26771-2076-4B50-83F1-3C5592306D86</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:EFD26771-2076-4B50-83F1-3C5592306D86"/>
    <pav:createdOn>2014-07-18 13:43:37 -0700</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-24.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N7077c8b2f073401d949b5e63390868f0">
    <domeo:sets rdf:resource="urn:pddi:uuid:D38AF6AA-4E2D-418F-9389-D56A758CE615"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:5975A18C-9750-49AF-9CBD-E13C8DFBA413">
    <pav:createdOn>2014-07-18 13:51:09 -0700</pav:createdOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotation:1E1FBE55-6AAA-47B7-B94A-48F3F99E76F0</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lastSavedOn>2014-07-18 16:51:47 -0400</pav:lastSavedOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:455E5E9F-232E-451B-8C43-9687045AD008"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoclient:uuid:B8452517-26D0-419F-88FD-A818925FDE06</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:AC4605E1-BB47-46C6-87EA-F8DDE5BC9868">
    <ao:context rdf:resource="urn:domeoclient:uuid:D4C5E020-24D9-465B-97AB-8A4E6685160F"/>
    <domeo:belongsToSet>urn:domeoclient:uuid:2F716A41-B68F-48AE-B5C1-E31F1704C565</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
    <domeo:belongsToSet>urn:domeoserver:annotationset:6FFFF211-BFDC-4E16-968C-A296868530C4</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lastSavedOn>2014-07-16 10:20:50 -0700</pav:lastSavedOn>
    <pav:lastSavedOn>2014-07-16 13:20:50 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotationset:C8D7FDC6-6816-4BD4-BC7F-88ABDCC37D79</pav:lineageUri>
    <pav:createdOn>2014-07-16 10:19:46 -0700</pav:createdOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:DA8D6B42-B41F-4576-BF10-1285DF3EAB80</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotation:C264E3CF-A22F-4984-A6D5-3778E4D0730F</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:AAD02A4C-E01E-4C82-BC8A-D0F4639844FA</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoserver:annotationset:883587E1-49C1-4EE0-909E-4ADBAE13DD3A">
    <ao:item rdf:resource="urn:domeoclient:uuid:D1062598-B310-4CF4-8237-5F8F8F74933F"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:BFCAC108-C978-4C7B-A79A-9887A3CA3C6C"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:C66BBCCE-CA43-44FB-8D97-2084E19C48FF"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:BF8175E8-F52D-4CE3-9DE9-BAE3E2CE04A1"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:76E5F11A-7EC2-4412-BCB7-E9B0542040DE"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:90386835-AD59-4BAA-A860-3003ABCAF86C"/>
    <pav:createdOn>2014-07-15 14:02:34 -0700</pav:createdOn>
    <ao:item rdf:resource="urn:domeoclient:uuid:446899E9-2BB7-4629-AA6E-75AF9EC38F08"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:785FFE99-34A3-41C7-A3D5-65DC60E0807D"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:8CA72313-3E32-44D6-A336-EDE69F22975A"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:3051A76E-96A2-4A70-91F9-A241566DEFD1"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:A688F7D2-43BF-4838-A9A1-339829ADA43A"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:2AAEA179-90D2-4661-9105-64A780850DEB"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:52A12616-29C9-4323-A81B-949195D51273"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:7CAB3CEB-53D4-45C0-BDE2-D01D9FD9219C"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:F8EED65F-31D9-41A0-9BB4-436FCBA969FA"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:9CAD6283-FE79-428D-A3CE-B664A09583CB"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:8F11E81F-1EDB-4EA8-8E4A-47D93E06FFF2"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:7443907B-C475-4EA4-B081-8C3D55A1EF69"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:A3DBEE5E-C93B-4DBE-A1E3-317DA19FA203"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:DC20D454-AAA8-4A81-915D-03526B8FC40B"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:BED0BB6E-5962-4714-A49A-2DB5A1787334"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:CA792FCD-C812-49FE-9EDF-15DA0F056A53"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:29A7AD86-B18C-409C-86E9-985BFF28A757"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:6F7C3F13-3AE2-43EA-93D3-9F0AF79252AC"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:C54A1798-BD47-4D4C-89DF-B37F5A3AB9F0"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:D1D92634-CB40-4585-8260-1917D2119CC7"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:5415B79F-FEAF-4999-A78E-2C1039116F7C"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:A4632682-84C0-4DFD-915D-D1C3B235F095"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:12CCDE72-9FC0-4264-A3F2-C533F792F613"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:68AD55C4-223A-46C6-896A-87345A781B61"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:FDDEE9D3-D4C2-40CB-BC92-305777AFD63E"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:BB6F25A1-6FFC-4CE5-8F5F-AD5806D52477"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:A1A5580F-53D7-4F22-824E-5430565EDBF1"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:14655D75-DC23-4E82-84C9-F40B702E4B69"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:A77ED33E-10B2-43BE-8BC6-D5F14E2FE208"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:DC71B917-C3C7-4475-B462-6525E8CEF601"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:A5A82A3B-FE45-46DE-9048-8E85995D8F43"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:5C0FAFB3-9734-473A-85E5-980D1051DADD"/>
    <pav:lineageUri>urn:domeoserver:annotationset:75FC1225-8399-469B-AE9D-7F697713E6AC</pav:lineageUri>
    <rdfs:label>Default Set</rdfs:label>
    <pav:lastSavedOn>2014-07-15 17:19:34 -0400</pav:lastSavedOn>
    <ao:item rdf:resource="urn:domeoclient:uuid:6EB13D46-B414-424C-9D7C-BADA59079327"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:7130A96C-7BF2-4DBE-A880-248C420268E9"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
    <ao:item rdf:resource="urn:domeoclient:uuid:71089688-5934-49A8-BBF4-07B4CAD41AA7"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:7DF78E91-4010-455D-9300-16EAD7D6AB87"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:914C2061-E547-4CFD-9F3C-C0070F56BF90"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:1453C795-84C1-4C48-AF84-AEEE18ED1682"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:4D3BA7C7-A806-41A4-84AC-38A85FF0F9C2"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:C1A443CA-B8D4-4A28-825B-B97ECDEC88D7"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:AA5B502F-CF57-4C65-81A8-140217111073"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:A056C491-9BB0-438A-A716-FE909F2281AD"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:34A66F13-B248-4FD8-A3CE-7AAAC40B7ACC"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:12D5CA7C-401C-4376-A246-03585C5F9AC0"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:5CE6135C-97A9-4B21-9915-11E87A1697A5"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:60AE44A7-769C-4774-8E4D-7AF66A2F2EA1"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:82FFD7F0-AC94-462F-BA86-70CFD849B686"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:D707EDCF-5B5D-4AB9-9815-32BDDA05721F"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:0A8134EE-D8E3-447B-9EB9-2CB597651AB4"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:C025BBE5-19A7-4D05-9813-E49F4799CB23"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">5</pav:versionNumber>
    <ao:item rdf:resource="urn:domeoclient:uuid:C4D81A7B-4D7D-4EBA-A2C1-0E5AC4A8CE5C"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:ADFEE70E-EDC2-4D08-90AB-0ABAFD52BC6F"/>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:annotatesResource>
    <ao:item rdf:resource="urn:domeoclient:uuid:24229507-32A8-4A26-89C0-59655390DA1A"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:E2A636FF-8FE8-44E9-B454-573E4E7470FA"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:A2215D32-FF99-4DC9-90B9-5C350C098EEB"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:274D4FB3-81D3-46CA-BE6A-31286B260E56"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:63FB79CC-576B-4FFD-A109-FF63DAE371C0"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:A252FD3C-4309-4CCB-8491-4B23A2848662"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:DA483938-DFFC-4F6C-85C3-FED68E6D4DE8"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:65047D28-4B70-4701-B243-A146C45926A7"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:51770B89-7CCF-409A-A2E9-D4576F9DB59A"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:F87C43FC-DD9B-42FA-953B-C8C25AA48C91"/>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046812afe0146812ce85a0000"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:E0EC9718-8100-4840-9F10-BFE3FC7823F2"/>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <permissions:permissions rdf:nodeID="N345cd2b584764af3a6b3f342ec8a2d6e"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:4CD0874F-AA43-4C04-958D-6CFBFA68EC61"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:24886D93-A995-41A8-9E66-1BF6DF77E9D2"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:797BAFBC-5256-4C7D-9ACC-064403D70DDB"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:D2174191-CE1D-4EF2-8DD5-03008A9706DE"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:AD757AC1-7E10-42A9-A8ED-0BD21ADA30A7"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:8900088E-395F-4576-960E-1B67ECCA0A65"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:312701AC-EC1C-4292-B01F-44DD40979EEA"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:79C3BE8E-51D8-473A-AC88-0ADB7AE9D239"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:6FED0630-F5B3-4A05-892B-CB86D31FD6DF"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:A526C161-102B-469E-9242-8D2CB0C94450"/>
    <dct:description>The default set is created automatically by Domeo when no other set is existing.</dct:description>
    <ao:item rdf:resource="urn:domeoclient:uuid:926EB546-FC66-4BEC-B38A-18749E06CCE5"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:85B5BEBE-D146-414B-A979-B9CEBE9C57E6"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:AAA6478C-E7E4-4D30-9F06-AA094434B620"/>
    <domeo:deleted>false</domeo:deleted>
    <ao:item rdf:resource="urn:domeoclient:uuid:C91DD2D9-B8D7-4C80-85A1-EE73345B059A"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:BCC5E7E8-854A-4B02-859A-36A9EC807AF5"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:318D970E-E791-465D-B650-869C74523D2C"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <pav:previousVersion>urn:domeoserver:annotationset:570DA392-7779-456C-9C18-1FC0E579BBE6</pav:previousVersion>
    <ao:item rdf:resource="urn:domeoclient:uuid:920B7836-2155-4EE5-9028-A6274B846CBA"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:D8773E33-77FB-4402-ABAD-8048CB22BB84">
    <pav:lineageUri>urn:domeoserver:annotation:34F14117-3108-4BAB-A576-1DDAE021A186</pav:lineageUri>
    <pav:createdOn>2014-07-18 13:48:22 -0700</pav:createdOn>
    <pav:lastSavedOn>2014-07-18 16:48:39 -0400</pav:lastSavedOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:D0DA49DD-64B6-4DB4-8411-726DBD8A6893"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
    <pav:lineageUri>urn:domeoserver:annotationset:748BB253-1066-4977-91B2-35D8C6906790</pav:lineageUri>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lastSavedOn>2014-07-18 13:48:39 -0700</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A7F21A3D-50B3-495E-884A-2C707B40C763</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoclient:uuid:53775C4C-7CC4-46EB-9EFC-EDF9D3D264ED</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:83325641-7434-4321-A570-829337F41ADF">
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-20.txt.html</ao:hasSource>
    <ao:prefix>xsd:String</ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:83325641-7434-4321-A570-829337F41ADF"/>
    <ao:exact>Sertraline hydrochloride</ao:exact>
    <ao:suffix> i</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid></domeo:uuid>
    <domeo:uuid>83325641-7434-4321-A570-829337F41ADF</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2014-07-16 10:36:22 -0700</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:61CB1DA8-A104-4CBC-A3C7-E8898B001ECF">
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:A229E325-2C87-4EFC-8114-8F692F9FE147"/>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:F057A8DE-7885-47B0-B2D9-E9C3D877EC02">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2014-07-16 15:44:20 -0700</pav:createdOn>
    <ao:prefix>xsd:String</ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid>F057A8DE-7885-47B0-B2D9-E9C3D877EC02</domeo:uuid>
    <ao:suffix>. However, the administration of</ao:suffix>
    <ao:exact>Fluconazole 100 mg was administered as a single oral dose alone and two hours after a single dose of cimetidine 400 mg to six healthy male volunteers. After the administration of cimetidine, there was a significant decrease in fluconazole AUC and Cmax. There was a mean ± SD decrease in fluconazole AUC of 13% ± 11% (range: -3.4 to -31%) and Cmax decreased 19% ± 14% (range: -5 to -40%)</ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:F057A8DE-7885-47B0-B2D9-E9C3D877EC02"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-23.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:FBA60B3A-004D-4687-B7EC-56E7B9D4A78B">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/0DCDA0D5-A5B2-483F-AFDF-50EAB4D41396"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/276A1818-8600-415C-BF4E-E95E1BB0E0CC"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:2AAEA179-90D2-4661-9105-64A780850DEB">
    <pav:lastSavedOn>2014-07-15 17:04:06 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9C0B4E8B-9FFE-4E47-9B4C-A6EA4527A384</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoserver:annotationset:5B6A462D-57EA-4BBD-87E1-A0EC2FAF5196</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E6A1493E-98EE-4FDE-9301-752AB8E3453F</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:883587E1-49C1-4EE0-909E-4ADBAE13DD3A</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotation:C434D567-7705-4957-9B74-533EB1C6C8C9</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:21B0E479-04F9-4D66-B396-B773EFE53882</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:46636445-93A2-49F0-9E9C-5AEBF17046D2</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoclient:uuid:9B307D8B-D2B0-4795-8850-FAAAAC6B5AF4</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:984705CF-6418-4362-AA0D-0A0DD15065D1"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:5758DAC0-E1C0-49EB-BE9C-56FFBAF3B6F4</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:570DA392-7779-456C-9C18-1FC0E579BBE6</domeo:belongsToSet>
    <pav:createdOn>2014-07-15 14:03:06 -0700</pav:createdOn>
    <pav:lastSavedOn>2014-07-15 14:04:06 -0700</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:1575950D-32D4-46DE-A44F-8E9E614F997F</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:FA8D1DAC-C616-456C-BB3D-29F18DED21A1</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E8194531-C5B3-43AE-BC13-14A252C54824</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:2E5CE73B-BFD4-4E35-9A07-D5E37A9E87AE</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:previousVersion>xsd:String</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoserver:annotationset:2D3D9594-163C-4299-854D-3987A43B7DCF">
    <rdfs:label>Default Set</rdfs:label>
    <ao:item rdf:resource="urn:domeoclient:uuid:0FE2C318-FF67-459F-9092-2EF6E04B1472"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:BD319A5A-0B87-457E-BF99-76BC4728CC77"/>
    <pav:lineageUri>urn:domeoserver:annotationset:C94BECCE-E3E9-4B70-AC23-F715B9D3EEFF</pav:lineageUri>
    <ao:item rdf:resource="urn:domeoclient:uuid:B2690ED3-4A3B-4FA6-84FF-6800464F3D50"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:D590AF4F-FC05-41EA-8CBC-29156060B437"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <domeo:deleted>false</domeo:deleted>
    <pav:lastSavedOn>2014-07-17 18:56:11 -0400</pav:lastSavedOn>
    <pav:previousVersion>urn:domeoclient:uuid:4E57D817-C3D5-47E5-AECC-169C5A1EF60D</pav:previousVersion>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <pav:createdOn>2014-07-17 15:53:34 -0700</pav:createdOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">2</pav:versionNumber>
    <ao:item rdf:resource="urn:domeoclient:uuid:6F6FACEE-5C35-4020-BE6D-26958BA10CA6"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:B230469B-00AA-4A73-A839-6D9826213D36"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:item rdf:resource="urn:domeoclient:uuid:079A4E14-C541-4AC8-B876-063FC489849B"/>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046812afe0146812ce85a0000"/>
    <permissions:permissions rdf:nodeID="N57dea7f0d13b4c98bdf8e04d63e1bd5f"/>
    <dct:description>The default set is created automatically by Domeo when no other set is existing.</dct:description>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
    <ao:annotatesResource>				http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-23.txt.html																													</ao:annotatesResource>
    <ao:item rdf:resource="urn:domeoclient:uuid:95E933E3-09F5-4362-96D4-CF14B045A370"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:75978B88-8F19-4550-921C-BCAB17F30E80">
    <domeo:uuid></domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix>Excretion: </ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>Risperidone</ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:75978B88-8F19-4550-921C-BCAB17F30E80"/>
    <domeo:uuid>75978B88-8F19-4550-921C-BCAB17F30E80</domeo:uuid>
    <pav:createdOn>2014-07-15 14:17:00 -0700</pav:createdOn>
    <ao:suffix> and its metabolites are eliminated via the urine and, to a much lesser extent, via the feces. As illustrated by a mass balance study of a single 1 mg oral dose of 14C-risperidone administered as solution to three healthy male volunteers, total recovery </ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:51770B89-7CCF-409A-A2E9-D4576F9DB59A">
    <pav:createdOn>2014-07-15 14:15:52 -0700</pav:createdOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E8194531-C5B3-43AE-BC13-14A252C54824</domeo:belongsToSet>
    <pav:previousVersion>urn:domeoserver:annotationset:2E5CE73B-BFD4-4E35-9A07-D5E37A9E87AE</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
    <domeo:belongsToSet>urn:domeoserver:annotationset:5758DAC0-E1C0-49EB-BE9C-56FFBAF3B6F4</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:46636445-93A2-49F0-9E9C-5AEBF17046D2</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9C0B4E8B-9FFE-4E47-9B4C-A6EA4527A384</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:883587E1-49C1-4EE0-909E-4ADBAE13DD3A</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-15 17:17:26 -0400</pav:lastSavedOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoserver:annotationset:5B6A462D-57EA-4BBD-87E1-A0EC2FAF5196</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E6A1493E-98EE-4FDE-9301-752AB8E3453F</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:570DA392-7779-456C-9C18-1FC0E579BBE6</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lineageUri>urn:domeoserver:annotation:D0DFCBEA-5FF6-478F-8409-2748CE149534</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:21B0E479-04F9-4D66-B396-B773EFE53882</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotationset:75FC1225-8399-469B-AE9D-7F697713E6AC</pav:lineageUri>
    <pav:lastSavedOn>2014-07-15 14:17:25 -0700</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">4</pav:versionNumber>
    <ao:context rdf:resource="urn:domeoclient:uuid:0ABB2266-B2C7-44A9-8367-C5FE4916C02B"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Ne4a626b8318845d4bb9d818c02fcc3eb">
    <domeo:sets rdf:resource="urn:pddi:uuid:FC0B6A3C-A2F8-4ACD-9832-BF13C7065BAE"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Nebd935185b0d4c7497e66bca237b9c62">
    <permissions:accessType>urn:domeo:access:public</permissions:accessType>
    <permissions:isLocked>false</permissions:isLocked>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:40C3CB86-AAFD-4D68-AE0D-699574B044BD">
    <ao:exact>sulfamethazine (100 mcg/mL), warfarin (10 mcg/mL), and carbamazepine (10 mcg/mL) caused only a slight increase in the free fraction of risperidone at 10 ng/mL and 9-hydroxyrisperidone at 50 ng/mL,</ao:exact>
    <pav:createdOn>2014-07-18 15:17:44 -0700</pav:createdOn>
    <ao:suffix> changes of unknown clinical significance</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:40C3CB86-AAFD-4D68-AE0D-699574B044BD"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>40C3CB86-AAFD-4D68-AE0D-699574B044BD</domeo:uuid>
    <ao:prefix>xsd:String</ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:B2931C8A-EC31-47B6-AE9D-7EFD2AFC6C76">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <ao:context rdf:resource="urn:domeoclient:uuid:EC1C5E61-FA3B-468A-A86F-BC4B06CEB624"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdOn>2014-07-17 15:59:01 -0700</pav:createdOn>
    <domeo:belongsToSet>urn:domeoclient:uuid:83B2E87D-3732-4699-AA3D-363A6EB95959</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotationset:B716A719-3E66-4B72-87E0-370D90F3B8F7</pav:lineageUri>
    <pav:lineageUri>urn:domeoserver:annotation:535A6E3D-0955-4CA1-AE01-4B29D441D7FD</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:8DEBE5AF-B171-4BE8-880B-76A2BEE742A6</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-17 18:59:36 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
    <pav:lastSavedOn>2014-07-17 15:59:35 -0700</pav:lastSavedOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:CA792FCD-C812-49FE-9EDF-15DA0F056A53">
    <domeo:belongsToSet>urn:domeoserver:annotationset:E6A1493E-98EE-4FDE-9301-752AB8E3453F</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:5758DAC0-E1C0-49EB-BE9C-56FFBAF3B6F4</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:570DA392-7779-456C-9C18-1FC0E579BBE6</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-15 17:11:14 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotation:2057A694-4518-498B-B065-0F8DC56570A5</pav:lineageUri>
    <ao:context rdf:resource="urn:domeoclient:uuid:FE91163B-25D4-45FB-AD96-78A70FE948D6"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:2E5CE73B-BFD4-4E35-9A07-D5E37A9E87AE</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E8194531-C5B3-43AE-BC13-14A252C54824</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9C0B4E8B-9FFE-4E47-9B4C-A6EA4527A384</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoserver:annotationset:5B6A462D-57EA-4BBD-87E1-A0EC2FAF5196</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-15 14:11:14 -0700</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:883587E1-49C1-4EE0-909E-4ADBAE13DD3A</domeo:belongsToSet>
    <pav:createdOn>2014-07-15 14:10:43 -0700</pav:createdOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:21B0E479-04F9-4D66-B396-B773EFE53882</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:46636445-93A2-49F0-9E9C-5AEBF17046D2</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:892E6482-5108-4155-B6F2-763924AB0616">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>892E6482-5108-4155-B6F2-763924AB0616</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:892E6482-5108-4155-B6F2-763924AB0616"/>
    <pav:createdOn>2014-07-10 11:17:03 -0700</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix>xsd:String</ao:prefix>
    <ao:exact>When a single 100 mg dose of sildenafil was co-administered with erythromycin, a CYP3A inhibitor, at steady state (500 mg BID for 5 days), there was a 182% increase in sildenafil systemic exposure (AUC)</ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:hasSource>
    <ao:suffix>xsd:String</ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:9A5182DA-4DAC-48D6-946F-8283D026674F">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lineageUri>urn:domeoserver:annotation:B87CC34F-8B98-4E82-835E-39A3B10EA5E5</pav:lineageUri>
    <ao:context rdf:resource="urn:domeoclient:uuid:EEEDCB2D-0F2D-42A1-AF30-23CDE2191AB4"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdOn>2014-07-18 13:55:33 -0700</pav:createdOn>
    <pav:lastSavedOn>2014-07-18 16:56:04 -0400</pav:lastSavedOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoclient:uuid:82AC5ADA-B8CE-47A9-AA99-E7187ABEFACA</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
    <domeo:belongsToSet>urn:domeoserver:annotationset:99826AC3-3668-4F74-9E9D-DADD1F7098F0</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-18 13:56:04 -0700</pav:lastSavedOn>
    <rdfs:label>Highlight</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Nbe9b47c3a0ec4d5bb46340cdbeb7d951">
    <permissions:accessType>urn:domeo:access:public</permissions:accessType>
    <permissions:isLocked>false</permissions:isLocked>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:026A9D62-B81B-44DD-A18F-6776E5D0E1A2">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>026A9D62-B81B-44DD-A18F-6776E5D0E1A2</domeo:uuid>
    <domeo:uuid></domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:026A9D62-B81B-44DD-A18F-6776E5D0E1A2"/>
    <pav:createdOn>2014-07-15 14:16:07 -0700</pav:createdOn>
    <ao:suffix> do not suggest important differences between poor and extensive metabolizers. Second, co-administration of known enzyme inducers (e.g., carbamazepine, phenytoin, rifampin, and phenobarbital) with risperidone may cause a decrease in the combined plasma c</ao:suffix>
    <ao:exact> risperidone</ao:exact>
    <ao:prefix> have not been evaluated, but observations in a modest number (N≅70) of poor metabolizers given</ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:4D3BA7C7-A806-41A4-84AC-38A85FF0F9C2">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">2</pav:versionNumber>
    <pav:lastSavedOn>2014-07-15 14:07:58 -0700</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:21B0E479-04F9-4D66-B396-B773EFE53882</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:46636445-93A2-49F0-9E9C-5AEBF17046D2</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E8194531-C5B3-43AE-BC13-14A252C54824</domeo:belongsToSet>
    <pav:previousVersion>urn:domeoclient:uuid:9B307D8B-D2B0-4795-8850-FAAAAC6B5AF4</pav:previousVersion>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lastSavedOn>2014-07-15 17:07:57 -0400</pav:lastSavedOn>
    <pav:lastSavedOn>2014-07-15 17:07:58 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:2E5CE73B-BFD4-4E35-9A07-D5E37A9E87AE</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:2BB10533-7A8A-4C30-95A1-E3816F2A9980"/>
    <pav:createdOn>2014-07-15 14:06:36 -0700</pav:createdOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:1575950D-32D4-46DE-A44F-8E9E614F997F</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
    <domeo:belongsToSet>urn:domeoserver:annotationset:FA8D1DAC-C616-456C-BB3D-29F18DED21A1</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <rdfs:label>Highlight</rdfs:label>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotationset:75FC1225-8399-469B-AE9D-7F697713E6AC</pav:lineageUri>
    <pav:lineageUri>urn:domeoserver:annotation:66EA6A87-75EC-40A0-B523-88B23FE80090</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9C0B4E8B-9FFE-4E47-9B4C-A6EA4527A384</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:883587E1-49C1-4EE0-909E-4ADBAE13DD3A</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:5B6A462D-57EA-4BBD-87E1-A0EC2FAF5196</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotation:633F9FB5-9D3D-4F37-B022-1F25B09D1B52</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E6A1493E-98EE-4FDE-9301-752AB8E3453F</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:5758DAC0-E1C0-49EB-BE9C-56FFBAF3B6F4</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:570DA392-7779-456C-9C18-1FC0E579BBE6</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:7A2CAFDF-C49B-4054-971B-E8074913A461">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/84F0BF77-BE8B-434E-9DD7-38ABB593D8D4"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/7FC5C56B-C663-4285-8BB1-9294F364E6DE"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:D0A91F52-6752-4FEC-A801-601958619292">
    <ao:prefix> is rapidly distributed. The volume of distribution is 1 to 2 L/kg. In plasma, </ao:prefix>
    <domeo:uuid>D0A91F52-6752-4FEC-A801-601958619292</domeo:uuid>
    <ao:exact>risperidone</ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:D0A91F52-6752-4FEC-A801-601958619292"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid></domeo:uuid>
    <pav:createdOn>2014-07-15 14:07:38 -0700</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix> is bound to albumin and α1-acid glycoprotein. The plasma protein binding of risperidone is 90%, and that of its major metabolite, 9-hydroxyrisperidone, is 77%. Neither risperidone nor 9-hydroxyrisperidone displaces each other from plasma binding sites. </ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:A9E905EC-FD3B-44E6-9603-8C4B7B645A61">
    <domeo:belongsToSet>urn:domeoserver:annotationset:6FFFF211-BFDC-4E16-968C-A296868530C4</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:C4E9DA8F-91C3-4A6F-9726-C8A51040AAC3"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:AAD02A4C-E01E-4C82-BC8A-D0F4639844FA</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">2</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotationset:C8D7FDC6-6816-4BD4-BC7F-88ABDCC37D79</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:DA8D6B42-B41F-4576-BF10-1285DF3EAB80</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-16 10:21:09 -0700</pav:lastSavedOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotation:872BF4DD-F66D-4F0A-9562-1552D55BDDCB</pav:lineageUri>
    <pav:previousVersion>urn:domeoclient:uuid:2F716A41-B68F-48AE-B5C1-E31F1704C565</pav:previousVersion>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lastSavedOn>2014-07-16 13:21:09 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
    <pav:createdOn>2014-07-16 10:21:01 -0700</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:3A410142-DDEC-496D-86F6-76E692FBA77E">
    <pav:lastSavedOn>2014-07-18 17:22:23 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:7BA312DF-BB65-4A90-8B7D-A54425D7C553</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotation:0D4D8D25-063B-40EF-AFCD-BAC6B8FA59D2</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <ao:context rdf:resource="urn:domeoclient:uuid:5D12662E-B4E8-4D82-82D8-C7038995144A"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdOn>2014-07-18 14:22:23 -0700</pav:createdOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
    <ao:body rdf:nodeID="N854c8cbe91074eea8f4227a25349bddf"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:F6BE9E0C-96F1-4A3F-BE0A-413829714A90">
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:97152B9D-CEAA-4BF5-BCF3-8D56F516DD36"/>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/80039273-3912-42BE-B7A9-ACED668AB27A">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/metabolite"/>
    <rdfs:label>9-hydroxyrisperidone</rdfs:label>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/679314</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:BE8D3AAD-5714-40E9-8521-B30676F883D5">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:previousVersion>urn:domeoclient:uuid:8B8B88D4-5E42-47CB-9E37-EED59C74FD96</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotation:97A9603C-2BC2-4A80-9EED-AFFC909F32BF</pav:lineageUri>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lastSavedOn>2014-07-09 16:56:36 -0400</pav:lastSavedOn>
    <pav:createdOn>2014-07-09 13:56:32 -0700</pav:createdOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">2</pav:versionNumber>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <domeo:belongsToSet>urn:domeoserver:annotationset:88784842-2713-4D3B-A293-A9498ACCA54A</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <ao:body rdf:nodeID="Na984382f798044a29d8988e44a3cba1b"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:80304B91-FB8B-4EF5-87EC-80F59A689F2A</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
    <pav:lastSavedOn>2014-07-09 16:57:52 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotationset:2C25A7F3-8A42-4060-A64C-5C2AB24D4675</pav:lineageUri>
    <ao:context rdf:resource="urn:domeoclient:uuid:882C3E53-3401-4418-9864-3D34134F9C86"/>
    <ao:body rdf:nodeID="N788e9911c5f942cea64b0f7331acf157"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:9D63988E-3AF5-4F4F-84C5-3B867069EBD1"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N950fa95e82634eed9ace2518059e709f">
    <permissions:isLocked>false</permissions:isLocked>
    <permissions:accessType>urn:domeo:access:public</permissions:accessType>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:1B6D54E8-D781-4B59-A1BC-6120E5CF9015">
    <pav:lastSavedOn>2014-07-18 17:07:27 -0400</pav:lastSavedOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoclient:uuid:346C4DA6-A4F5-4B6F-AADB-4E76B1FDE36F</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:B480EE53-5881-4650-9D82-D1F972071243</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lastSavedOn>2014-07-18 14:07:26 -0700</pav:lastSavedOn>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
    <pav:createdOn>2014-07-18 14:07:26 -0700</pav:createdOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotationset:B136901C-38A0-4F12-B35D-BF814374DB34</pav:lineageUri>
    <ao:context rdf:resource="urn:domeoclient:uuid:8C5430EE-8C8A-44B7-9A28-80BDAB1B381C"/>
    <pav:lineageUri>urn:domeoserver:annotation:403AF96C-21B3-4AA8-911A-13A87F132BC9</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:EDA74310-A0B5-4356-940A-7C74749CD2EF">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>sertraline</ao:exact>
    <ao:prefix>s supplied for oral administration as scored tablets containing sertraline hydrochloride equivalent to 25, 50, 100, 150 and 200 mg of </ao:prefix>
    <domeo:uuid></domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:EDA74310-A0B5-4356-940A-7C74749CD2EF"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-20.txt.html</ao:hasSource>
    <domeo:uuid>EDA74310-A0B5-4356-940A-7C74749CD2EF</domeo:uuid>
    <pav:createdOn>2014-07-16 10:36:33 -0700</pav:createdOn>
    <ao:suffix> and the following inactive ingredients: dibasic calcium phosphate dihydrate, hydroxypropyl cellulose, hypromellose, magnesium stearate, microcrystalline cellulose, polyethylene glycol, sodium starch glycolate, talc, and titanium dioxide.</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoserver:annotationset:DA8D6B42-B41F-4576-BF10-1285DF3EAB80">
    <domeo:agents rdf:resource="urn:person:uuid:080e143046812afe0146812ce85a0000"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:75261373-1FF5-4BA4-8887-FD4548F77DE6"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:34BFAD74-FE4D-4E30-8ACE-10002901EAA2"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:A9E905EC-FD3B-44E6-9603-8C4B7B645A61"/>
    <pav:lineageUri>urn:domeoserver:annotationset:C8D7FDC6-6816-4BD4-BC7F-88ABDCC37D79</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:item rdf:resource="urn:domeoclient:uuid:6395774E-A61F-4CC3-AC03-4A9A97F402CB"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:50B64AB9-5E00-4F5D-BE7F-9B8CE91BCF2A"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
    <pav:lastSavedOn>2014-07-16 13:21:09 -0400</pav:lastSavedOn>
    <ao:item rdf:resource="urn:domeoclient:uuid:6B42267E-6924-4453-B105-2F66C330186C"/>
    <permissions:permissions rdf:nodeID="N3b67ceeea10744b78901ffd0a0cad3d0"/>
    <pav:previousVersion>urn:domeoclient:uuid:2F716A41-B68F-48AE-B5C1-E31F1704C565</pav:previousVersion>
    <ao:item rdf:resource="urn:domeoclient:uuid:06A59058-E7B5-4A71-9D10-07FD98051EBF"/>
    <rdfs:label>Default Set</rdfs:label>
    <pav:createdOn>2014-07-16 10:18:37 -0700</pav:createdOn>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:annotatesResource>
    <ao:item rdf:resource="urn:domeoclient:uuid:069D387B-708F-4C78-BA75-2E62415C81C9"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:8D0FBEEE-F2C5-4EBC-892B-1E8DE2D584AE"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:F89E37D5-CA53-4C58-B4D2-AE8F0A3FBCE2"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:EDA5CCDC-B45B-4C9D-9286-2C6331B0DC2E"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">2</pav:versionNumber>
    <ao:item rdf:resource="urn:domeoclient:uuid:11B78A9D-1251-420C-8AE2-B343DD8F857F"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:0623A94E-6CBD-441E-92B8-16C280BD8650"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:785FC8A2-DE5D-4084-8BEC-107690A111CB"/>
    <dct:description>The default set is created automatically by Domeo when no other set is existing.</dct:description>
    <ao:item rdf:resource="urn:domeoclient:uuid:18EE2CB9-3D4F-42B6-A49D-245BF6C564CA"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:AC4605E1-BB47-46C6-87EA-F8DDE5BC9868"/>
    <domeo:deleted>false</domeo:deleted>
    <ao:item rdf:resource="urn:domeoclient:uuid:ADF2DC89-FCCE-47DE-8493-BEC599C898E4"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:F2AF7A08-3EE5-4851-BC7F-4DF99BFE382A"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:81DA2C24-D202-4991-9DC6-FFA54776B4D2"/>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/F76EC146-E955-47C7-96D5-A7F508A56E5A">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdfs:label>carbamazepine</rdfs:label>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/2002</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/4F35C443-9DBC-4CC5-A6B5-6AC7F37CD815">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdfs:label>cimetidine</rdfs:label>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/2541</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:797BAFBC-5256-4C7D-9ACC-064403D70DDB">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E8194531-C5B3-43AE-BC13-14A252C54824</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-15 14:11:14 -0700</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9C0B4E8B-9FFE-4E47-9B4C-A6EA4527A384</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:883587E1-49C1-4EE0-909E-4ADBAE13DD3A</domeo:belongsToSet>
    <pav:createdOn>2014-07-15 14:08:51 -0700</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotation:602391D0-01F6-4A8E-A578-660F21D18E55</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:5B6A462D-57EA-4BBD-87E1-A0EC2FAF5196</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E6A1493E-98EE-4FDE-9301-752AB8E3453F</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:5758DAC0-E1C0-49EB-BE9C-56FFBAF3B6F4</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:570DA392-7779-456C-9C18-1FC0E579BBE6</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-15 17:11:14 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:21B0E479-04F9-4D66-B396-B773EFE53882</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:46636445-93A2-49F0-9E9C-5AEBF17046D2</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:2E5CE73B-BFD4-4E35-9A07-D5E37A9E87AE</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <ao:context rdf:resource="urn:domeoclient:uuid:FBBE65E6-567D-48EE-99B9-B5E8C8480685"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
    <rdfs:label>Highlight</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:F5FD5F49-D620-4FE1-9968-D31A01410DEC">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <ao:context rdf:resource="urn:domeoclient:uuid:AF7B07B6-2BD9-490B-95BF-D760C5399474"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:239B4C6D-1110-4B65-AC66-F8A394187814</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoserver:annotationset:15A537D1-5648-41B2-8BFA-0D0BA3DF4393</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:970963DF-8BCE-4936-9DFC-328A36014E1B</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-10 11:14:30 -0700</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:DBBBAD55-D12B-4890-A2AF-85D3C85A7BEF</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:2BFC2FB6-6BE9-4822-A245-973533533023</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:3F81414E-B149-4B05-925B-18735B554A13</domeo:belongsToSet>
    <pav:createdOn>2014-07-10 11:10:37 -0700</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
    <domeo:belongsToSet>urn:domeoserver:annotationset:516C333C-B517-4F84-999E-51185DD6E859</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-10 14:14:30 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotation:357EF864-DD43-4B3D-B0D4-05133DC26F05</pav:lineageUri>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:A30AACD8-E9A8-4B2C-9DB3-7E44F147751F">
    <pav:lastSavedOn>2014-07-10 11:21:41 -0700</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoserver:annotationset:15A537D1-5648-41B2-8BFA-0D0BA3DF4393</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:970963DF-8BCE-4936-9DFC-328A36014E1B</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">6</pav:versionNumber>
    <pav:lastSavedOn>2014-07-10 14:21:41 -0400</pav:lastSavedOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:9B093B77-913B-463D-96DF-69C0A7A14BD4"/>
    <pav:createdOn>2014-07-10 11:20:49 -0700</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotation:AB90B41B-1A77-4A97-A49D-2B16205C6EDC</pav:lineageUri>
    <pav:lineageUri>urn:domeoserver:annotationset:BE290CA3-79BD-411A-BE2E-69AA4D19607D</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
    <domeo:belongsToSet>urn:domeoserver:annotationset:239B4C6D-1110-4B65-AC66-F8A394187814</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:516C333C-B517-4F84-999E-51185DD6E859</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:previousVersion>urn:domeoserver:annotationset:2BFC2FB6-6BE9-4822-A245-973533533023</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:35CDD2E7-70B2-4586-B719-AE865BE6C293">
    <ao:context rdf:resource="urn:domeoclient:uuid:E2070D1E-ACA9-4A94-BC6D-885BA2DE100C"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lastSavedOn>2014-07-18 13:56:04 -0700</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotation:FD41E7F4-0BFF-4655-AF6A-DB36A69B65D2</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoclient:uuid:82AC5ADA-B8CE-47A9-AA99-E7187ABEFACA</domeo:belongsToSet>
    <pav:createdOn>2014-07-18 13:55:43 -0700</pav:createdOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:99826AC3-3668-4F74-9E9D-DADD1F7098F0</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-18 16:56:04 -0400</pav:lastSavedOn>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
    <pav:previousVersion>xsd:String</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:7130A96C-7BF2-4DBE-A880-248C420268E9">
    <pav:previousVersion>urn:domeoserver:annotationset:2E5CE73B-BFD4-4E35-9A07-D5E37A9E87AE</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotation:67D02C87-0A08-4F7A-8EC7-3EE29225104C</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:883587E1-49C1-4EE0-909E-4ADBAE13DD3A</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9C0B4E8B-9FFE-4E47-9B4C-A6EA4527A384</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotationset:75FC1225-8399-469B-AE9D-7F697713E6AC</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:46636445-93A2-49F0-9E9C-5AEBF17046D2</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E6A1493E-98EE-4FDE-9301-752AB8E3453F</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:5758DAC0-E1C0-49EB-BE9C-56FFBAF3B6F4</domeo:belongsToSet>
    <pav:createdOn>2014-07-15 14:16:55 -0700</pav:createdOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E8194531-C5B3-43AE-BC13-14A252C54824</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:570B84EB-A83D-4275-82DA-1B306C0F0E33"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoserver:annotationset:21B0E479-04F9-4D66-B396-B773EFE53882</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoserver:annotationset:570DA392-7779-456C-9C18-1FC0E579BBE6</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-15 14:17:25 -0700</pav:lastSavedOn>
    <pav:lastSavedOn>2014-07-15 17:17:26 -0400</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">4</pav:versionNumber>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
    <domeo:belongsToSet>urn:domeoserver:annotationset:5B6A462D-57EA-4BBD-87E1-A0EC2FAF5196</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:41134D12-A312-4FDD-ADEA-5285A0740BFA">
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
    <pav:lastSavedOn>2014-07-16 13:23:07 -0400</pav:lastSavedOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:AAD02A4C-E01E-4C82-BC8A-D0F4639844FA</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
    <ao:context rdf:resource="urn:domeoclient:uuid:FBE4D752-3492-405C-8C46-E0FAC0507DD3"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:6FFFF211-BFDC-4E16-968C-A296868530C4</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-16 10:23:07 -0700</pav:lastSavedOn>
    <pav:createdOn>2014-07-16 10:22:00 -0700</pav:createdOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotation:8A513507-73B4-452F-947A-B7973A3A467C</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:DC20D454-AAA8-4A81-915D-03526B8FC40B">
    <pav:lineageUri>urn:domeoserver:annotation:067DD517-77F6-46CE-952D-88DCC4CCD969</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:570DA392-7779-456C-9C18-1FC0E579BBE6</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:46636445-93A2-49F0-9E9C-5AEBF17046D2</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:2E5CE73B-BFD4-4E35-9A07-D5E37A9E87AE</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdOn>2014-07-15 14:08:46 -0700</pav:createdOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E8194531-C5B3-43AE-BC13-14A252C54824</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lastSavedOn>2014-07-15 14:11:14 -0700</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9C0B4E8B-9FFE-4E47-9B4C-A6EA4527A384</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:883587E1-49C1-4EE0-909E-4ADBAE13DD3A</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:7B06A286-D3FC-41A8-A621-60C6E027265C"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E6A1493E-98EE-4FDE-9301-752AB8E3453F</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:5B6A462D-57EA-4BBD-87E1-A0EC2FAF5196</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-15 17:11:14 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:21B0E479-04F9-4D66-B396-B773EFE53882</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:5758DAC0-E1C0-49EB-BE9C-56FFBAF3B6F4</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoserver:annotationset:A1747CFE-8798-401D-BFC7-1E14B7B3B1B1">
    <pav:previousVersion>urn:domeoclient:uuid:AA2CF58E-6DB1-4267-8DFC-33DE11331D87</pav:previousVersion>
    <domeo:deleted>false</domeo:deleted>
    <ao:item rdf:resource="urn:domeoclient:uuid:2ECA95EB-4370-4C4C-8C95-4A2BE49873EF"/>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <dct:description>The default set is created automatically by Domeo when no other set is existing.</dct:description>
    <ao:item rdf:resource="urn:domeoclient:uuid:E2360225-A46C-436D-A3D6-1502801E2F92"/>
    <pav:lastSavedOn>2014-07-18 17:26:00 -0400</pav:lastSavedOn>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046812afe0146812ce85a0000"/>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-51.txt.html</ao:annotatesResource>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
    <pav:lineageUri>urn:domeoserver:annotationset:D0F2204E-5148-4A33-AAD0-599FB1F44EFC</pav:lineageUri>
    <ao:item rdf:resource="urn:domeoclient:uuid:9C861997-137E-4C3F-A9A5-BF78640820A1"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <pav:createdOn>2014-07-18 14:23:36 -0700</pav:createdOn>
    <rdfs:label>Default Set</rdfs:label>
    <ao:item rdf:resource="urn:domeoclient:uuid:3600E64E-4D3A-48CE-A0E8-33E1B78E99E5"/>
    <permissions:permissions rdf:nodeID="Ncf79e18c69d24ad8bc14d6fc7e168b89"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">2</pav:versionNumber>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:9E954CE3-F61D-4171-A4FE-6FAE429FF615">
    <domeo:belongsToSet>urn:domeoserver:annotationset:B480EE53-5881-4650-9D82-D1F972071243</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
    <pav:lineageUri>urn:domeoserver:annotation:8264D0C9-B444-4521-8761-A9DF6DE30DF1</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <ao:context rdf:resource="urn:domeoclient:uuid:0C8A7DFF-59B1-4852-B9E4-A60D88CD3918"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoclient:uuid:346C4DA6-A4F5-4B6F-AADB-4E76B1FDE36F</domeo:belongsToSet>
    <pav:createdOn>2014-07-18 14:07:20 -0700</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotationset:B136901C-38A0-4F12-B35D-BF814374DB34</pav:lineageUri>
    <pav:lastSavedOn>2014-07-18 17:07:27 -0400</pav:lastSavedOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lastSavedOn>2014-07-18 14:07:26 -0700</pav:lastSavedOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:16AE9675-2124-48E2-984A-6251D41F39B6">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>Theophylline</ao:exact>
    <pav:createdOn>2014-07-18 14:03:12 -0700</pav:createdOn>
    <ao:prefix> AUC increased 21% ± 16% (range: -5 to 48%). The Cmax increased 13% ± 17% (range: -13 to 40%). </ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-28.txt.html</ao:hasSource>
    <ao:suffix> clearance decreased 16% ± 11 % (range: -32 to 5%). The half-life of theophylline increased from 6.6 ± 1.7 hours to 7.9 ± 1.5 hours. (See PRECAUTIONS.)</ao:suffix>
    <domeo:uuid>16AE9675-2124-48E2-984A-6251D41F39B6</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:16AE9675-2124-48E2-984A-6251D41F39B6"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:C8A30D50-862D-473B-A05C-42C01434E780">
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
    <ao:context rdf:resource="urn:domeoclient:uuid:612ABB21-3ECF-401B-9B38-AA1A866FE000"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdOn>2014-07-18 14:32:24 -0700</pav:createdOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoclient:uuid:567E7CC2-49BA-4366-A98A-8E4134A9A74B</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotation:5543F979-9AD2-451B-BEB4-B0DD8D480F71</pav:lineageUri>
    <pav:lastSavedOn>2014-07-18 17:32:28 -0400</pav:lastSavedOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:E7893705-3CF7-42B9-9C7F-93F25693DB84">
    <pav:lineageUri>urn:domeoserver:annotationset:C00C2C3C-0648-4779-A135-09D440F1CEA8</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:FF76049E-6B2C-46A9-ACF7-CA565C8087F3</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoclient:uuid:23AC741A-2236-437C-90AA-82B2E00E875C</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdOn>2014-07-18 13:43:13 -0700</pav:createdOn>
    <pav:lastSavedOn>2014-07-18 13:43:48 -0700</pav:lastSavedOn>
    <pav:lastSavedOn>2014-07-18 16:43:48 -0400</pav:lastSavedOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:23BAF555-C96E-4707-8EBA-34BCE14B71F5"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
    <pav:lineageUri>urn:domeoserver:annotation:649BE971-6495-40FE-9B5C-6885CA84D88C</pav:lineageUri>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:95E933E3-09F5-4362-96D4-CF14B045A370">
    <rdfs:label>Highlight</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotation:D2E2F8C4-17CB-483C-9F30-9FFB95B2AA47</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lineageUri>urn:domeoserver:annotationset:C94BECCE-E3E9-4B70-AC23-F715B9D3EEFF</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoclient:uuid:4E57D817-C3D5-47E5-AECC-169C5A1EF60D</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-17 15:54:46 -0700</pav:lastSavedOn>
    <pav:lastSavedOn>2014-07-17 18:54:47 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:2D3D9594-163C-4299-854D-3987A43B7DCF</domeo:belongsToSet>
    <pav:createdOn>2014-07-17 15:54:34 -0700</pav:createdOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:96BAB4C7-6F7A-4EBA-BAC1-134F746F11FA</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:F7635891-9395-4AA7-B1C6-22B3D89F0719"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:FBE4D752-3492-405C-8C46-E0FAC0507DD3">
    <ao:prefix>xsd:String</ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:FBE4D752-3492-405C-8C46-E0FAC0507DD3"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2014-07-16 10:22:00 -0700</pav:createdOn>
    <ao:exact>9-hydroxyrisperidone</ao:exact>
    <ao:suffix> </ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>FBE4D752-3492-405C-8C46-E0FAC0507DD3</domeo:uuid>
    <domeo:uuid></domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:AAA6478C-E7E4-4D30-9F06-AA094434B620">
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:570DA392-7779-456C-9C18-1FC0E579BBE6</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:21B0E479-04F9-4D66-B396-B773EFE53882</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
    <pav:previousVersion>urn:domeoserver:annotationset:2E5CE73B-BFD4-4E35-9A07-D5E37A9E87AE</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:5B6A462D-57EA-4BBD-87E1-A0EC2FAF5196</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E6A1493E-98EE-4FDE-9301-752AB8E3453F</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">4</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotation:4B2915A2-FCDE-4F04-B732-5DF659259480</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:883587E1-49C1-4EE0-909E-4ADBAE13DD3A</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:E7E6B698-CDF9-4B67-A4F6-CC3D84C50315"/>
    <pav:lineageUri>urn:domeoserver:annotationset:75FC1225-8399-469B-AE9D-7F697713E6AC</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lastSavedOn>2014-07-15 14:17:25 -0700</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:46636445-93A2-49F0-9E9C-5AEBF17046D2</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9C0B4E8B-9FFE-4E47-9B4C-A6EA4527A384</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:5758DAC0-E1C0-49EB-BE9C-56FFBAF3B6F4</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E8194531-C5B3-43AE-BC13-14A252C54824</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-15 17:17:26 -0400</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdOn>2014-07-15 14:15:56 -0700</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:60AE44A7-769C-4774-8E4D-7AF66A2F2EA1">
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:570DA392-7779-456C-9C18-1FC0E579BBE6</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotation:06DA1217-1467-4CEA-A2CA-B27000E40DD0</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:21B0E479-04F9-4D66-B396-B773EFE53882</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
    <pav:previousVersion>urn:domeoserver:annotationset:2E5CE73B-BFD4-4E35-9A07-D5E37A9E87AE</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:5B6A462D-57EA-4BBD-87E1-A0EC2FAF5196</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E6A1493E-98EE-4FDE-9301-752AB8E3453F</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">4</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:883587E1-49C1-4EE0-909E-4ADBAE13DD3A</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotationset:75FC1225-8399-469B-AE9D-7F697713E6AC</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lastSavedOn>2014-07-15 14:17:25 -0700</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:46636445-93A2-49F0-9E9C-5AEBF17046D2</domeo:belongsToSet>
    <pav:createdOn>2014-07-15 14:16:39 -0700</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:5758DAC0-E1C0-49EB-BE9C-56FFBAF3B6F4</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9C0B4E8B-9FFE-4E47-9B4C-A6EA4527A384</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:37FB0E70-766B-4459-A183-3C9D1DA69A86"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E8194531-C5B3-43AE-BC13-14A252C54824</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lastSavedOn>2014-07-15 17:17:26 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/2EE5C88D-F1A3-4B71-A118-7683DC8A0550">
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <rdfs:label>bosentan</rdfs:label>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/75207</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:D1062598-B310-4CF4-8237-5F8F8F74933F">
    <domeo:belongsToSet>urn:domeoserver:annotationset:E8194531-C5B3-43AE-BC13-14A252C54824</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdOn>2014-07-15 14:07:31 -0700</pav:createdOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:FA8D1DAC-C616-456C-BB3D-29F18DED21A1</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:883587E1-49C1-4EE0-909E-4ADBAE13DD3A</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-15 14:07:58 -0700</pav:lastSavedOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">2</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotation:08905F35-F998-400A-BE3A-7F3602D3A70C</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:5B6A462D-57EA-4BBD-87E1-A0EC2FAF5196</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-15 17:07:57 -0400</pav:lastSavedOn>
    <pav:lastSavedOn>2014-07-15 17:07:58 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:5758DAC0-E1C0-49EB-BE9C-56FFBAF3B6F4</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:570DA392-7779-456C-9C18-1FC0E579BBE6</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotationset:75FC1225-8399-469B-AE9D-7F697713E6AC</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E6A1493E-98EE-4FDE-9301-752AB8E3453F</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:46636445-93A2-49F0-9E9C-5AEBF17046D2</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:2E5CE73B-BFD4-4E35-9A07-D5E37A9E87AE</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:21B0E479-04F9-4D66-B396-B773EFE53882</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <ao:context rdf:resource="urn:domeoclient:uuid:2FE06202-CAC5-466E-B0DA-E34428ADAEF3"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:1575950D-32D4-46DE-A44F-8E9E614F997F</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotation:D090CCC0-D17A-46BB-A678-DE28930ACEB3</pav:lineageUri>
    <rdfs:label>Highlight</rdfs:label>
    <pav:previousVersion>urn:domeoclient:uuid:9B307D8B-D2B0-4795-8850-FAAAAC6B5AF4</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9C0B4E8B-9FFE-4E47-9B4C-A6EA4527A384</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:E0676820-4037-444B-AE4D-9C1ED43E28D9">
    <ao:exact> fluconazole</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix> AUC of 23% ± 9% (range: -13 to -42%). Apparent oral clearance of fluconazole increased 32% ± 17% (range: 16 to 72%). Fluconazole half-life decreased from 33.4 ± 4.4 hours to 26.8 ± 3.9 hours. (See PRECAUTIONS.)</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:E0676820-4037-444B-AE4D-9C1ED43E28D9"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2014-07-17 15:59:21 -0700</pav:createdOn>
    <ao:hasSource>			http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-24.txt.html</ao:hasSource>
    <domeo:uuid>E0676820-4037-444B-AE4D-9C1ED43E28D9</domeo:uuid>
    <ao:prefix>. There was a mean ± SD reduction in</ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:82AC5ADA-B8CE-47A9-AA99-E7187ABEFACA">
    <pav:createdOn>2014-07-18 13:55:33 -0700</pav:createdOn>
    <ao:item rdf:resource="urn:domeoclient:uuid:17BE6274-5C33-43EE-85E7-EC723ACF1134"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:35CDD2E7-70B2-4586-B719-AE865BE6C293"/>
    <dct:description>The default set is created automatically by Domeo when no other set is existing.</dct:description>
    <rdfs:label>Default Set</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046812afe0146812ce85a0000"/>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-27.txt.html</ao:annotatesResource>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lastSavedOn>2014-07-18 16:56:04 -0400</pav:lastSavedOn>
    <permissions:permissions rdf:nodeID="N3f85ee25e2dc4ab9bf4056215cd20eca"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:F6C87C3C-DE3E-4C1E-A1AE-B620C6D1B31E"/>
    <domeo:deleted>false</domeo:deleted>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
    <ao:item rdf:resource="urn:domeoclient:uuid:DAD17BCA-9CFC-4DE8-932B-E68F8A5FAD45"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:9A5182DA-4DAC-48D6-946F-8283D026674F"/>
    <pav:lineageUri>urn:domeoserver:annotationset:C084ABD9-9B0C-479B-B9AC-42D7E6E50879</pav:lineageUri>
    <ao:item rdf:resource="urn:domeoclient:uuid:4BD1F108-6B86-46B9-94ED-17733AF67E71"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:A688F7D2-43BF-4838-A9A1-339829ADA43A">
    <domeo:belongsToSet>urn:domeoserver:annotationset:E8194531-C5B3-43AE-BC13-14A252C54824</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:883587E1-49C1-4EE0-909E-4ADBAE13DD3A</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdOn>2014-07-15 14:14:29 -0700</pav:createdOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:5B6A462D-57EA-4BBD-87E1-A0EC2FAF5196</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:21CD752E-6211-4C49-B6F0-F912F29E4F0E"/>
    <pav:lineageUri>urn:domeoserver:annotation:CA26441C-8241-456B-835B-2B65C5CEB9D0</pav:lineageUri>
    <pav:lastSavedOn>2014-07-15 17:17:26 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:5758DAC0-E1C0-49EB-BE9C-56FFBAF3B6F4</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:570DA392-7779-456C-9C18-1FC0E579BBE6</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-15 14:17:25 -0700</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotationset:75FC1225-8399-469B-AE9D-7F697713E6AC</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E6A1493E-98EE-4FDE-9301-752AB8E3453F</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">4</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:46636445-93A2-49F0-9E9C-5AEBF17046D2</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:21B0E479-04F9-4D66-B396-B773EFE53882</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:previousVersion>urn:domeoserver:annotationset:2E5CE73B-BFD4-4E35-9A07-D5E37A9E87AE</pav:previousVersion>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9C0B4E8B-9FFE-4E47-9B4C-A6EA4527A384</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:A60BA1DD-61D6-4A5F-906B-D67F0B3C7692">
    <ao:prefix>, giving essentially all recipients a </ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:A60BA1DD-61D6-4A5F-906B-D67F0B3C7692"/>
    <ao:suffix> pharmacokinetic profile typical of poor metabolizers. The therapeutic benefits and adverse effects of risperidone in patients receiving quinidine have not been evaluated, but observations in a modest number (N≅70) of poor metabolizers given risperidone </ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <ao:exact>risperidone</ao:exact>
    <domeo:uuid></domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2014-07-15 14:15:43 -0700</pav:createdOn>
    <domeo:uuid>A60BA1DD-61D6-4A5F-906B-D67F0B3C7692</domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:8A01C077-1FE2-4DD4-96E1-C475228628A9">
    <domeo:uuid></domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:8A01C077-1FE2-4DD4-96E1-C475228628A9"/>
    <ao:prefix>xsd:String</ao:prefix>
    <domeo:uuid>8A01C077-1FE2-4DD4-96E1-C475228628A9</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2014-07-16 10:21:21 -0700</pav:createdOn>
    <ao:suffix> </ao:suffix>
    <ao:exact>9-hydroxyrisperidone</ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:D590AF4F-FC05-41EA-8CBC-29156060B437">
    <pav:createdOn>2014-07-17 15:53:34 -0700</pav:createdOn>
    <pav:lastSavedOn>2014-07-17 15:54:46 -0700</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoclient:uuid:4E57D817-C3D5-47E5-AECC-169C5A1EF60D</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
    <ao:context rdf:resource="urn:domeoclient:uuid:C9AAECF8-1252-4F78-95C3-766B0DC2CF93"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lineageUri>urn:domeoserver:annotation:5F130938-895E-4FAD-B8B1-57A2B1762D44</pav:lineageUri>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lastSavedOn>2014-07-17 18:54:47 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:96BAB4C7-6F7A-4EBA-BAC1-134F746F11FA</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotationset:C94BECCE-E3E9-4B70-AC23-F715B9D3EEFF</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:2D3D9594-163C-4299-854D-3987A43B7DCF</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:32A0FE11-022B-463B-8705-7B1DFD8D84DC">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/B6084BE9-4101-468F-985F-F42789F59869"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/D897A818-DCCA-4D6F-9782-6DA45BBFD745"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:5C7A7116-C174-4EB1-933E-3A46CEE71709">
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:item rdf:resource="urn:domeoclient:uuid:7D975807-A259-49EC-97EB-1E0EC9EB112C"/>
    <pav:createdOn>2014-07-16 15:32:30 -0700</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:787C8DA7-E4FF-4344-8E03-827399F78206"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lastSavedOn>2014-07-16 18:33:06 -0400</pav:lastSavedOn>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046812afe0146812ce85a0000"/>
    <dct:description>The default set is created automatically by Domeo when no other set is existing.</dct:description>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <pav:lineageUri>urn:domeoserver:annotationset:7AE68AC7-9B47-4954-8C65-45A6F0DC80C2</pav:lineageUri>
    <permissions:permissions rdf:nodeID="Nb9d4439607b84e74a472a4f71169a8f7"/>
    <domeo:deleted>false</domeo:deleted>
    <rdfs:label>Default Set</rdfs:label>
    <ao:item rdf:resource="urn:domeoclient:uuid:51D42CFA-4CB2-4B55-9EFE-A1109484AC25"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:5A671621-83D0-48B3-B249-7E1ECC849539"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:33ED9F46-26DA-4463-B66D-77E2995BE5C0"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-22.txt.html</ao:annotatesResource>
    <ao:item rdf:resource="urn:domeoclient:uuid:5153D183-17EE-480B-9FF3-A9FB70E3CB26"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:040CDB6C-0256-4144-8293-65FE5BE6A8FC">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:040CDB6C-0256-4144-8293-65FE5BE6A8FC"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid></domeo:uuid>
    <ao:exact>warfarin (10 mcg/mL), and carbamazepine (10 mcg/mL) caused only a slight increase in the free fraction of risperidone at 10 ng/mL and 9-hydroxyrisperidone at 50 ng/mL</ao:exact>
    <ao:prefix>xsd:String</ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <domeo:uuid>040CDB6C-0256-4144-8293-65FE5BE6A8FC</domeo:uuid>
    <ao:suffix>xsd:String</ao:suffix>
    <pav:createdOn>2014-07-15 14:26:47 -0700</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:14655D75-DC23-4E82-84C9-F40B702E4B69">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdOn>2014-07-15 14:17:13 -0700</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotationset:75FC1225-8399-469B-AE9D-7F697713E6AC</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E8194531-C5B3-43AE-BC13-14A252C54824</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:8F5BD518-01AA-46D8-B893-6470B014CC3B"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9C0B4E8B-9FFE-4E47-9B4C-A6EA4527A384</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:883587E1-49C1-4EE0-909E-4ADBAE13DD3A</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">4</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:5B6A462D-57EA-4BBD-87E1-A0EC2FAF5196</domeo:belongsToSet>
    <pav:previousVersion>urn:domeoserver:annotationset:2E5CE73B-BFD4-4E35-9A07-D5E37A9E87AE</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E6A1493E-98EE-4FDE-9301-752AB8E3453F</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:5758DAC0-E1C0-49EB-BE9C-56FFBAF3B6F4</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:570DA392-7779-456C-9C18-1FC0E579BBE6</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotation:5C8E90A8-836C-40BA-B541-F69BDABFD8B3</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:21B0E479-04F9-4D66-B396-B773EFE53882</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:46636445-93A2-49F0-9E9C-5AEBF17046D2</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-15 14:17:25 -0700</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lastSavedOn>2014-07-15 17:17:26 -0400</pav:lastSavedOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
    <rdfs:label>Highlight</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:B7BF01C6-A444-43C9-8592-E7548AF045AB">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix> [see 7 DRUG INTERACTIONS]. This occurs with</ao:prefix>
    <ao:exact> quinidine, giving essentially all recipients a risperidone pharmacokinetic profile typical of poor metabolizers</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:B7BF01C6-A444-43C9-8592-E7548AF045AB"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <ao:suffix>. The therapeutic benefits and adverse effects of</ao:suffix>
    <domeo:uuid></domeo:uuid>
    <domeo:uuid>B7BF01C6-A444-43C9-8592-E7548AF045AB</domeo:uuid>
    <pav:createdOn>2014-07-15 14:28:14 -0700</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:0ED8918B-EAC0-44B8-AA42-B78AD724F7BE">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoclient:uuid:B8452517-26D0-419F-88FD-A818925FDE06</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotation:A9D10DC5-1563-4B76-AF53-88F671A32A18</pav:lineageUri>
    <pav:lastSavedOn>2014-07-18 16:51:47 -0400</pav:lastSavedOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:5E5C736D-1CA1-4B67-82D7-01FF596E3F63"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdOn>2014-07-18 13:51:22 -0700</pav:createdOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:EE597E16-26DA-463C-A72C-1CA155D4131A">
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:590959F7-F15A-4306-BE23-1D37D8B0C281"/>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <dikbD2R:modality>ncit:negative</dikbD2R:modality>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:F87C43FC-DD9B-42FA-953B-C8C25AA48C91">
    <pav:lastSavedOn>2014-07-15 17:07:58 -0400</pav:lastSavedOn>
    <rdfs:label>Highlight</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">2</pav:versionNumber>
    <pav:lastSavedOn>2014-07-15 17:07:57 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:1575950D-32D4-46DE-A44F-8E9E614F997F</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoserver:annotationset:21B0E479-04F9-4D66-B396-B773EFE53882</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:2E5CE73B-BFD4-4E35-9A07-D5E37A9E87AE</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:883587E1-49C1-4EE0-909E-4ADBAE13DD3A</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
    <domeo:belongsToSet>urn:domeoserver:annotationset:46636445-93A2-49F0-9E9C-5AEBF17046D2</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotation:E5E060D4-450A-4DF5-A513-93CFA767F868</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E6A1493E-98EE-4FDE-9301-752AB8E3453F</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:5DF27E07-C0B9-48CC-97AF-10E8A9830A54"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:570DA392-7779-456C-9C18-1FC0E579BBE6</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:5758DAC0-E1C0-49EB-BE9C-56FFBAF3B6F4</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-15 14:07:58 -0700</pav:lastSavedOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:previousVersion>urn:domeoclient:uuid:9B307D8B-D2B0-4795-8850-FAAAAC6B5AF4</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:5B6A462D-57EA-4BBD-87E1-A0EC2FAF5196</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdOn>2014-07-15 14:07:09 -0700</pav:createdOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:FA8D1DAC-C616-456C-BB3D-29F18DED21A1</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotation:29687A3D-9E88-46E2-9855-49B58F5349BF</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E8194531-C5B3-43AE-BC13-14A252C54824</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotationset:75FC1225-8399-469B-AE9D-7F697713E6AC</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9C0B4E8B-9FFE-4E47-9B4C-A6EA4527A384</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoserver:annotationset:E3DA2E5E-FC19-4C22-AF6C-A9CB4B450554">
    <ao:item rdf:resource="urn:domeoclient:uuid:B2C03A2F-0DF1-4E82-B58C-1909B3460EAA"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">2</pav:versionNumber>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-23.txt.html</ao:annotatesResource>
    <ao:item rdf:resource="urn:domeoclient:uuid:ABA94567-EA53-40B6-AF02-E6FC02E40AD6"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:2EFDE02B-EB81-4773-A923-937E941963E2"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:71649D2A-6308-46A5-9322-DFC56F36E8F3"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:F7888D3F-B736-44E1-8FF0-7C578EEDD97E"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046812afe0146812ce85a0000"/>
    <dct:description>The default set is created automatically by Domeo when no other set is existing.</dct:description>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
    <domeo:deleted>false</domeo:deleted>
    <pav:previousVersion>urn:domeoclient:uuid:98DABE9A-9F89-4DF9-9DEE-B6853D1F5CC1</pav:previousVersion>
    <ao:item rdf:resource="urn:domeoclient:uuid:CB645A75-8C80-4DBE-A619-BDD15DFC4DF3"/>
    <pav:lineageUri>urn:domeoserver:annotationset:E97673F8-7E4F-465A-9DDA-320EE8E031C1</pav:lineageUri>
    <pav:lastSavedOn>2014-07-16 18:46:13 -0400</pav:lastSavedOn>
    <ao:item rdf:resource="urn:domeoclient:uuid:9AF357DC-FE46-4BA4-BC30-1C0C4232273D"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:3776F388-42AA-4941-B8F9-416DFC230546"/>
    <rdfs:label>Default Set</rdfs:label>
    <pav:createdOn>2014-07-16 15:39:34 -0700</pav:createdOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <permissions:permissions rdf:nodeID="Nac444ae820f14dfb9125a1f77d88cab6"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:887773A9-6D1A-46C3-A7F4-E2255F7FBE67"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:4E844D74-03C0-41B6-B571-7703666D11BA">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/0F60CDA1-1EF3-48A8-B482-B23A5151B7B7"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/F620DDE8-4C9B-4A5E-8FA3-1F42BF3BD963"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:2A85543D-D428-4598-B706-98C5E81EE7F2">
    <dikbD2R:modality>ncit:negative</dikbD2R:modality>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:22097E52-FDC1-4F33-B19C-C5FBE58E871D"/>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:36A9182C-B7D6-405A-BBF7-D0B654870FAE">
    <ao:hasSource>				http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-23.txt.html																													</ao:hasSource>
    <domeo:uuid>36A9182C-B7D6-405A-BBF7-D0B654870FAE</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:36A9182C-B7D6-405A-BBF7-D0B654870FAE"/>
    <ao:exact>cimetidine</ao:exact>
    <pav:createdOn>2014-07-17 15:53:45 -0700</pav:createdOn>
    <ao:suffix>, there was a significant decrease in fluconazole AUC and Cmax. There was a mean ± SD decrease in fluconazole AUC of 13% ± 11% (range: -3.4 to -31%) and Cmax decreased 19% ± 14% (range: -5 to -40%). However, the administration of cimetidine 600 mg to 900</ao:suffix>
    <ao:prefix> 400 mg to six healthy male volunteers. After the administration of </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:446899E9-2BB7-4629-AA6E-75AF9EC38F08">
    <pav:lineageUri>urn:domeoserver:annotation:2A77ED44-7A24-44A3-804A-12F4E3277AA5</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9C0B4E8B-9FFE-4E47-9B4C-A6EA4527A384</domeo:belongsToSet>
    <pav:createdOn>2014-07-15 14:08:40 -0700</pav:createdOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoserver:annotationset:2E5CE73B-BFD4-4E35-9A07-D5E37A9E87AE</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E6A1493E-98EE-4FDE-9301-752AB8E3453F</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:91F1D915-0F2B-4B98-A86E-D0E424CBADC1"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
    <pav:lastSavedOn>2014-07-15 17:11:14 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:21B0E479-04F9-4D66-B396-B773EFE53882</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:570DA392-7779-456C-9C18-1FC0E579BBE6</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:5758DAC0-E1C0-49EB-BE9C-56FFBAF3B6F4</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lastSavedOn>2014-07-15 14:11:14 -0700</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:46636445-93A2-49F0-9E9C-5AEBF17046D2</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:883587E1-49C1-4EE0-909E-4ADBAE13DD3A</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E8194531-C5B3-43AE-BC13-14A252C54824</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:5B6A462D-57EA-4BBD-87E1-A0EC2FAF5196</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:815EB9E4-0D7B-4F13-8599-927BD9549BDB">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>carbamazepine (10 mcg/mL) caused only a slight increase in the free fraction of risperidone at 10 ng/mL and 9-hydroxyrisperidone </ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:815EB9E4-0D7B-4F13-8599-927BD9549BDB"/>
    <ao:suffix>xsd:String</ao:suffix>
    <domeo:uuid>815EB9E4-0D7B-4F13-8599-927BD9549BDB</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <ao:prefix>xsd:String</ao:prefix>
    <pav:createdOn>2014-07-15 14:27:04 -0700</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:AA2CF58E-6DB1-4267-8DFC-33DE11331D87">
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <pav:lineageUri>urn:domeoserver:annotationset:D0F2204E-5148-4A33-AAD0-599FB1F44EFC</pav:lineageUri>
    <ao:item rdf:resource="urn:domeoclient:uuid:9C861997-137E-4C3F-A9A5-BF78640820A1"/>
    <pav:createdOn>2014-07-18 14:23:36 -0700</pav:createdOn>
    <ao:item rdf:resource="urn:domeoclient:uuid:2ECA95EB-4370-4C4C-8C95-4A2BE49873EF"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046812afe0146812ce85a0000"/>
    <permissions:permissions rdf:nodeID="N915c2679169147f0b64c66ab323f70e5"/>
    <dct:description>The default set is created automatically by Domeo when no other set is existing.</dct:description>
    <ao:item rdf:resource="urn:domeoclient:uuid:3600E64E-4D3A-48CE-A0E8-33E1B78E99E5"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
    <domeo:deleted>false</domeo:deleted>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-51.txt.html</ao:annotatesResource>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdfs:label>Default Set</rdfs:label>
    <pav:lastSavedOn>2014-07-18 17:23:49 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:3CE58974-7E1B-4366-B479-80D2CA8B6A5B">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>risperidone</ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:3CE58974-7E1B-4366-B479-80D2CA8B6A5B"/>
    <domeo:uuid>3CE58974-7E1B-4366-B479-80D2CA8B6A5B</domeo:uuid>
    <domeo:uuid></domeo:uuid>
    <ao:suffix>.</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2014-07-16 10:19:26 -0700</pav:createdOn>
    <ao:prefix>[see 12 CLINICAL PHARMACOLOGY]. Antagonism at receptors other than D2 and 5HT2 [see 12 CLINICAL PHARMACOLOGY] may explain some of the other effects of </ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:BAF30A3C-A239-441C-8B34-9AC0EFD5ED8E">
    <domeo:uuid>BAF30A3C-A239-441C-8B34-9AC0EFD5ED8E</domeo:uuid>
    <pav:createdOn>2014-07-18 13:48:18 -0700</pav:createdOn>
    <ao:suffix> (oral fluconazole 200 mg daily for 16 days) in 10 normal male volunteers. There was a significant increase in phenytoin AUC. The mean ± SD increase in phenytoin AUC was 88% ± 68% (range: 16 to 247%). The absolute magnitude of this interaction is unknown</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:BAF30A3C-A239-441C-8B34-9AC0EFD5ED8E"/>
    <ao:exact>fluconazole</ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-25.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix> dosing (200 mg daily, orally for 3 days followed by 250 mg intravenously for one dose) both with and without the administration of </ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoserver:annotationset:A7F21A3D-50B3-495E-884A-2C707B40C763">
    <ao:item rdf:resource="urn:domeoclient:uuid:D8773E33-77FB-4402-ABAD-8048CB22BB84"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:4ACE7F4B-F57E-4417-9D3D-B18148E82D1E"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046812afe0146812ce85a0000"/>
    <permissions:permissions rdf:nodeID="N1bf593e39ea8472e8e6263957c1a0cd9"/>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-25.txt.html</ao:annotatesResource>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
    <ao:item rdf:resource="urn:domeoclient:uuid:862041D3-5963-4DC0-966F-207E3A62BA47"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdOn>2014-07-18 13:48:05 -0700</pav:createdOn>
    <ao:item rdf:resource="urn:domeoclient:uuid:E960B89C-B215-4093-9AF7-C100D8D48511"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:D75527AE-44F3-49BF-B7AB-31C1D6E91722"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:FCAC7AB3-7719-4C9B-8378-64BF0D2B4AD2"/>
    <dct:description>The default set is created automatically by Domeo when no other set is existing.</dct:description>
    <ao:item rdf:resource="urn:domeoclient:uuid:372E2DC2-9D30-4E6B-AD72-5B085AE1A42F"/>
    <pav:previousVersion>urn:domeoclient:uuid:53775C4C-7CC4-46EB-9EFC-EDF9D3D264ED</pav:previousVersion>
    <domeo:deleted>false</domeo:deleted>
    <rdfs:label>Default Set</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotationset:748BB253-1066-4977-91B2-35D8C6906790</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">2</pav:versionNumber>
    <pav:lastSavedOn>2014-07-18 16:49:32 -0400</pav:lastSavedOn>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:92E5C2B0-A019-4BC5-BDC7-295AFBB9DF17">
    <ao:suffix> increased by 24% (95% C.I. range 18 to 31%) and 13% (95% C.I. range 8 to 18%), respectively relative to placebo. Fluconazole treatment did not cause a decrease in the ethinyl estradiol AUC of any individual subject in this study compared to placebo dosi</ao:suffix>
    <domeo:uuid></domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>norethindrone</ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:92E5C2B0-A019-4BC5-BDC7-295AFBB9DF17"/>
    <ao:prefix> and </ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-21.txt.html</ao:hasSource>
    <domeo:uuid>92E5C2B0-A019-4BC5-BDC7-295AFBB9DF17</domeo:uuid>
    <pav:createdOn>2014-07-16 14:04:04 -0700</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoserver:annotationset:DBBBAD55-D12B-4890-A2AF-85D3C85A7BEF">
    <pav:lastSavedOn>2014-07-10 14:15:41 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
    <ao:item rdf:resource="urn:domeoclient:uuid:94AD2935-8FE6-4D3D-847A-A1AC66E35692"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">4</pav:versionNumber>
    <pav:previousVersion>urn:domeoserver:annotationset:3F81414E-B149-4B05-925B-18735B554A13</pav:previousVersion>
    <ao:item rdf:resource="urn:domeoclient:uuid:C4DD997B-59E6-4FDF-944E-0E3151C25851"/>
    <permissions:permissions rdf:nodeID="N5d60867c76f34dcdacacfaeac1c9d1f8"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:C820B82D-AF0E-4A71-9E65-5AB73DFE5206"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:977A2BC8-0744-472F-9FA2-CCF897431CA1"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:C70E2E47-3AA5-4F01-A8A1-711E946726F5"/>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:annotatesResource>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046812afe0146812ce85a0000"/>
    <dct:description>The default set is created automatically by Domeo when no other set is existing.</dct:description>
    <pav:createdOn>2014-07-10 10:59:34 -0700</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <domeo:deleted>false</domeo:deleted>
    <ao:item rdf:resource="urn:domeoclient:uuid:EFED6610-75EB-4165-827C-237B7D245279"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:32208944-92E0-40BE-AA45-03DC0663A09C"/>
    <rdfs:label>Default Set</rdfs:label>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:B9DE1789-19F9-43BC-B292-659F900EA6EB"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:item rdf:resource="urn:domeoclient:uuid:F5FD5F49-D620-4FE1-9968-D31A01410DEC"/>
    <pav:lineageUri>urn:domeoserver:annotationset:BE290CA3-79BD-411A-BE2E-69AA4D19607D</pav:lineageUri>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:ECE81054-6CF5-460C-88CE-88C1E5F148ED">
    <pav:lastSavedOn>2014-07-18 16:43:48 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
    <domeo:belongsToSet>urn:domeoserver:annotationset:FF76049E-6B2C-46A9-ACF7-CA565C8087F3</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:61EFE295-187A-4B36-B127-C54D8E2D8B4D"/>
    <domeo:belongsToSet>urn:domeoclient:uuid:23AC741A-2236-437C-90AA-82B2E00E875C</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotation:A94FA296-E6D4-47AB-976C-04C21EC09129</pav:lineageUri>
    <pav:lastSavedOn>2014-07-18 13:43:48 -0700</pav:lastSavedOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdOn>2014-07-18 13:43:41 -0700</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotationset:C00C2C3C-0648-4779-A135-09D440F1CEA8</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:E34E3E0D-B50B-4B49-B4D0-AD4C76A51252">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:E34E3E0D-B50B-4B49-B4D0-AD4C76A51252"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact> fluconazole</ao:exact>
    <domeo:uuid></domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix> to parent drug ratio significantly decreased after the administration of</ao:prefix>
    <pav:createdOn>2014-07-18 13:56:03 -0700</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-27.txt.html</ao:hasSource>
    <ao:suffix>, from 7.6 ± 3.6 to 5.7 ± 2.2.</ao:suffix>
    <domeo:uuid>E34E3E0D-B50B-4B49-B4D0-AD4C76A51252</domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:B3F40D13-C4D5-491E-B9BE-818D5A568EC5">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:B3F40D13-C4D5-491E-B9BE-818D5A568EC5"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-13.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix> did not significantly alter steady-state</ao:prefix>
    <domeo:uuid>B3F40D13-C4D5-491E-B9BE-818D5A568EC5</domeo:uuid>
    <pav:createdOn>2014-07-09 13:36:36 -0700</pav:createdOn>
    <ao:exact> lithium</ao:exact>
    <ao:suffix> levels or the renal clearance of lithium.</ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:50B64AB9-5E00-4F5D-BE7F-9B8CE91BCF2A">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoserver:annotationset:AAD02A4C-E01E-4C82-BC8A-D0F4639844FA</domeo:belongsToSet>
    <pav:createdOn>2014-07-16 10:19:14 -0700</pav:createdOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lastSavedOn>2014-07-16 10:20:50 -0700</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotation:01F7766F-DA53-4934-88FD-84209178AEC0</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoclient:uuid:2F716A41-B68F-48AE-B5C1-E31F1704C565</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotationset:C8D7FDC6-6816-4BD4-BC7F-88ABDCC37D79</pav:lineageUri>
    <ao:context rdf:resource="urn:domeoclient:uuid:FECBEFAB-2C18-4C64-93DF-19494748E804"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lastSavedOn>2014-07-16 13:20:50 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
    <domeo:belongsToSet>urn:domeoserver:annotationset:6FFFF211-BFDC-4E16-968C-A296868530C4</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:DA8D6B42-B41F-4576-BF10-1285DF3EAB80</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:862041D3-5963-4DC0-966F-207E3A62BA47">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <ao:context rdf:resource="urn:domeoclient:uuid:FF56FD55-EDC5-4596-9E28-37011839842A"/>
    <pav:createdOn>2014-07-18 13:48:33 -0700</pav:createdOn>
    <domeo:belongsToSet>urn:domeoclient:uuid:53775C4C-7CC4-46EB-9EFC-EDF9D3D264ED</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdfs:label>Highlight</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lineageUri>urn:domeoserver:annotationset:748BB253-1066-4977-91B2-35D8C6906790</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
    <pav:lastSavedOn>2014-07-18 16:48:39 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotation:250645CC-86C5-4BE2-926C-284A00AEDD5C</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A7F21A3D-50B3-495E-884A-2C707B40C763</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-18 13:48:39 -0700</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:46F4178C-1487-4F57-A6D9-06D0CE8BE565">
    <ao:prefix>. The combination of both drugs did not lead to clinically significant changes in blood pressure (supine or standing). Concomitant administration of potent CYP3A inducers is expected to cause greater decreases in plasma levels of </ao:prefix>
    <ao:exact>sildenafil</ao:exact>
    <pav:createdOn>2014-07-10 11:20:21 -0700</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:46F4178C-1487-4F57-A6D9-06D0CE8BE565"/>
    <ao:suffix>.</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>46F4178C-1487-4F57-A6D9-06D0CE8BE565</domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:9DE6AF1A-97A2-486C-8C39-E06C073F68E4">
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:1AA7E714-DDFA-450C-A589-5EA4319B4691"/>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:05BFE4D9-CD9B-4F44-B4A5-28A1E4F90000">
    <pav:lastSavedOn>2014-07-09 16:39:37 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:80304B91-FB8B-4EF5-87EC-80F59A689F2A</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lastSavedOn>2014-07-09 13:39:37 -0700</pav:lastSavedOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdOn>2014-07-09 13:36:36 -0700</pav:createdOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
    <ao:context rdf:resource="urn:domeoclient:uuid:B3F40D13-C4D5-491E-B9BE-818D5A568EC5"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotationset:2C25A7F3-8A42-4060-A64C-5C2AB24D4675</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:88784842-2713-4D3B-A293-A9498ACCA54A</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoclient:uuid:8B8B88D4-5E42-47CB-9E37-EED59C74FD96</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotation:4CD94F98-CC28-4DAF-8C6A-88F6C7D16ED9</pav:lineageUri>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:B71CF81C-58B7-42D8-94AA-D3DE86C41757">
    <ao:context rdf:resource="urn:domeoclient:uuid:815EB9E4-0D7B-4F13-8599-927BD9549BDB"/>
    <ao:body rdf:nodeID="N7077c8b2f073401d949b5e63390868f0"/>
    <pav:lineageUri>urn:domeoserver:annotationset:75FC1225-8399-469B-AE9D-7F697713E6AC</pav:lineageUri>
    <pav:lineageUri>urn:domeoserver:annotation:E2C031F6-799B-472A-B483-D0435C809591</pav:lineageUri>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:lastSavedOn>2014-07-15 17:30:45 -0400</pav:lastSavedOn>
    <pav:lastSavedOn>2014-07-15 17:30:47 -0400</pav:lastSavedOn>
    <pav:createdOn>2014-07-15 14:26:03 -0700</pav:createdOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E6A1493E-98EE-4FDE-9301-752AB8E3453F</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:5758DAC0-E1C0-49EB-BE9C-56FFBAF3B6F4</domeo:belongsToSet>
    <ao:body rdf:nodeID="Nc84da17ee4cb445e87f9708b8ff44a30"/>
    <pav:lineageUri>urn:domeoserver:annotation:9651D68A-0BEF-48E4-A45B-E448AED68AD3</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:21B0E479-04F9-4D66-B396-B773EFE53882</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:46636445-93A2-49F0-9E9C-5AEBF17046D2</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-15 17:30:43 -0400</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <ao:body rdf:nodeID="Nc967c2be66e740bca26f01bce73d1370"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotation:E462FA4A-3ED6-4F46-BA2C-3E337F6ABD22</pav:lineageUri>
    <pav:lastSavedOn>2014-07-15 14:30:47 -0700</pav:lastSavedOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">6</pav:versionNumber>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
    <ao:body rdf:nodeID="Nd96edd2552374072b45af0a1676a76bf"/>
    <pav:previousVersion>urn:domeoserver:annotationset:883587E1-49C1-4EE0-909E-4ADBAE13DD3A</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:114FB83A-C60C-42F5-AB92-9462558A06FC">
    <ao:body rdf:nodeID="Nfc4f214e3bee4bd1b6236d2d8fcf6295"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:15A537D1-5648-41B2-8BFA-0D0BA3DF4393</domeo:belongsToSet>
    <ao:body rdf:nodeID="Nf7e6bddc379949799259f7378c641905"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:970963DF-8BCE-4936-9DFC-328A36014E1B</domeo:belongsToSet>
    <ao:body rdf:nodeID="N0e293d4a0ce740aba23ee8a5d99cc68e"/>
    <pav:lastSavedOn>2014-07-10 14:17:08 -0400</pav:lastSavedOn>
    <ao:body rdf:nodeID="N8fb8323cb79b415abac0facb0ea9b004"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">5</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:2BFC2FB6-6BE9-4822-A245-973533533023</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotationset:BE290CA3-79BD-411A-BE2E-69AA4D19607D</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <domeo:belongsToSet>urn:domeoserver:annotationset:239B4C6D-1110-4B65-AC66-F8A394187814</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:516C333C-B517-4F84-999E-51185DD6E859</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotation:9DE12EF6-5F66-4E74-8B4B-1296281208AA</pav:lineageUri>
    <pav:lastSavedOn>2014-07-10 11:17:08 -0700</pav:lastSavedOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:892E6482-5108-4155-B6F2-763924AB0616"/>
    <pav:previousVersion>urn:domeoserver:annotationset:DBBBAD55-D12B-4890-A2AF-85D3C85A7BEF</pav:previousVersion>
    <pav:createdOn>2014-07-10 11:17:03 -0700</pav:createdOn>
    <ao:body rdf:nodeID="N8531c33fb2ab4ab19f30030cf770160f"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:43429665-4067-4181-A816-0B492E549D7A">
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:859E1AF5-02AF-407E-8AFD-7DE7B211AB48"/>
    <dikbD2R:modality>ncit:negative</dikbD2R:modality>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:98211317-4C78-4697-963F-262D8DC874A6">
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <dikbD2R:modality>ncit:negative</dikbD2R:modality>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:DFDD5EFD-409F-40D4-A7AC-80093B99AAFA"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:13602CFC-088D-4008-B42C-EA497E316CB4">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:13602CFC-088D-4008-B42C-EA497E316CB4"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid></domeo:uuid>
    <pav:createdOn>2014-07-16 10:22:41 -0700</pav:createdOn>
    <ao:exact>9-hydroxyrisperidone</ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <domeo:uuid>13602CFC-088D-4008-B42C-EA497E316CB4</domeo:uuid>
    <ao:prefix>xsd:String</ao:prefix>
    <ao:suffix>xsd:String</ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:427474F1-6F8A-40AF-BCE5-B758B7F7E955">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix> AUC, Cmax, and half-life with a corresponding decrease in clearance. The mean ± SD </ao:prefix>
    <pav:createdOn>2014-07-18 14:03:04 -0700</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-28.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:427474F1-6F8A-40AF-BCE5-B758B7F7E955"/>
    <domeo:uuid>427474F1-6F8A-40AF-BCE5-B758B7F7E955</domeo:uuid>
    <ao:exact>theophylline</ao:exact>
    <ao:suffix> AUC increased 21% ± 16% (range: -5 to 48%). The Cmax increased 13% ± 17% (range: -13 to 40%). Theophylline clearance decreased 16% ± 11 % (range: -32 to 5%). The half-life of theophylline increased from 6.6 ± 1.7 hours to 7.9 ± 1.5 hours. (See PRECAUTIO</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:B0997699-FE17-48DB-97D8-9BA9ABDD0C90">
    <pav:createdOn>2014-07-15 14:18:48 -0700</pav:createdOn>
    <ao:suffix> and 9-hydroxyrisperidone was decreased, and elimination half-lives were prolonged compared to young healthy subjects. Dosing should be modified accordingly in the elderly patients [see 2 DOSAGE AND ADMINISTRATION].</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:B0997699-FE17-48DB-97D8-9BA9ABDD0C90"/>
    <ao:prefix>Elderly: In healthy elderly subjects, renal clearance of both </ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid>B0997699-FE17-48DB-97D8-9BA9ABDD0C90</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid></domeo:uuid>
    <ao:exact>risperidone</ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/824BF6A0-F3B4-4249-BFA7-C700B01561D9">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdfs:label>carbamazepine</rdfs:label>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/2002</dailymed:activeMoietyRxCUI>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:58452268-E11A-438D-ACF7-C32BA04261F1">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:58452268-E11A-438D-ACF7-C32BA04261F1"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-27.txt.html</ao:hasSource>
    <pav:createdOn>2014-07-18 13:55:49 -0700</pav:createdOn>
    <ao:prefix> dose for at least two weeks. There was a significant increase in zidovudine AUC following the administration of</ao:prefix>
    <domeo:uuid>58452268-E11A-438D-ACF7-C32BA04261F1</domeo:uuid>
    <ao:suffix>. The mean ± SD increase in AUC was 20% ± 32% (range: -27 to 104%). The metabolite, GZDV, to parent drug ratio significantly decreased after the administration of fluconazole, from 7.6 ± 3.6 to 5.7 ± 2.2.</ao:suffix>
    <domeo:uuid></domeo:uuid>
    <ao:exact> fluconazole</ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:CB5A75B5-09F1-40D7-97B6-D21EA870EF66">
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <domeo:uuid></domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix> (10 mcg/mL) caused only a slight increase in the free fraction of risperidone at 10 ng/mL and 9-hydroxyrisperidone at 50 ng/mL, changes of unknown clinical significance.</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>CB5A75B5-09F1-40D7-97B6-D21EA870EF66</domeo:uuid>
    <pav:createdOn>2014-07-15 14:09:12 -0700</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:CB5A75B5-09F1-40D7-97B6-D21EA870EF66"/>
    <ao:exact>carbamazepine</ao:exact>
    <ao:prefix> (10 mcg/mL), and </ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:CE892364-BAE9-432B-976E-743B57F2408B">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2014-07-15 14:03:13 -0700</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:CE892364-BAE9-432B-976E-743B57F2408B"/>
    <ao:suffix> and its major metabolite, 9-hydroxyrisperidone [see 12 CLINICAL PHARMACOLOGY]. Antagonism at receptors other than D2 and 5HT2 [see 12 CLINICAL PHARMACOLOGY] may explain some of the other effects of risperidone.</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <domeo:uuid>CE892364-BAE9-432B-976E-743B57F2408B</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>risperidone</ao:exact>
    <domeo:uuid></domeo:uuid>
    <ao:prefix> results from the combined concentrations of </ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:05321D03-FF55-4658-854E-AEE6CA65C7B5">
    <ao:suffix>xsd:String</ao:suffix>
    <ao:exact> single dose both before and after the oral administration of fluconazole 50 mg once daily for 10 days in 10 healthy women. There was no significant difference in ethinyl estradiol or levonorgestrel AUC after the administration of 50 mg of fluconazole. The mean increase in ethinyl estradiol AUC was 6% (range: -47 to 108%) and levonorgestrel AUC increased 17% (range: -33 to 141%)</ao:exact>
    <ao:prefix>xsd:String</ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:05321D03-FF55-4658-854E-AEE6CA65C7B5"/>
    <domeo:uuid>05321D03-FF55-4658-854E-AEE6CA65C7B5</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2014-07-16 15:36:36 -0700</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-22.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:31B6ED7E-D003-4C21-A285-EBE6FB28E552">
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:128DD788-D47E-4F4B-AD6D-B82C77B2F11B"/>
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:CFF4DD39-5FB5-46B5-9868-D724A30FB42C">
    <pav:createdOn>2014-07-18 14:03:12 -0700</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotation:9CDD54DE-2FC6-47B3-9B45-2838AA99DA58</pav:lineageUri>
    <ao:context rdf:resource="urn:domeoclient:uuid:16AE9675-2124-48E2-984A-6251D41F39B6"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
    <domeo:belongsToSet>urn:domeoserver:annotationset:6DBCB873-26F3-4E6A-9BD4-311369B43736</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoclient:uuid:E65FF29A-8FE7-4D0E-A93C-4DA8136F4956</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-18 17:03:19 -0400</pav:lastSavedOn>
    <rdfs:label>Highlight</rdfs:label>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lastSavedOn>2014-07-18 14:03:19 -0700</pav:lastSavedOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotationset:9AA0507C-281E-45C8-9719-03E66F12C069</pav:lineageUri>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:23AC741A-2236-437C-90AA-82B2E00E875C">
    <ao:item rdf:resource="urn:domeoclient:uuid:30DE360C-B631-4F35-8C09-DC4BC562543A"/>
    <pav:lineageUri>urn:domeoserver:annotationset:C00C2C3C-0648-4779-A135-09D440F1CEA8</pav:lineageUri>
    <ao:item rdf:resource="urn:domeoclient:uuid:16CA4CDD-75E6-4B6B-8392-4CE5B648D48E"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <pav:createdOn>2014-07-18 13:43:09 -0700</pav:createdOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
    <pav:lastSavedOn>2014-07-18 16:43:48 -0400</pav:lastSavedOn>
    <ao:item rdf:resource="urn:domeoclient:uuid:ECE81054-6CF5-460C-88CE-88C1E5F148ED"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:deleted>false</domeo:deleted>
    <ao:item rdf:resource="urn:domeoclient:uuid:E7893705-3CF7-42B9-9C7F-93F25693DB84"/>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046812afe0146812ce85a0000"/>
    <rdfs:label>Default Set</rdfs:label>
    <ao:item rdf:resource="urn:domeoclient:uuid:548F8E3A-F3DF-41D2-B65F-5C14C8EE8007"/>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-24.txt.html</ao:annotatesResource>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:E68A8F1A-49B1-485B-9508-70DEE10CB0DB"/>
    <dct:description>The default set is created automatically by Domeo when no other set is existing.</dct:description>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:item rdf:resource="urn:domeoclient:uuid:31737AE9-0835-48DB-82BD-A713405999A3"/>
    <permissions:permissions rdf:nodeID="Nc0a8a6ffd9aa40c8954f3d400a804dc0"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:15C80BDC-57FE-49D1-830F-1A9F2C7BCA2C">
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:15C80BDC-57FE-49D1-830F-1A9F2C7BCA2C"/>
    <domeo:uuid></domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2014-07-15 14:17:46 -0700</pav:createdOn>
    <ao:exact>risperidone</ao:exact>
    <domeo:uuid>15C80BDC-57FE-49D1-830F-1A9F2C7BCA2C</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix>Renal Impairment: In patients with moderate to severe renal disease, clearance of the sum of </ao:prefix>
    <ao:suffix> and its active metabolite decreased by 60% compared to young healthy subjects. Risperidone doses should be reduced in patients with renal disease [see 2 DOSAGE AND ADMINISTRATION and 5 WARNINGS AND PRECAUTIONS].</ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:E455E1D2-B393-4131-81F1-25CAC07249AA">
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:E455E1D2-B393-4131-81F1-25CAC07249AA"/>
    <domeo:uuid></domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact> risperidone</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>E455E1D2-B393-4131-81F1-25CAC07249AA</domeo:uuid>
    <pav:createdOn>2014-07-15 14:15:27 -0700</pav:createdOn>
    <ao:suffix> to 9-hydroxyrisperidone [see 7 DRUG INTERACTIONS]. This occurs with quinidine, giving essentially all recipients a risperidone pharmacokinetic profile typical of poor metabolizers. The therapeutic benefits and adverse effects of risperidone in patients </ao:suffix>
    <ao:prefix>could be subject to two kinds of drug-drug interactions. First, inhibitors of CYP 2D6 interfere with conversion of</ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:DDF11329-3CD1-4391-B01E-D821B9E4C7F3">
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
    <domeo:belongsToSet>urn:domeoserver:annotationset:46636445-93A2-49F0-9E9C-5AEBF17046D2</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:00F35F1A-5924-40DE-A59C-C43123E99A77"/>
    <pav:lastSavedOn>2014-07-15 17:30:45 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotationset:75FC1225-8399-469B-AE9D-7F697713E6AC</pav:lineageUri>
    <ao:body rdf:nodeID="N1949cbd8fdd0465383c1405253457dc9"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">6</pav:versionNumber>
    <ao:body rdf:nodeID="N61403a6ebe9e4be89fdf16620220d3f1"/>
    <pav:lineageUri>urn:domeoserver:annotation:2910A5DF-AFC1-4674-8637-0A12951F1527</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:5B6A462D-57EA-4BBD-87E1-A0EC2FAF5196</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:previousVersion>urn:domeoserver:annotationset:883587E1-49C1-4EE0-909E-4ADBAE13DD3A</pav:previousVersion>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lastSavedOn>2014-07-15 14:30:47 -0700</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotation:75E524B3-2214-4598-86AC-2E41B93F44BF</pav:lineageUri>
    <pav:createdOn>2014-07-15 14:22:25 -0700</pav:createdOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotation:E8BF3288-9BC7-4B3F-84ED-3704320B88BE</pav:lineageUri>
    <pav:lastSavedOn>2014-07-15 17:30:47 -0400</pav:lastSavedOn>
    <ao:body rdf:nodeID="N1971c3847c1c44868084bc0e7fe59b4f"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E6A1493E-98EE-4FDE-9301-752AB8E3453F</domeo:belongsToSet>
    <ao:body rdf:nodeID="Ncb5d6a25f20247878eb8aba54b4a9634"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E8194531-C5B3-43AE-BC13-14A252C54824</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoserver:annotationset:21B0E479-04F9-4D66-B396-B773EFE53882</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:5758DAC0-E1C0-49EB-BE9C-56FFBAF3B6F4</domeo:belongsToSet>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <ao:body rdf:nodeID="N847ff6f9e2fe47dba0a178753931d455"/>
    <ao:body rdf:nodeID="Nef75cde762c443a3858c1527ba433e17"/>
    <pav:lastSavedOn>2014-07-15 17:30:43 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:7A1CC34D-A3D8-43C2-AC0E-2F3EF96927DD">
    <ao:exact>risperidone</ao:exact>
    <domeo:uuid></domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:7A1CC34D-A3D8-43C2-AC0E-2F3EF96927DD"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>7A1CC34D-A3D8-43C2-AC0E-2F3EF96927DD</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2014-07-15 14:07:02 -0700</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <ao:suffix> are reached in 1 day in extensive metabolizers and would be expected to reach steady-state in about 5 days in poor metabolizers. Steady-state concentrations of 9-hydroxyrisperidone are reached in 5 to 6 days (measured in extensive metabolizers).</ao:suffix>
    <ao:prefix> occurred at about 3 hours in extensive metabolizers, and 17 hours in poor metabolizers. Steady-state concentrations of </ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:DADF82D0-0BE9-4691-8522-E52C0C20266C">
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <ao:suffix> has low to moderate affinity (Ki of 47 to 253 nM) for the serotonin 5HT1C, 5HT1D, and 5HT1A receptors, weak affinity (Ki of 620 to 800 nM) for the dopamine D1 and haloperidol-sensitive sigma site, and no affinity (when tested at concentrations &gt;10-5 M) </ao:suffix>
    <domeo:uuid></domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:DADF82D0-0BE9-4691-8522-E52C0C20266C"/>
    <domeo:uuid>DADF82D0-0BE9-4691-8522-E52C0C20266C</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix> acts as an antagonist at other receptors, but with lower potency. </ao:prefix>
    <ao:exact>Risperidone</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2014-07-16 10:19:02 -0700</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/D2D77AB7-3C46-4DFC-B865-AE7E85601849">
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/2002</dailymed:activeMoietyRxCUI>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <rdfs:label>carbamazepine</rdfs:label>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <dct:description>Referred to the drug in the interaction.</dct:description>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:35ABEAB8-91E9-4F2D-B158-A3AE422D3EB0">
    <ao:prefix> administered as 600 mg daily in eight healthy male volunteers resulted in a significant decrease in </ao:prefix>
    <ao:suffix> AUC and a significant increase in apparent oral clearance of fluconazole. There was a mean ± SD reduction in fluconazole AUC of 23% ± 9% (range: -13 to -42%). Apparent oral clearance of fluconazole increased 32% ± 17% (range: 16 to 72%). Fluconazole hal</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:35ABEAB8-91E9-4F2D-B158-A3AE422D3EB0"/>
    <domeo:uuid>35ABEAB8-91E9-4F2D-B158-A3AE422D3EB0</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>fluconazole</ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-24.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2014-07-18 13:43:20 -0700</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoserver:annotationset:3F81414E-B149-4B05-925B-18735B554A13">
    <domeo:deleted>false</domeo:deleted>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">3</pav:versionNumber>
    <permissions:permissions rdf:nodeID="Nebd935185b0d4c7497e66bca237b9c62"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:EFED6610-75EB-4165-827C-237B7D245279"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:B9DE1789-19F9-43BC-B292-659F900EA6EB"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:32208944-92E0-40BE-AA45-03DC0663A09C"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:C70E2E47-3AA5-4F01-A8A1-711E946726F5"/>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:annotatesResource>
    <pav:previousVersion>urn:domeoserver:annotationset:A57C5101-A9A5-4504-A046-944A7401D498</pav:previousVersion>
    <ao:item rdf:resource="urn:domeoclient:uuid:C820B82D-AF0E-4A71-9E65-5AB73DFE5206"/>
    <pav:lineageUri>urn:domeoserver:annotationset:BE290CA3-79BD-411A-BE2E-69AA4D19607D</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <pav:createdOn>2014-07-10 10:59:34 -0700</pav:createdOn>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <dct:description>The default set is created automatically by Domeo when no other set is existing.</dct:description>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046812afe0146812ce85a0000"/>
    <rdfs:label>Default Set</rdfs:label>
    <ao:item rdf:resource="urn:domeoclient:uuid:F5FD5F49-D620-4FE1-9968-D31A01410DEC"/>
    <pav:lastSavedOn>2014-07-10 14:14:30 -0400</pav:lastSavedOn>
    <ao:item rdf:resource="urn:domeoclient:uuid:94AD2935-8FE6-4D3D-847A-A1AC66E35692"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:A2FA427B-9D1C-4042-8796-682C2C547E30">
    <pav:lineageUri>urn:domeoserver:annotation:BD6D0955-BF0D-4645-9244-A4A9E38D8457</pav:lineageUri>
    <pav:lastSavedOn>2014-07-16 14:06:30 -0700</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoclient:uuid:8C39EA63-3E52-40B4-8935-6ADC75CCA74D</domeo:belongsToSet>
    <pav:createdOn>2014-07-16 14:03:34 -0700</pav:createdOn>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:C2A39432-076D-421D-8007-22690EDA5A0C</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:AD2FD8CD-1032-462E-833D-451021CE67B2</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:B3F0B84F-756D-4724-B177-98D0D290D00D</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:02EFD3A2-6206-483D-8A82-D5AB320CD4B0"/>
    <pav:lastSavedOn>2014-07-16 17:06:30 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:8049D373-44B2-4E73-95D6-3445DE0002F8">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix> compared to similar placebo dosing. The mean AUCs of ethinyl estradiol and norethindrone increased by 24% (95% C.I. range 18 to 31%) and 13% (95% C.I. range 8 to 18%), respectively relative to placebo. Fluconazole treatment did not cause a decrease in t</ao:suffix>
    <domeo:uuid>8049D373-44B2-4E73-95D6-3445DE0002F8</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:8049D373-44B2-4E73-95D6-3445DE0002F8"/>
    <pav:createdOn>2014-07-16 14:03:51 -0700</pav:createdOn>
    <ao:prefix> and </ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-21.txt.html</ao:hasSource>
    <domeo:uuid></domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>norethindrone </ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:33ED9F46-26DA-4463-B66D-77E2995BE5C0">
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
    <domeo:belongsToSet>urn:domeoserver:annotationset:0F87EEF0-40A6-43E2-8222-95E7D1335A0B</domeo:belongsToSet>
    <pav:createdOn>2014-07-16 15:32:37 -0700</pav:createdOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lineageUri>urn:domeoserver:annotation:A135AD99-DCAB-417A-A80A-973770936A11</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lastSavedOn>2014-07-16 18:33:07 -0400</pav:lastSavedOn>
    <pav:lastSavedOn>2014-07-16 15:33:06 -0700</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoclient:uuid:5C7A7116-C174-4EB1-933E-3A46CEE71709</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotationset:7AE68AC7-9B47-4954-8C65-45A6F0DC80C2</pav:lineageUri>
    <ao:context rdf:resource="urn:domeoclient:uuid:ECDDC20F-1C2B-469E-98F0-C0EB9DA754E2"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:33374D0E-AF28-4161-ACC9-7713697436CB">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:5E6D4B4B-5988-41DE-96F1-703204EEF5AF"/>
    <pav:lastSavedOn>2014-07-10 11:21:41 -0700</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">6</pav:versionNumber>
    <pav:lastSavedOn>2014-07-10 14:21:41 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:239B4C6D-1110-4B65-AC66-F8A394187814</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoserver:annotationset:516C333C-B517-4F84-999E-51185DD6E859</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:15A537D1-5648-41B2-8BFA-0D0BA3DF4393</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
    <pav:lineageUri>urn:domeoserver:annotation:3BAD3ACA-869C-4A83-8A44-39FB8ABD1475</pav:lineageUri>
    <pav:lineageUri>urn:domeoserver:annotationset:BE290CA3-79BD-411A-BE2E-69AA4D19607D</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:970963DF-8BCE-4936-9DFC-328A36014E1B</domeo:belongsToSet>
    <pav:createdOn>2014-07-10 11:20:50 -0700</pav:createdOn>
    <pav:previousVersion>urn:domeoserver:annotationset:2BFC2FB6-6BE9-4822-A245-973533533023</pav:previousVersion>
    <pav:previousVersion>xsd:String</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:3F707B16-9AC0-4A46-A0C5-ED7358D7F764">
    <domeo:belongsToSet>urn:domeoserver:annotationset:15A537D1-5648-41B2-8BFA-0D0BA3DF4393</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotation:6AC2CDDE-009A-42D8-AED6-D4F05222AF44</pav:lineageUri>
    <pav:lineageUri>urn:domeoserver:annotationset:BE290CA3-79BD-411A-BE2E-69AA4D19607D</pav:lineageUri>
    <pav:createdOn>2014-07-10 11:19:20 -0700</pav:createdOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:239B4C6D-1110-4B65-AC66-F8A394187814</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:D31038BF-BD20-49DC-B15A-84202B180FA2"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:970963DF-8BCE-4936-9DFC-328A36014E1B</domeo:belongsToSet>
    <pav:previousVersion>urn:domeoserver:annotationset:2BFC2FB6-6BE9-4822-A245-973533533023</pav:previousVersion>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lastSavedOn>2014-07-10 11:21:41 -0700</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">6</pav:versionNumber>
    <pav:lastSavedOn>2014-07-10 14:21:41 -0400</pav:lastSavedOn>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoserver:annotationset:516C333C-B517-4F84-999E-51185DD6E859</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:9C571DAA-DD40-49B9-9828-24A46A158061">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/DA1E3525-C5D9-473E-8402-BDC110AF5313"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/AC9A1D27-44BD-40B7-A83D-E484627AE823"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:046CE425-7371-402F-A18F-6913B0C03124">
    <domeo:belongsToSet>urn:domeoserver:annotationset:96BAB4C7-6F7A-4EBA-BAC1-134F746F11FA</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:6491BF48-AC35-48FA-A8D2-102002F8E57E"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:createdOn>2014-07-17 15:56:45 -0700</pav:createdOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lastSavedOn>2014-07-17 18:56:48 -0400</pav:lastSavedOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
    <pav:lineageUri>urn:domeoserver:annotation:4D55F9FA-B792-4C06-8530-A362B2C70BA5</pav:lineageUri>
    <ao:body rdf:nodeID="Nc8b0c1d6706e4e9e8e24456dcf776ca9"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoserver:annotationset:8DEBE5AF-B171-4BE8-880B-76A2BEE742A6">
    <ao:item rdf:resource="urn:domeoclient:uuid:5A49ECAF-CE5A-41FF-B8D4-43B060247DBA"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdfs:label>Default Set</rdfs:label>
    <permissions:permissions rdf:nodeID="N37844053ae7d48518c7d2eafb1991533"/>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <pav:previousVersion>urn:domeoclient:uuid:83B2E87D-3732-4699-AA3D-363A6EB95959</pav:previousVersion>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046812afe0146812ce85a0000"/>
    <dct:description>The default set is created automatically by Domeo when no other set is existing.</dct:description>
    <ao:item rdf:resource="urn:domeoclient:uuid:21394BF5-9EBD-45B5-A3E3-29F92CC4E65F"/>
    <pav:lineageUri>urn:domeoserver:annotationset:B716A719-3E66-4B72-87E0-370D90F3B8F7</pav:lineageUri>
    <pav:lastSavedOn>2014-07-17 19:00:13 -0400</pav:lastSavedOn>
    <ao:item rdf:resource="urn:domeoclient:uuid:7CD9615A-69D6-4A70-94B2-EF43CF591997"/>
    <ao:annotatesResource>			http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-24.txt.html</ao:annotatesResource>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">2</pav:versionNumber>
    <ao:item rdf:resource="urn:domeoclient:uuid:0AE1727A-ACA3-43E1-8A12-B8F0F479A3DF"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:B2931C8A-EC31-47B6-AE9D-7EFD2AFC6C76"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:025B9C60-3F34-47FE-83EE-A415FB50E5FC"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
    <ao:item rdf:resource="urn:domeoclient:uuid:ED9173BA-30D7-4181-85F1-37CC30DFF11C"/>
    <pav:createdOn>2014-07-17 15:58:55 -0700</pav:createdOn>
    <domeo:deleted>false</domeo:deleted>
    <ao:item rdf:resource="urn:domeoclient:uuid:5692BCB9-DDA3-438D-9E49-F80218BB67C8"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:C66BBCCE-CA43-44FB-8D97-2084E19C48FF">
    <pav:lastSavedOn>2014-07-15 17:04:06 -0400</pav:lastSavedOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:CE892364-BAE9-432B-976E-743B57F2408B"/>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lastSavedOn>2014-07-15 14:04:06 -0700</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:1575950D-32D4-46DE-A44F-8E9E614F997F</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoserver:annotationset:21B0E479-04F9-4D66-B396-B773EFE53882</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:2E5CE73B-BFD4-4E35-9A07-D5E37A9E87AE</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
    <domeo:belongsToSet>urn:domeoserver:annotationset:46636445-93A2-49F0-9E9C-5AEBF17046D2</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E6A1493E-98EE-4FDE-9301-752AB8E3453F</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoclient:uuid:9B307D8B-D2B0-4795-8850-FAAAAC6B5AF4</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:570DA392-7779-456C-9C18-1FC0E579BBE6</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:5758DAC0-E1C0-49EB-BE9C-56FFBAF3B6F4</domeo:belongsToSet>
    <pav:createdOn>2014-07-15 14:03:13 -0700</pav:createdOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E8194531-C5B3-43AE-BC13-14A252C54824</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:5B6A462D-57EA-4BBD-87E1-A0EC2FAF5196</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotation:B3190C68-4AD0-4462-BE08-70DB24E80259</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:883587E1-49C1-4EE0-909E-4ADBAE13DD3A</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:FA8D1DAC-C616-456C-BB3D-29F18DED21A1</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9C0B4E8B-9FFE-4E47-9B4C-A6EA4527A384</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/595576F3-EC50-44DE-92FC-A9FC2111AFB6">
    <rdfs:label>estradiol</rdfs:label>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:65047D28-4B70-4701-B243-A146C45926A7">
    <pav:createdOn>2014-07-15 14:02:59 -0700</pav:createdOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:883587E1-49C1-4EE0-909E-4ADBAE13DD3A</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9C0B4E8B-9FFE-4E47-9B4C-A6EA4527A384</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoclient:uuid:9B307D8B-D2B0-4795-8850-FAAAAC6B5AF4</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:46636445-93A2-49F0-9E9C-5AEBF17046D2</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:5758DAC0-E1C0-49EB-BE9C-56FFBAF3B6F4</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:1575950D-32D4-46DE-A44F-8E9E614F997F</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E8194531-C5B3-43AE-BC13-14A252C54824</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:2E5CE73B-BFD4-4E35-9A07-D5E37A9E87AE</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lastSavedOn>2014-07-15 17:04:06 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotation:78CEB220-43DA-4746-897F-A8FFEDD2BDD8</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:21B0E479-04F9-4D66-B396-B773EFE53882</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoserver:annotationset:570DA392-7779-456C-9C18-1FC0E579BBE6</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:FA8D1DAC-C616-456C-BB3D-29F18DED21A1</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E6A1493E-98EE-4FDE-9301-752AB8E3453F</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
    <ao:context rdf:resource="urn:domeoclient:uuid:B4A4923A-11E7-4579-931D-08B5995E3BC1"/>
    <pav:lastSavedOn>2014-07-15 14:04:06 -0700</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:5B6A462D-57EA-4BBD-87E1-A0EC2FAF5196</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:30DE360C-B631-4F35-8C09-DC4BC562543A">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotation:77B445E8-60AA-4EBD-8247-EE68C902681B</pav:lineageUri>
    <pav:createdOn>2014-07-18 13:43:09 -0700</pav:createdOn>
    <pav:lastSavedOn>2014-07-18 13:43:48 -0700</pav:lastSavedOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:005571AF-9B7B-4186-B036-1D92080F00CA"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:FF76049E-6B2C-46A9-ACF7-CA565C8087F3</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoclient:uuid:23AC741A-2236-437C-90AA-82B2E00E875C</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
    <rdfs:label>Highlight</rdfs:label>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lastSavedOn>2014-07-18 16:43:48 -0400</pav:lastSavedOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotationset:C00C2C3C-0648-4779-A135-09D440F1CEA8</pav:lineageUri>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:E3D4514F-8C2B-4E16-B53E-81B363D7FDBE">
    <domeo:belongsToSet>urn:domeoserver:annotationset:21B0E479-04F9-4D66-B396-B773EFE53882</domeo:belongsToSet>
    <ao:body rdf:nodeID="N39c1e0a97b1b424898b19d13b50b7326"/>
    <pav:lastSavedOn>2014-07-15 17:30:43 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:46636445-93A2-49F0-9E9C-5AEBF17046D2</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:B7BF01C6-A444-43C9-8592-E7548AF045AB"/>
    <pav:lineageUri>urn:domeoserver:annotationset:75FC1225-8399-469B-AE9D-7F697713E6AC</pav:lineageUri>
    <ao:body rdf:nodeID="N0f15fcd8a07045cc85ba92f52b42b156"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">6</pav:versionNumber>
    <pav:lastSavedOn>2014-07-15 17:30:45 -0400</pav:lastSavedOn>
    <pav:createdOn>2014-07-15 14:28:14 -0700</pav:createdOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:5B6A462D-57EA-4BBD-87E1-A0EC2FAF5196</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotation:ECC6A5EC-4A2A-4B36-BE69-9B738F717954</pav:lineageUri>
    <ao:body rdf:nodeID="Ne933c0da3ead40b9b3a77fbee9d05c9d"/>
    <ao:body rdf:nodeID="N126b3162582e4f75b30cc7724bc26472"/>
    <pav:lastSavedOn>2014-07-15 17:30:48 -0400</pav:lastSavedOn>
    <pav:lastSavedOn>2014-07-15 14:30:47 -0700</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotation:C286EECC-56F8-4881-BDEB-4AE2A4718C20</pav:lineageUri>
    <pav:lineageUri>urn:domeoserver:annotation:63FE190F-21E7-4DCE-852B-8B86E93A82BA</pav:lineageUri>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:previousVersion>urn:domeoserver:annotationset:883587E1-49C1-4EE0-909E-4ADBAE13DD3A</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E6A1493E-98EE-4FDE-9301-752AB8E3453F</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E8194531-C5B3-43AE-BC13-14A252C54824</domeo:belongsToSet>
    <ao:body rdf:nodeID="N326e95db960f4c31ae0919fc8806e9dc"/>
    <ao:body rdf:nodeID="N4a415880464740babbd3b1e9cbfaf014"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:5758DAC0-E1C0-49EB-BE9C-56FFBAF3B6F4</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:EEEDCB2D-0F2D-42A1-AF30-23CDE2191AB4">
    <domeo:uuid>EEEDCB2D-0F2D-42A1-AF30-23CDE2191AB4</domeo:uuid>
    <ao:exact>zidovudine</ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-27.txt.html</ao:hasSource>
    <domeo:uuid></domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:EEEDCB2D-0F2D-42A1-AF30-23CDE2191AB4"/>
    <ao:suffix> concentrations were determined on two occasions (before and following fluconazole 200 mg daily for 15 days) in 13 volunteers with AIDS or ARC who were on a stable zidovudine dose for at least two weeks. There was a significant increase in zidovudine AUC</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2014-07-18 13:55:33 -0700</pav:createdOn>
    <ao:prefix>Plasma </ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:65491747-3FED-4091-AB6D-7A1B627B89AD">
    <ao:prefix> (100 mg) did not affect the steady-state pharmacokinetics of the HIV protease inhibitors </ao:prefix>
    <ao:exact>saquinavir</ao:exact>
    <domeo:uuid>65491747-3FED-4091-AB6D-7A1B627B89AD</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:65491747-3FED-4091-AB6D-7A1B627B89AD"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:hasSource>
    <ao:suffix> and ritonavir, both of which are CYP3A substrates.</ao:suffix>
    <pav:createdOn>2014-07-10 11:20:45 -0700</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/A7E56081-CD67-4A16-A78C-32BEED516AE5">
    <rdfs:label>risperidone</rdfs:label>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/35636</dailymed:activeMoietyRxCUI>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dct:description>Referred to the drug in the interaction.</dct:description>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:DC0B1C38-224C-4FD8-BC2A-B7D2AE11EBF8">
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:DE10284C-BBEF-4195-99FD-8E0DF00E83B5"/>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:380253B1-58A2-45B6-B271-96D870E13796">
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">6</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotation:D17A86DC-B8D3-4915-8D75-C8321727E861</pav:lineageUri>
    <pav:lastSavedOn>2014-07-10 14:21:41 -0400</pav:lastSavedOn>
    <pav:previousVersion>urn:domeoserver:annotationset:2BFC2FB6-6BE9-4822-A245-973533533023</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:516C333C-B517-4F84-999E-51185DD6E859</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdOn>2014-07-10 11:20:11 -0700</pav:createdOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lastSavedOn>2014-07-10 11:21:41 -0700</pav:lastSavedOn>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoserver:annotationset:970963DF-8BCE-4936-9DFC-328A36014E1B</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:CDFED240-5630-45F7-B475-A3C10DC429E0"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:15A537D1-5648-41B2-8BFA-0D0BA3DF4393</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:239B4C6D-1110-4B65-AC66-F8A394187814</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotationset:BE290CA3-79BD-411A-BE2E-69AA4D19607D</pav:lineageUri>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/E5665B96-F57B-4E5D-A279-724307FF4350">
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/</dailymed:activeMoietyRxCUI>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <rdfs:label>sulfamethazine</rdfs:label>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:7A667B8B-937A-4A7A-89C2-95F2DCF9BE12">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/1C45B97D-FA8F-4C81-903B-A6CBE6A57B86"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/1FBE5AF2-2CAB-4F7D-8ACF-A30A014D69AF"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/B647582C-D9C5-493D-9D1E-21B820C9FB2B">
    <rdfs:label>erythromycin</rdfs:label>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/4053</dailymed:activeMoietyRxCUI>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:C4C14FED-0642-4B44-8AD5-DFA9D02E5B99">
    <pav:lastSavedOn>2014-07-10 11:21:41 -0700</pav:lastSavedOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:516C333C-B517-4F84-999E-51185DD6E859</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotation:0590960B-B0BC-4BB4-B89D-C1633DDB7BC9</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:15A537D1-5648-41B2-8BFA-0D0BA3DF4393</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-10 14:21:41 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
    <pav:lineageUri>urn:domeoserver:annotationset:BE290CA3-79BD-411A-BE2E-69AA4D19607D</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <ao:context rdf:resource="urn:domeoclient:uuid:FE6DEC5A-2EFB-4D44-817D-5B910C9A906D"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:239B4C6D-1110-4B65-AC66-F8A394187814</domeo:belongsToSet>
    <pav:previousVersion>urn:domeoserver:annotationset:2BFC2FB6-6BE9-4822-A245-973533533023</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:970963DF-8BCE-4936-9DFC-328A36014E1B</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">6</pav:versionNumber>
    <pav:createdOn>2014-07-10 11:20:35 -0700</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:9AF357DC-FE46-4BA4-BC30-1C0C4232273D">
    <domeo:belongsToSet>urn:domeoclient:uuid:98DABE9A-9F89-4DF9-9DEE-B6853D1F5CC1</domeo:belongsToSet>
    <pav:createdOn>2014-07-16 15:39:34 -0700</pav:createdOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E3DA2E5E-FC19-4C22-AF6C-A9CB4B450554</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotation:0E4C899A-6757-4D55-8BFC-FEDC7728D34C</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lastSavedOn>2014-07-16 15:40:55 -0700</pav:lastSavedOn>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
    <ao:context rdf:resource="urn:domeoclient:uuid:C52DDDDD-59AD-4D62-94B9-F53565B2D800"/>
    <pav:lastSavedOn>2014-07-16 18:40:55 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:83B2E87D-3732-4699-AA3D-363A6EB95959">
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <domeo:deleted>false</domeo:deleted>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdfs:label>Default Set</rdfs:label>
    <dct:description>The default set is created automatically by Domeo when no other set is existing.</dct:description>
    <pav:lineageUri>urn:domeoserver:annotationset:B716A719-3E66-4B72-87E0-370D90F3B8F7</pav:lineageUri>
    <ao:item rdf:resource="urn:domeoclient:uuid:5692BCB9-DDA3-438D-9E49-F80218BB67C8"/>
    <pav:lastSavedOn>2014-07-17 18:59:35 -0400</pav:lastSavedOn>
    <ao:annotatesResource>			http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-24.txt.html</ao:annotatesResource>
    <ao:item rdf:resource="urn:domeoclient:uuid:0AE1727A-ACA3-43E1-8A12-B8F0F479A3DF"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:21394BF5-9EBD-45B5-A3E3-29F92CC4E65F"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <ao:item rdf:resource="urn:domeoclient:uuid:7CD9615A-69D6-4A70-94B2-EF43CF591997"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
    <ao:item rdf:resource="urn:domeoclient:uuid:ED9173BA-30D7-4181-85F1-37CC30DFF11C"/>
    <pav:createdOn>2014-07-17 15:58:55 -0700</pav:createdOn>
    <ao:item rdf:resource="urn:domeoclient:uuid:B2931C8A-EC31-47B6-AE9D-7EFD2AFC6C76"/>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046812afe0146812ce85a0000"/>
    <permissions:permissions rdf:nodeID="Ne3169e6abd4c4208b5e22c4cf166dca5"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:5A49ECAF-CE5A-41FF-B8D4-43B060247DBA"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:10C3FD12-EB69-4E8A-9C52-BB5ED70A7565">
    <domeo:uuid>10C3FD12-EB69-4E8A-9C52-BB5ED70A7565</domeo:uuid>
    <ao:suffix>, its major metabolite, 9-hydroxyrisperidone, and risperidone plus 9-hydroxyrisperidone are dose proportional over the dosing range of 1 to 16 mg daily (0.5 to 8 mg twice daily). Following oral administration of solution or tablet, mean peak plasma conce</ao:suffix>
    <ao:exact>risperidone</ao:exact>
    <pav:createdOn>2014-07-16 10:20:06 -0700</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:10C3FD12-EB69-4E8A-9C52-BB5ED70A7565"/>
    <domeo:uuid></domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix>Plasma concentrations of </ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:21985ECB-619E-48CC-8AB3-93723B535D1F">
    <dikbD2R:modality>ncit:negative</dikbD2R:modality>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:4EBFF001-A193-4148-8196-B7FA14D67CD4"/>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:F5CF7F61-B7F1-4B7C-AF06-558EB0A245B6">
    <pav:createdOn>2014-07-15 14:16:25 -0700</pav:createdOn>
    <domeo:uuid>F5CF7F61-B7F1-4B7C-AF06-558EB0A245B6</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:F5CF7F61-B7F1-4B7C-AF06-558EB0A245B6"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid></domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <ao:exact>phenobarbital</ao:exact>
    <ao:suffix>) with risperidone may cause a decrease in the combined plasma concentrations of risperidone and 9-hydroxyrisperidone [see 7 DRUG INTERACTIONS]. It would also be possible for risperidone to interfere with metabolism of other drugs metabolized by CYP 2D6.</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix>, and </ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/5E972E60-CC16-43FB-B91B-88EDC51512DD">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <rdfs:label>lithium</rdfs:label>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/</dailymed:activeMoietyRxCUI>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <dct:description>Referred to the drug in the interaction.</dct:description>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:BED0BB6E-5962-4714-A49A-2DB5A1787334">
    <pav:createdOn>2014-07-15 14:09:52 -0700</pav:createdOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:5B6A462D-57EA-4BBD-87E1-A0EC2FAF5196</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:55703ACD-B978-421D-82AE-69E7022573D6"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:5758DAC0-E1C0-49EB-BE9C-56FFBAF3B6F4</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9C0B4E8B-9FFE-4E47-9B4C-A6EA4527A384</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E8194531-C5B3-43AE-BC13-14A252C54824</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-15 17:11:14 -0400</pav:lastSavedOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoserver:annotationset:46636445-93A2-49F0-9E9C-5AEBF17046D2</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:2E5CE73B-BFD4-4E35-9A07-D5E37A9E87AE</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoserver:annotationset:570DA392-7779-456C-9C18-1FC0E579BBE6</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-15 14:11:14 -0700</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E6A1493E-98EE-4FDE-9301-752AB8E3453F</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
    <domeo:belongsToSet>urn:domeoserver:annotationset:21B0E479-04F9-4D66-B396-B773EFE53882</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:883587E1-49C1-4EE0-909E-4ADBAE13DD3A</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotation:8288AD6F-5E38-44AB-8425-B5F017B96EB1</pav:lineageUri>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:51A184F8-19CA-4489-AB8F-9AF92E4BE5BE">
    <domeo:deleted>false</domeo:deleted>
    <ao:item rdf:resource="urn:domeoclient:uuid:844AAE28-6A60-487D-810E-79FA4BF0CAB5"/>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:92F5F5C5-9A9C-4B47-AB81-A514809088C8"/>
    <pav:lineageUri>urn:domeoserver:annotationset:1EE1D64B-EDD4-4170-B797-D8F83B927DCE</pav:lineageUri>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-50.txt.html</ao:annotatesResource>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <permissions:permissions rdf:nodeID="Nfda6afe2d7f94fa2ab12a6a56a8dd407"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:41E33AFA-32CF-4F33-A475-CBE51A5010FA"/>
    <pav:createdOn>2014-07-18 14:20:17 -0700</pav:createdOn>
    <dct:description>The default set is created automatically by Domeo when no other set is existing.</dct:description>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046812afe0146812ce85a0000"/>
    <rdfs:label>Default Set</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lastSavedOn>2014-07-18 17:20:41 -0400</pav:lastSavedOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:item rdf:resource="urn:domeoclient:uuid:17162313-6A55-4157-B495-83AA9CF1A26A"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/498E6806-6DCA-4705-867A-311AE66F8A32">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/36437</dailymed:activeMoietyRxCUI>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <rdfs:label>sertraline</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoserver:annotationset:1575950D-32D4-46DE-A44F-8E9E614F997F">
    <pav:previousVersion>urn:domeoclient:uuid:9B307D8B-D2B0-4795-8850-FAAAAC6B5AF4</pav:previousVersion>
    <ao:item rdf:resource="urn:domeoclient:uuid:6F7C3F13-3AE2-43EA-93D3-9F0AF79252AC"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:65047D28-4B70-4701-B243-A146C45926A7"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:312701AC-EC1C-4292-B01F-44DD40979EEA"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">2</pav:versionNumber>
    <ao:item rdf:resource="urn:domeoclient:uuid:D2174191-CE1D-4EF2-8DD5-03008A9706DE"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:4D3BA7C7-A806-41A4-84AC-38A85FF0F9C2"/>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <permissions:permissions rdf:nodeID="Nba81ce7d58ee49cf95d2281e9476a419"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:12D5CA7C-401C-4376-A246-03585C5F9AC0"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:12CCDE72-9FC0-4264-A3F2-C533F792F613"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:F87C43FC-DD9B-42FA-953B-C8C25AA48C91"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:ADFEE70E-EDC2-4D08-90AB-0ABAFD52BC6F"/>
    <pav:lastSavedOn>2014-07-15 17:07:57 -0400</pav:lastSavedOn>
    <ao:item rdf:resource="urn:domeoclient:uuid:D1062598-B310-4CF4-8237-5F8F8F74933F"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:item rdf:resource="urn:domeoclient:uuid:785FFE99-34A3-41C7-A3D5-65DC60E0807D"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:BFCAC108-C978-4C7B-A79A-9887A3CA3C6C"/>
    <dct:description>The default set is created automatically by Domeo when no other set is existing.</dct:description>
    <ao:item rdf:resource="urn:domeoclient:uuid:24886D93-A995-41A8-9E66-1BF6DF77E9D2"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:90386835-AD59-4BAA-A860-3003ABCAF86C"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:E2A636FF-8FE8-44E9-B454-573E4E7470FA"/>
    <pav:createdOn>2014-07-15 14:02:34 -0700</pav:createdOn>
    <ao:item rdf:resource="urn:domeoclient:uuid:2AAEA179-90D2-4661-9105-64A780850DEB"/>
    <rdfs:label>Default Set</rdfs:label>
    <ao:item rdf:resource="urn:domeoclient:uuid:0A8134EE-D8E3-447B-9EB9-2CB597651AB4"/>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:annotatesResource>
    <pav:lineageUri>urn:domeoserver:annotationset:75FC1225-8399-469B-AE9D-7F697713E6AC</pav:lineageUri>
    <ao:item rdf:resource="urn:domeoclient:uuid:A1A5580F-53D7-4F22-824E-5430565EDBF1"/>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046812afe0146812ce85a0000"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:82FFD7F0-AC94-462F-BA86-70CFD849B686"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:199E47E3-ECB3-4CC4-AF72-217C37FF517C"/>
    <domeo:deleted>false</domeo:deleted>
    <ao:item rdf:resource="urn:domeoclient:uuid:34A66F13-B248-4FD8-A3CE-7AAAC40B7ACC"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:C66BBCCE-CA43-44FB-8D97-2084E19C48FF"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:D1D92634-CB40-4585-8260-1917D2119CC7"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:6EB13D46-B414-424C-9D7C-BADA59079327"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:A056C491-9BB0-438A-A716-FE909F2281AD"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:5415B79F-FEAF-4999-A78E-2C1039116F7C"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:AB6A5C23-94A9-4771-82D0-E81F57F7430F">
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-28.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:AB6A5C23-94A9-4771-82D0-E81F57F7430F"/>
    <ao:exact>theophylline</ao:exact>
    <domeo:uuid>AB6A5C23-94A9-4771-82D0-E81F57F7430F</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix> clearance decreased 16% ± 11 % (range: -32 to 5%). The half-life of </ao:prefix>
    <ao:suffix> increased from 6.6 ± 1.7 hours to 7.9 ± 1.5 hours. (See PRECAUTIONS.)</ao:suffix>
    <pav:createdOn>2014-07-18 14:03:17 -0700</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/DF4CD9EA-6625-46E6-9FB2-ECF205397DE3">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdfs:label>bosentan</rdfs:label>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/75207</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:F8EAECE2-30A6-49BF-883F-70A7B4280D18">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/ADE2E1DA-D3E9-438C-A1E1-D82219070E28"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/FA53ED44-367B-4D92-8F10-3F967033E9F0"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:2ECA95EB-4370-4C4C-8C95-4A2BE49873EF">
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
    <pav:lineageUri>urn:domeoserver:annotation:1AB09B5E-29E9-437D-9F20-F055503548CD</pav:lineageUri>
    <pav:createdOn>2014-07-18 14:23:36 -0700</pav:createdOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <ao:context rdf:resource="urn:domeoclient:uuid:728539A9-7322-4281-848B-5507BB82A585"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoclient:uuid:AA2CF58E-6DB1-4267-8DFC-33DE11331D87</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-18 17:23:51 -0400</pav:lastSavedOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A1747CFE-8798-401D-BFC7-1E14B7B3B1B1</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotationset:D0F2204E-5148-4A33-AAD0-599FB1F44EFC</pav:lineageUri>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lastSavedOn>2014-07-18 14:23:49 -0700</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:A9B54FB4-D4A5-4FA0-ABB3-A05CFA1F5934">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lastSavedOn>2014-07-16 17:10:58 -0400</pav:lastSavedOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:60698783-AF86-402C-ADB4-1162CCD89EBA"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:C2A39432-076D-421D-8007-22690EDA5A0C</domeo:belongsToSet>
    <ao:body rdf:nodeID="N7f0784cce2494edfa265d44e58e5bbd2"/>
    <pav:createdOn>2014-07-16 14:09:37 -0700</pav:createdOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:lineageUri>urn:domeoserver:annotation:2B478044-BBD7-4785-9DD7-003991731548</pav:lineageUri>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:ADE68C3A-6684-4E35-B3C0-F519065A2D66">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix> oral solution is bioequivalent to</ao:suffix>
    <domeo:uuid></domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:ADE68C3A-6684-4E35-B3C0-F519065A2D66"/>
    <ao:exact>risperidone</ao:exact>
    <pav:createdOn>2014-07-15 14:06:21 -0700</pav:createdOn>
    <ao:prefix>xsd:String</ao:prefix>
    <domeo:uuid>ADE68C3A-6684-4E35-B3C0-F519065A2D66</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:540A603C-5624-405F-9660-D636865AE01B">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix>. The combination of both drugs did not lead to clinically significant changes in blood pressure (supine or standing). Concomitant administration of potent CYP3A inducers is expected to cause greater decreases in plasma levels of sildenafil.</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:540A603C-5624-405F-9660-D636865AE01B"/>
    <pav:createdOn>2014-07-10 11:20:15 -0700</pav:createdOn>
    <domeo:uuid>540A603C-5624-405F-9660-D636865AE01B</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:hasSource>
    <ao:prefix> Cmax. Co-administration resulted in a 50% increase in AUC of </ao:prefix>
    <ao:exact>bosentan</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:C0577481-DCD6-4058-A293-BB8EFDB9B578">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:C0577481-DCD6-4058-A293-BB8EFDB9B578"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix> (5 mg oral once daily) by 35%, 37%, and 67%, respectively, compared to </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix> alone at steady state. If anticholinergic effects are seen, the dose of procyclidine should be reduced.</ao:suffix>
    <ao:exact>procyclidine</ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-50.txt.html</ao:hasSource>
    <domeo:uuid>C0577481-DCD6-4058-A293-BB8EFDB9B578</domeo:uuid>
    <pav:createdOn>2014-07-18 14:20:30 -0700</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:FE91163B-25D4-45FB-AD96-78A70FE948D6">
    <domeo:uuid>FE91163B-25D4-45FB-AD96-78A70FE948D6</domeo:uuid>
    <ao:exact>risperidone</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid></domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:FE91163B-25D4-45FB-AD96-78A70FE948D6"/>
    <pav:createdOn>2014-07-15 14:10:43 -0700</pav:createdOn>
    <ao:prefix> </ao:prefix>
    <ao:suffix>xsd:String</ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:31737AE9-0835-48DB-82BD-A713405999A3">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoclient:uuid:23AC741A-2236-437C-90AA-82B2E00E875C</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:EFD26771-2076-4B50-83F1-3C5592306D86"/>
    <pav:createdOn>2014-07-18 13:43:37 -0700</pav:createdOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotationset:C00C2C3C-0648-4779-A135-09D440F1CEA8</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:FF76049E-6B2C-46A9-ACF7-CA565C8087F3</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotation:0504C453-4419-46A4-BB20-5FB13151936C</pav:lineageUri>
    <pav:lastSavedOn>2014-07-18 16:43:48 -0400</pav:lastSavedOn>
    <pav:lastSavedOn>2014-07-18 13:43:48 -0700</pav:lastSavedOn>
    <rdfs:label>Highlight</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:548F8E3A-F3DF-41D2-B65F-5C14C8EE8007">
    <pav:lineageUri>urn:domeoserver:annotation:DB5D45FD-01EE-4E55-B8D6-3D209D267599</pav:lineageUri>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotationset:C00C2C3C-0648-4779-A135-09D440F1CEA8</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lastSavedOn>2014-07-18 16:43:48 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:FF76049E-6B2C-46A9-ACF7-CA565C8087F3</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lastSavedOn>2014-07-18 13:43:48 -0700</pav:lastSavedOn>
    <pav:createdOn>2014-07-18 13:43:20 -0700</pav:createdOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:35ABEAB8-91E9-4F2D-B158-A3AE422D3EB0"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoclient:uuid:23AC741A-2236-437C-90AA-82B2E00E875C</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/0DCDA0D5-A5B2-483F-AFDF-50EAB4D41396">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/7514</dailymed:activeMoietyRxCUI>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <rdfs:label>norethindrone</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:B3D0F9C9-FF6E-49C9-83A0-E46C52456757">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/1FC51968-9D21-44A1-9E75-B063933AF89E"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/D3E8CE76-944F-40F2-AF66-51EBF76481A9"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:44695E00-3FB6-4D5F-B815-8E3CED70A3F6">
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:3601F178-6758-48FF-9A7C-218ADE3838A3"/>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/D4B9A038-2770-4F91-9562-10173A7F2D34">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdfs:label>cimetidine</rdfs:label>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/2541</dailymed:activeMoietyRxCUI>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:7AB175A5-BD20-41A8-91C0-16D5DF981557">
    <domeo:uuid></domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix>administered as solution to three healthy male volunteers, total recovery of radioactivity at 1 week was 84%, including 70% in the urine and 14% in the feces.</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:7AB175A5-BD20-41A8-91C0-16D5DF981557"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <ao:exact>risperidone </ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid>7AB175A5-BD20-41A8-91C0-16D5DF981557</domeo:uuid>
    <ao:prefix> and its metabolites are eliminated via the urine and, to a much lesser extent, via the feces. As illustrated by a mass balance study of a single 1 mg oral dose of 14C-</ao:prefix>
    <pav:createdOn>2014-07-15 14:17:07 -0700</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:A1A5580F-53D7-4F22-824E-5430565EDBF1">
    <pav:lastSavedOn>2014-07-15 14:04:06 -0700</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:5758DAC0-E1C0-49EB-BE9C-56FFBAF3B6F4</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E6A1493E-98EE-4FDE-9301-752AB8E3453F</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E8194531-C5B3-43AE-BC13-14A252C54824</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-15 17:04:06 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:46636445-93A2-49F0-9E9C-5AEBF17046D2</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9C0B4E8B-9FFE-4E47-9B4C-A6EA4527A384</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoclient:uuid:9B307D8B-D2B0-4795-8850-FAAAAC6B5AF4</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:2E5CE73B-BFD4-4E35-9A07-D5E37A9E87AE</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:883587E1-49C1-4EE0-909E-4ADBAE13DD3A</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotation:11B910BF-1D1A-4CDC-AEE8-7EB159B8DDE1</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:1575950D-32D4-46DE-A44F-8E9E614F997F</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:570DA392-7779-456C-9C18-1FC0E579BBE6</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:FA8D1DAC-C616-456C-BB3D-29F18DED21A1</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:25FC3270-77CF-4552-800B-3A6E31592E33"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:21B0E479-04F9-4D66-B396-B773EFE53882</domeo:belongsToSet>
    <pav:createdOn>2014-07-15 14:02:44 -0700</pav:createdOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:5B6A462D-57EA-4BBD-87E1-A0EC2FAF5196</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:C039DC79-C2B3-4581-A409-2060854712D2">
    <pav:lineageUri>urn:domeoserver:annotation:3DA2685F-E7CD-44B7-8191-43C3200458E4</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lastSavedOn>2014-07-16 13:36:38 -0400</pav:lastSavedOn>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
    <pav:lastSavedOn>2014-07-16 10:36:38 -0700</pav:lastSavedOn>
    <pav:createdOn>2014-07-16 10:36:22 -0700</pav:createdOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:2CE33325-EF3D-4298-BBCC-82F0A45DA665</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:83325641-7434-4321-A570-829337F41ADF"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoclient:uuid:C5D9EC69-52E2-48F5-B3D8-867DE23DEC96</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:3600E64E-4D3A-48CE-A0E8-33E1B78E99E5">
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
    <pav:lineageUri>urn:domeoserver:annotation:53864B5E-16B9-44F0-8F14-DFFE95BC66B5</pav:lineageUri>
    <pav:createdOn>2014-07-18 14:23:45 -0700</pav:createdOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:3B501E10-7673-4F8E-889F-7048994F6D90"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoclient:uuid:AA2CF58E-6DB1-4267-8DFC-33DE11331D87</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-18 17:23:51 -0400</pav:lastSavedOn>
    <pav:lastSavedOn>2014-07-18 14:23:49 -0700</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotationset:D0F2204E-5148-4A33-AAD0-599FB1F44EFC</pav:lineageUri>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A1747CFE-8798-401D-BFC7-1E14B7B3B1B1</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:4148B6C7-21F7-44D9-9466-BC519FF61DF1">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:4148B6C7-21F7-44D9-9466-BC519FF61DF1"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-25.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix> dosing (200 mg daily, orally for 3 days followed by 250 mg intravenously for one dose) both with and without the administration of fluconazole (oral fluconazole 200 mg daily for 16 days) in 10 normal male volunteers. There was a significant increase in </ao:suffix>
    <ao:prefix> AUC was determined after 4 days of </ao:prefix>
    <domeo:uuid>4148B6C7-21F7-44D9-9466-BC519FF61DF1</domeo:uuid>
    <pav:createdOn>2014-07-18 13:48:11 -0700</pav:createdOn>
    <ao:exact>phenytoin</ao:exact>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Nd47b3c4b1c5240a0bab5e055336f7be9">
    <domeo:sets rdf:resource="urn:pddi:uuid:EE597E16-26DA-463C-A72C-1CA155D4131A"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:079A4E14-C541-4AC8-B876-063FC489849B">
    <pav:lineageUri>urn:domeoserver:annotation:5A2DFF00-32F6-4B8F-8E45-E0E219203A62</pav:lineageUri>
    <pav:lineageUri>urn:domeoserver:annotationset:C94BECCE-E3E9-4B70-AC23-F715B9D3EEFF</pav:lineageUri>
    <pav:lastSavedOn>2014-07-17 15:54:46 -0700</pav:lastSavedOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdOn>2014-07-17 15:54:41 -0700</pav:createdOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:96BAB4C7-6F7A-4EBA-BAC1-134F746F11FA</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoserver:annotationset:2D3D9594-163C-4299-854D-3987A43B7DCF</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoclient:uuid:4E57D817-C3D5-47E5-AECC-169C5A1EF60D</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-17 18:54:47 -0400</pav:lastSavedOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:01F43ADA-D582-470E-9E9C-774668C5EF3D"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/6B3BAFED-E091-412E-B7AB-A9DC8567890B">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/4450</dailymed:activeMoietyRxCUI>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <rdfs:label>fluconazole</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:BD319A5A-0B87-457E-BF99-76BC4728CC77">
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lastSavedOn>2014-07-17 18:54:47 -0400</pav:lastSavedOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:E03B1442-AB3D-475E-AEE8-EFD5DC37D96C"/>
    <pav:lastSavedOn>2014-07-17 15:54:46 -0700</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotation:903431A1-C3AA-49C4-A4F3-7D24C827579A</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:2D3D9594-163C-4299-854D-3987A43B7DCF</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoclient:uuid:4E57D817-C3D5-47E5-AECC-169C5A1EF60D</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdOn>2014-07-17 15:53:41 -0700</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotationset:C94BECCE-E3E9-4B70-AC23-F715B9D3EEFF</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:96BAB4C7-6F7A-4EBA-BAC1-134F746F11FA</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:567E7CC2-49BA-4366-A98A-8E4134A9A74B">
    <pav:lineageUri>urn:domeoserver:annotationset:46F6E8D2-4020-433A-A976-216B25CC416D</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
    <permissions:permissions rdf:nodeID="Nc0a0bd956632436f93f7feba79595d92"/>
    <dct:description>The default set is created automatically by Domeo when no other set is existing.</dct:description>
    <pav:createdOn>2014-07-18 14:32:24 -0700</pav:createdOn>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046812afe0146812ce85a0000"/>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-52.txt.html</ao:annotatesResource>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lastSavedOn>2014-07-18 17:32:28 -0400</pav:lastSavedOn>
    <rdfs:label>Default Set</rdfs:label>
    <ao:item rdf:resource="urn:domeoclient:uuid:C8A30D50-862D-473B-A05C-42C01434E780"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <domeo:deleted>false</domeo:deleted>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:previousVersion>xsd:String</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:31F660CD-C617-4D06-85AD-7A9D8F2EDEEC">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <ao:context rdf:resource="urn:domeoclient:uuid:F247102D-970B-4569-BFF9-4021B0D33CE0"/>
    <pav:lineageUri>urn:domeoserver:annotationset:BE290CA3-79BD-411A-BE2E-69AA4D19607D</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:970963DF-8BCE-4936-9DFC-328A36014E1B</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
    <pav:previousVersion>urn:domeoserver:annotationset:2BFC2FB6-6BE9-4822-A245-973533533023</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:239B4C6D-1110-4B65-AC66-F8A394187814</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">6</pav:versionNumber>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdOn>2014-07-10 11:20:13 -0700</pav:createdOn>
    <pav:lastSavedOn>2014-07-10 11:21:41 -0700</pav:lastSavedOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:15A537D1-5648-41B2-8BFA-0D0BA3DF4393</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:516C333C-B517-4F84-999E-51185DD6E859</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotation:E4350656-FCE6-492B-8481-93701F60730B</pav:lineageUri>
    <pav:lastSavedOn>2014-07-10 14:21:41 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:FECBEFAB-2C18-4C64-93DF-19494748E804">
    <pav:createdOn>2014-07-16 10:19:14 -0700</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:FECBEFAB-2C18-4C64-93DF-19494748E804"/>
    <domeo:uuid>FECBEFAB-2C18-4C64-93DF-19494748E804</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix> and its major metabolite, 9-hydroxyrisperidone [see 12 CLINICAL PHARMACOLOGY]. Antagonism at receptors other than D2 and 5HT2 [see 12 CLINICAL PHARMACOLOGY] may explain some of the other effects of risperidone.</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>risperidone</ao:exact>
    <domeo:uuid></domeo:uuid>
    <ao:prefix> results from the combined concentrations of </ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:C9D98AB8-FCA0-4A14-92DD-EBD32CC6776E">
    <pav:previousVersion>urn:domeoserver:annotationset:2BFC2FB6-6BE9-4822-A245-973533533023</pav:previousVersion>
    <pav:createdOn>2014-07-10 11:20:24 -0700</pav:createdOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:D166220A-E6E2-4ECF-B03B-AF573EEAE31B"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:970963DF-8BCE-4936-9DFC-328A36014E1B</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotationset:BE290CA3-79BD-411A-BE2E-69AA4D19607D</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">6</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotation:E0EA74DB-B2F8-484F-91C0-D3CF002E6856</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:239B4C6D-1110-4B65-AC66-F8A394187814</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:15A537D1-5648-41B2-8BFA-0D0BA3DF4393</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lastSavedOn>2014-07-10 14:21:41 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:516C333C-B517-4F84-999E-51185DD6E859</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-10 11:21:41 -0700</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoserver:annotationset:A57C5101-A9A5-4504-A046-944A7401D498">
    <ao:item rdf:resource="urn:domeoclient:uuid:EFED6610-75EB-4165-827C-237B7D245279"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
    <pav:lastSavedOn>2014-07-10 14:01:56 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotationset:BE290CA3-79BD-411A-BE2E-69AA4D19607D</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">2</pav:versionNumber>
    <domeo:deleted>false</domeo:deleted>
    <rdfs:label>Default Set</rdfs:label>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <dct:description>The default set is created automatically by Domeo when no other set is existing.</dct:description>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046812afe0146812ce85a0000"/>
    <pav:previousVersion>urn:domeoclient:uuid:8A7DE042-9FA7-424C-B98E-9C19498D7977</pav:previousVersion>
    <pav:createdOn>2014-07-10 10:59:34 -0700</pav:createdOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:annotatesResource>
    <permissions:permissions rdf:nodeID="Nc0a4606fa0a44afd87f9ea0e06b77d0a"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:11B78A9D-1251-420C-8AE2-B343DD8F857F">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdOn>2014-07-16 10:20:10 -0700</pav:createdOn>
    <pav:lastSavedOn>2014-07-16 10:20:50 -0700</pav:lastSavedOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoclient:uuid:2F716A41-B68F-48AE-B5C1-E31F1704C565</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:AF9D4143-A4AD-4E55-AADC-39F03048D6F3"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:DA8D6B42-B41F-4576-BF10-1285DF3EAB80</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotationset:C8D7FDC6-6816-4BD4-BC7F-88ABDCC37D79</pav:lineageUri>
    <pav:lineageUri>urn:domeoserver:annotation:4D02CF1E-E8E5-46A5-ACF6-9111D06E9BED</pav:lineageUri>
    <pav:lastSavedOn>2014-07-16 13:20:50 -0400</pav:lastSavedOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:6F6FACEE-5C35-4020-BE6D-26958BA10CA6">
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
    <pav:lastSavedOn>2014-07-17 15:54:46 -0700</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotationset:C94BECCE-E3E9-4B70-AC23-F715B9D3EEFF</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoclient:uuid:4E57D817-C3D5-47E5-AECC-169C5A1EF60D</domeo:belongsToSet>
    <pav:createdOn>2014-07-17 15:54:08 -0700</pav:createdOn>
    <pav:lastSavedOn>2014-07-17 18:54:47 -0400</pav:lastSavedOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotation:DC7715E4-B095-4848-B67F-376A48663B03</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoserver:annotationset:96BAB4C7-6F7A-4EBA-BAC1-134F746F11FA</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:C7811B96-6935-4053-BDA0-233B88584EB2"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:2D3D9594-163C-4299-854D-3987A43B7DCF</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/518C4EF2-C804-4CF7-9CBD-9075D385C990">
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdfs:label>quinidine</rdfs:label>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/9068</dailymed:activeMoietyRxCUI>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:984705CF-6418-4362-AA0D-0A0DD15065D1">
    <ao:suffix> results from the combined concentrations of risperidone and its major metabolite, 9-hydroxyrisperidone [see 12 CLINICAL PHARMACOLOGY]. Antagonism at receptors other than D2 and 5HT2 [see 12 CLINICAL PHARMACOLOGY] may explain some of the other effects of</ao:suffix>
    <ao:prefix>The clinical effect from</ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:984705CF-6418-4362-AA0D-0A0DD15065D1"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid></domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2014-07-15 14:03:06 -0700</pav:createdOn>
    <domeo:uuid>984705CF-6418-4362-AA0D-0A0DD15065D1</domeo:uuid>
    <ao:exact> risperidone</ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:7247E1B1-4BA1-4DE0-AA64-CA56899212F6">
    <ao:suffix> drug products.</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <pav:createdOn>2014-07-15 14:19:12 -0700</pav:createdOn>
    <ao:prefix>harmacokinetic information for pediatric patients with schizophrenia, 13to 17 years of age, bipolar mania, 10 to 17 years old, and irritability associated with autistic disorder,5 to 16 years of age, is approved for Janssen Pharmaceuticals Corporation’s </ao:prefix>
    <ao:exact>risperidone</ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:7247E1B1-4BA1-4DE0-AA64-CA56899212F6"/>
    <domeo:uuid>7247E1B1-4BA1-4DE0-AA64-CA56899212F6</domeo:uuid>
    <domeo:uuid></domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:A2215D32-FF99-4DC9-90B9-5C350C098EEB">
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:5B6A462D-57EA-4BBD-87E1-A0EC2FAF5196</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:5758DAC0-E1C0-49EB-BE9C-56FFBAF3B6F4</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:46636445-93A2-49F0-9E9C-5AEBF17046D2</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9C0B4E8B-9FFE-4E47-9B4C-A6EA4527A384</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E8194531-C5B3-43AE-BC13-14A252C54824</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:2E5CE73B-BFD4-4E35-9A07-D5E37A9E87AE</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E6A1493E-98EE-4FDE-9301-752AB8E3453F</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:570DA392-7779-456C-9C18-1FC0E579BBE6</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:AEA36B1F-63F1-4CF9-8B5E-4649C4B9F028"/>
    <pav:lastSavedOn>2014-07-15 17:11:14 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:21B0E479-04F9-4D66-B396-B773EFE53882</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdOn>2014-07-15 14:11:08 -0700</pav:createdOn>
    <pav:lastSavedOn>2014-07-15 14:11:14 -0700</pav:lastSavedOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoserver:annotationset:883587E1-49C1-4EE0-909E-4ADBAE13DD3A</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotation:A478A219-F6F2-4E61-B58F-0E374B4C9D0D</pav:lineageUri>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:99CBB508-3AAE-4160-9820-7A057C3D6498">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:99CBB508-3AAE-4160-9820-7A057C3D6498"/>
    <pav:createdOn>2014-07-16 14:04:24 -0700</pav:createdOn>
    <ao:exact>individual AUC values of norethindrone decreased very slightly</ao:exact>
    <ao:suffix> (&lt;5%) in 3 of the 21 subjects after fluconazole treatment.</ao:suffix>
    <ao:prefix>ed by 24% (95% C.I. range 18 to 31%) and 13% (95% C.I. range 8 to 18%), respectively relative to placebo. Fluconazole treatment did not cause a decrease in the ethinyl estradiol AUC of any individual subject in this study compared to placebo dosing. The </ao:prefix>
    <domeo:uuid>99CBB508-3AAE-4160-9820-7A057C3D6498</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-21.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:926EB546-FC66-4BEC-B38A-18749E06CCE5">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">4</pav:versionNumber>
    <pav:previousVersion>urn:domeoserver:annotationset:2E5CE73B-BFD4-4E35-9A07-D5E37A9E87AE</pav:previousVersion>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotation:F15DCB3F-891E-49A4-996F-2950F83E34D9</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E6A1493E-98EE-4FDE-9301-752AB8E3453F</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:21B0E479-04F9-4D66-B396-B773EFE53882</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:5758DAC0-E1C0-49EB-BE9C-56FFBAF3B6F4</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:570DA392-7779-456C-9C18-1FC0E579BBE6</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-15 17:17:26 -0400</pav:lastSavedOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:75978B88-8F19-4550-921C-BCAB17F30E80"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
    <pav:createdOn>2014-07-15 14:17:00 -0700</pav:createdOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:46636445-93A2-49F0-9E9C-5AEBF17046D2</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E8194531-C5B3-43AE-BC13-14A252C54824</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9C0B4E8B-9FFE-4E47-9B4C-A6EA4527A384</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-15 14:17:25 -0700</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:883587E1-49C1-4EE0-909E-4ADBAE13DD3A</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotationset:75FC1225-8399-469B-AE9D-7F697713E6AC</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:5B6A462D-57EA-4BBD-87E1-A0EC2FAF5196</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:6491BF48-AC35-48FA-A8D2-102002F8E57E">
    <domeo:uuid>6491BF48-AC35-48FA-A8D2-102002F8E57E</domeo:uuid>
    <pav:createdOn>2014-07-17 15:56:45 -0700</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:6491BF48-AC35-48FA-A8D2-102002F8E57E"/>
    <ao:suffix>xsd:String</ao:suffix>
    <ao:hasSource>				http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-23.txt.html																													</ao:hasSource>
    <ao:prefix>. However, the </ao:prefix>
    <ao:exact>administration of cimetidine 600 mg to 900 mg intravenously over a four-hour period (from one hour before to 3 hours after a single oral dose of fluconazole 200 mg) did not affect the bioavailability or pharmacokinetics of fluconazole in 24 healthy male volunteers</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/D2018278-5A34-478E-8004-540890604BD3">
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/679314</dailymed:activeMoietyRxCUI>
    <rdfs:label>9-hydroxyrisperidone</rdfs:label>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/metabolite"/>
    <dct:description>Referred to the drug in the interaction.</dct:description>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:274D4FB3-81D3-46CA-BE6A-31286B260E56">
    <pav:lastSavedOn>2014-07-15 17:11:14 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:21B0E479-04F9-4D66-B396-B773EFE53882</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:46636445-93A2-49F0-9E9C-5AEBF17046D2</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotation:A33A59D0-2BD7-42C9-87D9-CB819AC41E8C</pav:lineageUri>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:2E5CE73B-BFD4-4E35-9A07-D5E37A9E87AE</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:98825CF8-1CA0-489D-A1C4-2239A4A1278A"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E8194531-C5B3-43AE-BC13-14A252C54824</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
    <rdfs:label>Highlight</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdOn>2014-07-15 14:10:55 -0700</pav:createdOn>
    <pav:lastSavedOn>2014-07-15 14:11:14 -0700</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9C0B4E8B-9FFE-4E47-9B4C-A6EA4527A384</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:883587E1-49C1-4EE0-909E-4ADBAE13DD3A</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:5B6A462D-57EA-4BBD-87E1-A0EC2FAF5196</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E6A1493E-98EE-4FDE-9301-752AB8E3453F</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:5758DAC0-E1C0-49EB-BE9C-56FFBAF3B6F4</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:570DA392-7779-456C-9C18-1FC0E579BBE6</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:F0444DBB-743A-42A1-A053-40E5E11BBD66">
    <pav:createdOn>2014-07-16 14:07:50 -0700</pav:createdOn>
    <ao:exact> fluconazole</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid></domeo:uuid>
    <domeo:uuid>F0444DBB-743A-42A1-A053-40E5E11BBD66</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-21.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:F0444DBB-743A-42A1-A053-40E5E11BBD66"/>
    <ao:prefix> (&lt;5%) in 3 of the 21 subjects after</ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix> treatment.</ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:8C676DD4-0D35-4578-AF3F-F66853FF712A">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
    <pav:lineageUri>urn:domeoserver:annotation:418CA3DF-9103-4C2E-B3FB-ECD0EEC61C91</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:B480EE53-5881-4650-9D82-D1F972071243</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdOn>2014-07-18 14:07:10 -0700</pav:createdOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotationset:B136901C-38A0-4F12-B35D-BF814374DB34</pav:lineageUri>
    <pav:lastSavedOn>2014-07-18 14:07:26 -0700</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoclient:uuid:346C4DA6-A4F5-4B6F-AADB-4E76B1FDE36F</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:A96A53F5-6219-428F-A3F8-43699BB234C3"/>
    <pav:lastSavedOn>2014-07-18 17:07:27 -0400</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:75261373-1FF5-4BA4-8887-FD4548F77DE6">
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
    <pav:lineageUri>urn:domeoserver:annotationset:C8D7FDC6-6816-4BD4-BC7F-88ABDCC37D79</pav:lineageUri>
    <pav:createdOn>2014-07-16 10:19:56 -0700</pav:createdOn>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotation:C9060959-C004-4026-9508-F357A64A3F41</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:6FFFF211-BFDC-4E16-968C-A296868530C4</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoserver:annotationset:DA8D6B42-B41F-4576-BF10-1285DF3EAB80</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:AAD02A4C-E01E-4C82-BC8A-D0F4639844FA</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:BEEF40B4-6424-4E52-8991-9FA7249F61E5"/>
    <pav:lastSavedOn>2014-07-16 10:20:50 -0700</pav:lastSavedOn>
    <pav:lastSavedOn>2014-07-16 13:20:50 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoclient:uuid:2F716A41-B68F-48AE-B5C1-E31F1704C565</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/17338360-FF55-4D91-8F6A-612551EEFC58">
    <rdfs:label>fluconazole</rdfs:label>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/4450</dailymed:activeMoietyRxCUI>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:A5A82A3B-FE45-46DE-9048-8E85995D8F43">
    <domeo:belongsToSet>urn:domeoserver:annotationset:2E5CE73B-BFD4-4E35-9A07-D5E37A9E87AE</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-15 14:11:14 -0700</pav:lastSavedOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:570DA392-7779-456C-9C18-1FC0E579BBE6</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotation:C8EFF1C4-C4FB-4CBB-A08A-C7EA79DBA43E</pav:lineageUri>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
    <pav:createdOn>2014-07-15 14:09:46 -0700</pav:createdOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:5B6A462D-57EA-4BBD-87E1-A0EC2FAF5196</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E6A1493E-98EE-4FDE-9301-752AB8E3453F</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:21B0E479-04F9-4D66-B396-B773EFE53882</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:883587E1-49C1-4EE0-909E-4ADBAE13DD3A</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoserver:annotationset:46636445-93A2-49F0-9E9C-5AEBF17046D2</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9C0B4E8B-9FFE-4E47-9B4C-A6EA4527A384</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-15 17:11:14 -0400</pav:lastSavedOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:5758DAC0-E1C0-49EB-BE9C-56FFBAF3B6F4</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E8194531-C5B3-43AE-BC13-14A252C54824</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:D9907CFF-B778-4B29-8773-70DE74FE7759"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:0C20AD1B-8F9C-472D-A102-E6A1F85BDC4E">
    <pav:lineageUri>urn:domeoserver:annotation:7EC16932-4B45-4E99-BD42-2FCDF16C4F6D</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:6FFFF211-BFDC-4E16-968C-A296868530C4</domeo:belongsToSet>
    <pav:createdOn>2014-07-16 10:23:02 -0700</pav:createdOn>
    <pav:lastSavedOn>2014-07-16 10:23:07 -0700</pav:lastSavedOn>
    <rdfs:label>Highlight</rdfs:label>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:30F7EA47-3832-4833-A7F4-22FA71A2083F"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:AAD02A4C-E01E-4C82-BC8A-D0F4639844FA</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lastSavedOn>2014-07-16 13:23:07 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:D3E83240-5B88-4E8A-9F52-DF6E195AAF5D">
    <domeo:belongsToSet>urn:domeoserver:annotationset:6FFFF211-BFDC-4E16-968C-A296868530C4</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <pav:createdOn>2014-07-18 15:24:32 -0700</pav:createdOn>
    <pav:lastSavedOn>2014-07-18 18:26:41 -0400</pav:lastSavedOn>
    <ao:body rdf:nodeID="Nfd87afae819c4b5db88abfa807ee766b"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:94A95C57-5A20-472B-87AE-DD634374AADD"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
    <pav:lineageUri>urn:domeoserver:annotation:979284A9-B754-4E29-92E7-8BFA59BFC91A</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:7443907B-C475-4EA4-B081-8C3D55A1EF69">
    <pav:lineageUri>urn:domeoserver:annotation:F3519808-15C2-48AA-8344-8BFE8F7E6625</pav:lineageUri>
    <ao:context rdf:resource="urn:domeoclient:uuid:0BB528F0-CD4A-4BAC-AA5B-3FF33FCFF9B7"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:570DA392-7779-456C-9C18-1FC0E579BBE6</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E6A1493E-98EE-4FDE-9301-752AB8E3453F</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-15 14:11:14 -0700</pav:lastSavedOn>
    <pav:createdOn>2014-07-15 14:09:39 -0700</pav:createdOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:2E5CE73B-BFD4-4E35-9A07-D5E37A9E87AE</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:46636445-93A2-49F0-9E9C-5AEBF17046D2</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-15 17:11:14 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:21B0E479-04F9-4D66-B396-B773EFE53882</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9C0B4E8B-9FFE-4E47-9B4C-A6EA4527A384</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:5758DAC0-E1C0-49EB-BE9C-56FFBAF3B6F4</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
    <domeo:belongsToSet>urn:domeoserver:annotationset:5B6A462D-57EA-4BBD-87E1-A0EC2FAF5196</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E8194531-C5B3-43AE-BC13-14A252C54824</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:883587E1-49C1-4EE0-909E-4ADBAE13DD3A</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:199E47E3-ECB3-4CC4-AF72-217C37FF517C">
    <ao:context rdf:resource="urn:domeoclient:uuid:A4CB337C-2A42-4BB9-AADC-A7635FC3DAA5"/>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:1575950D-32D4-46DE-A44F-8E9E614F997F</domeo:belongsToSet>
    <pav:createdOn>2014-07-15 14:07:44 -0700</pav:createdOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lastSavedOn>2014-07-15 17:07:58 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotation:E42A67A9-550A-481E-A232-D4A6DB6895C2</pav:lineageUri>
    <pav:lastSavedOn>2014-07-15 17:07:57 -0400</pav:lastSavedOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotation:F97ECD00-AF8A-4A5F-9D7C-C28CF4FCC24C</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:FA8D1DAC-C616-456C-BB3D-29F18DED21A1</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:47D397AD-5153-40DA-83B8-C0A45725E6BC">
    <ao:prefix> to </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2014-07-15 14:10:02 -0700</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:47D397AD-5153-40DA-83B8-C0A45725E6BC"/>
    <ao:exact>9-hydroxyrisperidone</ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <ao:suffix> by the enzyme, CYP 2D6. A minor metabolic pathway is through N-dealkylation. The main metabolite, 9-hydroxyrisperidone, has similar pharmacological activity as risperidone. Consequently, the clinical effect of the drug results from the combined concentr</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>47D397AD-5153-40DA-83B8-C0A45725E6BC</domeo:uuid>
    <domeo:uuid></domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:C9AAECF8-1252-4F78-95C3-766B0DC2CF93">
    <domeo:uuid>C9AAECF8-1252-4F78-95C3-766B0DC2CF93</domeo:uuid>
    <ao:exact>Fluconazole</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:C9AAECF8-1252-4F78-95C3-766B0DC2CF93"/>
    <ao:suffix> 100 mg was administered as a single oral dose alone and two hours after a single dose of cimetidine 400 mg to six healthy male volunteers. After the administration of cimetidine, there was a significant decrease in fluconazole AUC and Cmax. There was a </ao:suffix>
    <ao:prefix>xsd:String</ao:prefix>
    <pav:createdOn>2014-07-17 15:53:34 -0700</pav:createdOn>
    <ao:hasSource>				http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-23.txt.html																													</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:E9DA4784-7755-4859-B2A0-96322779CF59">
    <ao:prefix> is supplied for oral administration as scored tablets containing </ao:prefix>
    <pav:createdOn>2014-07-16 14:02:20 -0700</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix>equivalent to 25, 50, 100, 150 and 200 mg of </ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>sertraline hydrochloride </ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:E9DA4784-7755-4859-B2A0-96322779CF59"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-20.txt.html</ao:hasSource>
    <domeo:uuid>E9DA4784-7755-4859-B2A0-96322779CF59</domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:AD7753FF-D1E8-489F-B53D-1F96A5C7118D">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:AAD02A4C-E01E-4C82-BC8A-D0F4639844FA</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lastSavedOn>2014-07-16 13:23:07 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotation:0ED84F3F-026A-4100-92FC-0F849E55CAE3</pav:lineageUri>
    <ao:context rdf:resource="urn:domeoclient:uuid:B82EA451-7796-4E93-B7B5-692C0393EDDE"/>
    <pav:createdOn>2014-07-16 10:21:54 -0700</pav:createdOn>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
    <pav:lastSavedOn>2014-07-16 10:23:07 -0700</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:6FFFF211-BFDC-4E16-968C-A296868530C4</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:7B656CB9-304A-4F35-9AAE-0A055011F03C">
    <ao:prefix> was about 21 hours (CV=20%) in extensive metabolizers and 30 hours (CV=25%) in poor metabolizers. The pharmacokinetics of </ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:7B656CB9-304A-4F35-9AAE-0A055011F03C"/>
    <pav:createdOn>2014-07-15 14:17:31 -0700</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid></domeo:uuid>
    <ao:exact>risperidone</ao:exact>
    <ao:suffix> and 9-hydroxyrisperidone combined, after single and multiple doses, were similar in extensive and poor metabolizers, with an overall mean elimination half-life of about 20 hours.</ao:suffix>
    <domeo:uuid>7B656CB9-304A-4F35-9AAE-0A055011F03C</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:EC1C5E61-FA3B-468A-A86F-BC4B06CEB624">
    <domeo:uuid>EC1C5E61-FA3B-468A-A86F-BC4B06CEB624</domeo:uuid>
    <pav:createdOn>2014-07-17 15:59:01 -0700</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:EC1C5E61-FA3B-468A-A86F-BC4B06CEB624"/>
    <ao:hasSource>			http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-24.txt.html</ao:hasSource>
    <ao:prefix> after 15 days of </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix> administered as 600 mg daily in eight healthy male volunteers resulted in a significant decrease in fluconazole AUC and a significant increase in apparent oral clearance of fluconazole. There was a mean ± SD reduction in fluconazole AUC of 23% ± 9% (ran</ao:suffix>
    <ao:exact>rifampin</ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:B2690ED3-4A3B-4FA6-84FF-6800464F3D50">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lineageUri>urn:domeoserver:annotationset:C94BECCE-E3E9-4B70-AC23-F715B9D3EEFF</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:96BAB4C7-6F7A-4EBA-BAC1-134F746F11FA</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
    <pav:lastSavedOn>2014-07-17 18:54:47 -0400</pav:lastSavedOn>
    <pav:createdOn>2014-07-17 15:54:16 -0700</pav:createdOn>
    <domeo:belongsToSet>urn:domeoclient:uuid:4E57D817-C3D5-47E5-AECC-169C5A1EF60D</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:2D3D9594-163C-4299-854D-3987A43B7DCF</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotation:54633865-F0EF-49A9-B692-22E355EC5D36</pav:lineageUri>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lastSavedOn>2014-07-17 15:54:46 -0700</pav:lastSavedOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:D1D04FEE-3479-4F04-B0D6-9FC8F29285CE"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:F4E4C204-187C-449E-9023-BF663418A548">
    <domeo:belongsToSet>urn:domeoserver:annotationset:516C333C-B517-4F84-999E-51185DD6E859</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:15A537D1-5648-41B2-8BFA-0D0BA3DF4393</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdOn>2014-07-10 11:20:33 -0700</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotationset:BE290CA3-79BD-411A-BE2E-69AA4D19607D</pav:lineageUri>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:previousVersion>urn:domeoserver:annotationset:2BFC2FB6-6BE9-4822-A245-973533533023</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotation:9F4606B8-13A9-4901-BB31-106D04F7176B</pav:lineageUri>
    <pav:lastSavedOn>2014-07-10 14:21:41 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
    <domeo:belongsToSet>urn:domeoserver:annotationset:970963DF-8BCE-4936-9DFC-328A36014E1B</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">6</pav:versionNumber>
    <ao:context rdf:resource="urn:domeoclient:uuid:666583ED-95C0-4F25-8463-3174C806F5FF"/>
    <pav:lastSavedOn>2014-07-10 11:21:41 -0700</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:239B4C6D-1110-4B65-AC66-F8A394187814</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Nf875c1192bd04da8ba587becb06dbb99">
    <domeo:sets rdf:resource="urn:pddi:uuid:3B7229C1-BBC3-4F13-A2D8-9C5E932927F8"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:3C55FE98-387B-4122-94EC-ABF9B03F8B03">
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:B3A2FE9F-B6D1-4F2D-8EB2-E8EA69DEC037"/>
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/EB5D25E9-EAE4-4A5C-BDE0-2EDF1AA4D125">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdfs:label>paroxetine</rdfs:label>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/32937</dailymed:activeMoietyRxCUI>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:34BFAD74-FE4D-4E30-8ACE-10002901EAA2">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:DA8D6B42-B41F-4576-BF10-1285DF3EAB80</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lastSavedOn>2014-07-16 13:20:50 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:AAD02A4C-E01E-4C82-BC8A-D0F4639844FA</domeo:belongsToSet>
    <pav:createdOn>2014-07-16 10:18:37 -0700</pav:createdOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:4CE774DD-EF4B-488F-AD09-38B151FCAC2F"/>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoclient:uuid:2F716A41-B68F-48AE-B5C1-E31F1704C565</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotationset:C8D7FDC6-6816-4BD4-BC7F-88ABDCC37D79</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:6FFFF211-BFDC-4E16-968C-A296868530C4</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotation:542E29B4-AC3B-4722-9788-3593A391793B</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
    <pav:lastSavedOn>2014-07-16 10:20:50 -0700</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:616A7F11-F942-4085-A069-8C230D26C0CF">
    <pav:createdOn>2014-07-18 13:43:30 -0700</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix>. There was a mean ± SD reduction in </ao:prefix>
    <ao:suffix> AUC of 23% ± 9% (range: -13 to -42%). Apparent oral clearance of fluconazole increased 32% ± 17% (range: 16 to 72%). Fluconazole half-life decreased from 33.4 ± 4.4 hours to 26.8 ± 3.9 hours. (See PRECAUTIONS.)</ao:suffix>
    <ao:exact>fluconazole</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-24.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:616A7F11-F942-4085-A069-8C230D26C0CF"/>
    <domeo:uuid>616A7F11-F942-4085-A069-8C230D26C0CF</domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/1AE17014-4CEE-4452-A8DB-A7AD795E46A5">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/8814</dailymed:activeMoietyRxCUI>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <rdfs:label>epoprostenol</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:4BD1F108-6B86-46B9-94ED-17733AF67E71">
    <domeo:belongsToSet>urn:domeoclient:uuid:82AC5ADA-B8CE-47A9-AA99-E7187ABEFACA</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdOn>2014-07-18 13:56:03 -0700</pav:createdOn>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoserver:annotationset:99826AC3-3668-4F74-9E9D-DADD1F7098F0</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-18 13:56:04 -0700</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lineageUri>urn:domeoserver:annotation:9A8779B8-6D9E-42E8-A5A7-43649245B924</pav:lineageUri>
    <pav:lastSavedOn>2014-07-18 16:56:04 -0400</pav:lastSavedOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:E34E3E0D-B50B-4B49-B4D0-AD4C76A51252"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:3ABC05DD-EC5F-4576-86DC-D8C25A0E287D">
    <domeo:uuid>3ABC05DD-EC5F-4576-86DC-D8C25A0E287D</domeo:uuid>
    <ao:suffix>xsd:String</ao:suffix>
    <ao:exact>In a study of healthy volunteers, sildenafil (100 mg) did not affect the steady-state pharmacokinetics of the HIV protease inhibitors saquinavir and ritonavir, both of which are CYP3A substrates</ao:exact>
    <ao:prefix>xsd:String</ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:3ABC05DD-EC5F-4576-86DC-D8C25A0E287D"/>
    <pav:createdOn>2014-07-10 11:24:33 -0700</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:F2AF7A08-3EE5-4851-BC7F-4DF99BFE382A">
    <pav:lineageUri>urn:domeoserver:annotationset:C8D7FDC6-6816-4BD4-BC7F-88ABDCC37D79</pav:lineageUri>
    <pav:lastSavedOn>2014-07-16 13:20:50 -0400</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotation:1E948006-A4C1-47EC-AA7C-157AF882BD95</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
    <domeo:belongsToSet>urn:domeoserver:annotationset:6FFFF211-BFDC-4E16-968C-A296868530C4</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoserver:annotationset:DA8D6B42-B41F-4576-BF10-1285DF3EAB80</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoserver:annotationset:AAD02A4C-E01E-4C82-BC8A-D0F4639844FA</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:3CE58974-7E1B-4366-B479-80D2CA8B6A5B"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lastSavedOn>2014-07-16 10:20:50 -0700</pav:lastSavedOn>
    <pav:createdOn>2014-07-16 10:19:26 -0700</pav:createdOn>
    <domeo:belongsToSet>urn:domeoclient:uuid:2F716A41-B68F-48AE-B5C1-E31F1704C565</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:52926929-04E3-4243-A2C3-5B9100F9FBE1">
    <ao:body rdf:nodeID="Ne57d03d49ada45caaa0b15b5b8bf770a"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:lineageUri>urn:domeoserver:annotationset:75FC1225-8399-469B-AE9D-7F697713E6AC</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:5B6A462D-57EA-4BBD-87E1-A0EC2FAF5196</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-15 17:30:45 -0400</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <ao:body rdf:nodeID="N8f897fbf9a454608b5eab177a117b9d5"/>
    <pav:lastSavedOn>2014-07-15 14:30:47 -0700</pav:lastSavedOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:040CDB6C-0256-4144-8293-65FE5BE6A8FC"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E6A1493E-98EE-4FDE-9301-752AB8E3453F</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-15 17:30:47 -0400</pav:lastSavedOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:21B0E479-04F9-4D66-B396-B773EFE53882</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:5758DAC0-E1C0-49EB-BE9C-56FFBAF3B6F4</domeo:belongsToSet>
    <pav:previousVersion>urn:domeoserver:annotationset:883587E1-49C1-4EE0-909E-4ADBAE13DD3A</pav:previousVersion>
    <ao:body rdf:nodeID="N5ce09eba37984fe9b6ab275a17e31b77"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:46636445-93A2-49F0-9E9C-5AEBF17046D2</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotation:F3B6C686-34B2-46E8-90D4-320FA8A3D4CE</pav:lineageUri>
    <pav:lastSavedOn>2014-07-15 17:30:43 -0400</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">6</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <ao:body rdf:nodeID="N8d07473393e54f2c91da3ddf7f612957"/>
    <pav:lineageUri>urn:domeoserver:annotation:5411F2EE-CB1D-493C-86F7-6235114A22C4</pav:lineageUri>
    <pav:createdOn>2014-07-15 14:23:11 -0700</pav:createdOn>
    <ao:body rdf:nodeID="N2d8480186c6e4c128872bfe67884f461"/>
    <pav:lineageUri>urn:domeoserver:annotation:D1D84F13-F18D-44EA-AB6C-75F8181BFD6C</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E8194531-C5B3-43AE-BC13-14A252C54824</domeo:belongsToSet>
    <ao:body rdf:nodeID="N8be54a2e5a6146bd9129189a355b882d"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:372E2DC2-9D30-4E6B-AD72-5B085AE1A42F">
    <pav:lineageUri>urn:domeoserver:annotation:3FD0B464-381E-48E3-8E4B-CFFB6EAA6EDF</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A7F21A3D-50B3-495E-884A-2C707B40C763</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:C51A06F1-DF50-4438-A801-D1307CBA609A"/>
    <ao:body rdf:nodeID="N03481a990efd4a81b1875ff213414888"/>
    <pav:createdOn>2014-07-18 13:49:30 -0700</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
    <pav:lastSavedOn>2014-07-18 16:49:32 -0400</pav:lastSavedOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:1AF9FCBE-D690-435E-848A-C035A391B132">
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:A1F526CA-6030-4127-9BB6-6D4E1719252E"/>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <dikbD2R:modality>ncit:negative</dikbD2R:modality>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Nfda6afe2d7f94fa2ab12a6a56a8dd407">
    <permissions:accessType>urn:domeo:access:public</permissions:accessType>
    <permissions:isLocked>false</permissions:isLocked>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N3b67ceeea10744b78901ffd0a0cad3d0">
    <permissions:accessType>urn:domeo:access:public</permissions:accessType>
    <permissions:isLocked>false</permissions:isLocked>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:F68205D1-C26C-4CDF-8BC6-B801BDEFE695">
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <dikbD2R:modality>ncit:negative</dikbD2R:modality>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:31106440-9B03-40EC-87ED-9D0BFE935266"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:F906594B-BBC1-48AF-8F3D-C4A2E2A96B54">
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:ACA9D41B-D228-4B02-A61E-CA2C8E027440"/>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <dikbD2R:modality>ncit:negative</dikbD2R:modality>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:085B00A2-6C6B-488C-9382-36A86ADDE1DE">
    <ao:prefix>xsd:String</ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-22.txt.html</ao:hasSource>
    <ao:exact>estradiol</ao:exact>
    <pav:createdOn>2014-07-16 15:32:41 -0700</pav:createdOn>
    <domeo:uuid>085B00A2-6C6B-488C-9382-36A86ADDE1DE</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:085B00A2-6C6B-488C-9382-36A86ADDE1DE"/>
    <ao:suffix> or levonorgestrel AUC after the administration of 50 mg of fluconazole. The mean increase in ethinyl estradiol AUC was 6% (range: -47 to 108%) and levonorgestrel AUC increased 17% (range: -33 to 141%).</ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Nb9d4439607b84e74a472a4f71169a8f7">
    <permissions:accessType>urn:domeo:access:public</permissions:accessType>
    <permissions:isLocked>false</permissions:isLocked>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:49A3E368-5986-471F-9A56-C7C0F8072A9E">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact> fluconazole</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid></domeo:uuid>
    <domeo:uuid>49A3E368-5986-471F-9A56-C7C0F8072A9E</domeo:uuid>
    <pav:createdOn>2014-07-16 14:03:15 -0700</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-21.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:49A3E368-5986-471F-9A56-C7C0F8072A9E"/>
    <ao:prefix>A third study evaluated the potential interaction of once weekly dosing of</ao:prefix>
    <ao:suffix> 300 mg to 21 normal females taking an oral contraceptive containing ethinyl estradiol and norethindrone. In this placebo-controlled, double-blind, randomized, two-way crossover study carried out over three cycles of oral contraceptive treatment, flucona</ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:3601F178-6758-48FF-9A7C-218ADE3838A3">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/0A391966-16D3-4D0D-ACE8-794D85C254DC"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/37773057-2593-4F89-A721-5933D9C73741"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:18EE2CB9-3D4F-42B6-A49D-245BF6C564CA">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoserver:annotationset:AAD02A4C-E01E-4C82-BC8A-D0F4639844FA</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:B09717CD-B9B4-417C-B2AA-D11A10E5FE3E"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lastSavedOn>2014-07-16 10:20:50 -0700</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoclient:uuid:2F716A41-B68F-48AE-B5C1-E31F1704C565</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotationset:C8D7FDC6-6816-4BD4-BC7F-88ABDCC37D79</pav:lineageUri>
    <pav:lastSavedOn>2014-07-16 13:20:50 -0400</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdOn>2014-07-16 10:19:09 -0700</pav:createdOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
    <domeo:belongsToSet>urn:domeoserver:annotationset:6FFFF211-BFDC-4E16-968C-A296868530C4</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoserver:annotationset:DA8D6B42-B41F-4576-BF10-1285DF3EAB80</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotation:5BB5DBEE-CB92-4FEA-B755-4B6A401F12D5</pav:lineageUri>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoserver:annotationset:B3F0B84F-756D-4724-B177-98D0D290D00D">
    <ao:item rdf:resource="urn:domeoclient:uuid:DCA6DB56-8ED4-4BF0-9368-16ACBA6F82AE"/>
    <domeo:deleted>false</domeo:deleted>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046812afe0146812ce85a0000"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:05F3AC40-8EB1-409A-9E01-317E8C07400C"/>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:item rdf:resource="urn:domeoclient:uuid:5DCE0D50-99F3-4301-8B36-DE5F9A87ECDD"/>
    <rdfs:label>Default Set</rdfs:label>
    <ao:item rdf:resource="urn:domeoclient:uuid:7EF340BC-FC51-443A-B404-48D9728F2E15"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:EB1F59F5-F04B-4836-B1C9-90E20E62B91E"/>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-21.txt.html</ao:annotatesResource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:B7CDA6B5-18B6-4EB0-A176-5FA6DF4BD169"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:C8EE5491-20E0-446F-BE4F-48D8F8CDCAB9"/>
    <pav:previousVersion>urn:domeoclient:uuid:8C39EA63-3E52-40B4-8935-6ADC75CCA74D</pav:previousVersion>
    <dct:description>The default set is created automatically by Domeo when no other set is existing.</dct:description>
    <ao:item rdf:resource="urn:domeoclient:uuid:0C9C3F3B-D652-4BC5-8BE9-2D01F09D0D62"/>
    <pav:lineageUri>urn:domeoserver:annotationset:03DD4E8D-1756-4822-B979-A160AAF90F82</pav:lineageUri>
    <ao:item rdf:resource="urn:domeoclient:uuid:A2FA427B-9D1C-4042-8796-682C2C547E30"/>
    <permissions:permissions rdf:nodeID="N56feba46f95c4035af532037d678420d"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:F77BE7E4-398E-4B73-9848-3A5055B88BD4"/>
    <pav:lastSavedOn>2014-07-16 17:07:53 -0400</pav:lastSavedOn>
    <ao:item rdf:resource="urn:domeoclient:uuid:73C19DFA-F31A-4286-BFC2-5C8757F59492"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">2</pav:versionNumber>
    <ao:item rdf:resource="urn:domeoclient:uuid:CA979FCE-441A-47D4-9797-5CC727F01663"/>
    <pav:createdOn>2014-07-16 14:03:15 -0700</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:73C19DFA-F31A-4286-BFC2-5C8757F59492">
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdfs:label>Highlight</rdfs:label>
    <ao:context rdf:resource="urn:domeoclient:uuid:3E2E0F2D-3281-4126-8A9C-921B0A849990"/>
    <domeo:belongsToSet>urn:domeoclient:uuid:8C39EA63-3E52-40B4-8935-6ADC75CCA74D</domeo:belongsToSet>
    <pav:createdOn>2014-07-16 14:03:46 -0700</pav:createdOn>
    <pav:lastSavedOn>2014-07-16 14:06:30 -0700</pav:lastSavedOn>
    <pav:lastSavedOn>2014-07-16 17:06:30 -0400</pav:lastSavedOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoserver:annotationset:B3F0B84F-756D-4724-B177-98D0D290D00D</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:C2A39432-076D-421D-8007-22690EDA5A0C</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:AD2FD8CD-1032-462E-833D-451021CE67B2</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lineageUri>urn:domeoserver:annotation:C586DBB5-BE53-48E7-ACD5-8863ACBCD5CE</pav:lineageUri>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:46A0754E-C451-439B-B685-374909D4C42D">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix>spe</ao:suffix>
    <ao:exact> ri</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:46A0754E-C451-439B-B685-374909D4C42D"/>
    <pav:createdOn>2014-07-15 14:08:20 -0700</pav:createdOn>
    <domeo:uuid></domeo:uuid>
    <ao:prefix>xsd:String</ao:prefix>
    <domeo:uuid>46A0754E-C451-439B-B685-374909D4C42D</domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:54821DEB-AB64-414E-803A-23F9B9CF1CE7">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>9-hydroxyrisperidone </ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:54821DEB-AB64-414E-803A-23F9B9CF1CE7"/>
    <pav:createdOn>2014-07-15 14:03:20 -0700</pav:createdOn>
    <ao:suffix> [see 12 CLINICAL PHARMACOLOGY]. Antagonism at receptors other than D2 and 5HT2 [see 12 CLINICAL PHARMACOLOGY] may explain some of the other effects of risperidone.</ao:suffix>
    <domeo:uuid></domeo:uuid>
    <domeo:uuid>54821DEB-AB64-414E-803A-23F9B9CF1CE7</domeo:uuid>
    <ao:prefix> and its major metabolite, </ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:EF537613-8BA0-4920-9501-06EA08F94E71">
    <ao:prefix> concentrations when co-administered with </ao:prefix>
    <pav:createdOn>2014-07-10 11:09:23 -0700</pav:createdOn>
    <ao:suffix> (50 mg) to healthy volunteers.</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:EF537613-8BA0-4920-9501-06EA08F94E71"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid></domeo:uuid>
    <ao:exact>sildenafil</ao:exact>
    <domeo:uuid>EF537613-8BA0-4920-9501-06EA08F94E71</domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:16CA4CDD-75E6-4B6B-8392-4CE5B648D48E">
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoclient:uuid:23AC741A-2236-437C-90AA-82B2E00E875C</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotationset:C00C2C3C-0648-4779-A135-09D440F1CEA8</pav:lineageUri>
    <pav:createdOn>2014-07-18 13:43:23 -0700</pav:createdOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:891ADA8B-FE3B-424C-BA58-775CE8AC2E75"/>
    <pav:lastSavedOn>2014-07-18 13:43:48 -0700</pav:lastSavedOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotation:B666D4BD-7ADB-4D5A-BE37-C764DFEEF8FF</pav:lineageUri>
    <pav:lastSavedOn>2014-07-18 16:43:48 -0400</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:FF76049E-6B2C-46A9-ACF7-CA565C8087F3</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:ACA9D41B-D228-4B02-A61E-CA2C8E027440">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/54E13418-11DC-4671-AB00-7B464BF4A389"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/30725548-E65C-4611-B944-3E83F4ECA098"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:9AEC1350-B38C-47B6-8956-CA137F414E0B">
    <ao:prefix>Race and Gender Effects: No specific pharmacokinetic study was conducted to investigate race and gender effects, but a population pharmacokinetic analysis did not identify important differences in the disposition of </ao:prefix>
    <ao:exact>risperidone</ao:exact>
    <pav:createdOn>2014-07-15 14:19:21 -0700</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:9AEC1350-B38C-47B6-8956-CA137F414E0B"/>
    <domeo:uuid></domeo:uuid>
    <domeo:uuid>9AEC1350-B38C-47B6-8956-CA137F414E0B</domeo:uuid>
    <ao:suffix> due to gender (whether corrected for body weight or not) or race.</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:E960B89C-B215-4093-9AF7-C100D8D48511">
    <pav:lineageUri>urn:domeoserver:annotationset:748BB253-1066-4977-91B2-35D8C6906790</pav:lineageUri>
    <pav:lastSavedOn>2014-07-18 16:48:39 -0400</pav:lastSavedOn>
    <pav:lastSavedOn>2014-07-18 13:48:39 -0700</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotation:2DE8D74E-3C23-4CA5-A943-AE0CFBBC3C8C</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoclient:uuid:53775C4C-7CC4-46EB-9EFC-EDF9D3D264ED</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:45DF7FF1-EC0B-4049-BA97-01C05E9D3DFE"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A7F21A3D-50B3-495E-884A-2C707B40C763</domeo:belongsToSet>
    <pav:createdOn>2014-07-18 13:48:28 -0700</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <rdfs:label>Highlight</rdfs:label>
    <pav:previousVersion>xsd:String</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/F284651A-2CF1-43FE-A8FB-93C6E543AD6F">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <rdfs:label>risperidone</rdfs:label>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/35636</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:0C8A7DFF-59B1-4852-B9E4-A60D88CD3918">
    <ao:prefix>. There was a mean ± SD increase in </ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:0C8A7DFF-59B1-4852-B9E4-A60D88CD3918"/>
    <pav:createdOn>2014-07-18 14:07:20 -0700</pav:createdOn>
    <domeo:uuid>0C8A7DFF-59B1-4852-B9E4-A60D88CD3918</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>tolbutamide</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix> AUC of 26% ± 9% (range: 12 to 39%). Tolbutamide Cmax increased 11% ± 9% (range: -6 to 27%). (See PRECAUTIONS.)</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-29.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:5A49ECAF-CE5A-41FF-B8D4-43B060247DBA">
    <pav:lastSavedOn>2014-07-17 18:59:36 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotationset:B716A719-3E66-4B72-87E0-370D90F3B8F7</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lastSavedOn>2014-07-17 15:59:35 -0700</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoclient:uuid:83B2E87D-3732-4699-AA3D-363A6EB95959</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:82C41618-75F7-4A21-9E13-4028DB75BB70"/>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
    <pav:createdOn>2014-07-17 15:59:32 -0700</pav:createdOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotation:A1152E00-5E28-4934-9DBF-0E5D7B6A8851</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:8DEBE5AF-B171-4BE8-880B-76A2BEE742A6</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:D1D92634-CB40-4585-8260-1917D2119CC7">
    <domeo:belongsToSet>urn:domeoserver:annotationset:5758DAC0-E1C0-49EB-BE9C-56FFBAF3B6F4</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:570DA392-7779-456C-9C18-1FC0E579BBE6</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotation:BDE3993E-FDBA-44D3-A11C-2C41CA0A930F</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E6A1493E-98EE-4FDE-9301-752AB8E3453F</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:977E8B6B-E0A2-4EB3-998A-A0DCF25EB2D6"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:2E5CE73B-BFD4-4E35-9A07-D5E37A9E87AE</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-15 14:07:58 -0700</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9C0B4E8B-9FFE-4E47-9B4C-A6EA4527A384</domeo:belongsToSet>
    <pav:createdOn>2014-07-15 14:06:52 -0700</pav:createdOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:1575950D-32D4-46DE-A44F-8E9E614F997F</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoserver:annotationset:FA8D1DAC-C616-456C-BB3D-29F18DED21A1</domeo:belongsToSet>
    <pav:previousVersion>urn:domeoclient:uuid:9B307D8B-D2B0-4795-8850-FAAAAC6B5AF4</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
    <domeo:belongsToSet>urn:domeoserver:annotationset:5B6A462D-57EA-4BBD-87E1-A0EC2FAF5196</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E8194531-C5B3-43AE-BC13-14A252C54824</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotation:9F500D6C-7337-43BA-80DA-664FBBAD168E</pav:lineageUri>
    <pav:lastSavedOn>2014-07-15 17:07:58 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:883587E1-49C1-4EE0-909E-4ADBAE13DD3A</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">2</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotationset:75FC1225-8399-469B-AE9D-7F697713E6AC</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:46636445-93A2-49F0-9E9C-5AEBF17046D2</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-15 17:07:57 -0400</pav:lastSavedOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:21B0E479-04F9-4D66-B396-B773EFE53882</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/7FC5C56B-C663-4285-8BB1-9294F364E6DE">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <rdfs:label>warfarin</rdfs:label>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/11289</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:5E5C736D-1CA1-4B67-82D7-01FF596E3F63">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:5E5C736D-1CA1-4B67-82D7-01FF596E3F63"/>
    <ao:prefix> 200 mg daily for 14 days in eight renal transplant patients who had been on </ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-26.txt.html</ao:hasSource>
    <pav:createdOn>2014-07-18 13:51:22 -0700</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid>5E5C736D-1CA1-4B67-82D7-01FF596E3F63</domeo:uuid>
    <ao:suffix> therapy for at least 6 months and on a stable cyclosporine dose for at least 6 weeks. There was a significant increase in cyclosporine AUC, Cmax, Cmin (24-hour concentration), and a significant reduction in apparent oral clearance following the administ</ao:suffix>
    <ao:exact>cyclosporine</ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:4E5794FD-667C-4031-AE7A-DDDC905400BE">
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:27F79494-9F47-4316-BFC1-FA15F20D67F3"/>
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:DE86A623-45C7-446E-BC44-389610395DA9">
    <ao:suffix> 50 mg once daily for 10 days in 10 healthy women. There was no significant difference in ethinyl estradiol or levonorgestrel AUC after the administration of 50 mg of fluconazole. The mean increase in ethinyl estradiol AUC was 6% (range: -47 to 108%) and</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-22.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:DE86A623-45C7-446E-BC44-389610395DA9"/>
    <domeo:uuid>DE86A623-45C7-446E-BC44-389610395DA9</domeo:uuid>
    <pav:createdOn>2014-07-16 15:32:30 -0700</pav:createdOn>
    <ao:prefix>Oral contraceptives were administered as a single dose both before and after the oral administration of </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>fluconazole</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:14EF1296-9281-4C53-B309-5C368E7DBD5D">
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-21.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:14EF1296-9281-4C53-B309-5C368E7DBD5D"/>
    <ao:prefix> flucon</ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2014-07-16 14:03:38 -0700</pav:createdOn>
    <ao:exact>azol</ao:exact>
    <ao:suffix>e dosing resulted in small increases in the mean AUCs of ethinyl estradiol and norethindrone compared to similar placebo dosing. The mean AUCs of ethinyl estradiol and norethindrone increased by 24% (95% C.I. range 18 to 31%) and 13% (95% C.I. range 8 to</ao:suffix>
    <domeo:uuid>14EF1296-9281-4C53-B309-5C368E7DBD5D</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid></domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:31106440-9B03-40EC-87ED-9D0BFE935266">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/4AF09D72-39A6-4BC4-A512-26DBDD3392E4"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/78CA8426-F17B-4F98-AB2F-F77F74181051"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:346C4DA6-A4F5-4B6F-AADB-4E76B1FDE36F">
    <dct:description>The default set is created automatically by Domeo when no other set is existing.</dct:description>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046812afe0146812ce85a0000"/>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-29.txt.html</ao:annotatesResource>
    <ao:item rdf:resource="urn:domeoclient:uuid:547CD07E-3BE0-408B-82B7-99021E41003B"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:8C676DD4-0D35-4578-AF3F-F66853FF712A"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:9E954CE3-F61D-4171-A4FE-6FAE429FF615"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:deleted>false</domeo:deleted>
    <pav:lineageUri>urn:domeoserver:annotationset:B136901C-38A0-4F12-B35D-BF814374DB34</pav:lineageUri>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <pav:createdOn>2014-07-18 14:07:10 -0700</pav:createdOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
    <pav:lastSavedOn>2014-07-18 17:07:26 -0400</pav:lastSavedOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <permissions:permissions rdf:nodeID="Na70e812eeb254f70b51f7b7971a53f64"/>
    <rdfs:label>Default Set</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <ao:item rdf:resource="urn:domeoclient:uuid:1B6D54E8-D781-4B59-A1BC-6120E5CF9015"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:03498850-C0AC-4682-B3F3-91FD27180D38">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:03498850-C0AC-4682-B3F3-91FD27180D38"/>
    <ao:prefix> was 3 hours (CV=30%) in extensive metabolizers and 20 hours (CV=40%) in poor metabolizers. The apparent half-life of </ao:prefix>
    <pav:createdOn>2014-07-15 14:17:20 -0700</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <domeo:uuid></domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix> was about 21 hours (CV=20%) in extensive metabolizers and 30 hours (CV=25%) in poor metabolizers. The pharmacokinetics of risperidone and 9-hydroxyrisperidone combined, after single and multiple doses, were similar in extensive and poor metabolizers, wi</ao:suffix>
    <domeo:uuid>03498850-C0AC-4682-B3F3-91FD27180D38</domeo:uuid>
    <ao:exact>9-hydroxyrisperidone</ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:C7811B96-6935-4053-BDA0-233B88584EB2">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:C7811B96-6935-4053-BDA0-233B88584EB2"/>
    <ao:suffix> AUC of 13% ± 11% (range: -3.4 to -31%) and Cmax decreased 19% ± 14% (range: -5 to -40%). However, the administration of cimetidine 600 mg to 900 mg intravenously over a four-hour period (from one hour before to 3 hours after a single oral dose of flucon</ao:suffix>
    <ao:prefix>fluconazole AUC and Cmax. There was a mean ± SD decrease in </ao:prefix>
    <domeo:uuid>C7811B96-6935-4053-BDA0-233B88584EB2</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2014-07-17 15:54:08 -0700</pav:createdOn>
    <ao:exact>fluconazole</ao:exact>
    <ao:hasSource>				http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-23.txt.html																													</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:9A899E70-DA16-4FA1-A716-CEF8414FF84E">
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:03C138A3-3A62-41DC-8535-D728778DDD42"/>
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <dikbD2R:modality>ncit:negative</dikbD2R:modality>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:E2360225-A46C-436D-A3D6-1502801E2F92">
    <pav:lastSavedOn>2014-07-18 17:26:00 -0400</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdOn>2014-07-18 14:25:59 -0700</pav:createdOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A1747CFE-8798-401D-BFC7-1E14B7B3B1B1</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
    <ao:context rdf:resource="urn:domeoclient:uuid:9C850E9D-0903-4A7D-8362-E39D7560ABB0"/>
    <pav:lineageUri>urn:domeoserver:annotation:AA735FDF-88DE-41B1-8E77-5DAA5722B10D</pav:lineageUri>
    <ao:body rdf:nodeID="N5dcde12194d54b40bca8e29a1aaf1884"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:A0073BE0-0C00-42AF-8C67-EADDD1F4519E">
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:0B393FF7-1BB4-4312-85CF-8C8D73B22BB7"/>
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:D2174191-CE1D-4EF2-8DD5-03008A9706DE">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">2</pav:versionNumber>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotation:86B6B89D-6E09-4CA5-9D77-FED261088518</pav:lineageUri>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lastSavedOn>2014-07-15 17:07:57 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:570DA392-7779-456C-9C18-1FC0E579BBE6</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E6A1493E-98EE-4FDE-9301-752AB8E3453F</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:21B0E479-04F9-4D66-B396-B773EFE53882</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:FA8D1DAC-C616-456C-BB3D-29F18DED21A1</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:883587E1-49C1-4EE0-909E-4ADBAE13DD3A</domeo:belongsToSet>
    <pav:previousVersion>urn:domeoclient:uuid:9B307D8B-D2B0-4795-8850-FAAAAC6B5AF4</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:5B6A462D-57EA-4BBD-87E1-A0EC2FAF5196</domeo:belongsToSet>
    <pav:createdOn>2014-07-15 14:07:02 -0700</pav:createdOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:7A1CC34D-A3D8-43C2-AC0E-2F3EF96927DD"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:5758DAC0-E1C0-49EB-BE9C-56FFBAF3B6F4</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9C0B4E8B-9FFE-4E47-9B4C-A6EA4527A384</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotationset:75FC1225-8399-469B-AE9D-7F697713E6AC</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E8194531-C5B3-43AE-BC13-14A252C54824</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-15 14:07:58 -0700</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:46636445-93A2-49F0-9E9C-5AEBF17046D2</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:2E5CE73B-BFD4-4E35-9A07-D5E37A9E87AE</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lastSavedOn>2014-07-15 17:07:58 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotation:86B1E288-D3ED-4F7D-B660-44998AC4BA9D</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:1575950D-32D4-46DE-A44F-8E9E614F997F</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/D3C6A443-5788-4C8E-B4F0-D1A386132459">
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/2002</dailymed:activeMoietyRxCUI>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <rdfs:label>carbamazepine</rdfs:label>
    <dct:description>Referred to the drug in the interaction.</dct:description>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N6ea4e6cc350240bc92037029a44e43e1">
    <permissions:isLocked>false</permissions:isLocked>
    <permissions:accessType>urn:domeo:access:public</permissions:accessType>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/F0D97621-1E50-45F0-BAA1-F81268B95E28">
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/4450</dailymed:activeMoietyRxCUI>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <rdfs:label>fluconazole</rdfs:label>
    <dct:description>Referred to the drug in the interaction.</dct:description>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:D4C5E020-24D9-465B-97AB-8A4E6685160F">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid>D4C5E020-24D9-465B-97AB-8A4E6685160F</domeo:uuid>
    <pav:createdOn>2014-07-16 10:19:46 -0700</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:D4C5E020-24D9-465B-97AB-8A4E6685160F"/>
    <ao:exact>risperidone</ao:exact>
    <domeo:uuid></domeo:uuid>
    <ao:prefix> is 70% (CV=25%). The relative oral bioavailability of </ao:prefix>
    <ao:suffix> from a tablet is 94% (CV=10%) when compared to a solution.</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:1EC63B9B-4ECA-4533-97EA-FF3CFF05DB75">
    <ao:exact>Risperidone</ao:exact>
    <domeo:uuid></domeo:uuid>
    <ao:suffix> is a selective monoaminergic antagonist with high affinity (Ki of 0.12 to 7.3 nM) for the serotonin Type 2 (5HT2), dopamine Type 2 (D2), α1 and α2 adrenergic, and H1 histaminergic receptors. Risperidone acts as an antagonist at other receptors, but with</ao:suffix>
    <ao:prefix>xsd:String</ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:1EC63B9B-4ECA-4533-97EA-FF3CFF05DB75"/>
    <domeo:uuid>1EC63B9B-4ECA-4533-97EA-FF3CFF05DB75</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <pav:createdOn>2014-07-16 10:18:44 -0700</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:D65EE4FB-C2D2-4BA1-977B-5D3CB6873FE9">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>sulfamethazine</ao:exact>
    <pav:createdOn>2014-07-15 14:09:01 -0700</pav:createdOn>
    <ao:suffix> (100 mcg/mL), warfarin (10 mcg/mL), and carbamazepine (10 mcg/mL) caused only a slight increase in the free fraction of risperidone at 10 ng/mL and 9-hydroxyrisperidone at 50 ng/mL, changes of unknown clinical significance.</ao:suffix>
    <domeo:uuid>D65EE4FB-C2D2-4BA1-977B-5D3CB6873FE9</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:D65EE4FB-C2D2-4BA1-977B-5D3CB6873FE9"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <domeo:uuid></domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix> displaces each other from plasma binding sites. High therapeutic concentrations of </ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:3363C787-8AF1-4899-903A-F4812DD65C36">
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:D2E85468-7CF7-4CD4-BDCA-9028642087EE"/>
    <dikbD2R:modality>ncit:negative</dikbD2R:modality>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:34E48324-D870-4398-B241-2FAE6690C98C">
    <ao:exact>fluconazole</ao:exact>
    <ao:suffix> 200 mg daily for 15 days) in 13 volunteers with AIDS or ARC who were on a stable zidovudine dose for at least two weeks. There was a significant increase in zidovudine AUC following the administration of fluconazole. The mean ± SD increase in AUC was 20</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid></domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix> concentrations were determined on two occasions (before and following </ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:34E48324-D870-4398-B241-2FAE6690C98C"/>
    <pav:createdOn>2014-07-18 13:55:37 -0700</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-27.txt.html</ao:hasSource>
    <domeo:uuid>34E48324-D870-4398-B241-2FAE6690C98C</domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:D2E85468-7CF7-4CD4-BDCA-9028642087EE">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/D2018278-5A34-478E-8004-540890604BD3"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/B54D2CA7-6597-43FB-AC52-34E959AFBD56"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:BF8175E8-F52D-4CE3-9DE9-BAE3E2CE04A1">
    <domeo:belongsToSet>urn:domeoserver:annotationset:5758DAC0-E1C0-49EB-BE9C-56FFBAF3B6F4</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
    <domeo:belongsToSet>urn:domeoserver:annotationset:46636445-93A2-49F0-9E9C-5AEBF17046D2</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E8194531-C5B3-43AE-BC13-14A252C54824</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9C0B4E8B-9FFE-4E47-9B4C-A6EA4527A384</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:883587E1-49C1-4EE0-909E-4ADBAE13DD3A</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:47D397AD-5153-40DA-83B8-C0A45725E6BC"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:5B6A462D-57EA-4BBD-87E1-A0EC2FAF5196</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:570DA392-7779-456C-9C18-1FC0E579BBE6</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E6A1493E-98EE-4FDE-9301-752AB8E3453F</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lastSavedOn>2014-07-15 14:11:14 -0700</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotation:8BB0959D-8DED-4C4F-8D65-ACFF43731ED4</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:2E5CE73B-BFD4-4E35-9A07-D5E37A9E87AE</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:21B0E479-04F9-4D66-B396-B773EFE53882</domeo:belongsToSet>
    <pav:createdOn>2014-07-15 14:10:02 -0700</pav:createdOn>
    <pav:lastSavedOn>2014-07-15 17:11:14 -0400</pav:lastSavedOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/E0D97E91-2E7D-4932-BF6E-D14381A9B58A">
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/4450</dailymed:activeMoietyRxCUI>
    <rdfs:label>Fluconazole</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:61EFE295-187A-4B36-B127-C54D8E2D8B4D">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-24.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:61EFE295-187A-4B36-B127-C54D8E2D8B4D"/>
    <ao:suffix> half-life decreased from 33.4 ± 4.4 hours to 26.8 ± 3.9 hours. (See PRECAUTIONS.)</ao:suffix>
    <ao:exact>Fluconazole</ao:exact>
    <ao:prefix> increased 32% ± 17% (range: 16 to 72%). </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2014-07-18 13:43:41 -0700</pav:createdOn>
    <domeo:uuid>61EFE295-187A-4B36-B127-C54D8E2D8B4D</domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:9D63988E-3AF5-4F4F-84C5-3B867069EBD1">
    <pav:createdOn>2014-07-09 13:56:32 -0700</pav:createdOn>
    <ao:exact>In a placebo-controlled trial in normal volunteers, the administration of two doses of sertraline did not significantly alter steady-state lithium levels or the renal clearance of lithium</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:9D63988E-3AF5-4F4F-84C5-3B867069EBD1"/>
    <ao:suffix>xsd:String</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-13.txt.html</ao:hasSource>
    <domeo:uuid>9D63988E-3AF5-4F4F-84C5-3B867069EBD1</domeo:uuid>
    <ao:prefix>xsd:String</ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:D74FA7C5-5531-44B7-99F1-8D9CCAA862A7">
    <dikbD2R:modality>ncit:negative</dikbD2R:modality>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:25F38526-D98C-49CE-873D-4D75248FDE0A"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/30725548-E65C-4611-B944-3E83F4ECA098">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/2541</dailymed:activeMoietyRxCUI>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <rdfs:label>cimetidine</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:E8921F3A-7792-4582-AEB4-1956E549C6E3">
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <ao:suffix> plus 9-hydroxyrisperidone.</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>E8921F3A-7792-4582-AEB4-1956E549C6E3</domeo:uuid>
    <ao:prefix>. Consequently, the clinical effect of the drug results from the combined concentrations of </ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:E8921F3A-7792-4582-AEB4-1956E549C6E3"/>
    <ao:exact>risperidone</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid></domeo:uuid>
    <pav:createdOn>2014-07-15 14:13:56 -0700</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/2440B2BA-E703-439E-9D9D-F871F0C7006D">
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/4450</dailymed:activeMoietyRxCUI>
    <rdfs:label>Fluconazole</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/1C45B97D-FA8F-4C81-903B-A6CBE6A57B86">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <rdfs:label>risperidone</rdfs:label>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/35636</dailymed:activeMoietyRxCUI>
    <dct:description>Referred to the drug in the interaction.</dct:description>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Ncf79e18c69d24ad8bc14d6fc7e168b89">
    <permissions:accessType>urn:domeo:access:public</permissions:accessType>
    <permissions:isLocked>false</permissions:isLocked>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:D779518E-9AC6-475E-AE81-120556E044A3">
    <domeo:uuid>D779518E-9AC6-475E-AE81-120556E044A3</domeo:uuid>
    <ao:prefix>xsd:String</ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:hasSource>
    <pav:createdOn>2014-07-10 11:22:24 -0700</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:D779518E-9AC6-475E-AE81-120556E044A3"/>
    <ao:suffix>. The effect of</ao:suffix>
    <ao:exact>The mean reduction of sildenafil (80 mg tid) bioavailability due to co-administration of epoprostenol was 28%, resulting in about 22% lower mean average steady state concentrations. Therefore, the slight decrease of sildenafil exposure in the presence of epoprostenol is not considered clinically relevant</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:632CBF5A-9363-46AA-BF07-49466689FFD1">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/D2D77AB7-3C46-4DFC-B865-AE7E85601849"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/53C53ABF-54FF-48FB-8A92-C02082DDB82F"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:702BE5BD-B486-4EEB-9B0C-8C790AAA768A">
    <pav:previousVersion>urn:domeoserver:annotationset:2BFC2FB6-6BE9-4822-A245-973533533023</pav:previousVersion>
    <pav:lastSavedOn>2014-07-10 14:21:41 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:516C333C-B517-4F84-999E-51185DD6E859</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-10 11:21:41 -0700</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">6</pav:versionNumber>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:15A537D1-5648-41B2-8BFA-0D0BA3DF4393</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotation:44EDDF8F-02D2-4741-8C40-0965C9BF0659</pav:lineageUri>
    <pav:createdOn>2014-07-10 11:19:20 -0700</pav:createdOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:239B4C6D-1110-4B65-AC66-F8A394187814</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:7A239FA7-0EC5-40B4-BB98-C16757BB8044"/>
    <pav:lineageUri>urn:domeoserver:annotationset:BE290CA3-79BD-411A-BE2E-69AA4D19607D</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:970963DF-8BCE-4936-9DFC-328A36014E1B</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/E2C33A26-EBDB-4674-BEC1-C76A9750E5F7">
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/136411</dailymed:activeMoietyRxCUI>
    <rdfs:label>sildenafil</rdfs:label>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:3A31AA07-7919-4161-9DEB-01C06D730BF5">
    <ao:prefix>, a CYP3A inhibitor, at steady state (500 mg BID for 5 days), there was a 182% increase in </ao:prefix>
    <ao:suffix> systemic exposure (AUC).</ao:suffix>
    <domeo:uuid>3A31AA07-7919-4161-9DEB-01C06D730BF5</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:3A31AA07-7919-4161-9DEB-01C06D730BF5"/>
    <pav:createdOn>2014-07-10 11:10:53 -0700</pav:createdOn>
    <ao:exact>sildenafil</ao:exact>
    <domeo:uuid></domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:146409FD-1622-4B3D-BC72-24835C4FD699">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/6B86F899-B737-4700-BD45-A7A2D76ED9A5"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/175C780B-E011-4DC0-94B4-BBEC5EDDC82A"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:7A59961D-051E-4238-8A44-2BD5D13E656F">
    <pav:createdOn>2014-07-18 13:51:33 -0700</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:7A59961D-051E-4238-8A44-2BD5D13E656F"/>
    <domeo:uuid>7A59961D-051E-4238-8A44-2BD5D13E656F</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-26.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix> AUC, Cmax, Cmin (24-hour concentration), and a significant reduction in apparent oral clearance following the administration of fluconazole. The mean ± SD increase in AUC was 92% ± 43% (range: 18 to 147%). The Cmax increased 60% ± 48% (range: -5 to 133%</ao:suffix>
    <ao:exact>cyclosporine</ao:exact>
    <ao:prefix> dose for at least 6 weeks. There was a significant increase in </ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:8B8B88D4-5E42-47CB-9E37-EED59C74FD96">
    <ao:item rdf:resource="urn:domeoclient:uuid:1FD70F7A-986E-48F8-93F4-DA3377C3E107"/>
    <permissions:permissions rdf:nodeID="N6ea4e6cc350240bc92037029a44e43e1"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:52C23FEF-CB29-459B-934E-EDA40F63DD1E"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotationset:2C25A7F3-8A42-4060-A64C-5C2AB24D4675</pav:lineageUri>
    <domeo:deleted>false</domeo:deleted>
    <dct:description>The default set is created automatically by Domeo when no other set is existing.</dct:description>
    <pav:createdOn>2014-07-09 13:36:31 -0700</pav:createdOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:05BFE4D9-CD9B-4F44-B4A5-28A1E4F90000"/>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-13.txt.html</ao:annotatesResource>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
    <pav:lastSavedOn>2014-07-09 16:39:37 -0400</pav:lastSavedOn>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046812afe0146812ce85a0000"/>
    <rdfs:label>Default Set</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:A156EC26-7CF9-490B-8F02-67A6FCC98E56">
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix> may cause a decrease in the combined plasma concentrations of risperidone and 9-hydroxyrisperidone [see 7 DRUG INTERACTIONS]. It would also be possible for risperidone to interfere with metabolism of other drugs metabolized by CYP 2D6. Relatively weak b</ao:suffix>
    <domeo:uuid></domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:A156EC26-7CF9-490B-8F02-67A6FCC98E56"/>
    <ao:exact>risperidone</ao:exact>
    <ao:prefix>) with </ao:prefix>
    <domeo:uuid>A156EC26-7CF9-490B-8F02-67A6FCC98E56</domeo:uuid>
    <pav:createdOn>2014-07-15 14:16:29 -0700</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:02EFD3A2-6206-483D-8A82-D5AB320CD4B0">
    <domeo:uuid>02EFD3A2-6206-483D-8A82-D5AB320CD4B0</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact> fluconaz</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix>ole dosing resulted in small increases in the mean AUCs of ethinyl estradiol and norethindrone compared to similar placebo dosing. The mean AUCs of ethinyl estradiol and norethindrone increased by 24% (95% C.I. range 18 to 31%) and 13% (95% C.I. range 8 </ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-21.txt.html</ao:hasSource>
    <domeo:uuid></domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:02EFD3A2-6206-483D-8A82-D5AB320CD4B0"/>
    <ao:prefix>. In this placebo-controlled, double-blind, randomized, two-way crossover study carried out over three cycles of oral contraceptive treatment,</ao:prefix>
    <pav:createdOn>2014-07-16 14:03:34 -0700</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:E4FC0A1A-8003-4267-9EC8-5C1F467D2F5F">
    <domeo:uuid>E4FC0A1A-8003-4267-9EC8-5C1F467D2F5F</domeo:uuid>
    <ao:exact>lithium</ao:exact>
    <pav:createdOn>2014-07-09 13:36:40 -0700</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:E4FC0A1A-8003-4267-9EC8-5C1F467D2F5F"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-13.txt.html</ao:hasSource>
    <ao:suffix>.</ao:suffix>
    <ao:prefix> levels or the renal clearance of </ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:A4632682-84C0-4DFD-915D-D1C3B235F095">
    <domeo:belongsToSet>urn:domeoserver:annotationset:5758DAC0-E1C0-49EB-BE9C-56FFBAF3B6F4</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lineageUri>urn:domeoserver:annotation:FF07EEB2-0B2B-4173-92EE-8542A47C29B8</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:46636445-93A2-49F0-9E9C-5AEBF17046D2</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:883587E1-49C1-4EE0-909E-4ADBAE13DD3A</domeo:belongsToSet>
    <pav:previousVersion>urn:domeoserver:annotationset:2E5CE73B-BFD4-4E35-9A07-D5E37A9E87AE</pav:previousVersion>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">4</pav:versionNumber>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:5B6A462D-57EA-4BBD-87E1-A0EC2FAF5196</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdOn>2014-07-15 14:16:07 -0700</pav:createdOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9C0B4E8B-9FFE-4E47-9B4C-A6EA4527A384</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-15 14:17:25 -0700</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E8194531-C5B3-43AE-BC13-14A252C54824</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotationset:75FC1225-8399-469B-AE9D-7F697713E6AC</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lastSavedOn>2014-07-15 17:17:26 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E6A1493E-98EE-4FDE-9301-752AB8E3453F</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:026A9D62-B81B-44DD-A18F-6776E5D0E1A2"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
    <domeo:belongsToSet>urn:domeoserver:annotationset:21B0E479-04F9-4D66-B396-B773EFE53882</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:570DA392-7779-456C-9C18-1FC0E579BBE6</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/C47A2842-C13E-4BAB-8DB6-578609EBC0CA">
    <rdfs:label>carbamazepine</rdfs:label>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/2002</dailymed:activeMoietyRxCUI>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:DC11109C-477E-45E9-8790-252CE45CAC57">
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
    <dikbD2R:modality>ncit:negative</dikbD2R:modality>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:1D349D03-1383-435E-97D6-A0B3DDED281A"/>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:F11CBAD8-E220-415C-81B8-EC30E7A34762">
    <ao:suffix>xsd:String</ao:suffix>
    <ao:exact>study evaluated the potential interaction of once weekly dosing of fluconazole 300 mg to 21 normal females taking an oral contraceptive containing ethinyl estradiol and norethindrone. In this placebo-controlled, double-blind, randomized, two-way crossover study carried out over three cycles of oral contraceptive treatment, fluconazole dosing resulted in small increases in the mean AUCs of ethinyl estradiol and norethindrone compared to similar placebo dosing. The mean AUCs of ethinyl estradiol and norethindrone increased by 24% (95% C.I. range 18 to 31%) and 13% (95% C.I. range 8 to 18%), respectively relative to placebo. Fluconazole treatment did not cause a decrease in the ethinyl estradiol AUC of any individual subject in this study compared to placebo dosing. The individual AUC values of norethindrone decreased very slightly (&lt;5%) in 3 of the 21 subjects after fluconazole treatment</ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:F11CBAD8-E220-415C-81B8-EC30E7A34762"/>
    <pav:createdOn>2014-07-16 14:10:22 -0700</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-21.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix>xsd:String</ao:prefix>
    <domeo:uuid>F11CBAD8-E220-415C-81B8-EC30E7A34762</domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/1FBE5AF2-2CAB-4F7D-8ACF-A30A014D69AF">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/</dailymed:activeMoietyRxCUI>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <rdfs:label>sulfamethazine</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:A7527009-01DC-4E9A-8438-D89D172BDEAA">
    <domeo:uuid>A7527009-01DC-4E9A-8438-D89D172BDEAA</domeo:uuid>
    <pav:createdOn>2014-07-18 14:02:36 -0700</pav:createdOn>
    <ao:exact>theophylline</ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:A7527009-01DC-4E9A-8438-D89D172BDEAA"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix>The pharmacokinetics of </ao:prefix>
    <ao:suffix> were determined from a single intravenous dose of aminophylline (6 mg/kg) before and after the oral administration of fluconazole 200 mg daily for 14 days in 16 normal male volunteers. There were significant increases in theophylline AUC, Cmax, and half</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-28.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:F7635891-9395-4AA7-B1C6-22B3D89F0719">
    <ao:prefix> </ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:F7635891-9395-4AA7-B1C6-22B3D89F0719"/>
    <ao:hasSource>				http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-23.txt.html																													</ao:hasSource>
    <domeo:uuid>F7635891-9395-4AA7-B1C6-22B3D89F0719</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>fluconazole</ao:exact>
    <pav:createdOn>2014-07-17 15:54:34 -0700</pav:createdOn>
    <ao:suffix> 200 mg) did not affect the bioavailability or pharmacokinetics of fluconazole in 24 healthy male volunteers</ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:A5A2521E-A463-45F1-BFC8-4843561F5EFD">
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
    <ao:context rdf:resource="urn:domeoclient:uuid:AB6A5C23-94A9-4771-82D0-E81F57F7430F"/>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lastSavedOn>2014-07-18 17:03:19 -0400</pav:lastSavedOn>
    <pav:createdOn>2014-07-18 14:03:17 -0700</pav:createdOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:6DBCB873-26F3-4E6A-9BD4-311369B43736</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-18 14:03:19 -0700</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lineageUri>urn:domeoserver:annotationset:9AA0507C-281E-45C8-9719-03E66F12C069</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoclient:uuid:E65FF29A-8FE7-4D0E-A93C-4DA8136F4956</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotation:84B0273D-F281-4089-A27F-A60E460B39CA</pav:lineageUri>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:2BE39456-0995-441E-9B43-639B42929C06">
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:F1D1B89D-DB23-4CCB-9037-CD647F4B2A5F"/>
    <dikbD2R:modality>ncit:negative</dikbD2R:modality>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:05FDCD78-BAF2-46D7-9D0F-0636684A6834">
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdOn>2014-07-18 13:51:33 -0700</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotation:D46DAB63-DFCF-4B24-9A25-769A3C80AF51</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoclient:uuid:B8452517-26D0-419F-88FD-A818925FDE06</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lastSavedOn>2014-07-18 16:51:47 -0400</pav:lastSavedOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:7A59961D-051E-4238-8A44-2BD5D13E656F"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/09FCD917-E332-4552-87D1-A1B73168DBA1">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <rdfs:label>sulfamethazine</rdfs:label>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/</dailymed:activeMoietyRxCUI>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <dct:description>Referred to the drug in the interaction.</dct:description>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Ncdc9507dadc748aebfb4babe734b11c0">
    <permissions:isLocked>false</permissions:isLocked>
    <permissions:accessType>urn:domeo:access:public</permissions:accessType>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:DB99EE39-D6AF-4C66-A7BF-D1186DCE23D6">
    <domeo:uuid>DB99EE39-D6AF-4C66-A7BF-D1186DCE23D6</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix> AUC and a significant increase in apparent oral clearance of fluconazole. There was a mean ± SD reduction in fluconazole AUC of 23% ± 9% (range: -13 to -42%). Apparent oral clearance of fluconazole increased 32% ± 17% (range: 16 to 72%). Fluconazole hal</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:DB99EE39-D6AF-4C66-A7BF-D1186DCE23D6"/>
    <ao:prefix> administered as 600 mg daily in eight healthy male volunteers resulted in a significant decrease in</ao:prefix>
    <pav:createdOn>2014-07-17 15:59:07 -0700</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>			http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-24.txt.html</ao:hasSource>
    <ao:exact> fluconazole</ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:21EAE98A-5FE8-4364-AD53-F77A42DFEE51">
    <domeo:uuid></domeo:uuid>
    <ao:prefix>ris</ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:21EAE98A-5FE8-4364-AD53-F77A42DFEE51"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>21EAE98A-5FE8-4364-AD53-F77A42DFEE51</domeo:uuid>
    <pav:createdOn>2014-07-15 14:04:04 -0700</pav:createdOn>
    <ao:suffix>eridon</ao:suffix>
    <ao:exact>p</ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:2F4ED2A9-99ED-44E0-8D7A-82BB231F6DBB">
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:AE0CC832-EE7D-4E19-8731-01D46C24AA3D"/>
    <dikbD2R:modality>ncit:negative</dikbD2R:modality>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:A420EA3F-BB84-4220-A684-2224CB4B6C3D">
    <ao:prefix> (500 mg single dose) AUC and Cmax following the administration of </ao:prefix>
    <ao:suffix>. There was a mean ± SD increase in tolbutamide AUC of 26% ± 9% (range: 12 to 39%). Tolbutamide Cmax increased 11% ± 9% (range: -6 to 27%). (See PRECAUTIONS.)</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:A420EA3F-BB84-4220-A684-2224CB4B6C3D"/>
    <domeo:uuid>A420EA3F-BB84-4220-A684-2224CB4B6C3D</domeo:uuid>
    <pav:createdOn>2014-07-18 14:07:15 -0700</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-29.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>fluconazole</ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:65B1AF5D-CC49-4B9F-BACA-07320E9834D7">
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:49FCC0DB-01A0-4D81-BC7E-4E5BA9BCB5A0"/>
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:887773A9-6D1A-46C3-A7F4-E2255F7FBE67">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <ao:body rdf:nodeID="Ne3f71507c6784f1b9c4c02bffffdf912"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:createdOn>2014-07-16 15:44:20 -0700</pav:createdOn>
    <pav:lastSavedOn>2014-07-16 18:46:13 -0400</pav:lastSavedOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:F057A8DE-7885-47B0-B2D9-E9C3D877EC02"/>
    <pav:lineageUri>urn:domeoserver:annotation:8D624D14-9F33-4059-A979-A132EC3D7292</pav:lineageUri>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E3DA2E5E-FC19-4C22-AF6C-A9CB4B450554</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:5153D183-17EE-480B-9FF3-A9FB70E3CB26">
    <domeo:belongsToSet>urn:domeoclient:uuid:5C7A7116-C174-4EB1-933E-3A46CEE71709</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lastSavedOn>2014-07-16 15:33:06 -0700</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdOn>2014-07-16 15:32:56 -0700</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:9C730C18-D51E-4ABD-B037-60F8C4579F49"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:0F87EEF0-40A6-43E2-8222-95E7D1335A0B</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lastSavedOn>2014-07-16 18:33:07 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotationset:7AE68AC7-9B47-4954-8C65-45A6F0DC80C2</pav:lineageUri>
    <pav:lineageUri>urn:domeoserver:annotation:4DCDA997-4726-4891-89D6-32BFA5EA6CCA</pav:lineageUri>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:A216BADD-014F-4644-9641-24F03B40257D">
    <domeo:belongsToSet>urn:domeoserver:annotationset:6FFFF211-BFDC-4E16-968C-A296868530C4</domeo:belongsToSet>
    <pav:createdOn>2014-07-16 10:21:21 -0700</pav:createdOn>
    <pav:lastSavedOn>2014-07-16 10:23:07 -0700</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotation:EABEEB7D-C8D4-4F28-AC7D-F8B20016A4DB</pav:lineageUri>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:AAD02A4C-E01E-4C82-BC8A-D0F4639844FA</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <ao:context rdf:resource="urn:domeoclient:uuid:8A01C077-1FE2-4DD4-96E1-C475228628A9"/>
    <pav:lastSavedOn>2014-07-16 13:23:07 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:4DC7A7E5-5253-4EB7-AEC1-2FD55FEF5068">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:4DC7A7E5-5253-4EB7-AEC1-2FD55FEF5068"/>
    <ao:suffix> and</ao:suffix>
    <ao:exact> single dose both before and after the oral administration of fluconazole 50 mg once daily for 10 days in 10 healthy women. There was no significant difference in ethinyl estradiol or levonorgestrel AUC after the administration of 50 mg of fluconazole. The mean increase in ethinyl estradiol AUC was 6% (range: -47 to 108%)</ao:exact>
    <ao:prefix>Oral contraceptives were administered as a</ao:prefix>
    <domeo:uuid>4DC7A7E5-5253-4EB7-AEC1-2FD55FEF5068</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-22.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2014-07-16 15:35:39 -0700</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:DEA7496B-9CAF-4929-AD2C-2B22EB0C5A6B">
    <ao:prefix>Plasma concentrations of </ao:prefix>
    <ao:suffix>, its major metabolite, 9-hydroxyrisperidone, and risperidone plus 9-hydroxyrisperidone are dose proportional over the dosing range of 1 to 16 mg daily (0.5 to 8 mg twice daily). Following oral administration of solution or tablet, mean peak plasma conce</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:DEA7496B-9CAF-4929-AD2C-2B22EB0C5A6B"/>
    <pav:createdOn>2014-07-15 14:06:27 -0700</pav:createdOn>
    <ao:exact>risperidone</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid></domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <domeo:uuid>DEA7496B-9CAF-4929-AD2C-2B22EB0C5A6B</domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:10EA2F12-BD12-4F54-9D90-CD6B3DC5179E">
    <pav:lineageUri>urn:domeoserver:annotationset:BE290CA3-79BD-411A-BE2E-69AA4D19607D</pav:lineageUri>
    <pav:lastSavedOn>2014-07-10 11:21:41 -0700</pav:lastSavedOn>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
    <pav:createdOn>2014-07-10 11:20:07 -0700</pav:createdOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:15A537D1-5648-41B2-8BFA-0D0BA3DF4393</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">6</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotation:B0240DCD-6308-4F3F-8CEF-D70271C64320</pav:lineageUri>
    <pav:lastSavedOn>2014-07-10 14:21:41 -0400</pav:lastSavedOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:542B35CF-4581-4FCE-8D90-B315B353F9BE"/>
    <pav:previousVersion>urn:domeoserver:annotationset:2BFC2FB6-6BE9-4822-A245-973533533023</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:516C333C-B517-4F84-999E-51185DD6E859</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:239B4C6D-1110-4B65-AC66-F8A394187814</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:970963DF-8BCE-4936-9DFC-328A36014E1B</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/A3473ECA-4411-4CF5-A4E8-ABE5F8CA6A53">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdfs:label>fluconazole</rdfs:label>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/4450</dailymed:activeMoietyRxCUI>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N80221a75a9164b95951a0153fd8ac4b3">
    <permissions:accessType>urn:domeo:access:public</permissions:accessType>
    <permissions:isLocked>false</permissions:isLocked>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/88F80C49-1D15-4DDF-86BB-BC4D3583608D">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdfs:label>sildenafil</rdfs:label>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/136411</dailymed:activeMoietyRxCUI>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:DBB0F4E1-DD60-4C7C-94FB-551FD745535F">
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-27.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid>DBB0F4E1-DD60-4C7C-94FB-551FD745535F</domeo:uuid>
    <ao:prefix>. The mean ± SD increase in AUC was 20% ± 32% (range: -27 to 104%). The metabolite, </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:DBB0F4E1-DD60-4C7C-94FB-551FD745535F"/>
    <pav:createdOn>2014-07-18 13:55:55 -0700</pav:createdOn>
    <domeo:uuid></domeo:uuid>
    <ao:suffix> to parent drug ratio significantly decreased after the administration of fluconazole, from 7.6 ± 3.6 to 5.7 ± 2.2.</ao:suffix>
    <ao:exact>GZDV,</ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/3A85B371-E653-4667-9F67-A08A4188190B">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/9384</dailymed:activeMoietyRxCUI>
    <rdfs:label>rifampin</rdfs:label>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:9A1D2CFB-D308-4756-8AAA-6F32083CC598">
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:7A667B8B-937A-4A7A-89C2-95F2DCF9BE12"/>
    <dikbD2R:modality>ncit:negative</dikbD2R:modality>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:4CD0874F-AA43-4C04-958D-6CFBFA68EC61">
    <pav:lineageUri>urn:domeoserver:annotation:416B4946-D0CD-4B48-92D7-EF56FE6244BC</pav:lineageUri>
    <pav:lastSavedOn>2014-07-15 14:19:34 -0700</pav:lastSavedOn>
    <pav:lastSavedOn>2014-07-15 17:19:34 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:5758DAC0-E1C0-49EB-BE9C-56FFBAF3B6F4</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
    <domeo:belongsToSet>urn:domeoserver:annotationset:5B6A462D-57EA-4BBD-87E1-A0EC2FAF5196</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E8194531-C5B3-43AE-BC13-14A252C54824</domeo:belongsToSet>
    <pav:createdOn>2014-07-15 14:19:12 -0700</pav:createdOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:46636445-93A2-49F0-9E9C-5AEBF17046D2</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:883587E1-49C1-4EE0-909E-4ADBAE13DD3A</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotation:93D5917A-205E-46B0-9DE7-4C1529BDE33E</pav:lineageUri>
    <pav:lastSavedOn>2014-07-15 17:19:32 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:21B0E479-04F9-4D66-B396-B773EFE53882</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:7247E1B1-4BA1-4DE0-AA64-CA56899212F6"/>
    <rdfs:label>Highlight</rdfs:label>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E6A1493E-98EE-4FDE-9301-752AB8E3453F</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9C0B4E8B-9FFE-4E47-9B4C-A6EA4527A384</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Nba81ce7d58ee49cf95d2281e9476a419">
    <permissions:isLocked>false</permissions:isLocked>
    <permissions:accessType>urn:domeo:access:public</permissions:accessType>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:801BF977-34B8-44B2-9E5A-A5D9E2906430">
    <pav:createdOn>2014-07-10 10:59:54 -0700</pav:createdOn>
    <domeo:uuid></domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix>, therefore, increases cGMP within pulmonary vascular smooth muscle cells resulting in relaxation. In patients with pulmonary hypertension, this can lead to vasodilation of the pulmonary vascular bed and, to a lesser degree, vasodilatation in the systemi</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:801BF977-34B8-44B2-9E5A-A5D9E2906430"/>
    <ao:prefix> is an inhibitor of cGMP specific phosphodiesterase type-5 (PDE5) in the smooth muscle of the pulmonary vasculature, where PDE5 is responsible for degradation of cGMP. </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>Sildenafil</ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:hasSource>
    <domeo:uuid>801BF977-34B8-44B2-9E5A-A5D9E2906430</domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:3564DC3A-4069-432B-A29D-98AB86C42DF6">
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:lineageUri>urn:domeoserver:annotation:EFDAF0B4-5DB4-4A27-B9EE-3B518A18CDE2</pav:lineageUri>
    <pav:lastSavedOn>2014-07-18 17:08:09 -0400</pav:lastSavedOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:body rdf:nodeID="Nea6a65c660354023a6f2662072a91800"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:81FD23EC-BBD2-4E95-B296-364F882C43DB"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:B480EE53-5881-4650-9D82-D1F972071243</domeo:belongsToSet>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <pav:createdOn>2014-07-18 14:08:08 -0700</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:1FFE9DE2-04AD-4E77-8218-3B3AECFFDAA7">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/09FCD917-E332-4552-87D1-A1B73168DBA1"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/8A890D90-4AB4-4DD3-A520-217921B71116"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:7B416A74-DC20-4C40-8395-6E603CABC003">
    <dikbD2R:modality>ncit:negative</dikbD2R:modality>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:04D05202-1972-48E0-8430-96BCC4F013A1"/>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:8CA72313-3E32-44D6-A336-EDE69F22975A">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:41C2DB2C-7077-4ABE-8A8A-54A08326A7B8"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E8194531-C5B3-43AE-BC13-14A252C54824</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9C0B4E8B-9FFE-4E47-9B4C-A6EA4527A384</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:883587E1-49C1-4EE0-909E-4ADBAE13DD3A</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:5B6A462D-57EA-4BBD-87E1-A0EC2FAF5196</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-15 17:19:32 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E6A1493E-98EE-4FDE-9301-752AB8E3453F</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:5758DAC0-E1C0-49EB-BE9C-56FFBAF3B6F4</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-15 17:19:34 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:21B0E479-04F9-4D66-B396-B773EFE53882</domeo:belongsToSet>
    <pav:createdOn>2014-07-15 14:18:20 -0700</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotation:90801A16-10A7-49A8-B684-48F8350FB818</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotation:B177D05E-0019-4034-A51D-3F1A9583C8D7</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoserver:annotationset:46636445-93A2-49F0-9E9C-5AEBF17046D2</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lastSavedOn>2014-07-15 14:19:34 -0700</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:728539A9-7322-4281-848B-5507BB82A585">
    <ao:exact>fosamprenavir/ritonavir</ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:728539A9-7322-4281-848B-5507BB82A585"/>
    <domeo:uuid>728539A9-7322-4281-848B-5507BB82A585</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix> with paroxetine significantly decreased plasma levels of paroxetine. Any dose adjustment should be guided by clinical effect (tolerability and efficacy). </ao:suffix>
    <pav:createdOn>2014-07-18 14:23:36 -0700</pav:createdOn>
    <ao:prefix>Co-administration of </ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-51.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:844F447A-D83F-4BF1-A0FE-F99E548B8383">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/A1BA9036-F53C-4EFD-BBA8-76308D7248BA"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/46D5C2E3-F87A-4E1D-95D3-2486A57FD111"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:5261237F-686F-41D7-B860-16364A944D37">
    <ao:suffix>, and phenobarbital) with risperidone may cause a decrease in the combined plasma concentrations of risperidone and 9-hydroxyrisperidone [see 7 DRUG INTERACTIONS]. It would also be possible for risperidone to interfere with metabolism of other drugs meta</ao:suffix>
    <pav:createdOn>2014-07-15 14:16:19 -0700</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:5261237F-686F-41D7-B860-16364A944D37"/>
    <domeo:uuid>5261237F-686F-41D7-B860-16364A944D37</domeo:uuid>
    <ao:exact>rifampin</ao:exact>
    <domeo:uuid></domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix>, </ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:1AA7E714-DDFA-450C-A589-5EA4319B4691">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/20605659-64E0-42A7-BDB2-B4AA5CBC2059"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/5DE2E202-6D4F-4F94-96E7-9AC3DF505EFC"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/B54D2CA7-6597-43FB-AC52-34E959AFBD56">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <rdfs:label>carbamazepine</rdfs:label>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/2002</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/EC076291-AAD4-470B-AEA2-F25F4E7DC70B">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/11289</dailymed:activeMoietyRxCUI>
    <rdfs:label>warfarin</rdfs:label>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <dct:description>Referred to the drug in the interaction.</dct:description>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:E38D9228-C97F-4151-9702-C3C8F519D87E">
    <rdfs:label>Highlight</rdfs:label>
    <ao:context rdf:resource="urn:domeoclient:uuid:ED6E68B4-D2C7-419B-A740-99C70A25F570"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdOn>2014-07-15 13:56:25 -0700</pav:createdOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoclient:uuid:1C00DD3B-AD96-4229-AD96-9CFE64EA4677</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-15 16:58:25 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
    <pav:lineageUri>urn:domeoserver:annotation:97CA2BFC-4AC9-49DF-A924-849AE4D18CCA</pav:lineageUri>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoserver:annotationset:88784842-2713-4D3B-A293-A9498ACCA54A">
    <pav:previousVersion>urn:domeoclient:uuid:8B8B88D4-5E42-47CB-9E37-EED59C74FD96</pav:previousVersion>
    <dct:description>The default set is created automatically by Domeo when no other set is existing.</dct:description>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:deleted>false</domeo:deleted>
    <ao:item rdf:resource="urn:domeoclient:uuid:05BFE4D9-CD9B-4F44-B4A5-28A1E4F90000"/>
    <pav:createdOn>2014-07-09 13:36:31 -0700</pav:createdOn>
    <ao:item rdf:resource="urn:domeoclient:uuid:BE8D3AAD-5714-40E9-8521-B30676F883D5"/>
    <permissions:permissions rdf:nodeID="N950fa95e82634eed9ace2518059e709f"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
    <ao:item rdf:resource="urn:domeoclient:uuid:1FD70F7A-986E-48F8-93F4-DA3377C3E107"/>
    <rdfs:label>Default Set</rdfs:label>
    <pav:lastSavedOn>2014-07-09 16:56:35 -0400</pav:lastSavedOn>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-13.txt.html</ao:annotatesResource>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">2</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotationset:2C25A7F3-8A42-4060-A64C-5C2AB24D4675</pav:lineageUri>
    <ao:item rdf:resource="urn:domeoclient:uuid:52C23FEF-CB29-459B-934E-EDA40F63DD1E"/>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046812afe0146812ce85a0000"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:9F2162C5-D2E9-42F5-99DE-E7F470A1AD7C">
    <domeo:uuid></domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:9F2162C5-D2E9-42F5-99DE-E7F470A1AD7C"/>
    <ao:suffix> to 9-hydroxyrisperidone by the enzyme, CYP 2D6. A minor metabolic pathway is through N-dealkylation. The main metabolite, 9-hydroxyrisperidone, has similar pharmacological activity as risperidone. Consequently, the clinical effect of the drug results fr</ao:suffix>
    <ao:exact>risperidone</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix> is extensively metabolized in the liver. The main metabolic pathway is through hydroxylation of </ao:prefix>
    <domeo:uuid>9F2162C5-D2E9-42F5-99DE-E7F470A1AD7C</domeo:uuid>
    <pav:createdOn>2014-07-15 14:09:57 -0700</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/8C365411-C391-4ADB-A80A-FF1FC3DA4D2D">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <rdfs:label>sildenafil</rdfs:label>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/136411</dailymed:activeMoietyRxCUI>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <dct:description>Referred to the drug in the interaction.</dct:description>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N415318f07c154292bae45e2099521a0c">
    <permissions:accessType>urn:domeo:access:public</permissions:accessType>
    <permissions:isLocked>false</permissions:isLocked>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/B7E6915D-737A-4835-AD3F-AA797AC2E586">
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/35636</dailymed:activeMoietyRxCUI>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <rdfs:label>risperidone</rdfs:label>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:446A1126-39C6-4A5E-8A9C-13D15F81AD8C">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix> after 15 days of rifampin administered as 600 mg daily in eight healthy male volunteers resulted in a significant decrease in fluconazole AUC and a significant increase in apparent oral clearance of fluconazole. There was a mean ± SD reduction in flucon</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:446A1126-39C6-4A5E-8A9C-13D15F81AD8C"/>
    <pav:createdOn>2014-07-17 15:58:55 -0700</pav:createdOn>
    <domeo:uuid>446A1126-39C6-4A5E-8A9C-13D15F81AD8C</domeo:uuid>
    <ao:exact>fluconazole</ao:exact>
    <ao:prefix>Administration of a single oral 200 mg dose of </ao:prefix>
    <ao:hasSource>			http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-24.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:0FE2C318-FF67-459F-9092-2EF6E04B1472">
    <domeo:belongsToSet>urn:domeoserver:annotationset:2D3D9594-163C-4299-854D-3987A43B7DCF</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotationset:C94BECCE-E3E9-4B70-AC23-F715B9D3EEFF</pav:lineageUri>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoserver:annotationset:96BAB4C7-6F7A-4EBA-BAC1-134F746F11FA</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdOn>2014-07-17 15:56:08 -0700</pav:createdOn>
    <pav:lastSavedOn>2014-07-17 18:56:11 -0400</pav:lastSavedOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:D1D630F4-743B-425E-8FB2-C96DB1D59EEE"/>
    <ao:body rdf:nodeID="Ne53c3da88e0547958da74d3efa70fb52"/>
    <pav:lastSavedOn>2014-07-17 15:56:11 -0700</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">2</pav:versionNumber>
    <pav:previousVersion>urn:domeoclient:uuid:4E57D817-C3D5-47E5-AECC-169C5A1EF60D</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotation:DFC375BA-0691-4FD1-8C46-A62233150246</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
    <ao:body rdf:nodeID="N898eb35cd03a44da9bf4e02d06b4a3b0"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:A77ED33E-10B2-43BE-8BC6-D5F14E2FE208">
    <pav:lineageUri>urn:domeoserver:annotation:8ECF3B26-2486-428F-935F-AA635202A049</pav:lineageUri>
    <ao:context rdf:resource="urn:domeoclient:uuid:9AA1C371-A08E-41E5-AC8E-B7624054B9FF"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:46636445-93A2-49F0-9E9C-5AEBF17046D2</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:21B0E479-04F9-4D66-B396-B773EFE53882</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:883587E1-49C1-4EE0-909E-4ADBAE13DD3A</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-15 17:17:26 -0400</pav:lastSavedOn>
    <pav:previousVersion>urn:domeoserver:annotationset:2E5CE73B-BFD4-4E35-9A07-D5E37A9E87AE</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:5B6A462D-57EA-4BBD-87E1-A0EC2FAF5196</domeo:belongsToSet>
    <pav:createdOn>2014-07-15 14:14:23 -0700</pav:createdOn>
    <pav:lastSavedOn>2014-07-15 14:17:25 -0700</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9C0B4E8B-9FFE-4E47-9B4C-A6EA4527A384</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">4</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E8194531-C5B3-43AE-BC13-14A252C54824</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:570DA392-7779-456C-9C18-1FC0E579BBE6</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:5758DAC0-E1C0-49EB-BE9C-56FFBAF3B6F4</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E6A1493E-98EE-4FDE-9301-752AB8E3453F</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotationset:75FC1225-8399-469B-AE9D-7F697713E6AC</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/3786B2EC-7B7E-486B-9D91-E1B956AA357E">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/11289</dailymed:activeMoietyRxCUI>
    <rdfs:label>warfarin</rdfs:label>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <dct:description>Referred to the drug in the interaction.</dct:description>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/4512FD1D-26DF-4608-92A5-E0B5D3388329">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <rdfs:label>sulfamethazine</rdfs:label>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/</dailymed:activeMoietyRxCUI>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:612ABB21-3ECF-401B-9B38-AA1A866FE000">
    <ao:exact>Paroxetine</ao:exact>
    <pav:createdOn>2014-07-18 14:32:24 -0700</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:612ABB21-3ECF-401B-9B38-AA1A866FE000"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-52.txt.html</ao:hasSource>
    <ao:suffix> produced no genotoxic effects in a battery of 5 in vitro and 2 in vivo assays that included the following: Bacterial mutation assay, mouse lymphoma mutation assay, unscheduled DNA synthesis assay, and tests for cytogenetic aberrations in vivo in mouse b</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix>xsd:String</ao:prefix>
    <domeo:uuid>612ABB21-3ECF-401B-9B38-AA1A866FE000</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/83246816-D7FF-44ED-AF9B-04CDD30DDA0F">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/4450</dailymed:activeMoietyRxCUI>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <rdfs:label>fluconazole</rdfs:label>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/FA53ED44-367B-4D92-8F10-3F967033E9F0">
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/4450</dailymed:activeMoietyRxCUI>
    <rdfs:label>fluconazole</rdfs:label>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <dct:description>Referred to the drug in the interaction.</dct:description>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:22097E52-FDC1-4F33-B19C-C5FBE58E871D">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/4F35C443-9DBC-4CC5-A6B5-6AC7F37CD815"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/2440B2BA-E703-439E-9D9D-F871F0C7006D"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoserver:annotationset:2BFC2FB6-6BE9-4822-A245-973533533023">
    <rdfs:label>Default Set</rdfs:label>
    <ao:item rdf:resource="urn:domeoclient:uuid:C4DD997B-59E6-4FDF-944E-0E3151C25851"/>
    <pav:lineageUri>urn:domeoserver:annotationset:BE290CA3-79BD-411A-BE2E-69AA4D19607D</pav:lineageUri>
    <pav:previousVersion>urn:domeoserver:annotationset:DBBBAD55-D12B-4890-A2AF-85D3C85A7BEF</pav:previousVersion>
    <ao:item rdf:resource="urn:domeoclient:uuid:114FB83A-C60C-42F5-AB92-9462558A06FC"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:C70E2E47-3AA5-4F01-A8A1-711E946726F5"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
    <ao:item rdf:resource="urn:domeoclient:uuid:94AD2935-8FE6-4D3D-847A-A1AC66E35692"/>
    <dct:description>The default set is created automatically by Domeo when no other set is existing.</dct:description>
    <pav:createdOn>2014-07-10 10:59:34 -0700</pav:createdOn>
    <pav:lastSavedOn>2014-07-10 14:17:08 -0400</pav:lastSavedOn>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:annotatesResource>
    <ao:item rdf:resource="urn:domeoclient:uuid:32208944-92E0-40BE-AA45-03DC0663A09C"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:B9DE1789-19F9-43BC-B292-659F900EA6EB"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:C820B82D-AF0E-4A71-9E65-5AB73DFE5206"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">5</pav:versionNumber>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:EFED6610-75EB-4165-827C-237B7D245279"/>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046812afe0146812ce85a0000"/>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <domeo:deleted>false</domeo:deleted>
    <ao:item rdf:resource="urn:domeoclient:uuid:F5FD5F49-D620-4FE1-9968-D31A01410DEC"/>
    <permissions:permissions rdf:nodeID="N7becc7d2e945433299294dfe825ef7c5"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:977A2BC8-0744-472F-9FA2-CCF897431CA1"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/E75B503C-DB0D-4C60-A261-8CE7BCE1D9D4">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <rdfs:label>warfarin</rdfs:label>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/11289</dailymed:activeMoietyRxCUI>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:EC8E54B5-0BA4-4BDD-B164-66B9C1417149">
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:9494FE3F-439F-4A1E-80B8-C98ADC78ACCF"/>
    <dikbD2R:modality>ncit:negative</dikbD2R:modality>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Nd1f535489f10490faa3c8931af14d98f">
    <permissions:isLocked>false</permissions:isLocked>
    <permissions:accessType>urn:domeo:access:public</permissions:accessType>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Ne856021d8a7f43319d62e2b149ab919a">
    <domeo:sets rdf:resource="urn:pddi:uuid:0261AF60-9879-4F43-A258-63443FAFA74D"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:688A40AF-929E-4DEA-858A-D3762D3C014B">
    <pav:lastSavedOn>2014-07-18 16:59:52 -0400</pav:lastSavedOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:lineageUri>urn:domeoserver:annotation:5A89661F-9824-4844-AED5-7313EED76025</pav:lineageUri>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
    <ao:body rdf:nodeID="N8c1a8a4da50d4b4d91354e3c429278f0"/>
    <pav:createdOn>2014-07-18 13:57:27 -0700</pav:createdOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:A3D1C555-823A-42D3-975B-C6C42C41329E"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:99826AC3-3668-4F74-9E9D-DADD1F7098F0</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:A3D1C555-823A-42D3-975B-C6C42C41329E">
    <pav:createdOn>2014-07-18 13:57:27 -0700</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-27.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:A3D1C555-823A-42D3-975B-C6C42C41329E"/>
    <domeo:uuid>A3D1C555-823A-42D3-975B-C6C42C41329E</domeo:uuid>
    <ao:prefix>xsd:String</ao:prefix>
    <ao:exact>zidovudine concentrations were determined on two occasions (before and following fluconazole 200 mg daily for 15 days) in 13 volunteers with AIDS or ARC who were on a stable zidovudine dose for at least two weeks. There was a significant increase in zidovudine AUC following the administration of fluconazole. The mean ± SD increase in AUC was 20% ± 32% (range: -27 to 104%). The metabolite, GZDV, to parent drug ratio significantly decreased after the administration of fluconazole, from 7.6 ± 3.6 to 5.7 ± 2.2</ao:exact>
    <ao:suffix>xsd:String</ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:2BB10533-7A8A-4C30-95A1-E3816F2A9980">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid>2BB10533-7A8A-4C30-95A1-E3816F2A9980</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <ao:suffix> plus 9-hydroxyrisperidone are dose proportional over the dosing range of 1 to 16 mg daily (0.5 to 8 mg twice daily). Following oral administration of solution or tablet, mean peak plasma concentrations of risperidone occurred at about 1 hour. Peak conce</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:2BB10533-7A8A-4C30-95A1-E3816F2A9980"/>
    <ao:exact>risperidone</ao:exact>
    <domeo:uuid></domeo:uuid>
    <pav:createdOn>2014-07-15 14:06:36 -0700</pav:createdOn>
    <ao:prefix>, and </ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:0995BA18-F2BB-481E-9F1F-AA682807B4CC">
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:8E283C96-F95C-4194-BC61-D0686F57EA11"/>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <dikbD2R:modality>ncit:negative</dikbD2R:modality>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:E2070D1E-ACA9-4A94-BC6D-885BA2DE100C">
    <domeo:uuid></domeo:uuid>
    <domeo:uuid>E2070D1E-ACA9-4A94-BC6D-885BA2DE100C</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-27.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:E2070D1E-ACA9-4A94-BC6D-885BA2DE100C"/>
    <ao:prefix> 200 mg daily for 15 days) in 13 volunteers with AIDS or ARC who were on a stable </ao:prefix>
    <pav:createdOn>2014-07-18 13:55:43 -0700</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix> dose for at least two weeks. There was a significant increase in zidovudine AUC following the administration of fluconazole. The mean ± SD increase in AUC was 20% ± 32% (range: -27 to 104%). The metabolite, GZDV, to parent drug ratio significantly decre</ao:suffix>
    <ao:exact>zidovudine</ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:5E7E2FCC-1143-4814-9FC9-A8EC73AFF960">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/2EE5C88D-F1A3-4B71-A118-7683DC8A0550"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/8A564946-B312-4E79-B2E9-FDBA2D36B979"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:8B60173A-DE13-439C-A9A3-32C58F0F5E08">
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:36A89B29-F675-4E00-B50E-A68B59055C9F"/>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <dikbD2R:modality>ncit:negative</dikbD2R:modality>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/431D7F17-E533-4D99-B4EB-F68A78736463">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/</dailymed:activeMoietyRxCUI>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <rdfs:label>sulfamethazine</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:DCA6DB56-8ED4-4BF0-9368-16ACBA6F82AE">
    <domeo:belongsToSet>urn:domeoserver:annotationset:AD2FD8CD-1032-462E-833D-451021CE67B2</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-16 17:07:53 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotation:42447E7A-991B-4E48-9BA8-E5C03F8FFFAC</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:B3F0B84F-756D-4724-B177-98D0D290D00D</domeo:belongsToSet>
    <pav:createdOn>2014-07-16 14:07:50 -0700</pav:createdOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:C2A39432-076D-421D-8007-22690EDA5A0C</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lastSavedOn>2014-07-16 17:07:51 -0400</pav:lastSavedOn>
    <rdfs:label>Highlight</rdfs:label>
    <ao:context rdf:resource="urn:domeoclient:uuid:F0444DBB-743A-42A1-A053-40E5E11BBD66"/>
    <pav:lineageUri>urn:domeoserver:annotation:012A7BC4-2E5C-4129-A148-5D21293A0648</pav:lineageUri>
    <pav:lastSavedOn>2014-07-16 14:07:53 -0700</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/B497A525-4AF7-4AD5-98D7-46B660BDD1DD">
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <rdfs:label>erythromycin</rdfs:label>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/4053</dailymed:activeMoietyRxCUI>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dct:description>Referred to the drug in the interaction.</dct:description>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:D1D630F4-743B-425E-8FB2-C96DB1D59EEE">
    <ao:prefix>xsd:String</ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>Fluconazole 100 mg was administered as a single oral dose alone and two hours after a single dose of cimetidine 400 mg to six healthy male volunteers. After the administration of cimetidine, there was a significant decrease in fluconazole AUC and Cmax. There was a mean ± SD decrease in fluconazole AUC of 13% ± 11% (range: -3.4 to -31%) and Cmax decreased 19% ± 14% (range: -5 to -40%)</ao:exact>
    <ao:suffix>. However, the administration of</ao:suffix>
    <pav:createdOn>2014-07-17 15:56:08 -0700</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:D1D630F4-743B-425E-8FB2-C96DB1D59EEE"/>
    <ao:hasSource>				http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-23.txt.html																													</ao:hasSource>
    <domeo:uuid>D1D630F4-743B-425E-8FB2-C96DB1D59EEE</domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/CC9456BB-F2F5-4CE1-B12B-11D10CE387AE">
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <rdfs:label>Fluconazole</rdfs:label>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/4450</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:AF7B07B6-2BD9-490B-95BF-D760C5399474">
    <ao:suffix>sildenafil was co-administered with erythromycin, a CYP3A inhibitor, at steady state (500 mg BID for 5 days), there was a 182% increase in sildenafil systemic exposure (AUC).</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:hasSource>
    <domeo:uuid>AF7B07B6-2BD9-490B-95BF-D760C5399474</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:AF7B07B6-2BD9-490B-95BF-D760C5399474"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid></domeo:uuid>
    <ao:prefix>When a single 100 mg dose of</ao:prefix>
    <ao:exact> </ao:exact>
    <pav:createdOn>2014-07-10 11:10:37 -0700</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:F6C87C3C-DE3E-4C1E-A1AE-B620C6D1B31E">
    <domeo:belongsToSet>urn:domeoclient:uuid:82AC5ADA-B8CE-47A9-AA99-E7187ABEFACA</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotation:E4E42703-FD7D-4D0A-BA90-920A2D4F880E</pav:lineageUri>
    <ao:context rdf:resource="urn:domeoclient:uuid:34E48324-D870-4398-B241-2FAE6690C98C"/>
    <pav:createdOn>2014-07-18 13:55:37 -0700</pav:createdOn>
    <pav:lastSavedOn>2014-07-18 13:56:04 -0700</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lastSavedOn>2014-07-18 16:56:04 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:99826AC3-3668-4F74-9E9D-DADD1F7098F0</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:9CAD6283-FE79-428D-A3CE-B664A09583CB">
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
    <ao:context rdf:resource="urn:domeoclient:uuid:64D0C269-01F6-4340-8315-A41DCAE1D199"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:5B6A462D-57EA-4BBD-87E1-A0EC2FAF5196</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E6A1493E-98EE-4FDE-9301-752AB8E3453F</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:883587E1-49C1-4EE0-909E-4ADBAE13DD3A</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-15 17:17:26 -0400</pav:lastSavedOn>
    <pav:lastSavedOn>2014-07-15 14:17:25 -0700</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9C0B4E8B-9FFE-4E47-9B4C-A6EA4527A384</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotation:FF0D50F8-5E13-498E-A03E-36A27D056850</pav:lineageUri>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E8194531-C5B3-43AE-BC13-14A252C54824</domeo:belongsToSet>
    <pav:previousVersion>urn:domeoserver:annotationset:2E5CE73B-BFD4-4E35-9A07-D5E37A9E87AE</pav:previousVersion>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">4</pav:versionNumber>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdOn>2014-07-15 14:14:03 -0700</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotationset:75FC1225-8399-469B-AE9D-7F697713E6AC</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoserver:annotationset:46636445-93A2-49F0-9E9C-5AEBF17046D2</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:570DA392-7779-456C-9C18-1FC0E579BBE6</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:5758DAC0-E1C0-49EB-BE9C-56FFBAF3B6F4</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:21B0E479-04F9-4D66-B396-B773EFE53882</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/82489DE2-95D2-40DF-8FAB-FAEB9D14A3DA">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/9068</dailymed:activeMoietyRxCUI>
    <rdfs:label>quinidine</rdfs:label>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/DCAE7BE5-CA2D-42DE-AD2F-DA9E269EF211">
    <rdfs:label>risperidone</rdfs:label>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/35636</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N6d28ced8003844fea33c1556745360c5">
    <permissions:accessType>urn:domeo:access:public</permissions:accessType>
    <permissions:isLocked>false</permissions:isLocked>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:BEEF40B4-6424-4E52-8991-9FA7249F61E5">
    <domeo:uuid>BEEF40B4-6424-4E52-8991-9FA7249F61E5</domeo:uuid>
    <pav:createdOn>2014-07-16 10:19:56 -0700</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:BEEF40B4-6424-4E52-8991-9FA7249F61E5"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>risperidone</ao:exact>
    <ao:suffix> oral solution is bioequivalent to risperidone tablets.</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid></domeo:uuid>
    <ao:prefix>Pharmacokinetic studies showed that </ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:E5374C47-F6BA-4C76-BA79-A45CBC597A4C">
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <dikbD2R:modality>ncit:negative</dikbD2R:modality>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:E27EA287-6A73-4A85-91BA-05FF0671A1E5"/>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:D7826928-4C32-427A-B946-D947EB2451B5">
    <pav:createdOn>2014-07-10 11:15:15 -0700</pav:createdOn>
    <domeo:uuid>D7826928-4C32-427A-B946-D947EB2451B5</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:D7826928-4C32-427A-B946-D947EB2451B5"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>erythromycin</ao:exact>
    <ao:suffix>, a CYP3A inhibitor, at steady state (500 mg BID for 5 days), there was a 182% increase in </ao:suffix>
    <ao:prefix> was co-administered with </ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:FBBE65E6-567D-48EE-99B9-B5E8C8480685">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:FBBE65E6-567D-48EE-99B9-B5E8C8480685"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix> nor </ao:prefix>
    <pav:createdOn>2014-07-15 14:08:51 -0700</pav:createdOn>
    <ao:exact>9-hydroxyrisperidone</ao:exact>
    <domeo:uuid></domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>FBBE65E6-567D-48EE-99B9-B5E8C8480685</domeo:uuid>
    <ao:suffix> displaces each other from plasma binding sites. High therapeutic concentrations of sulfamethazine (100 mcg/mL), warfarin (10 mcg/mL), and carbamazepine (10 mcg/mL) caused only a slight increase in the free fraction of risperidone at 10 ng/mL and 9-hydro</ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:C966BEAA-709F-4F5C-9638-F94D75B69135">
    <pav:createdOn>2014-07-16 10:36:33 -0700</pav:createdOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoclient:uuid:C5D9EC69-52E2-48F5-B3D8-867DE23DEC96</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-16 13:36:38 -0400</pav:lastSavedOn>
    <pav:lastSavedOn>2014-07-16 10:36:38 -0700</pav:lastSavedOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
    <domeo:belongsToSet>urn:domeoserver:annotationset:2CE33325-EF3D-4298-BBCC-82F0A45DA665</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:EDA74310-A0B5-4356-940A-7C74749CD2EF"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lineageUri>urn:domeoserver:annotation:ED0BE9B7-B4C4-4EBF-AAFA-BF4510B72413</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeo:software:id:Domeo-2.1alpha-050">
    <rdfs:label>Domeo Annotation Toolkit</rdfs:label>
    <rdf:type rdf:resource="http://xmlns.com/foaf/0.1/Software"/>
    <foafx:version>2.1alpha</foafx:version>
    <foafx:homepage></foafx:homepage>
    <foafx:build>050</foafx:build>
    <foafx:name>Domeo Annotation Toolkit</foafx:name>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:98825CF8-1CA0-489D-A1C4-2239A4A1278A">
    <ao:prefix> </ao:prefix>
    <domeo:uuid></domeo:uuid>
    <domeo:uuid>98825CF8-1CA0-489D-A1C4-2239A4A1278A</domeo:uuid>
    <ao:suffix>xsd:String</ao:suffix>
    <ao:exact>risperidone</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:98825CF8-1CA0-489D-A1C4-2239A4A1278A"/>
    <pav:createdOn>2014-07-15 14:10:55 -0700</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/F620DDE8-4C9B-4A5E-8FA3-1F42BF3BD963">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <rdfs:label>sulfamethazine</rdfs:label>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/</dailymed:activeMoietyRxCUI>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:F69E5920-13F7-4233-8E5C-355591D43752">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lastSavedOn>2014-07-18 16:51:47 -0400</pav:lastSavedOn>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoclient:uuid:B8452517-26D0-419F-88FD-A818925FDE06</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
    <ao:context rdf:resource="urn:domeoclient:uuid:1C906DFD-63EC-472C-AD64-29043E8A58B1"/>
    <pav:createdOn>2014-07-18 13:51:41 -0700</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotation:2F75FC7D-FA23-4713-836C-9481CAAF5C89</pav:lineageUri>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:0216B801-6401-4E8A-B678-5222EA6AA098">
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lastSavedOn>2014-07-18 14:03:19 -0700</pav:lastSavedOn>
    <pav:createdOn>2014-07-18 14:03:04 -0700</pav:createdOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoclient:uuid:E65FF29A-8FE7-4D0E-A93C-4DA8136F4956</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:6DBCB873-26F3-4E6A-9BD4-311369B43736</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-18 17:03:19 -0400</pav:lastSavedOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:427474F1-6F8A-40AF-BCE5-B758B7F7E955"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotationset:9AA0507C-281E-45C8-9719-03E66F12C069</pav:lineageUri>
    <pav:lineageUri>urn:domeoserver:annotation:7C95EE92-6958-4998-B037-2BBF4C29433D</pav:lineageUri>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Nfd87afae819c4b5db88abfa807ee766b">
    <domeo:sets rdf:resource="urn:pddi:uuid:4B8784BF-1D41-417E-A20C-C9B069D76FAA"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:5DCE0D50-99F3-4301-8B36-DE5F9A87ECDD">
    <domeo:belongsToSet>urn:domeoclient:uuid:8C39EA63-3E52-40B4-8935-6ADC75CCA74D</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:C2A39432-076D-421D-8007-22690EDA5A0C</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:AD2FD8CD-1032-462E-833D-451021CE67B2</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoserver:annotationset:B3F0B84F-756D-4724-B177-98D0D290D00D</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotation:9E77CBDC-FE87-4054-9219-455A4C81D84B</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
    <ao:context rdf:resource="urn:domeoclient:uuid:8049D373-44B2-4E73-95D6-3445DE0002F8"/>
    <pav:createdOn>2014-07-16 14:03:51 -0700</pav:createdOn>
    <rdfs:label>Highlight</rdfs:label>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lastSavedOn>2014-07-16 14:06:30 -0700</pav:lastSavedOn>
    <pav:lastSavedOn>2014-07-16 17:06:30 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:F7888D3F-B736-44E1-8FF0-7C578EEDD97E">
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
    <domeo:belongsToSet>urn:domeoclient:uuid:98DABE9A-9F89-4DF9-9DEE-B6853D1F5CC1</domeo:belongsToSet>
    <pav:createdOn>2014-07-16 15:39:41 -0700</pav:createdOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:701B3F36-4375-4CB6-A9F8-C942C7D5632E"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E3DA2E5E-FC19-4C22-AF6C-A9CB4B450554</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotation:66F7DB88-E054-469D-820E-4EDCB75B0F44</pav:lineageUri>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lastSavedOn>2014-07-16 15:40:55 -0700</pav:lastSavedOn>
    <pav:lastSavedOn>2014-07-16 18:40:55 -0400</pav:lastSavedOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:A61CD8E1-11C9-4016-9EA7-411997F38BC7">
    <domeo:uuid>A61CD8E1-11C9-4016-9EA7-411997F38BC7</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:A61CD8E1-11C9-4016-9EA7-411997F38BC7"/>
    <ao:exact>risperidone</ao:exact>
    <ao:prefix>Hepatic Impairment: While the pharmacokinetics of </ao:prefix>
    <domeo:uuid></domeo:uuid>
    <ao:suffix> in subjects with liver disease were comparable to those in young healthy subjects, the mean free fraction of risperidone in plasma was increased by about 35% because of the diminished concentration of both albumin and α1-acid glycoprotein. Risperidone d</ao:suffix>
    <pav:createdOn>2014-07-15 14:18:29 -0700</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:2FC3C7A5-C738-4ED9-8908-673E98D7C9CB">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>			http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-24.txt.html</ao:hasSource>
    <pav:createdOn>2014-07-17 15:59:16 -0700</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:2FC3C7A5-C738-4ED9-8908-673E98D7C9CB"/>
    <domeo:uuid>2FC3C7A5-C738-4ED9-8908-673E98D7C9CB</domeo:uuid>
    <ao:suffix>. There was a mean ± SD reduction in fluconazole AUC of 23% ± 9% (range: -13 to -42%). Apparent oral clearance of fluconazole increased 32% ± 17% (range: 16 to 72%). Fluconazole half-life decreased from 33.4 ± 4.4 hours to 26.8 ± 3.9 hours. (See PRECAUTI</ao:suffix>
    <ao:prefix> AUC and a significant increase in apparent oral clearance of </ao:prefix>
    <ao:exact>fluconazole</ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:62C1B60E-3BDC-470D-A027-77547456BB31">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:62C1B60E-3BDC-470D-A027-77547456BB31"/>
    <pav:createdOn>2014-07-16 10:20:01 -0700</pav:createdOn>
    <ao:suffix> tablets.</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid>62C1B60E-3BDC-470D-A027-77547456BB31</domeo:uuid>
    <domeo:uuid></domeo:uuid>
    <ao:prefix> oral solution is bioequivalent to </ao:prefix>
    <ao:exact>risperidone</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/20605659-64E0-42A7-BDB2-B4AA5CBC2059">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/</dailymed:activeMoietyRxCUI>
    <rdfs:label>fosamprenavir/ritonavir</rdfs:label>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/A04865E8-787E-4761-9CCC-B05D3C433330">
    <rdfs:label>sildenafil</rdfs:label>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/136411</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:A252FD3C-4309-4CCB-8491-4B23A2848662">
    <domeo:belongsToSet>urn:domeoserver:annotationset:570DA392-7779-456C-9C18-1FC0E579BBE6</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-15 17:17:26 -0400</pav:lastSavedOn>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">4</pav:versionNumber>
    <ao:context rdf:resource="urn:domeoclient:uuid:A81A4371-A756-421B-8B30-D10382A032D4"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:883587E1-49C1-4EE0-909E-4ADBAE13DD3A</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:21B0E479-04F9-4D66-B396-B773EFE53882</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E6A1493E-98EE-4FDE-9301-752AB8E3453F</domeo:belongsToSet>
    <pav:previousVersion>urn:domeoserver:annotationset:2E5CE73B-BFD4-4E35-9A07-D5E37A9E87AE</pav:previousVersion>
    <pav:lastSavedOn>2014-07-15 14:17:25 -0700</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:5B6A462D-57EA-4BBD-87E1-A0EC2FAF5196</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:5758DAC0-E1C0-49EB-BE9C-56FFBAF3B6F4</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotationset:75FC1225-8399-469B-AE9D-7F697713E6AC</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E8194531-C5B3-43AE-BC13-14A252C54824</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:46636445-93A2-49F0-9E9C-5AEBF17046D2</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9C0B4E8B-9FFE-4E47-9B4C-A6EA4527A384</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lineageUri>urn:domeoserver:annotation:F4BE7660-3DAE-4C0F-A6A5-3E9CF5AADF06</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdOn>2014-07-15 14:14:40 -0700</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:6C376F0E-D7D6-4846-B8E9-1C50742E0CD2">
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">6</pav:versionNumber>
    <pav:lastSavedOn>2014-07-10 14:21:41 -0400</pav:lastSavedOn>
    <pav:previousVersion>urn:domeoserver:annotationset:2BFC2FB6-6BE9-4822-A245-973533533023</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:516C333C-B517-4F84-999E-51185DD6E859</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotation:B2B991BA-4DB0-4DDF-B17B-EF158F52DA66</pav:lineageUri>
    <ao:context rdf:resource="urn:domeoclient:uuid:4B77AEB1-052D-442D-91E6-921DAD259BC6"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lastSavedOn>2014-07-10 11:21:41 -0700</pav:lastSavedOn>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoserver:annotationset:970963DF-8BCE-4936-9DFC-328A36014E1B</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:15A537D1-5648-41B2-8BFA-0D0BA3DF4393</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:239B4C6D-1110-4B65-AC66-F8A394187814</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotationset:BE290CA3-79BD-411A-BE2E-69AA4D19607D</pav:lineageUri>
    <pav:createdOn>2014-07-10 11:20:41 -0700</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:B09717CD-B9B4-417C-B2AA-D11A10E5FE3E">
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:B09717CD-B9B4-417C-B2AA-D11A10E5FE3E"/>
    <domeo:uuid></domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>risperidone</ao:exact>
    <pav:createdOn>2014-07-16 10:19:09 -0700</pav:createdOn>
    <ao:suffix> results from the combined concentrations of risperidone and its major metabolite, 9-hydroxyrisperidone [see 12 CLINICAL PHARMACOLOGY]. Antagonism at receptors other than D2 and 5HT2 [see 12 CLINICAL PHARMACOLOGY] may explain some of the other effects of</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>B09717CD-B9B4-417C-B2AA-D11A10E5FE3E</domeo:uuid>
    <ao:prefix>The clinical effect from </ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:D4B04F76-068F-4446-8605-4EDC1E4CB4F3">
    <domeo:uuid></domeo:uuid>
    <pav:createdOn>2014-07-15 14:07:21 -0700</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:D4B04F76-068F-4446-8605-4EDC1E4CB4F3"/>
    <domeo:uuid>D4B04F76-068F-4446-8605-4EDC1E4CB4F3</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <ao:suffix>. Thus, risperidone can be given with or without meals.</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>risperidone</ao:exact>
    <ao:prefix>Food Effect: Food does not affect either the rate or extent of absorption of </ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:8C5430EE-8C8A-44B7-9A28-80BDAB1B381C">
    <ao:exact>Tolbutamide</ao:exact>
    <ao:suffix> Cmax increased 11% ± 9% (range: -6 to 27%). (See PRECAUTIONS.)</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:8C5430EE-8C8A-44B7-9A28-80BDAB1B381C"/>
    <domeo:uuid>8C5430EE-8C8A-44B7-9A28-80BDAB1B381C</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2014-07-18 14:07:26 -0700</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-29.txt.html</ao:hasSource>
    <ao:prefix> AUC of 26% ± 9% (range: 12 to 39%). </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:E5AC3B8B-F69B-4482-815F-54FC3F75312F">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">6</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:239B4C6D-1110-4B65-AC66-F8A394187814</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotationset:BE290CA3-79BD-411A-BE2E-69AA4D19607D</pav:lineageUri>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:516C333C-B517-4F84-999E-51185DD6E859</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:65491747-3FED-4091-AB6D-7A1B627B89AD"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:15A537D1-5648-41B2-8BFA-0D0BA3DF4393</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-10 11:21:41 -0700</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
    <domeo:belongsToSet>urn:domeoserver:annotationset:970963DF-8BCE-4936-9DFC-328A36014E1B</domeo:belongsToSet>
    <pav:createdOn>2014-07-10 11:20:45 -0700</pav:createdOn>
    <pav:previousVersion>urn:domeoserver:annotationset:2BFC2FB6-6BE9-4822-A245-973533533023</pav:previousVersion>
    <pav:lastSavedOn>2014-07-10 14:21:41 -0400</pav:lastSavedOn>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotation:FE873830-A925-4A9A-9665-DEE1ECC27A9A</pav:lineageUri>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/7CAC23C0-2167-45E7-9CB3-40D1B4A1CFED">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <rdfs:label>sildenafil</rdfs:label>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/136411</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/54E13418-11DC-4671-AB00-7B464BF4A389">
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/4450</dailymed:activeMoietyRxCUI>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdfs:label>fluconazole</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:1CA929CF-E1E3-4FA4-8B7E-65CF662A40DA">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/B323F1AF-E50F-49F8-9817-81EEE875A6B1"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/14706E71-7D17-4340-9C53-D35DEA1F60E7"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:8A7DE042-9FA7-424C-B98E-9C19498D7977">
    <permissions:permissions rdf:nodeID="Nd1d6288ba30f4599bb8bf4eb2f6211c1"/>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <domeo:deleted>false</domeo:deleted>
    <pav:lastSavedOn>2014-07-10 14:00:22 -0400</pav:lastSavedOn>
    <dct:description>The default set is created automatically by Domeo when no other set is existing.</dct:description>
    <rdfs:label>Default Set</rdfs:label>
    <pav:createdOn>2014-07-10 10:59:34 -0700</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotationset:BE290CA3-79BD-411A-BE2E-69AA4D19607D</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <ao:item rdf:resource="urn:domeoclient:uuid:EFED6610-75EB-4165-827C-237B7D245279"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:annotatesResource>
    <ao:item rdf:resource="urn:domeoclient:uuid:75CEFB15-ED07-4FCF-827C-D3813A7E7192"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046812afe0146812ce85a0000"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:B4A4923A-11E7-4579-931D-08B5995E3BC1">
    <ao:suffix> has low to moderate affinity (Ki of 47 to 253 nM) for the serotonin 5HT1C, 5HT1D, and 5HT1A receptors, weak affinity (Ki of 620 to 800 nM) for the dopamine D1 and haloperidol-sensitive sigma site, and no affinity (when tested at concentrations &gt;10-5 M) </ao:suffix>
    <ao:exact>Risperidone</ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix>e acts as an antagonist at other receptors, but with lower potency. </ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:B4A4923A-11E7-4579-931D-08B5995E3BC1"/>
    <pav:createdOn>2014-07-15 14:02:59 -0700</pav:createdOn>
    <domeo:uuid></domeo:uuid>
    <domeo:uuid>B4A4923A-11E7-4579-931D-08B5995E3BC1</domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:81FD23EC-BBD2-4E95-B296-364F882C43DB">
    <ao:exact>In 13 normal male volunteers, there was significant increase in tolbutamide (500 mg single dose) AUC and Cmax following the administration of fluconazole. There was a mean ± SD increase in tolbutamide AUC of 26% ± 9% (range: 12 to 39%). Tolbutamide Cmax increased 11% ± 9% (range: -6 to 27%)</ao:exact>
    <ao:prefix>xsd:String</ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:81FD23EC-BBD2-4E95-B296-364F882C43DB"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-29.txt.html</ao:hasSource>
    <pav:createdOn>2014-07-18 14:08:08 -0700</pav:createdOn>
    <ao:suffix>. (See PRECAUTIONS.</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>81FD23EC-BBD2-4E95-B296-364F882C43DB</domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:41D4DAFD-01A3-4F08-82F4-AB8B59CEEB2B">
    <pav:createdOn>2014-07-16 10:20:13 -0700</pav:createdOn>
    <domeo:uuid>41D4DAFD-01A3-4F08-82F4-AB8B59CEEB2B</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:41D4DAFD-01A3-4F08-82F4-AB8B59CEEB2B"/>
    <ao:prefix>, and </ao:prefix>
    <ao:suffix> plus 9-hydroxyrisperidone are dose proportional over the dosing range of 1 to 16 mg daily (0.5 to 8 mg twice daily). Following oral administration of solution or tablet, mean peak plasma concentrations of risperidone occurred at about 1 hour. Peak conce</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid></domeo:uuid>
    <ao:exact>risperidone</ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/84869E15-996D-41E7-8095-C6D364FE9596">
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/136411</dailymed:activeMoietyRxCUI>
    <rdfs:label>sildenafil</rdfs:label>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:49AC02A4-8391-4B23-ADA4-A757C853CF17">
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:F8EAECE2-30A6-49BF-883F-70A7B4280D18"/>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:30F7EA47-3832-4833-A7F4-22FA71A2083F">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:30F7EA47-3832-4833-A7F4-22FA71A2083F"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid>30F7EA47-3832-4833-A7F4-22FA71A2083F</domeo:uuid>
    <domeo:uuid></domeo:uuid>
    <ao:exact>9-hydroxyrisperidone</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix>xsd:String</ao:suffix>
    <pav:createdOn>2014-07-16 10:23:02 -0700</pav:createdOn>
    <ao:prefix>xsd:String</ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:EEAF2259-5093-4FDA-A5B5-9FB724127DB0">
    <ao:prefix> is well absorbed. The absolute oral bioavailability of </ao:prefix>
    <pav:createdOn>2014-07-16 10:19:38 -0700</pav:createdOn>
    <ao:exact>risperidone</ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:EEAF2259-5093-4FDA-A5B5-9FB724127DB0"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid></domeo:uuid>
    <ao:suffix> is 70% (CV=25%). The relative oral bioavailability of risperidone from a tablet is 94% (CV=10%) when compared to a solution.</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <domeo:uuid>EEAF2259-5093-4FDA-A5B5-9FB724127DB0</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/165E87BD-01D4-4D78-8A0D-F6089ECEF3AA">
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/4450</dailymed:activeMoietyRxCUI>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdfs:label>fluconazole</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:48E274BA-EE97-464C-9512-861F9207381F">
    <pav:lineageUri>urn:domeoserver:annotation:C8630003-1312-4A7A-979E-E1F79183B296</pav:lineageUri>
    <pav:lastSavedOn>2014-07-15 17:30:45 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E8194531-C5B3-43AE-BC13-14A252C54824</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">6</pav:versionNumber>
    <ao:body rdf:nodeID="N90eccee110fe4b1ab9a2d69527543e98"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
    <domeo:belongsToSet>urn:domeoserver:annotationset:5758DAC0-E1C0-49EB-BE9C-56FFBAF3B6F4</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotation:65F382D6-594A-4E03-A813-645517AB85AD</pav:lineageUri>
    <ao:body rdf:nodeID="Nae05c13f18064a84ac606c8afc944091"/>
    <ao:body rdf:nodeID="Nad12fcfe73cf48d88f8563a744c2f25d"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:3D2F7357-CD2E-446B-8A85-437E7D90CAA9"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E6A1493E-98EE-4FDE-9301-752AB8E3453F</domeo:belongsToSet>
    <ao:body rdf:nodeID="N789347a8eb994eeaaae16cbf6eb02d59"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lastSavedOn>2014-07-15 14:30:47 -0700</pav:lastSavedOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoserver:annotationset:5B6A462D-57EA-4BBD-87E1-A0EC2FAF5196</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotation:F4A456F1-2863-4C9C-8F1E-61301EC77F36</pav:lineageUri>
    <ao:body rdf:nodeID="Nde005fba6b0542c8a71e07e71f5a3232"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:46636445-93A2-49F0-9E9C-5AEBF17046D2</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-15 17:30:47 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:21B0E479-04F9-4D66-B396-B773EFE53882</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotationset:75FC1225-8399-469B-AE9D-7F697713E6AC</pav:lineageUri>
    <pav:lastSavedOn>2014-07-15 17:30:43 -0400</pav:lastSavedOn>
    <pav:previousVersion>urn:domeoserver:annotationset:883587E1-49C1-4EE0-909E-4ADBAE13DD3A</pav:previousVersion>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <ao:body rdf:nodeID="Nca1d22992ec443e29ab296850be1ce8a"/>
    <pav:createdOn>2014-07-15 14:24:15 -0700</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/F42BBCFB-733A-404A-8BEB-B260F9A5A30B">
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <rdfs:label>sildenafil</rdfs:label>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/136411</dailymed:activeMoietyRxCUI>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:AF9D4143-A4AD-4E55-AADC-39F03048D6F3">
    <pav:createdOn>2014-07-16 10:20:10 -0700</pav:createdOn>
    <ao:exact>9-hydroxyrisperidone</ao:exact>
    <ao:suffix>, and risperidone plus 9-hydroxyrisperidone are dose proportional over the dosing range of 1 to 16 mg daily (0.5 to 8 mg twice daily). Following oral administration of solution or tablet, mean peak plasma concentrations of risperidone occurred at about 1</ao:suffix>
    <domeo:uuid>AF9D4143-A4AD-4E55-AADC-39F03048D6F3</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:AF9D4143-A4AD-4E55-AADC-39F03048D6F3"/>
    <ao:prefix>, its major metabolite, </ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:3F3050AD-E886-4649-8017-65F649BAA9E7">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:3F3050AD-E886-4649-8017-65F649BAA9E7"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix> combined, after single and multiple doses, are similar in extensive and poor metabolizers.</ao:suffix>
    <pav:createdOn>2014-07-15 14:15:13 -0700</pav:createdOn>
    <ao:exact>9-hydroxyrisperidone</ao:exact>
    <domeo:uuid></domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>3F3050AD-E886-4649-8017-65F649BAA9E7</domeo:uuid>
    <ao:prefix> and </ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:ABA94567-EA53-40B6-AF02-E6FC02E40AD6">
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
    <pav:lastSavedOn>2014-07-16 15:40:55 -0700</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoclient:uuid:98DABE9A-9F89-4DF9-9DEE-B6853D1F5CC1</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:FE1313C3-E1E7-419F-9B99-0AFA7CE149F5"/>
    <pav:lastSavedOn>2014-07-16 18:40:55 -0400</pav:lastSavedOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E3DA2E5E-FC19-4C22-AF6C-A9CB4B450554</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotation:D6D403B6-0AB7-4752-BF22-C8CEC77D1E23</pav:lineageUri>
    <pav:createdOn>2014-07-16 15:40:52 -0700</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/73909726-6159-4FE8-9D74-430BABED53E4">
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <rdfs:label>risperidone</rdfs:label>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/35636</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:21180C8D-1095-4E2F-9A46-484DCC01879D">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <ao:body rdf:nodeID="N0f1ed5582b544732b7e7ced219fa898e"/>
    <pav:createdOn>2014-07-10 11:24:33 -0700</pav:createdOn>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
    <pav:lastSavedOn>2014-07-10 14:25:16 -0400</pav:lastSavedOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:3ABC05DD-EC5F-4576-86DC-D8C25A0E287D"/>
    <pav:lineageUri>urn:domeoserver:annotation:6B2FA09F-EFA4-4175-BB0D-C5E1AA855337</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:15A537D1-5648-41B2-8BFA-0D0BA3DF4393</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoserver:annotationset:99826AC3-3668-4F74-9E9D-DADD1F7098F0">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <rdfs:label>Default Set</rdfs:label>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <pav:createdOn>2014-07-18 13:55:33 -0700</pav:createdOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">2</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotationset:C084ABD9-9B0C-479B-B9AC-42D7E6E50879</pav:lineageUri>
    <ao:item rdf:resource="urn:domeoclient:uuid:17BE6274-5C33-43EE-85E7-EC723ACF1134"/>
    <dct:description>The default set is created automatically by Domeo when no other set is existing.</dct:description>
    <ao:item rdf:resource="urn:domeoclient:uuid:DAD17BCA-9CFC-4DE8-932B-E68F8A5FAD45"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:688A40AF-929E-4DEA-858A-D3762D3C014B"/>
    <domeo:agents rdf:resource="urn:person:uuid:080e143046812afe0146812ce85a0000"/>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-27.txt.html</ao:annotatesResource>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
    <pav:previousVersion>urn:domeoclient:uuid:82AC5ADA-B8CE-47A9-AA99-E7187ABEFACA</pav:previousVersion>
    <ao:item rdf:resource="urn:domeoclient:uuid:F6C87C3C-DE3E-4C1E-A1AE-B620C6D1B31E"/>
    <permissions:permissions rdf:nodeID="N2c6184f82bc04dba9b0a60124e85282d"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:35CDD2E7-70B2-4586-B719-AE865BE6C293"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lastSavedOn>2014-07-18 16:59:52 -0400</pav:lastSavedOn>
    <ao:item rdf:resource="urn:domeoclient:uuid:9A5182DA-4DAC-48D6-946F-8283D026674F"/>
    <domeo:deleted>false</domeo:deleted>
    <ao:item rdf:resource="urn:domeoclient:uuid:4BD1F108-6B86-46B9-94ED-17733AF67E71"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:9F493B28-AE3A-4E32-85C4-AE2C806F7BDA">
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:9F493B28-AE3A-4E32-85C4-AE2C806F7BDA"/>
    <domeo:uuid></domeo:uuid>
    <pav:createdOn>2014-07-15 14:02:34 -0700</pav:createdOn>
    <ao:exact>risperidone</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix>The mechanism of action of </ao:prefix>
    <ao:suffix>, as with other drugs used to treat schizophrenia, is unknown. However, it has been proposed that the drug’s therapeutic activity in schizophrenia is mediated through a combination of dopamine Type 2 (D2) and serotonin Type 2 (5HT2) receptor antagonism.</ao:suffix>
    <domeo:uuid>9F493B28-AE3A-4E32-85C4-AE2C806F7BDA</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N898eb35cd03a44da9bf4e02d06b4a3b0">
    <domeo:sets rdf:resource="urn:pddi:uuid:C2EEB01B-C8CC-4696-9720-1CBC5FFF068B"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/E6B9269E-0F1E-4EA7-9B11-2B410071D56E">
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdfs:label>9-hydroxyrisperidone</rdfs:label>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/679314</dailymed:activeMoietyRxCUI>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/metabolite"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N81442154b0614b38834e53fe09f8a316">
    <domeo:sets rdf:resource="urn:pddi:uuid:AFC84332-4270-4613-97A1-CFC4BE857816"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:FC5E2AEC-F9BE-4E70-A265-19B20FB3E3D2">
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:5E7E2FCC-1143-4814-9FC9-A8EC73AFF960"/>
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:DB032524-38CD-456B-A44B-C425DFD76D47">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:DB032524-38CD-456B-A44B-C425DFD76D47"/>
    <ao:suffix> to interfere with metabolism of other drugs metabolized by CYP 2D6. Relatively weak binding of risperidone to the enzyme suggests this is unlikely [see 7 DRUG INTERACTIONS].</ao:suffix>
    <domeo:uuid></domeo:uuid>
    <domeo:uuid>DB032524-38CD-456B-A44B-C425DFD76D47</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix> [see 7 DRUG INTERACTIONS]. It would also be possible for </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>risperidone</ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <pav:createdOn>2014-07-15 14:16:48 -0700</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:B372AAFD-51DF-43D9-B838-0F98E9692F16">
    <ao:body rdf:nodeID="N85089624aa664b80b60b53d56d87cc39"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:FF76049E-6B2C-46A9-ACF7-CA565C8087F3</domeo:belongsToSet>
    <pav:createdOn>2014-07-18 13:45:45 -0700</pav:createdOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
    <pav:lineageUri>urn:domeoserver:annotation:7D45B6D7-391F-41FC-9D7B-0B3F18F4A9B7</pav:lineageUri>
    <pav:lastSavedOn>2014-07-18 16:46:22 -0400</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:AB5F4799-5045-4FBD-ACF4-AFCEB256A943"/>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:0BB528F0-CD4A-4BAC-AA5B-3FF33FCFF9B7">
    <domeo:uuid></domeo:uuid>
    <ao:prefix>xsd:String</ao:prefix>
    <pav:createdOn>2014-07-15 14:09:39 -0700</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:0BB528F0-CD4A-4BAC-AA5B-3FF33FCFF9B7"/>
    <domeo:uuid>0BB528F0-CD4A-4BAC-AA5B-3FF33FCFF9B7</domeo:uuid>
    <ao:suffix> at 10 ng/mL and 9-hydroxyrisperidone at 50 ng/mL, changes of unknown clinical significance</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <ao:exact>risperidone</ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:17BE6274-5C33-43EE-85E7-EC723ACF1134">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lastSavedOn>2014-07-18 13:56:04 -0700</pav:lastSavedOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdOn>2014-07-18 13:55:55 -0700</pav:createdOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
    <domeo:belongsToSet>urn:domeoserver:annotationset:99826AC3-3668-4F74-9E9D-DADD1F7098F0</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-18 16:56:04 -0400</pav:lastSavedOn>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotation:B2598027-6899-4DCC-B719-FEB8338FFA83</pav:lineageUri>
    <ao:context rdf:resource="urn:domeoclient:uuid:DBB0F4E1-DD60-4C7C-94FB-551FD745535F"/>
    <domeo:belongsToSet>urn:domeoclient:uuid:82AC5ADA-B8CE-47A9-AA99-E7187ABEFACA</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:0846F768-2376-4051-A905-427746D087A6">
    <pav:createdOn>2014-07-15 14:15:37 -0700</pav:createdOn>
    <domeo:uuid></domeo:uuid>
    <ao:exact>quinidine</ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:0846F768-2376-4051-A905-427746D087A6"/>
    <domeo:uuid>0846F768-2376-4051-A905-427746D087A6</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix> [see 7 DRUG INTERACTIONS]. This occurs with </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <ao:suffix>, giving essentially all recipients a risperidone pharmacokinetic profile typical of poor metabolizers. The therapeutic benefits and adverse effects of risperidone in patients receiving quinidine have not been evaluated, but observations in a modest numb</ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:71089688-5934-49A8-BBF4-07B4CAD41AA7">
    <pav:lineageUri>urn:domeoserver:annotation:99EA2F48-346F-49BD-AB11-D7E9FF8B2671</pav:lineageUri>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E8194531-C5B3-43AE-BC13-14A252C54824</domeo:belongsToSet>
    <pav:previousVersion>urn:domeoserver:annotationset:2E5CE73B-BFD4-4E35-9A07-D5E37A9E87AE</pav:previousVersion>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">4</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotationset:75FC1225-8399-469B-AE9D-7F697713E6AC</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoserver:annotationset:46636445-93A2-49F0-9E9C-5AEBF17046D2</domeo:belongsToSet>
    <pav:createdOn>2014-07-15 14:13:56 -0700</pav:createdOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:570DA392-7779-456C-9C18-1FC0E579BBE6</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:5758DAC0-E1C0-49EB-BE9C-56FFBAF3B6F4</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:21B0E479-04F9-4D66-B396-B773EFE53882</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
    <domeo:belongsToSet>urn:domeoserver:annotationset:5B6A462D-57EA-4BBD-87E1-A0EC2FAF5196</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E6A1493E-98EE-4FDE-9301-752AB8E3453F</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:883587E1-49C1-4EE0-909E-4ADBAE13DD3A</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-15 17:17:26 -0400</pav:lastSavedOn>
    <pav:lastSavedOn>2014-07-15 14:17:25 -0700</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9C0B4E8B-9FFE-4E47-9B4C-A6EA4527A384</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:E8921F3A-7792-4582-AEB4-1956E549C6E3"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:FC5E4603-2CB7-4D28-ABE9-54E9294FD8DC">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:FC5E4603-2CB7-4D28-ABE9-54E9294FD8DC"/>
    <domeo:uuid></domeo:uuid>
    <domeo:uuid>FC5E4603-2CB7-4D28-ABE9-54E9294FD8DC</domeo:uuid>
    <ao:prefix> are dose proportional over the dosing range of 1 to 16 mg daily (0.5 to 8 mg twice daily). Following oral administration of solution or tablet, mean peak plasma concentrations of </ao:prefix>
    <ao:suffix> occurred at about 1 hour. Peak concentrations of 9-hydroxyrisperidone occurred at about 3 hours in extensive metabolizers, and 17 hours in poor metabolizers. Steady-state concentrations of risperidone are reached in 1 day in extensive metabolizers and w</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2014-07-15 14:06:47 -0700</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <ao:exact>risperidone</ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:BF7C4530-2603-4D20-BBB8-214E7FEF4085">
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:8495478D-931C-477B-8658-0378929F1BAF"/>
    <dikbD2R:modality>ncit:negative</dikbD2R:modality>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:B2C03A2F-0DF1-4E82-B58C-1909B3460EAA">
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lastSavedOn>2014-07-16 15:40:55 -0700</pav:lastSavedOn>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotation:9DA9A31B-CA56-4204-B178-1E74EE6E1E6F</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
    <domeo:belongsToSet>urn:domeoclient:uuid:98DABE9A-9F89-4DF9-9DEE-B6853D1F5CC1</domeo:belongsToSet>
    <pav:createdOn>2014-07-16 15:40:36 -0700</pav:createdOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E3DA2E5E-FC19-4C22-AF6C-A9CB4B450554</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-16 18:40:55 -0400</pav:lastSavedOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:3F6F9929-F258-49DD-AEE9-BEC5C27775EF"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:58CDDE97-D8B0-4830-BB7A-AAE058957A70">
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:F0AE4B90-85AC-42C7-B80E-8A27A4B6E455"/>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <dikbD2R:modality>ncit:negative</dikbD2R:modality>
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:A4BD01D1-8101-4C58-92D8-CF144E1497B9">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:A4BD01D1-8101-4C58-92D8-CF144E1497B9"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix>In a study performed in healthy volunteers, co-administration of the HIV protease inhibitor </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:hasSource>
    <ao:exact>saquinavir</ao:exact>
    <domeo:uuid>A4BD01D1-8101-4C58-92D8-CF144E1497B9</domeo:uuid>
    <ao:suffix>, a CYP3A inhibitor, at steady state (1200 mg TID) with sildenafil (100 mg single dose) resulted in a 140% increase in sildenafil Cmax and a 210% increase in sildenafil AUC.</ao:suffix>
    <pav:createdOn>2014-07-10 11:15:31 -0700</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/8AE718F6-37B9-4BDF-AFE7-EDA5106A59F7">
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdfs:label>quinidine</rdfs:label>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/9068</dailymed:activeMoietyRxCUI>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:5A671621-83D0-48B3-B249-7E1ECC849539">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoclient:uuid:5C7A7116-C174-4EB1-933E-3A46CEE71709</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:A8C9B71B-88CF-40BB-B2E7-05BB8108A261"/>
    <pav:lastSavedOn>2014-07-16 18:33:07 -0400</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
    <pav:lineageUri>urn:domeoserver:annotation:49CBA713-B014-4716-A3DE-3CCD23680F73</pav:lineageUri>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:0F87EEF0-40A6-43E2-8222-95E7D1335A0B</domeo:belongsToSet>
    <pav:createdOn>2014-07-16 15:32:46 -0700</pav:createdOn>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lastSavedOn>2014-07-16 15:33:06 -0700</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotationset:7AE68AC7-9B47-4954-8C65-45A6F0DC80C2</pav:lineageUri>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:368B4BB2-B03B-4EBF-97A2-1D8357999CE7">
    <pav:createdOn>2014-07-15 14:10:17 -0700</pav:createdOn>
    <ao:suffix>. Consequently, the clinical effect of the drug results from the combined concentrations of risperidone plus 9-hydroxyrisperidone.</ao:suffix>
    <ao:exact>risperidone</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:368B4BB2-B03B-4EBF-97A2-1D8357999CE7"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>368B4BB2-B03B-4EBF-97A2-1D8357999CE7</domeo:uuid>
    <ao:prefix>, has similar pharmacological activity as </ao:prefix>
    <domeo:uuid></domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:05F3AC40-8EB1-409A-9E01-317E8C07400C">
    <pav:createdOn>2014-07-16 14:03:26 -0700</pav:createdOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:C2A39432-076D-421D-8007-22690EDA5A0C</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
    <pav:lastSavedOn>2014-07-16 17:06:30 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotation:62B1B85D-E1E5-47D8-A52B-555785D4F8AE</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:AD2FD8CD-1032-462E-833D-451021CE67B2</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoclient:uuid:8C39EA63-3E52-40B4-8935-6ADC75CCA74D</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:81CA85AD-8F73-41B9-AEC4-5F2B934C9D93"/>
    <pav:lastSavedOn>2014-07-16 14:06:30 -0700</pav:lastSavedOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:B3F0B84F-756D-4724-B177-98D0D290D00D</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:4A892E21-8734-4284-A9E5-E434991F2B9C">
    <ao:prefix>xsd:String</ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:4A892E21-8734-4284-A9E5-E434991F2B9C"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:hasSource>
    <ao:exact>In a study of healthy volunteers, sildenafil (100 mg) did not affect the steady-state pharmacokinetics of the HIV protease inhibitors saquinavir and ritonavir, both of which are CYP3A substrates</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>4A892E21-8734-4284-A9E5-E434991F2B9C</domeo:uuid>
    <pav:createdOn>2014-07-10 11:25:13 -0700</pav:createdOn>
    <ao:suffix>xsd:String</ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:9006A3C1-1FFE-448B-887C-2F101EC30804">
    <pav:createdOn>2014-07-16 15:46:07 -0700</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>administration of cimetidine 600 mg to 900 mg intravenously over a four-hour period (from one hour before to 3 hours after a single oral dose of fluconazole 200 mg) did not affect the bioavailability or pharmacokinetics of fluconazole in 24 healthy male volunteers</ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:9006A3C1-1FFE-448B-887C-2F101EC30804"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>9006A3C1-1FFE-448B-887C-2F101EC30804</domeo:uuid>
    <ao:suffix>xsd:String</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-23.txt.html</ao:hasSource>
    <ao:prefix>. However, the </ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:4D132ADB-A976-4F25-A18F-56BA89AC252A">
    <pav:lastSavedOn>2014-07-16 17:06:30 -0400</pav:lastSavedOn>
    <pav:createdOn>2014-07-16 14:04:24 -0700</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotation:84C63164-1C2E-423B-AC89-9F2233720C18</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:99CBB508-3AAE-4160-9820-7A057C3D6498"/>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoclient:uuid:8C39EA63-3E52-40B4-8935-6ADC75CCA74D</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:B8206C01-73E3-49C2-B300-B5B0DE6FBC1B">
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:5E2AECBE-2BC8-474F-A9DF-7464B1923A05"/>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:977E8B6B-E0A2-4EB3-998A-A0DCF25EB2D6">
    <pav:createdOn>2014-07-15 14:06:52 -0700</pav:createdOn>
    <ao:exact>9-hydroxyrisperidone</ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:977E8B6B-E0A2-4EB3-998A-A0DCF25EB2D6"/>
    <domeo:uuid>977E8B6B-E0A2-4EB3-998A-A0DCF25EB2D6</domeo:uuid>
    <ao:prefix> occurred at about 1 hour. Peak concentrations of </ao:prefix>
    <ao:suffix> occurred at about 3 hours in extensive metabolizers, and 17 hours in poor metabolizers. Steady-state concentrations of risperidone are reached in 1 day in extensive metabolizers and would be expected to reach steady-state in about 5 days in poor metabol</ao:suffix>
    <domeo:uuid></domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N1971c3847c1c44868084bc0e7fe59b4f">
    <domeo:sets rdf:resource="urn:pddi:uuid:0995BA18-F2BB-481E-9F1F-AA682807B4CC"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N03481a990efd4a81b1875ff213414888">
    <domeo:sets rdf:resource="urn:pddi:uuid:8F4A61A4-B256-44BA-A917-3B5D6CDEEC4F"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:B8AA7B02-72B4-4632-9BDA-34C02C628D9A">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:B8AA7B02-72B4-4632-9BDA-34C02C628D9A"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix> is not considered clinically relevant. The effect of sildenafil on epoprostenol pharmacokinetics is not known.</ao:suffix>
    <pav:createdOn>2014-07-10 11:20:31 -0700</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid>B8AA7B02-72B4-4632-9BDA-34C02C628D9A</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:hasSource>
    <ao:exact>epoprostenol</ao:exact>
    <ao:prefix> exposure in the presence of </ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:4B77AEB1-052D-442D-91E6-921DAD259BC6">
    <ao:suffix> (100 mg) did not affect the steady-state pharmacokinetics of the HIV protease inhibitors saquinavir and ritonavir, both of which are CYP3A substrates.</ao:suffix>
    <domeo:uuid>4B77AEB1-052D-442D-91E6-921DAD259BC6</domeo:uuid>
    <ao:exact>sildenafil</ao:exact>
    <pav:createdOn>2014-07-10 11:20:41 -0700</pav:createdOn>
    <ao:prefix>In a study of healthy volunteers, </ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:4B77AEB1-052D-442D-91E6-921DAD259BC6"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/2582CF1F-9DA7-49BA-8998-D5BD27B5134B">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdfs:label>sulfamethazine</rdfs:label>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/</dailymed:activeMoietyRxCUI>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:3443022F-68AE-4016-8363-C6C96EE0AE69">
    <ao:exact>In a study of healthy male volunteers, co-administration of sildenafil at steady state (80 mg TID) with bosentan (a moderate inducer of CYP3A, CYP2C9 and possibly of cytochrome P450 2C19) at steady state (125 mg BID) resulted in a 63% decrease of sildenafil AUC and a 55% decrease in sildenafil Cmax</ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:3443022F-68AE-4016-8363-C6C96EE0AE69"/>
    <pav:createdOn>2014-07-10 11:21:39 -0700</pav:createdOn>
    <ao:prefix>xsd:String</ao:prefix>
    <ao:suffix>. Co-administration resulted in a 50% increase in AUC of</ao:suffix>
    <domeo:uuid>3443022F-68AE-4016-8363-C6C96EE0AE69</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N0f15fcd8a07045cc85ba92f52b42b156">
    <domeo:sets rdf:resource="urn:pddi:uuid:0D248DC0-8452-431C-B6AC-BAE6D8DD90A8"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:B9DE1789-19F9-43BC-B292-659F900EA6EB">
    <domeo:belongsToSet>urn:domeoserver:annotationset:516C333C-B517-4F84-999E-51185DD6E859</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:3F81414E-B149-4B05-925B-18735B554A13</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotation:6A83C9D2-32BF-47FE-8FCD-DD0E108CBF21</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:2BFC2FB6-6BE9-4822-A245-973533533023</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-10 14:14:30 -0400</pav:lastSavedOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:239B4C6D-1110-4B65-AC66-F8A394187814</domeo:belongsToSet>
    <pav:createdOn>2014-07-10 11:10:42 -0700</pav:createdOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:15A537D1-5648-41B2-8BFA-0D0BA3DF4393</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoserver:annotationset:970963DF-8BCE-4936-9DFC-328A36014E1B</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-10 11:14:30 -0700</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <ao:context rdf:resource="urn:domeoclient:uuid:587BEAE7-8AE9-4452-8478-FF400284EBF7"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:DBBBAD55-D12B-4890-A2AF-85D3C85A7BEF</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:D31038BF-BD20-49DC-B15A-84202B180FA2">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix>i</ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2014-07-10 11:19:20 -0700</pav:createdOn>
    <ao:exact>l</ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:hasSource>
    <domeo:uuid>D31038BF-BD20-49DC-B15A-84202B180FA2</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:D31038BF-BD20-49DC-B15A-84202B180FA2"/>
    <ao:suffix>denafil at steady state (80 mg TID) with bosentan (a moderate inducer of CYP3A, CYP2C9 and possibly of cytochrome P450 2C19) at steady state (125 mg BID) resulted in a 63% decrease of sildenafil AUC and a 55% decrease in sildenafil Cmax. Co-administratio</ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:914C2061-E547-4CFD-9F3C-C0070F56BF90">
    <domeo:belongsToSet>urn:domeoserver:annotationset:570DA392-7779-456C-9C18-1FC0E579BBE6</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-15 17:17:26 -0400</pav:lastSavedOn>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E6A1493E-98EE-4FDE-9301-752AB8E3453F</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">4</pav:versionNumber>
    <ao:context rdf:resource="urn:domeoclient:uuid:5261237F-686F-41D7-B860-16364A944D37"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:883587E1-49C1-4EE0-909E-4ADBAE13DD3A</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:21B0E479-04F9-4D66-B396-B773EFE53882</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:previousVersion>urn:domeoserver:annotationset:2E5CE73B-BFD4-4E35-9A07-D5E37A9E87AE</pav:previousVersion>
    <pav:lastSavedOn>2014-07-15 14:17:25 -0700</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:5B6A462D-57EA-4BBD-87E1-A0EC2FAF5196</domeo:belongsToSet>
    <pav:createdOn>2014-07-15 14:16:19 -0700</pav:createdOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:5758DAC0-E1C0-49EB-BE9C-56FFBAF3B6F4</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotationset:75FC1225-8399-469B-AE9D-7F697713E6AC</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E8194531-C5B3-43AE-BC13-14A252C54824</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:46636445-93A2-49F0-9E9C-5AEBF17046D2</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9C0B4E8B-9FFE-4E47-9B4C-A6EA4527A384</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotation:6147AD26-817D-49C3-A33C-C08D5ACFD3DA</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:2A97A957-DB63-4FC3-8222-06DF0BB64008">
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:5DC499BD-96C5-48A8-97BC-0704A7E34C48"/>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Ncb4832c4e4724406a354f03e0fe85ae0">
    <permissions:isLocked>false</permissions:isLocked>
    <permissions:accessType>urn:domeo:access:public</permissions:accessType>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:92F5F5C5-9A9C-4B47-AB81-A514809088C8">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lastSavedOn>2014-07-18 17:20:41 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:7BA312DF-BB65-4A90-8B7D-A54425D7C553</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotationset:1EE1D64B-EDD4-4170-B797-D8F83B927DCE</pav:lineageUri>
    <rdfs:label>Highlight</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:66EB6B71-8574-4EC7-B3B5-BA3D58493C78"/>
    <pav:lineageUri>urn:domeoserver:annotation:C009D68F-8D89-464E-ABA7-2A78EE96DD5E</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoclient:uuid:51A184F8-19CA-4489-AB8F-9AF92E4BE5BE</domeo:belongsToSet>
    <pav:createdOn>2014-07-18 14:20:23 -0700</pav:createdOn>
    <pav:lastSavedOn>2014-07-18 14:20:41 -0700</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:F8EED65F-31D9-41A0-9BB4-436FCBA969FA">
    <domeo:belongsToSet>urn:domeoserver:annotationset:5758DAC0-E1C0-49EB-BE9C-56FFBAF3B6F4</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotation:98EDA90E-C90D-4D63-98A6-D0E5B5AB1A9D</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:5B6A462D-57EA-4BBD-87E1-A0EC2FAF5196</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E8194531-C5B3-43AE-BC13-14A252C54824</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:883587E1-49C1-4EE0-909E-4ADBAE13DD3A</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:9AEC1350-B38C-47B6-8956-CA137F414E0B"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:46636445-93A2-49F0-9E9C-5AEBF17046D2</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:21B0E479-04F9-4D66-B396-B773EFE53882</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lastSavedOn>2014-07-15 14:19:34 -0700</pav:lastSavedOn>
    <pav:createdOn>2014-07-15 14:19:21 -0700</pav:createdOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E6A1493E-98EE-4FDE-9301-752AB8E3453F</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-15 17:19:32 -0400</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotation:072DB09A-99A4-403A-972C-3FEAD37BA60E</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9C0B4E8B-9FFE-4E47-9B4C-A6EA4527A384</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lastSavedOn>2014-07-15 17:19:34 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:5DF27E07-C0B9-48CC-97AF-10E8A9830A54">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2014-07-15 14:07:09 -0700</pav:createdOn>
    <ao:prefix> are reached in 1 day in extensive metabolizers and would be expected to reach steady-state in about 5 days in poor metabolizers. Steady-state concentrations of </ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:5DF27E07-C0B9-48CC-97AF-10E8A9830A54"/>
    <ao:exact>9-hydroxyrisperidone</ao:exact>
    <ao:suffix> are reached in 5 to 6 days (measured in extensive metabolizers).</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid>5DF27E07-C0B9-48CC-97AF-10E8A9830A54</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <domeo:uuid></domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:EEA8D937-1DA8-4F98-9D1E-B48786184636">
    <pav:createdOn>2014-07-18 13:51:15 -0700</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-26.txt.html</ao:hasSource>
    <ao:suffix> 200 mg daily for 14 days in eight renal transplant patients who had been on cyclosporine therapy for at least 6 months and on a stable cyclosporine dose for at least 6 weeks. There was a significant increase in cyclosporine AUC, Cmax, Cmin (24-hour conc</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:EEA8D937-1DA8-4F98-9D1E-B48786184636"/>
    <ao:prefix> AUC and Cmax were determined before and after the administration of</ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>EEA8D937-1DA8-4F98-9D1E-B48786184636</domeo:uuid>
    <ao:exact> fluconazole</ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:27F79494-9F47-4316-BFC1-FA15F20D67F3">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/84869E15-996D-41E7-8095-C6D364FE9596"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/FF754DDF-CE5F-4069-98EC-C8B743F74D04"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:C2EEB01B-C8CC-4696-9720-1CBC5FFF068B">
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:D5A340B0-D3A4-41A6-BBFF-E7008548903E"/>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:5CE6135C-97A9-4B21-9915-11E87A1697A5">
    <domeo:belongsToSet>urn:domeoserver:annotationset:9C0B4E8B-9FFE-4E47-9B4C-A6EA4527A384</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:A8C40C51-0B43-4493-80CC-949EA671E491"/>
    <pav:lastSavedOn>2014-07-15 14:19:34 -0700</pav:lastSavedOn>
    <pav:createdOn>2014-07-15 14:18:55 -0700</pav:createdOn>
    <pav:lastSavedOn>2014-07-15 17:19:32 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:5B6A462D-57EA-4BBD-87E1-A0EC2FAF5196</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:5758DAC0-E1C0-49EB-BE9C-56FFBAF3B6F4</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
    <domeo:belongsToSet>urn:domeoserver:annotationset:46636445-93A2-49F0-9E9C-5AEBF17046D2</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E6A1493E-98EE-4FDE-9301-752AB8E3453F</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotation:0FD3599A-19CB-44D9-9A0D-418DD52A028E</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:883587E1-49C1-4EE0-909E-4ADBAE13DD3A</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:21B0E479-04F9-4D66-B396-B773EFE53882</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotation:9EEF5EF6-F6F0-436C-A2A1-B786DCDF7C27</pav:lineageUri>
    <pav:lastSavedOn>2014-07-15 17:19:34 -0400</pav:lastSavedOn>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E8194531-C5B3-43AE-BC13-14A252C54824</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:CFD4FFA0-934F-4003-A721-60AFD1521572">
    <ao:exact>risperidone</ao:exact>
    <pav:createdOn>2014-07-15 14:03:43 -0700</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>CFD4FFA0-934F-4003-A721-60AFD1521572</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <ao:prefix> is 70% (CV=25%). The relative oral bioavailability of </ao:prefix>
    <domeo:uuid></domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:CFD4FFA0-934F-4003-A721-60AFD1521572"/>
    <ao:suffix> from a tablet is 94% (CV=10%) when compared to a solution.</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:9DDF1E26-0943-47B1-807E-9B8D4B5EBA05">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/EA846F11-F8CD-42D1-8BB5-6033431D84BF"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/601715ED-5AF4-42B7-BA5F-9E7FC0592FF6"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:7CD9615A-69D6-4A70-94B2-EF43CF591997">
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
    <pav:lineageUri>urn:domeoserver:annotation:538DF711-0B4B-4C7A-95F1-8D230373AEF7</pav:lineageUri>
    <pav:lastSavedOn>2014-07-17 18:59:36 -0400</pav:lastSavedOn>
    <rdfs:label>Highlight</rdfs:label>
    <ao:context rdf:resource="urn:domeoclient:uuid:DB99EE39-D6AF-4C66-A7BF-D1186DCE23D6"/>
    <domeo:belongsToSet>urn:domeoclient:uuid:83B2E87D-3732-4699-AA3D-363A6EB95959</domeo:belongsToSet>
    <pav:createdOn>2014-07-17 15:59:07 -0700</pav:createdOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotationset:B716A719-3E66-4B72-87E0-370D90F3B8F7</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:8DEBE5AF-B171-4BE8-880B-76A2BEE742A6</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-17 15:59:35 -0700</pav:lastSavedOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:7A239FA7-0EC5-40B4-BB98-C16757BB8044">
    <ao:prefix>In a study of healthy male volunteers, co-administration of </ao:prefix>
    <pav:createdOn>2014-07-10 11:19:20 -0700</pav:createdOn>
    <domeo:uuid>7A239FA7-0EC5-40B4-BB98-C16757BB8044</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:7A239FA7-0EC5-40B4-BB98-C16757BB8044"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix>ildenafil at steady state (80 mg TID) with bosentan (a moderate inducer of CYP3A, CYP2C9 and possibly of cytochrome P450 2C19) at steady state (125 mg BID) resulted in a 63% decrease of sildenafil AUC and a 55% decrease in sildenafil Cmax. Co-administrat</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>s</ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/929638DA-F799-437F-8033-228CF8F46D12">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdfs:label>warfarin</rdfs:label>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/11289</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:DFDD5EFD-409F-40D4-A7AC-80093B99AAFA">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/6B41C1F2-B78D-4561-B417-EC840EB0B22D"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/2A063602-BECD-4E27-881B-DF86652CE970"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:4B8784BF-1D41-417E-A20C-C9B069D76FAA">
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:C54C358E-1731-4D93-820E-2F87B9D286FE"/>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/D8D8ADB4-7CA8-48E1-AC8A-2DBE43F6BB49">
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/4450</dailymed:activeMoietyRxCUI>
    <rdfs:label>fluconazole</rdfs:label>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:85B5BEBE-D146-414B-A979-B9CEBE9C57E6">
    <pav:lastSavedOn>2014-07-15 17:17:26 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E6A1493E-98EE-4FDE-9301-752AB8E3453F</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:5B6A462D-57EA-4BBD-87E1-A0EC2FAF5196</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoserver:annotationset:21B0E479-04F9-4D66-B396-B773EFE53882</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoserver:annotationset:570DA392-7779-456C-9C18-1FC0E579BBE6</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-15 14:17:25 -0700</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotationset:75FC1225-8399-469B-AE9D-7F697713E6AC</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
    <pav:previousVersion>urn:domeoserver:annotationset:2E5CE73B-BFD4-4E35-9A07-D5E37A9E87AE</pav:previousVersion>
    <pav:createdOn>2014-07-15 14:15:08 -0700</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotation:CE6676D0-90AF-4A98-82CD-A79AE0C4121F</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">4</pav:versionNumber>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:A0FB0C6E-5133-4379-A6A1-718CC8383F46"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:5758DAC0-E1C0-49EB-BE9C-56FFBAF3B6F4</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9C0B4E8B-9FFE-4E47-9B4C-A6EA4527A384</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:46636445-93A2-49F0-9E9C-5AEBF17046D2</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E8194531-C5B3-43AE-BC13-14A252C54824</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:883587E1-49C1-4EE0-909E-4ADBAE13DD3A</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:ED9173BA-30D7-4181-85F1-37CC30DFF11C">
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
    <pav:lineageUri>urn:domeoserver:annotation:91B6BCED-352C-41A2-A725-0795735E3D88</pav:lineageUri>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:8DEBE5AF-B171-4BE8-880B-76A2BEE742A6</domeo:belongsToSet>
    <pav:createdOn>2014-07-17 15:58:55 -0700</pav:createdOn>
    <pav:lastSavedOn>2014-07-17 18:59:36 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotationset:B716A719-3E66-4B72-87E0-370D90F3B8F7</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lastSavedOn>2014-07-17 15:59:35 -0700</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoclient:uuid:83B2E87D-3732-4699-AA3D-363A6EB95959</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:446A1126-39C6-4A5E-8A9C-13D15F81AD8C"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:7A5B87F1-0D90-49BD-B71F-1710FF095850">
    <pav:lastSavedOn>2014-07-18 17:03:19 -0400</pav:lastSavedOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lineageUri>urn:domeoserver:annotation:8C3E5CDC-F7E4-4740-BCAF-10F714FB2459</pav:lineageUri>
    <pav:createdOn>2014-07-18 14:02:43 -0700</pav:createdOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotationset:9AA0507C-281E-45C8-9719-03E66F12C069</pav:lineageUri>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoclient:uuid:E65FF29A-8FE7-4D0E-A93C-4DA8136F4956</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
    <ao:context rdf:resource="urn:domeoclient:uuid:5B73CF3F-C910-4D04-9121-43AA38BE7F2F"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:6DBCB873-26F3-4E6A-9BD4-311369B43736</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-18 14:03:19 -0700</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:E2A636FF-8FE8-44E9-B454-573E4E7470FA">
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E8194531-C5B3-43AE-BC13-14A252C54824</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:9F493B28-AE3A-4E32-85C4-AE2C806F7BDA"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:1575950D-32D4-46DE-A44F-8E9E614F997F</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:2E5CE73B-BFD4-4E35-9A07-D5E37A9E87AE</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoserver:annotationset:46636445-93A2-49F0-9E9C-5AEBF17046D2</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoclient:uuid:9B307D8B-D2B0-4795-8850-FAAAAC6B5AF4</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:570DA392-7779-456C-9C18-1FC0E579BBE6</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:5758DAC0-E1C0-49EB-BE9C-56FFBAF3B6F4</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:21B0E479-04F9-4D66-B396-B773EFE53882</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
    <pav:lastSavedOn>2014-07-15 17:04:06 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:5B6A462D-57EA-4BBD-87E1-A0EC2FAF5196</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E6A1493E-98EE-4FDE-9301-752AB8E3453F</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotation:61CDF0ED-4B77-4286-ACD0-B0B8D2D03F7C</pav:lineageUri>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lastSavedOn>2014-07-15 14:04:06 -0700</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:883587E1-49C1-4EE0-909E-4ADBAE13DD3A</domeo:belongsToSet>
    <pav:createdOn>2014-07-15 14:02:34 -0700</pav:createdOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9C0B4E8B-9FFE-4E47-9B4C-A6EA4527A384</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:FA8D1DAC-C616-456C-BB3D-29F18DED21A1</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:0C9C3F3B-D652-4BC5-8BE9-2D01F09D0D62">
    <pav:lastSavedOn>2014-07-16 14:06:30 -0700</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoclient:uuid:8C39EA63-3E52-40B4-8935-6ADC75CCA74D</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
    <domeo:belongsToSet>urn:domeoserver:annotationset:C2A39432-076D-421D-8007-22690EDA5A0C</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:49A3E368-5986-471F-9A56-C7C0F8072A9E"/>
    <pav:lineageUri>urn:domeoserver:annotation:D926C2F6-78D7-4536-8A5A-699F2B8E5B74</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:AD2FD8CD-1032-462E-833D-451021CE67B2</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:B3F0B84F-756D-4724-B177-98D0D290D00D</domeo:belongsToSet>
    <pav:createdOn>2014-07-16 14:03:15 -0700</pav:createdOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lastSavedOn>2014-07-16 17:06:30 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:E3A87903-26B7-471E-B573-E6792F176AFA">
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-51.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:E3A87903-26B7-471E-B573-E6792F176AFA"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>E3A87903-26B7-471E-B573-E6792F176AFA</domeo:uuid>
    <ao:suffix> significantly decreased plasma levels of paroxetine. Any dose adjustment should be guided by clinical effect (tolerability and efficacy). </ao:suffix>
    <pav:createdOn>2014-07-18 14:23:40 -0700</pav:createdOn>
    <ao:prefix> with </ao:prefix>
    <ao:exact>paroxetine</ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:66EB6B71-8574-4EC7-B3B5-BA3D58493C78">
    <ao:prefix> (30 mg once daily) increased steady-state AUC0-24, Cmax, and Cmin values of </ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-50.txt.html</ao:hasSource>
    <pav:createdOn>2014-07-18 14:20:23 -0700</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:66EB6B71-8574-4EC7-B3B5-BA3D58493C78"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>procyclidine</ao:exact>
    <ao:suffix> (5 mg oral once daily) by 35%, 37%, and 67%, respectively, compared to procyclidine alone at steady state. If anticholinergic effects are seen, the dose of procyclidine should be reduced.</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>66EB6B71-8574-4EC7-B3B5-BA3D58493C78</domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/FE3925A8-8E3B-4F19-B5AB-889AF933932B">
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/4053</dailymed:activeMoietyRxCUI>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdfs:label>erythromycin</rdfs:label>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:0F043D82-C59E-477B-8CC6-ED534D6C8664">
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:F929AFAD-20F2-46BB-9E7C-A915CD8E65D0"/>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <dikbD2R:modality>ncit:negative</dikbD2R:modality>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/F87C05D6-DDC3-4EA8-9B34-3C2D17DDAE87">
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/679314</dailymed:activeMoietyRxCUI>
    <rdfs:label>9-hydroxyrisperidone</rdfs:label>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/metabolite"/>
    <dct:description>Referred to the drug in the interaction.</dct:description>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/46D5C2E3-F87A-4E1D-95D3-2486A57FD111">
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdfs:label>9-hydroxyrisperidone</rdfs:label>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/679314</dailymed:activeMoietyRxCUI>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/metabolite"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/DF1191C3-6141-4746-A199-21B382D35CD1">
    <rdfs:label>9-hydroxyrisperidone</rdfs:label>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/679314</dailymed:activeMoietyRxCUI>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/metabolite"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:21CD752E-6211-4C49-B6F0-F912F29E4F0E">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:21CD752E-6211-4C49-B6F0-F912F29E4F0E"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid></domeo:uuid>
    <pav:createdOn>2014-07-15 14:14:29 -0700</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <ao:exact>debrisoquin</ao:exact>
    <domeo:uuid>21CD752E-6211-4C49-B6F0-F912F29E4F0E</domeo:uuid>
    <ao:prefix>CYP 2D6, also called </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix> hydroxylase, is the enzyme responsible for metabolism of many neuroleptics, antidepressants, antiarrhythmics, and other drugs. CYP 2D6 is subject to genetic polymorphism (about 6% to 8% of Caucasians, and a very low percentage of Asians, have little or </ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/91BD65CC-68B4-4509-8BA3-953D283A8F7C">
    <rdfs:label>9-hydroxyrisperidone</rdfs:label>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/679314</dailymed:activeMoietyRxCUI>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/metabolite"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/A02C8A1F-1E5C-43D8-ABEA-D88CAF3D8A03">
    <rdfs:label>cimetidine</rdfs:label>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/2541</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:1D349D03-1383-435E-97D6-A0B3DDED281A">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/DF1191C3-6141-4746-A199-21B382D35CD1"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/73B0CF02-F5AC-4669-BF5A-F04EC6C8C020"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/DA1E3525-C5D9-473E-8402-BDC110AF5313">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <rdfs:label>epoprostenol</rdfs:label>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/8814</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:265448C4-47B0-4486-8371-443541B3EFD8">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/119D78D7-1083-4187-B873-BB210FB292F1"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/F76EC146-E955-47C7-96D5-A7F508A56E5A"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/601715ED-5AF4-42B7-BA5F-9E7FC0592FF6">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/</dailymed:activeMoietyRxCUI>
    <rdfs:label>sulfamethazine</rdfs:label>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:0C912224-9ADC-4466-B8BD-9A0D37DB3F64">
    <pav:createdOn>2014-07-15 14:09:05 -0700</pav:createdOn>
    <ao:exact>warfarin</ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:0C912224-9ADC-4466-B8BD-9A0D37DB3F64"/>
    <ao:prefix> (100 mcg/mL), </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid></domeo:uuid>
    <domeo:uuid>0C912224-9ADC-4466-B8BD-9A0D37DB3F64</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <ao:suffix> (10 mcg/mL), and carbamazepine (10 mcg/mL) caused only a slight increase in the free fraction of risperidone at 10 ng/mL and 9-hydroxyrisperidone at 50 ng/mL, changes of unknown clinical significance.</ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:C1A443CA-B8D4-4A28-825B-B97ECDEC88D7">
    <pav:lastSavedOn>2014-07-15 14:11:14 -0700</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:883587E1-49C1-4EE0-909E-4ADBAE13DD3A</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E8194531-C5B3-43AE-BC13-14A252C54824</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:46636445-93A2-49F0-9E9C-5AEBF17046D2</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9C0B4E8B-9FFE-4E47-9B4C-A6EA4527A384</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:5758DAC0-E1C0-49EB-BE9C-56FFBAF3B6F4</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotation:8F1DE52D-E566-44A5-B267-A501CC18ABA0</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:21B0E479-04F9-4D66-B396-B773EFE53882</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:2E5CE73B-BFD4-4E35-9A07-D5E37A9E87AE</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E6A1493E-98EE-4FDE-9301-752AB8E3453F</domeo:belongsToSet>
    <pav:createdOn>2014-07-15 14:10:17 -0700</pav:createdOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:570DA392-7779-456C-9C18-1FC0E579BBE6</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-15 17:11:14 -0400</pav:lastSavedOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:368B4BB2-B03B-4EBF-97A2-1D8357999CE7"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:5B6A462D-57EA-4BBD-87E1-A0EC2FAF5196</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:FF56FD55-EDC5-4596-9E28-37011839842A">
    <ao:prefix> AUC. The mean ± SD increase in </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>FF56FD55-EDC5-4596-9E28-37011839842A</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:FF56FD55-EDC5-4596-9E28-37011839842A"/>
    <ao:exact>phenytoin</ao:exact>
    <ao:suffix> AUC was 88% ± 68% (range: 16 to 247%). The absolute magnitude of this interaction is unknown because of the intrinsically nonlinear disposition of phenytoin. (See PRECAUTIONS.)</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-25.txt.html</ao:hasSource>
    <pav:createdOn>2014-07-18 13:48:33 -0700</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Nfc4f214e3bee4bd1b6236d2d8fcf6295">
    <domeo:sets rdf:resource="urn:pddi:uuid:3C55FE98-387B-4122-94EC-ABF9B03F8B03"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:0B7730D3-D7F2-4D65-B79F-6DB4ADEC18E6">
    <domeo:uuid></domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:0B7730D3-D7F2-4D65-B79F-6DB4ADEC18E6"/>
    <ao:exact>9-hydroxyrisperidone</ao:exact>
    <ao:suffix> concentrations than poor metabolizers, the pharmacokinetics of risperidone and 9-hydroxyrisperidone combined, after single and multiple doses, are similar in extensive and poor metabolizers.</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid>0B7730D3-D7F2-4D65-B79F-6DB4ADEC18E6</domeo:uuid>
    <pav:createdOn>2014-07-15 14:15:02 -0700</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <ao:prefix>and higher </ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:9F93C089-2263-4DFA-88D8-751123C0D847">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/E75B503C-DB0D-4C60-A261-8CE7BCE1D9D4"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/3D45A806-97FF-4B81-8DD4-0F089D52066D"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:AD757AC1-7E10-42A9-A8ED-0BD21ADA30A7">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoserver:annotationset:21B0E479-04F9-4D66-B396-B773EFE53882</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:883587E1-49C1-4EE0-909E-4ADBAE13DD3A</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:A156EC26-7CF9-490B-8F02-67A6FCC98E56"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E6A1493E-98EE-4FDE-9301-752AB8E3453F</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotationset:75FC1225-8399-469B-AE9D-7F697713E6AC</pav:lineageUri>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotation:302B114E-3949-48F6-A16E-8D4B695DFF2F</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:570DA392-7779-456C-9C18-1FC0E579BBE6</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-15 14:17:25 -0700</pav:lastSavedOn>
    <pav:previousVersion>urn:domeoserver:annotationset:2E5CE73B-BFD4-4E35-9A07-D5E37A9E87AE</pav:previousVersion>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdOn>2014-07-15 14:16:29 -0700</pav:createdOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E8194531-C5B3-43AE-BC13-14A252C54824</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9C0B4E8B-9FFE-4E47-9B4C-A6EA4527A384</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:46636445-93A2-49F0-9E9C-5AEBF17046D2</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">4</pav:versionNumber>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:5758DAC0-E1C0-49EB-BE9C-56FFBAF3B6F4</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-15 17:17:26 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:5B6A462D-57EA-4BBD-87E1-A0EC2FAF5196</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:B82EA451-7796-4E93-B7B5-692C0393EDDE">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2014-07-16 10:21:54 -0700</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:B82EA451-7796-4E93-B7B5-692C0393EDDE"/>
    <ao:suffix>xsd:String</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <ao:exact>hydroxyrisperidone </ao:exact>
    <domeo:uuid></domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix>9-</ao:prefix>
    <domeo:uuid>B82EA451-7796-4E93-B7B5-692C0393EDDE</domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:04D05202-1972-48E0-8430-96BCC4F013A1">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/2582CF1F-9DA7-49BA-8998-D5BD27B5134B"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/91BD65CC-68B4-4509-8BA3-953D283A8F7C"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:B419ACAE-832E-406D-9427-D88D93B6A405">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid></domeo:uuid>
    <pav:createdOn>2014-07-16 14:07:45 -0700</pav:createdOn>
    <ao:exact>norethindrone</ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:B419ACAE-832E-406D-9427-D88D93B6A405"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-21.txt.html</ao:hasSource>
    <ao:prefix>individual AUC values of </ao:prefix>
    <ao:suffix> decreased very slightly</ao:suffix>
    <domeo:uuid>B419ACAE-832E-406D-9427-D88D93B6A405</domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:1B280A2A-5A01-45FD-BA8D-9F6D2D706E50">
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <dikbD2R:modality>ncit:negative</dikbD2R:modality>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:9F93C089-2263-4DFA-88D8-751123C0D847"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:45DF7FF1-EC0B-4049-BA97-01C05E9D3DFE">
    <ao:exact>phenytoin</ao:exact>
    <ao:prefix>200 mg daily for 16 days) in 10 normal male volunteers. There was a significant increase in </ao:prefix>
    <domeo:uuid>45DF7FF1-EC0B-4049-BA97-01C05E9D3DFE</domeo:uuid>
    <ao:suffix> AUC. The mean ± SD increase in phenytoin AUC was 88% ± 68% (range: 16 to 247%). The absolute magnitude of this interaction is unknown because of the intrinsically nonlinear disposition of phenytoin. (See PRECAUTIONS.)</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:45DF7FF1-EC0B-4049-BA97-01C05E9D3DFE"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-25.txt.html</ao:hasSource>
    <pav:createdOn>2014-07-18 13:48:28 -0700</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:00F35F1A-5924-40DE-A59C-C43123E99A77">
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <domeo:uuid></domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:00F35F1A-5924-40DE-A59C-C43123E99A77"/>
    <ao:suffix>, changes of unknown clinical significance</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix> displaces each other from plasma binding sites. High therapeutic concentrations of</ao:prefix>
    <ao:exact> sulfamethazine (100 mcg/mL), warfarin (10 mcg/mL), and carbamazepine (10 mcg/mL) caused only a slight increase in the free fraction of risperidone at 10 ng/mL and 9-hydroxyrisperidone at 50 ng/mL</ao:exact>
    <pav:createdOn>2014-07-15 14:26:34 -0700</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid>00F35F1A-5924-40DE-A59C-C43123E99A77</domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:94220E4B-2D94-4374-8F09-2F8CAACF7723">
    <pav:lineageUri>urn:domeoserver:annotation:17EFB5BA-9EFA-4D0C-BB82-D8BBB7EA6411</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:body rdf:nodeID="Nfc0f1cf71b11466da2955618ef16e15d"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lastSavedOn>2014-07-18 18:26:41 -0400</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:6FFFF211-BFDC-4E16-968C-A296868530C4</domeo:belongsToSet>
    <pav:createdOn>2014-07-18 15:25:36 -0700</pav:createdOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:240CE9DC-DA1D-48D6-946F-B8B1FEC89249"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
    <rdfs:label>expertstudy Annotation</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:5DC499BD-96C5-48A8-97BC-0704A7E34C48">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/DF4CD9EA-6625-46E6-9FB2-ECF205397DE3"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/0C8D54BE-659B-44A2-AA7F-0DA5E5333F73"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:5E6D4B4B-5988-41DE-96F1-703204EEF5AF">
    <ao:prefix> (250 mg) or </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2014-07-10 11:20:50 -0700</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:hasSource>
    <ao:suffix> (40 mg), both of which are metabolized by CYP2C9.</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:5E6D4B4B-5988-41DE-96F1-703204EEF5AF"/>
    <ao:exact>warfarin</ao:exact>
    <domeo:uuid>5E6D4B4B-5988-41DE-96F1-703204EEF5AF</domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:025B9C60-3F34-47FE-83EE-A415FB50E5FC">
    <pav:createdOn>2014-07-17 16:00:10 -0700</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotation:3B0E9C37-2753-4F9C-9E67-80E4E93723C9</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
    <ao:body rdf:nodeID="Nf875c1192bd04da8ba587becb06dbb99"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <domeo:belongsToSet>urn:domeoserver:annotationset:8DEBE5AF-B171-4BE8-880B-76A2BEE742A6</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lastSavedOn>2014-07-17 19:00:13 -0400</pav:lastSavedOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:BA399F23-8D58-4471-8517-AC275675E0F0"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:B230469B-00AA-4A73-A839-6D9826213D36">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoserver:annotationset:2D3D9594-163C-4299-854D-3987A43B7DCF</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:36A9182C-B7D6-405A-BBF7-D0B654870FAE"/>
    <domeo:belongsToSet>urn:domeoclient:uuid:4E57D817-C3D5-47E5-AECC-169C5A1EF60D</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-17 18:54:47 -0400</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
    <pav:lineageUri>urn:domeoserver:annotation:5E74D9CD-2AA1-478E-937E-F00737DD95A1</pav:lineageUri>
    <pav:lineageUri>urn:domeoserver:annotationset:C94BECCE-E3E9-4B70-AC23-F715B9D3EEFF</pav:lineageUri>
    <pav:lastSavedOn>2014-07-17 15:54:46 -0700</pav:lastSavedOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdOn>2014-07-17 15:53:45 -0700</pav:createdOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:96BAB4C7-6F7A-4EBA-BAC1-134F746F11FA</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/0E179D30-7DE3-4459-A1C5-69426205C386">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <rdfs:label>cimetidine</rdfs:label>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/2541</dailymed:activeMoietyRxCUI>
    <dct:description>Referred to the drug in the interaction.</dct:description>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/4702EA7F-D817-4188-B0B3-15F9D82CDDBA">
    <rdfs:label>procyclidine</rdfs:label>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Nc0a4606fa0a44afd87f9ea0e06b77d0a">
    <permissions:accessType>urn:domeo:access:public</permissions:accessType>
    <permissions:isLocked>false</permissions:isLocked>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:D707EDCF-5B5D-4AB9-9815-32BDDA05721F">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lineageUri>urn:domeoserver:annotationset:75FC1225-8399-469B-AE9D-7F697713E6AC</pav:lineageUri>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9C0B4E8B-9FFE-4E47-9B4C-A6EA4527A384</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:8811156A-F82B-4936-A5FD-E973920A426B"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:883587E1-49C1-4EE0-909E-4ADBAE13DD3A</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">4</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:5B6A462D-57EA-4BBD-87E1-A0EC2FAF5196</domeo:belongsToSet>
    <pav:previousVersion>urn:domeoserver:annotationset:2E5CE73B-BFD4-4E35-9A07-D5E37A9E87AE</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E6A1493E-98EE-4FDE-9301-752AB8E3453F</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:5758DAC0-E1C0-49EB-BE9C-56FFBAF3B6F4</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:570DA392-7779-456C-9C18-1FC0E579BBE6</domeo:belongsToSet>
    <pav:createdOn>2014-07-15 14:16:12 -0700</pav:createdOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:21B0E479-04F9-4D66-B396-B773EFE53882</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:46636445-93A2-49F0-9E9C-5AEBF17046D2</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-15 14:17:25 -0700</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lastSavedOn>2014-07-15 17:17:26 -0400</pav:lastSavedOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E8194531-C5B3-43AE-BC13-14A252C54824</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
    <pav:lineageUri>urn:domeoserver:annotation:FB0E653B-3BCA-46D1-9495-463F82213CEC</pav:lineageUri>
    <rdfs:label>Highlight</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:666583ED-95C0-4F25-8463-3174C806F5FF">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix> on epoprostenol pharmacokinetics is not known.</ao:suffix>
    <domeo:uuid>666583ED-95C0-4F25-8463-3174C806F5FF</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:666583ED-95C0-4F25-8463-3174C806F5FF"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>sildenafil</ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:hasSource>
    <ao:prefix> is not considered clinically relevant. The effect of </ao:prefix>
    <pav:createdOn>2014-07-10 11:20:33 -0700</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:03C138A3-3A62-41DC-8535-D728778DDD42">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/6CA51826-BC17-4C41-9533-7687E5BBFB21"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/17338360-FF55-4D91-8F6A-612551EEFC58"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/B323F1AF-E50F-49F8-9817-81EEE875A6B1">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/9068</dailymed:activeMoietyRxCUI>
    <rdfs:label>quinidine</rdfs:label>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:2EFDE02B-EB81-4773-A923-937E941963E2">
    <pav:lastSavedOn>2014-07-16 18:46:13 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
    <pav:createdOn>2014-07-16 15:46:07 -0700</pav:createdOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotation:572B1D44-A4E2-4B1D-93B4-24E5BB651905</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:9006A3C1-1FFE-448B-887C-2F101EC30804"/>
    <ao:body rdf:nodeID="N59972b213fde4f518c1ad1b27b750240"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E3DA2E5E-FC19-4C22-AF6C-A9CB4B450554</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:1453C795-84C1-4C48-AF84-AEEE18ED1682">
    <domeo:belongsToSet>urn:domeoserver:annotationset:883587E1-49C1-4EE0-909E-4ADBAE13DD3A</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoserver:annotationset:21B0E479-04F9-4D66-B396-B773EFE53882</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:570DA392-7779-456C-9C18-1FC0E579BBE6</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E6A1493E-98EE-4FDE-9301-752AB8E3453F</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:2E5CE73B-BFD4-4E35-9A07-D5E37A9E87AE</domeo:belongsToSet>
    <pav:createdOn>2014-07-15 14:09:01 -0700</pav:createdOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9C0B4E8B-9FFE-4E47-9B4C-A6EA4527A384</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-15 14:11:14 -0700</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:46636445-93A2-49F0-9E9C-5AEBF17046D2</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:D65EE4FB-C2D2-4BA1-977B-5D3CB6873FE9"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:5758DAC0-E1C0-49EB-BE9C-56FFBAF3B6F4</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-15 17:11:14 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
    <domeo:belongsToSet>urn:domeoserver:annotationset:5B6A462D-57EA-4BBD-87E1-A0EC2FAF5196</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E8194531-C5B3-43AE-BC13-14A252C54824</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotation:BE4E6E88-B736-4374-9FE7-02AECE79780F</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:previousVersion>xsd:String</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/62B567F8-EBE4-4BA4-9B68-E81E9E1BCD30">
    <rdfs:label>risperidone</rdfs:label>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/35636</dailymed:activeMoietyRxCUI>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N3f85ee25e2dc4ab9bf4056215cd20eca">
    <permissions:isLocked>false</permissions:isLocked>
    <permissions:accessType>urn:domeo:access:public</permissions:accessType>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/134A6837-6F9F-4758-AAC4-3A4B621B5D17">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <rdfs:label>warfarin</rdfs:label>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/11289</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:6F73FE0C-9AF3-4741-ABB6-2D6C73C11FF8">
    <dikbD2R:modality>ncit:negative</dikbD2R:modality>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:265448C4-47B0-4486-8371-443541B3EFD8"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:541CB376-3C80-4099-9753-CC9C70F09426">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:541CB376-3C80-4099-9753-CC9C70F09426"/>
    <ao:suffix>, rifampin, and phenobarbital) with risperidone may cause a decrease in the combined plasma concentrations of risperidone and 9-hydroxyrisperidone [see 7 DRUG INTERACTIONS]. It would also be possible for risperidone to interfere with metabolism of other </ao:suffix>
    <ao:prefix>, </ao:prefix>
    <domeo:uuid>541CB376-3C80-4099-9753-CC9C70F09426</domeo:uuid>
    <ao:exact>phenytoin</ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <pav:createdOn>2014-07-15 14:16:16 -0700</pav:createdOn>
    <domeo:uuid></domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:0B393FF7-1BB4-4312-85CF-8C8D73B22BB7">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/EB5D25E9-EAE4-4A5C-BDE0-2EDF1AA4D125"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/4702EA7F-D817-4188-B0B3-15F9D82CDDBA"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N9690a7dc558e4518abc3a25d9569abd0">
    <domeo:sets rdf:resource="urn:pddi:uuid:58CDDE97-D8B0-4830-BB7A-AAE058957A70"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/0C8D54BE-659B-44A2-AA7F-0DA5E5333F73">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/136411</dailymed:activeMoietyRxCUI>
    <rdfs:label>sildenafil</rdfs:label>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:C98CE18F-F7E6-4A0B-9E8F-722C99D1E7A6">
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <dikbD2R:modality>ncit:negative</dikbD2R:modality>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:1F34CC8F-6DA9-47CE-AD8A-A80AB8D1E0F8"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:1EFF2490-0B61-41C8-834C-DB6A557BD8F0">
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <dikbD2R:modality>ncit:negative</dikbD2R:modality>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:8237D894-48AB-40ED-BA0C-2A88EF2D9CC4"/>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:EFED6610-75EB-4165-827C-237B7D245279">
    <domeo:belongsToSet>urn:domeoserver:annotationset:15A537D1-5648-41B2-8BFA-0D0BA3DF4393</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoclient:uuid:8A7DE042-9FA7-424C-B98E-9C19498D7977</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:239B4C6D-1110-4B65-AC66-F8A394187814</domeo:belongsToSet>
    <pav:createdOn>2014-07-10 10:59:54 -0700</pav:createdOn>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lastSavedOn>2014-07-10 11:00:22 -0700</pav:lastSavedOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotationset:BE290CA3-79BD-411A-BE2E-69AA4D19607D</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
    <domeo:belongsToSet>urn:domeoserver:annotationset:A57C5101-A9A5-4504-A046-944A7401D498</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:801BF977-34B8-44B2-9E5A-A5D9E2906430"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:516C333C-B517-4F84-999E-51185DD6E859</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoserver:annotationset:3F81414E-B149-4B05-925B-18735B554A13</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-10 14:00:22 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:2BFC2FB6-6BE9-4822-A245-973533533023</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <domeo:belongsToSet>urn:domeoserver:annotationset:970963DF-8BCE-4936-9DFC-328A36014E1B</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:DBBBAD55-D12B-4890-A2AF-85D3C85A7BEF</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotation:38E0C82A-17F4-4817-8467-79C346D6EF29</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:A8C40C51-0B43-4493-80CC-949EA671E491">
    <pav:createdOn>2014-07-15 14:18:55 -0700</pav:createdOn>
    <domeo:uuid></domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:A8C40C51-0B43-4493-80CC-949EA671E491"/>
    <ao:prefix> and </ao:prefix>
    <ao:exact>9-hydroxyrisperidone</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix> was decreased, and elimination half-lives were prolonged compared to young healthy subjects. Dosing should be modified accordingly in the elderly patients [see 2 DOSAGE AND ADMINISTRATION].</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <domeo:uuid>A8C40C51-0B43-4493-80CC-949EA671E491</domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/8A890D90-4AB4-4DD3-A520-217921B71116">
    <rdfs:label>9-hydroxyrisperidone</rdfs:label>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/679314</dailymed:activeMoietyRxCUI>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/metabolite"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N915c2679169147f0b64c66ab323f70e5">
    <permissions:isLocked>false</permissions:isLocked>
    <permissions:accessType>urn:domeo:access:public</permissions:accessType>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:542B35CF-4581-4FCE-8D90-B315B353F9BE">
    <domeo:uuid>542B35CF-4581-4FCE-8D90-B315B353F9BE</domeo:uuid>
    <ao:prefix> at steady state (80 mg TID) with </ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:hasSource>
    <ao:exact>bosentan</ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:542B35CF-4581-4FCE-8D90-B315B353F9BE"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2014-07-10 11:20:07 -0700</pav:createdOn>
    <ao:suffix> (a moderate inducer of CYP3A, CYP2C9 and possibly of cytochrome P450 2C19) at steady state (125 mg BID) resulted in a 63% decrease of sildenafil AUC and a 55% decrease in sildenafil Cmax. Co-administration resulted in a 50% increase in AUC of bosentan. </ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/3FD2DBDA-7F24-4B3D-829F-5ECB6A6E2D7B">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/9068</dailymed:activeMoietyRxCUI>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <rdfs:label>quinidine</rdfs:label>
    <dct:description>Referred to the drug in the interaction.</dct:description>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:9B093B77-913B-463D-96DF-69C0A7A14BD4">
    <ao:prefix>No significant interactions were shown with </ao:prefix>
    <domeo:uuid>9B093B77-913B-463D-96DF-69C0A7A14BD4</domeo:uuid>
    <ao:suffix> (250 mg) or warfarin (40 mg), both of which are metabolized by CYP2C9.</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:9B093B77-913B-463D-96DF-69C0A7A14BD4"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2014-07-10 11:20:49 -0700</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>tolbutamide</ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:3D2F7357-CD2E-446B-8A85-437E7D90CAA9">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:3D2F7357-CD2E-446B-8A85-437E7D90CAA9"/>
    <ao:exact>sulfamethazine (100 mcg/mL), warfarin (10 mcg/mL), and carbamazepine (10 mcg/mL) caused only a slight increase in the free fraction of risperidone at 10 ng/mL and 9-hydroxyrisperidone at 50 ng/mL</ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix>xsd:String</ao:prefix>
    <pav:createdOn>2014-07-15 14:26:41 -0700</pav:createdOn>
    <domeo:uuid></domeo:uuid>
    <domeo:uuid>3D2F7357-CD2E-446B-8A85-437E7D90CAA9</domeo:uuid>
    <ao:suffix>xsd:String</ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:8AD0A979-32CC-4AB1-A507-37A7920B4725">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix>xsd:String</ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2014-07-10 11:20:05 -0700</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:8AD0A979-32CC-4AB1-A507-37A7920B4725"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:hasSource>
    <ao:exact>sildenafil</ao:exact>
    <domeo:uuid>8AD0A979-32CC-4AB1-A507-37A7920B4725</domeo:uuid>
    <ao:suffix> at steady state (80 mg TID) with bosentan (a moderate inducer of CYP3A, CYP2C9 and possibly of cytochrome P450 2C19) at steady state (125 mg BID) resulted in a 63% decrease of sildenafil AUC and a 55% decrease in sildenafil Cmax. Co-administration resul</ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:75CEFB15-ED07-4FCF-827C-D3813A7E7192">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotation:DCF6ED10-C18E-4674-BF3C-019804CC3A51</pav:lineageUri>
    <pav:lastSavedOn>2014-07-10 14:00:22 -0400</pav:lastSavedOn>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdOn>2014-07-10 10:59:34 -0700</pav:createdOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:46F1B2A0-76BB-4BB0-9268-81BE8008B192"/>
    <domeo:belongsToSet>urn:domeoclient:uuid:8A7DE042-9FA7-424C-B98E-9C19498D7977</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/F8617FDB-EC1E-432B-A946-4F2CE4A8D3D5">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/metabolite"/>
    <rdfs:label>9-hydroxyrisperidone</rdfs:label>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/679314</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:1C1206FB-FFE6-4216-8FC7-016E9D7B0A16">
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:9533CE02-6E66-4E86-A2D3-E8EB0BF5E6A2"/>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/3B58FCCA-E6B2-45AE-ACE1-19D3FE8C36CD">
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/4053</dailymed:activeMoietyRxCUI>
    <rdfs:label>erythromycin</rdfs:label>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:94A95C57-5A20-472B-87AE-DD634374AADD">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix> do not suggest important differences between poor and extensive metabolizers. Second, co-administration of known enzyme inducers (e.g.,</ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact> carbamazepine, phenytoin, rifampin, and phenobarbital) with risperidone may cause a decrease in the combined plasma concentrations of risperidone and 9-hydroxyrisperidone</ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:94A95C57-5A20-472B-87AE-DD634374AADD"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <ao:suffix>xsd:String</ao:suffix>
    <pav:createdOn>2014-07-18 15:24:32 -0700</pav:createdOn>
    <domeo:uuid>94A95C57-5A20-472B-87AE-DD634374AADD</domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:3B7229C1-BBC3-4F13-A2D8-9C5E932927F8">
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:C99A2006-8591-4B3F-9788-B075E7E171FD"/>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:CDFED240-5630-45F7-B475-A3C10DC429E0">
    <pav:createdOn>2014-07-10 11:20:11 -0700</pav:createdOn>
    <ao:exact>sildenafil</ao:exact>
    <ao:prefix> (a moderate inducer of CYP3A, CYP2C9 and possibly of cytochrome P450 2C19) at steady state (125 mg BID) resulted in a 63% decrease of </ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:CDFED240-5630-45F7-B475-A3C10DC429E0"/>
    <domeo:uuid>CDFED240-5630-45F7-B475-A3C10DC429E0</domeo:uuid>
    <ao:suffix> AUC and a 55% decrease in sildenafil Cmax. Co-administration resulted in a 50% increase in AUC of bosentan. The combination of both drugs did not lead to clinically significant changes in blood pressure (supine or standing). Concomitant administration o</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-155.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:5A10196D-612D-427F-A010-CCF56DACBAEA">
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:71327EBC-8F62-4995-B5BE-B26C486DD473"/>
    <dikbD2R:modality>ncit:negative</dikbD2R:modality>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/119D78D7-1083-4187-B873-BB210FB292F1">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <rdfs:label>risperidone</rdfs:label>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/35636</dailymed:activeMoietyRxCUI>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:74592674-5629-4C4B-8931-FFAA6830CB3B">
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:6176C4B3-F970-4A01-84A9-4E5517225598"/>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <dikbD2R:modality>ncit:negative</dikbD2R:modality>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Nac444ae820f14dfb9125a1f77d88cab6">
    <permissions:isLocked>false</permissions:isLocked>
    <permissions:accessType>urn:domeo:access:public</permissions:accessType>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:1C906DFD-63EC-472C-AD64-29043E8A58B1">
    <pav:createdOn>2014-07-18 13:51:41 -0700</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact> fluconazole</ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:1C906DFD-63EC-472C-AD64-29043E8A58B1"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-26.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>1C906DFD-63EC-472C-AD64-29043E8A58B1</domeo:uuid>
    <ao:prefix> AUC, Cmax, Cmin (24-hour concentration), and a significant reduction in apparent oral clearance following the administration of</ao:prefix>
    <ao:suffix>. The mean ± SD increase in AUC was 92% ± 43% (range: 18 to 147%). The Cmax increased 60% ± 48% (range: -5 to 133%). The Cmin increased 157% ± 96% (range: 33 to 360%). The apparent oral clearance decreased 45% ± 15% (range: -15 to -60%). (See PRECAUTIONS</ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:3BD41FAC-162E-4141-B15C-C7AD0CAF56A0">
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:B3D0F9C9-FF6E-49C9-83A0-E46C52456757"/>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <dikbD2R:modality>ncit:negative</dikbD2R:modality>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:EB808AED-F3EE-4633-873E-90372A00493C">
    <ao:prefix>Daily oral dosing of immediate-release </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:EB808AED-F3EE-4633-873E-90372A00493C"/>
    <domeo:uuid>EB808AED-F3EE-4633-873E-90372A00493C</domeo:uuid>
    <pav:createdOn>2014-07-18 14:20:17 -0700</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-50.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix> (30 mg once daily) increased steady-state AUC0-24, Cmax, and Cmin values of procyclidine (5 mg oral once daily) by 35%, 37%, and 67%, respectively, compared to procyclidine alone at steady state. If anticholinergic effects are seen, the dose of procycli</ao:suffix>
    <ao:exact>paroxetine</ao:exact>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N486967aed5194782a3de45510624653e">
    <permissions:accessType>urn:domeo:access:public</permissions:accessType>
    <permissions:isLocked>false</permissions:isLocked>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N784a56c4988e43998f54bd4b168e8ee9">
    <permissions:accessType>urn:domeo:access:public</permissions:accessType>
    <permissions:isLocked>false</permissions:isLocked>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:E27EA287-6A73-4A85-91BA-05FF0671A1E5">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/CCD5C1F9-F7D3-4F1B-824F-366552008EE3"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/8C365411-C391-4ADB-A80A-FF1FC3DA4D2D"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/3D45A806-97FF-4B81-8DD4-0F089D52066D">
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/35636</dailymed:activeMoietyRxCUI>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <rdfs:label>risperidone</rdfs:label>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/73B0CF02-F5AC-4669-BF5A-F04EC6C8C020">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/11289</dailymed:activeMoietyRxCUI>
    <rdfs:label>warfarin</rdfs:label>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/E9F8DA0B-E7E6-4545-B4F7-E4DF1CE97D9F">
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/11289</dailymed:activeMoietyRxCUI>
    <rdfs:label>warfarin</rdfs:label>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dct:description>Referred to the drug in the interaction.</dct:description>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Na70e812eeb254f70b51f7b7971a53f64">
    <permissions:accessType>urn:domeo:access:public</permissions:accessType>
    <permissions:isLocked>false</permissions:isLocked>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:37FB0E70-766B-4459-A183-3C9D1DA69A86">
    <pav:createdOn>2014-07-15 14:16:39 -0700</pav:createdOn>
    <ao:exact>9-hydroxyrisperidone</ao:exact>
    <ao:suffix> [see 7 DRUG INTERACTIONS]. It would also be possible for risperidone to interfere with metabolism of other drugs metabolized by CYP 2D6. Relatively weak binding of risperidone to the enzyme suggests this is unlikely [see 7 DRUG INTERACTIONS].</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:37FB0E70-766B-4459-A183-3C9D1DA69A86"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid></domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <ao:prefix> and </ao:prefix>
    <domeo:uuid>37FB0E70-766B-4459-A183-3C9D1DA69A86</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:7A0209F9-EA1A-4BBA-865A-0A0F6CCAF57E">
    <pav:createdOn>2014-07-15 14:08:33 -0700</pav:createdOn>
    <ao:suffix> is 90%, and that of its major metabolite, 9-hydroxyrisperidone, is 77%. Neither risperidone nor 9-hydroxyrisperidone displaces each other from plasma binding sites. High therapeutic concentrations of sulfamethazine (100 mcg/mL), warfarin (10 mcg/mL), an</ao:suffix>
    <ao:exact>risperidone</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid>7A0209F9-EA1A-4BBA-865A-0A0F6CCAF57E</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:7A0209F9-EA1A-4BBA-865A-0A0F6CCAF57E"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix> </ao:prefix>
    <domeo:uuid></domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:4CE774DD-EF4B-488F-AD09-38B151FCAC2F">
    <ao:suffix>, as with other drugs used to treat schizophrenia, is unknown. However, it has been proposed that the drug’s therapeutic activity in schizophrenia is mediated through a combination of dopamine Type 2 (D2) and serotonin Type 2 (5HT2) receptor antagonism.</ao:suffix>
    <pav:createdOn>2014-07-16 10:18:37 -0700</pav:createdOn>
    <ao:exact>risperidone</ao:exact>
    <domeo:uuid>4CE774DD-EF4B-488F-AD09-38B151FCAC2F</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:4CE774DD-EF4B-488F-AD09-38B151FCAC2F"/>
    <domeo:uuid></domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix>The mechanism of action of </ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/A5A1C319-789D-4E34-9D41-8E64F0B79D55">
    <rdfs:label>9-hydroxyrisperidone</rdfs:label>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/679314</dailymed:activeMoietyRxCUI>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/metabolite"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:4BDAA007-22DC-4E1D-8BB3-46728661C2F1">
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
    <ao:body rdf:nodeID="Ne4a626b8318845d4bb9d818c02fcc3eb"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotation:0E7FAAC6-D462-439E-8A8E-930827B202EC</pav:lineageUri>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:2AA708F1-622C-4D5D-9D25-2946E06DCDDB"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdOn>2014-07-18 14:05:17 -0700</pav:createdOn>
    <pav:lastSavedOn>2014-07-18 17:05:18 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:6DBCB873-26F3-4E6A-9BD4-311369B43736</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/78CA8426-F17B-4F98-AB2F-F77F74181051">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdfs:label>saquinavir</rdfs:label>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/83395</dailymed:activeMoietyRxCUI>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/916F9EEF-4230-4F62-8A7F-5874EA7F603A">
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/</dailymed:activeMoietyRxCUI>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <rdfs:label>sulfamethazine</rdfs:label>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/4810A93A-921A-434E-9CAA-030002F8071B">
    <rdfs:label>carbamazepine</rdfs:label>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/2002</dailymed:activeMoietyRxCUI>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:9C850E9D-0903-4A7D-8362-E39D7560ABB0">
    <ao:exact>Co-administration of fosamprenavir/ritonavir with paroxetine significantly decreased plasma levels of paroxetine</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-51.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:9C850E9D-0903-4A7D-8362-E39D7560ABB0"/>
    <ao:prefix>xsd:String</ao:prefix>
    <ao:suffix>xsd:String</ao:suffix>
    <pav:createdOn>2014-07-18 14:25:59 -0700</pav:createdOn>
    <domeo:uuid>9C850E9D-0903-4A7D-8362-E39D7560ABB0</domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/E6AAB5C8-7D21-4FFF-957B-D45D2B203951">
    <rdfs:label>risperidone</rdfs:label>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/35636</dailymed:activeMoietyRxCUI>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:53C6241F-D757-403E-842E-927E95B2B792">
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <dikbD2R:modality>ncit:negative</dikbD2R:modality>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:661B4601-2894-4F1C-AF15-9A8877C53253"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/94ECD58C-7632-419B-93E6-7EC5C2CE733E">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdfs:label>carbamazepine</rdfs:label>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/2002</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Ncb5d6a25f20247878eb8aba54b4a9634">
    <domeo:sets rdf:resource="urn:pddi:uuid:43429665-4067-4181-A816-0B492E549D7A"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:CC8EDBDD-A7A3-41E7-8775-C12B2FD8C92B">
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:1FFE9DE2-04AD-4E77-8218-3B3AECFFDAA7"/>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <dikbD2R:modality>ncit:negative</dikbD2R:modality>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:75D8DE94-F5D4-4DC6-BC3F-9344C057C003">
    <pav:createdOn>2014-07-15 14:07:26 -0700</pav:createdOn>
    <ao:suffix> can be given with or without meals.</ao:suffix>
    <domeo:uuid>75D8DE94-F5D4-4DC6-BC3F-9344C057C003</domeo:uuid>
    <domeo:uuid></domeo:uuid>
    <ao:exact>risperidone</ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:75D8DE94-F5D4-4DC6-BC3F-9344C057C003"/>
    <ao:prefix>. Thus, </ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:287EB7AD-1FB2-4E91-A01C-FFE1A2CB547D">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:body rdf:nodeID="N29dad09cc6c54a5992be671bb14c4002"/>
    <pav:createdOn>2014-07-18 15:17:44 -0700</pav:createdOn>
    <pav:lastSavedOn>2014-07-18 18:26:41 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:6FFFF211-BFDC-4E16-968C-A296868530C4</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:40C3CB86-AAFD-4D68-AE0D-699574B044BD"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotation:2C6B5082-4151-4204-A301-043C0F3C9951</pav:lineageUri>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:4EBFF001-A193-4148-8196-B7FA14D67CD4">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/9E074531-245B-46FE-9C5E-1F5147C63ABC"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/845599E6-7015-4CD1-A3F8-82CE09DB0661"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:92A39181-37D0-41C9-B1A9-CE76BFF02C6F">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/B26407E4-88EB-4192-AB48-8E81668A0F5A"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/7CAC23C0-2167-45E7-9CB3-40D1B4A1CFED"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:8811156A-F82B-4936-A5FD-E973920A426B">
    <ao:suffix>, phenytoin, rifampin, and phenobarbital) with risperidone may cause a decrease in the combined plasma concentrations of risperidone and 9-hydroxyrisperidone [see 7 DRUG INTERACTIONS]. It would also be possible for risperidone to interfere with metabolis</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:8811156A-F82B-4936-A5FD-E973920A426B"/>
    <domeo:uuid>8811156A-F82B-4936-A5FD-E973920A426B</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>carbamazepine</ao:exact>
    <pav:createdOn>2014-07-15 14:16:12 -0700</pav:createdOn>
    <ao:prefix> do not suggest important differences between poor and extensive metabolizers. Second, co-administration of known enzyme inducers (e.g., </ao:prefix>
    <domeo:uuid></domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Nef3809c30def40ceb3a3debf303d7643">
    <domeo:sets rdf:resource="urn:pddi:uuid:2C83F977-3681-48B0-B3C1-D84A60204AF3"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:128DD788-D47E-4F4B-AD6D-B82C77B2F11B">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/0E179D30-7DE3-4459-A1C5-69426205C386"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/E0D97E91-2E7D-4932-BF6E-D14381A9B58A"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/ADE2E1DA-D3E9-438C-A1E1-D82219070E28">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/4124</dailymed:activeMoietyRxCUI>
    <rdfs:label>ethinyl estradiol</rdfs:label>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/845599E6-7015-4CD1-A3F8-82CE09DB0661">
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <rdfs:label>warfarin</rdfs:label>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/11289</dailymed:activeMoietyRxCUI>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:839BFC94-772B-4ABC-83E2-1B6874899A06">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/82489DE2-95D2-40DF-8FAB-FAEB9D14A3DA"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/DCD0BA65-3461-4AA7-BB38-38A15DD6EDF4"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/B6084BE9-4101-468F-985F-F42789F59869">
    <rdfs:label>phenytoin</rdfs:label>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/8183</dailymed:activeMoietyRxCUI>
    <dct:description>Referred to the drug in the interaction.</dct:description>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N4a415880464740babbd3b1e9cbfaf014">
    <domeo:sets rdf:resource="urn:pddi:uuid:D74FB459-7D36-43C5-A6D6-15F309939817"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:AC79320C-3C8F-46FE-94FF-193C575E7659">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/B7E6915D-737A-4835-AD3F-AA797AC2E586"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/916F9EEF-4230-4F62-8A7F-5874EA7F603A"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:43443A66-1162-4BDC-88F9-4CB789CFAF8B">
    <pav:lineageUri>urn:domeoserver:annotation:56E0D923-5115-443D-9DA6-488B28B808F8</pav:lineageUri>
    <ao:body rdf:nodeID="Nd47b3c4b1c5240a0bab5e055336f7be9"/>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:15A537D1-5648-41B2-8BFA-0D0BA3DF4393</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:4A892E21-8734-4284-A9E5-E434991F2B9C"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdOn>2014-07-10 11:25:13 -0700</pav:createdOn>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lastSavedOn>2014-07-10 14:25:16 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:01F43ADA-D582-470E-9E9C-774668C5EF3D">
    <domeo:uuid>01F43ADA-D582-470E-9E9C-774668C5EF3D</domeo:uuid>
    <ao:prefix> 200 mg) did not affect the bioavailability or pharmacokinetics of</ao:prefix>
    <ao:suffix> in 24 healthy male volunteers.</ao:suffix>
    <ao:hasSource>				http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-23.txt.html																													</ao:hasSource>
    <ao:exact> fluconazole</ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:01F43ADA-D582-470E-9E9C-774668C5EF3D"/>
    <pav:createdOn>2014-07-17 15:54:41 -0700</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Ndbecb8efe3064bab80577ec3baa2893d">
    <permissions:accessType>urn:domeo:access:public</permissions:accessType>
    <permissions:isLocked>false</permissions:isLocked>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/80952517-1424-4D02-AC72-0FF70FEA2BCA">
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdfs:label>quinidine</rdfs:label>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/9068</dailymed:activeMoietyRxCUI>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:240CE9DC-DA1D-48D6-946F-B8B1FEC89249">
    <pav:createdOn>2014-07-18 15:25:36 -0700</pav:createdOn>
    <ao:exact> carbamazepine, phenytoin, rifampin, and phenobarbital) with risperidone may cause a decrease in the combined plasma concentrations of risperidone and 9-hydroxyrisperidone </ao:exact>
    <ao:prefix>xsd:String</ao:prefix>
    <ao:suffix>[see 7 DRUG INTERACTIONS]. It would also be possible for</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:240CE9DC-DA1D-48D6-946F-B8B1FEC89249"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid>240CE9DC-DA1D-48D6-946F-B8B1FEC89249</domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/0F60CDA1-1EF3-48A8-B482-B23A5151B7B7">
    <rdfs:label>risperidone</rdfs:label>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/35636</dailymed:activeMoietyRxCUI>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N8c1a8a4da50d4b4d91354e3c429278f0">
    <domeo:sets rdf:resource="urn:pddi:uuid:65B1AF5D-CC49-4B9F-BACA-07320E9834D7"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N57dea7f0d13b4c98bdf8e04d63e1bd5f">
    <permissions:isLocked>false</permissions:isLocked>
    <permissions:accessType>urn:domeo:access:public</permissions:accessType>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Nc0a0bd956632436f93f7feba79595d92">
    <permissions:accessType>urn:domeo:access:public</permissions:accessType>
    <permissions:isLocked>false</permissions:isLocked>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:8A82BF7D-FCE6-4985-9C4B-E950C1124476">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#expertstudyAnnotation"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <ao:context rdf:resource="urn:domeoclient:uuid:05321D03-FF55-4658-854E-AEE6CA65C7B5"/>
    <rdfs:label>expertstudy Annotation</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdOn>2014-07-16 15:36:36 -0700</pav:createdOn>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
    <pav:lineageUri>urn:domeoserver:annotation:E82CAFB0-79BE-4952-A18B-AB34D1AEB9BB</pav:lineageUri>
    <pav:lastSavedOn>2014-07-16 18:38:32 -0400</pav:lastSavedOn>
    <ao:body rdf:nodeID="N3fd365a53bac4514b6700441ce6a387b"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:0F87EEF0-40A6-43E2-8222-95E7D1335A0B</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:9C0615DE-8C02-4011-9E8F-285A1438818F">
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:DD1D98FB-026A-4A63-A3CE-F2CF57FA0D72"/>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <dikbD2R:modality>ncit:negative</dikbD2R:modality>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Nd1a93b1bab044f6b83f2066a9ab08fe1">
    <domeo:sets rdf:resource="urn:pddi:uuid:BF7C4530-2603-4D20-BBB8-214E7FEF4085"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N134abbc44e9d49cc998663bcaa643749">
    <domeo:sets rdf:resource="urn:pddi:uuid:2A97A957-DB63-4FC3-8222-06DF0BB64008"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N61403a6ebe9e4be89fdf16620220d3f1">
    <domeo:sets rdf:resource="urn:pddi:uuid:7A9FA12F-6FE2-4EA8-B4AC-E3B6A73BE8C6"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:41E33AFA-32CF-4F33-A475-CBE51A5010FA">
    <domeo:belongsToSet>urn:domeoclient:uuid:51A184F8-19CA-4489-AB8F-9AF92E4BE5BE</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotationset:1EE1D64B-EDD4-4170-B797-D8F83B927DCE</pav:lineageUri>
    <pav:lastSavedOn>2014-07-18 14:20:41 -0700</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotation:CF37712B-F03C-425C-B578-97FE929B02CF</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:7BA312DF-BB65-4A90-8B7D-A54425D7C553</domeo:belongsToSet>
    <pav:lastSavedOn>2014-07-18 17:20:41 -0400</pav:lastSavedOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:EB808AED-F3EE-4633-873E-90372A00493C"/>
    <pav:createdOn>2014-07-18 14:20:17 -0700</pav:createdOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/6B41C1F2-B78D-4561-B417-EC840EB0B22D">
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdfs:label>9-hydroxyrisperidone</rdfs:label>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/metabolite"/>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/679314</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N8c3413f915c841d1b41279d4bb037e73">
    <permissions:isLocked>false</permissions:isLocked>
    <permissions:accessType>urn:domeo:access:public</permissions:accessType>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N2c6184f82bc04dba9b0a60124e85282d">
    <permissions:isLocked>false</permissions:isLocked>
    <permissions:accessType>urn:domeo:access:public</permissions:accessType>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:6176C4B3-F970-4A01-84A9-4E5517225598">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/929638DA-F799-437F-8033-228CF8F46D12"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/A854A7DE-A8FE-498F-9B31-F34790052689"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:A229E325-2C87-4EFC-8114-8F692F9FE147">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/62B567F8-EBE4-4BA4-9B68-E81E9E1BCD30"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/3FD2DBDA-7F24-4B3D-829F-5ECB6A6E2D7B"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/3C160E2B-4E7F-4651-8C33-B715669F67D7">
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <rdfs:label>sertraline</rdfs:label>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/36437</dailymed:activeMoietyRxCUI>
    <dct:description>Referred to the drug in the interaction.</dct:description>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:41C2DB2C-7077-4ABE-8A8A-54A08326A7B8">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>Risperidone</ao:exact>
    <pav:createdOn>2014-07-15 14:18:20 -0700</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:41C2DB2C-7077-4ABE-8A8A-54A08326A7B8"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <domeo:uuid>41C2DB2C-7077-4ABE-8A8A-54A08326A7B8</domeo:uuid>
    <domeo:uuid></domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix> decreased by 60% compared to young healthy subjects. </ao:prefix>
    <ao:suffix> doses should be reduced in patients with renal disease [see 2 DOSAGE AND ADMINISTRATION and 5 WARNINGS AND PRECAUTIONS].</ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N3fd365a53bac4514b6700441ce6a387b">
    <domeo:sets rdf:resource="urn:pddi:uuid:9A899E70-DA16-4FA1-A716-CEF8414FF84E"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:DE10284C-BBEF-4195-99FD-8E0DF00E83B5">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/B497A525-4AF7-4AD5-98D7-46B660BDD1DD"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/9AB5B89D-1FA6-423E-B30F-E487DFF7AF4F"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:27CD6522-EB84-4EA5-B85A-92DFCD2667EE">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/94ECD58C-7632-419B-93E6-7EC5C2CE733E"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/426B0374-C8D4-4202-B915-8FB41FCE1E34"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/D2062C41-A719-4900-9B45-2632D5CEE604">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/2002</dailymed:activeMoietyRxCUI>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <rdfs:label>carbamazepine</rdfs:label>
    <dct:description>Referred to the drug in the interaction.</dct:description>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/82CCB5FE-D88E-4927-8E8E-50DF768746E6">
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <rdfs:label>risperidone</rdfs:label>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/35636</dailymed:activeMoietyRxCUI>
    <dct:description>Referred to the drug in the interaction.</dct:description>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:9AA1C371-A08E-41E5-AC8E-B7624054B9FF">
    <ao:suffix>. Extensive CYP 2D6 metabolizers convert risperidone rapidly into 9-hydroxyrisperidone, whereas poor CYP 2D6 metabolizers convert it much more slowly. Although extensive metabolizers have lower risperidone and higher 9-hydroxyrisperidone concentrations t</ao:suffix>
    <pav:createdOn>2014-07-15 14:14:23 -0700</pav:createdOn>
    <domeo:uuid></domeo:uuid>
    <ao:exact>quinidine</ao:exact>
    <ao:prefix>r drugs. CYP 2D6 is subject to genetic polymorphism (about 6% to 8% of Caucasians, and a very low percentage of Asians, have little or no activity and are “poor metabolizers”) and to inhibition by a variety of substrates and some non-substrates, notably </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:9AA1C371-A08E-41E5-AC8E-B7624054B9FF"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <domeo:uuid>9AA1C371-A08E-41E5-AC8E-B7624054B9FF</domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N22b27ddb6cef4d4892aa72cae76c4d0f">
    <permissions:accessType>urn:domeo:access:public</permissions:accessType>
    <permissions:isLocked>false</permissions:isLocked>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:27E8BA7E-57CC-48C7-86F6-BFF286EBA6E0">
    <ao:suffix>, has similar pharmacological activity as risperidone. Consequently, the clinical effect of the drug results from the combined concentrations of risperidone plus 9-hydroxyrisperidone.</ao:suffix>
    <ao:exact>9-hydroxyrisperidone</ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix> by the enzyme, CYP 2D6. A minor metabolic pathway is through N-dealkylation. The main metabolite, </ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:27E8BA7E-57CC-48C7-86F6-BFF286EBA6E0"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>27E8BA7E-57CC-48C7-86F6-BFF286EBA6E0</domeo:uuid>
    <pav:createdOn>2014-07-15 14:10:12 -0700</pav:createdOn>
    <domeo:uuid></domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:E4704CA0-5730-4A9D-9D0B-72695CA1CAC6">
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:0F2A01F7-5870-48E8-B927-577A7FEDC2E6"/>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N87e6a4a5863445ab9cbc02ba28422c66">
    <permissions:accessType>urn:domeo:access:public</permissions:accessType>
    <permissions:isLocked>false</permissions:isLocked>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N4f5f13b2abed4423bd86717d16a5d8f9">
    <permissions:isLocked>false</permissions:isLocked>
    <permissions:accessType>urn:domeo:access:public</permissions:accessType>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/9AB5B89D-1FA6-423E-B30F-E487DFF7AF4F">
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdfs:label>sildenafil</rdfs:label>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/136411</dailymed:activeMoietyRxCUI>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/9C092694-B2C7-4517-AE2B-2F29437C3E14">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/</dailymed:activeMoietyRxCUI>
    <rdfs:label>sulfamethazine</rdfs:label>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/D897A818-DCCA-4D6F-9782-6DA45BBFD745">
    <rdfs:label>fluconazole</rdfs:label>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/4450</dailymed:activeMoietyRxCUI>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dct:description>Referred to the drug in the interaction.</dct:description>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:F929AFAD-20F2-46BB-9E7C-A915CD8E65D0">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/EDAB886F-D798-49C1-A0C4-ED5754179815"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/EC076291-AAD4-470B-AEA2-F25F4E7DC70B"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N0d649a3d31fb487a9e4a022b6c3336d5">
    <permissions:isLocked>false</permissions:isLocked>
    <permissions:accessType>urn:domeo:access:public</permissions:accessType>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:49FCC0DB-01A0-4D81-BC7E-4E5BA9BCB5A0">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/68169CA6-EEA6-4C01-BAD6-EB46996FEBC2"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/608E1DA9-C778-41BB-AF19-BEB866893872"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Nc6efe70c0f5f4e2c8de4fdc6f738cecb">
    <permissions:accessType>urn:domeo:access:public</permissions:accessType>
    <permissions:isLocked>false</permissions:isLocked>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Nd96edd2552374072b45af0a1676a76bf">
    <domeo:sets rdf:resource="urn:pddi:uuid:6F73FE0C-9AF3-4741-ABB6-2D6C73C11FF8"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:06D83359-3B18-4014-8D41-6A116B0BED04">
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:27CD6522-EB84-4EA5-B85A-92DFCD2667EE"/>
    <dikbD2R:modality>ncit:negative</dikbD2R:modality>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N627916f651634fcf86d85a92cc8ae545">
    <permissions:accessType>urn:domeo:access:public</permissions:accessType>
    <permissions:isLocked>false</permissions:isLocked>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:FC0B6A3C-A2F8-4ACD-9832-BF13C7065BAE">
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:742BAEF2-5B32-4F05-87AD-ACC7F302B35E"/>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:9494FE3F-439F-4A1E-80B8-C98ADC78ACCF">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/4810A93A-921A-434E-9CAA-030002F8071B"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/E6AAB5C8-7D21-4FFF-957B-D45D2B203951"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:F5EA08DB-0874-466C-8ADD-16FB922B834F">
    <pav:createdOn>2014-07-16 10:19:32 -0700</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix>Absorption: </ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:F5EA08DB-0874-466C-8ADD-16FB922B834F"/>
    <domeo:uuid>F5EA08DB-0874-466C-8ADD-16FB922B834F</domeo:uuid>
    <ao:suffix> is well absorbed. The absolute oral bioavailability of risperidone is 70% (CV=25%). The relative oral bioavailability of risperidone from a tablet is 94% (CV=10%) when compared to a solution.</ao:suffix>
    <ao:exact>Risperidone</ao:exact>
    <domeo:uuid></domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:580A3551-8F22-418F-831B-419485D8F711">
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:839BFC94-772B-4ABC-83E2-1B6874899A06"/>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:C99A2006-8591-4B3F-9788-B075E7E171FD">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/F995B9BA-3282-4734-8DF3-ADABDFFE80DD"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/D8D8ADB4-7CA8-48E1-AC8A-2DBE43F6BB49"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:FC34EFC8-BB07-4B83-AD21-D8DD09AB286D">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2014-07-18 14:02:56 -0700</pav:createdOn>
    <ao:exact>theophylline</ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:FC34EFC8-BB07-4B83-AD21-D8DD09AB286D"/>
    <ao:prefix> 200 mg daily for 14 days in 16 normal male volunteers. There were significant increases in </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix> AUC, Cmax, and half-life with a corresponding decrease in clearance. The mean ± SD theophylline AUC increased 21% ± 16% (range: -5 to 48%). The Cmax increased 13% ± 17% (range: -13 to 40%). Theophylline clearance decreased 16% ± 11 % (range: -32 to 5%).</ao:suffix>
    <domeo:uuid>FC34EFC8-BB07-4B83-AD21-D8DD09AB286D</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-28.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:2500769A-71A4-43D8-8E3E-130085DACC0D">
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:AC79320C-3C8F-46FE-94FF-193C575E7659"/>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <dikbD2R:modality>ncit:negative</dikbD2R:modality>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/1FC51968-9D21-44A1-9E75-B063933AF89E">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/35636</dailymed:activeMoietyRxCUI>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <rdfs:label>risperidone</rdfs:label>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:41F53CFC-A1D1-4460-AD5B-0F44E9396C8A">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/498E6806-6DCA-4705-867A-311AE66F8A32"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/F18B18E9-19FE-4C8D-BEE4-1C59CA30430D"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:CA979FCE-441A-47D4-9797-5CC727F01663">
    <domeo:belongsToSet>urn:domeoserver:annotationset:C2A39432-076D-421D-8007-22690EDA5A0C</domeo:belongsToSet>
    <domeo:belongsToSet>urn:domeoclient:uuid:8C39EA63-3E52-40B4-8935-6ADC75CCA74D</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
    <pav:lastSavedOn>2014-07-16 14:06:30 -0700</pav:lastSavedOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotation:BAAEB633-65CB-426D-AD31-0B36CB5F9EE4</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:AD2FD8CD-1032-462E-833D-451021CE67B2</domeo:belongsToSet>
    <pav:createdOn>2014-07-16 14:03:38 -0700</pav:createdOn>
    <pav:lastSavedOn>2014-07-16 17:06:30 -0400</pav:lastSavedOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoserver:annotationset:B3F0B84F-756D-4724-B177-98D0D290D00D</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:14EF1296-9281-4C53-B309-5C368E7DBD5D"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:81DA2C24-D202-4991-9DC6-FFA54776B4D2">
    <pav:lastSavedOn>2014-07-16 10:20:50 -0700</pav:lastSavedOn>
    <pav:lastSavedOn>2014-07-16 13:20:50 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:AAD02A4C-E01E-4C82-BC8A-D0F4639844FA</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotation:A582128C-1010-4203-8735-4DF6CD95AF39</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoclient:uuid:2F716A41-B68F-48AE-B5C1-E31F1704C565</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143046812afe0146812ce85a0000</pav:createdBy>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lineageUri>urn:domeoserver:annotationset:C8D7FDC6-6816-4BD4-BC7F-88ABDCC37D79</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:createdOn>2014-07-16 10:20:01 -0700</pav:createdOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:DA8D6B42-B41F-4576-BF10-1285DF3EAB80</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:62C1B60E-3BDC-470D-A027-77547456BB31"/>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoserver:annotationset:6FFFF211-BFDC-4E16-968C-A296868530C4</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/296C3432-7AB8-4E8A-B177-4F9932029F26">
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/35636</dailymed:activeMoietyRxCUI>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <rdfs:label>risperidone</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/FF754DDF-CE5F-4069-98EC-C8B743F74D04">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/75207</dailymed:activeMoietyRxCUI>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <rdfs:label>bosentan</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/DCD0BA65-3461-4AA7-BB38-38A15DD6EDF4">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <rdfs:label>risperidone</rdfs:label>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/35636</dailymed:activeMoietyRxCUI>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Ne6567c736ac14792a2b0be3721c09907">
    <domeo:sets rdf:resource="urn:pddi:uuid:3363C787-8AF1-4899-903A-F4812DD65C36"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/CCD5C1F9-F7D3-4F1B-824F-366552008EE3">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdfs:label>epoprostenol</rdfs:label>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/8814</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/6CA51826-BC17-4C41-9533-7687E5BBFB21">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <rdfs:label>levonorgestrel</rdfs:label>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/6373</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N8926cf7098424227b45f3e1e11d321ec">
    <permissions:accessType>urn:domeo:access:public</permissions:accessType>
    <permissions:isLocked>false</permissions:isLocked>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:80054AD6-BA25-42F5-A7DD-E6D78015E9FA">
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <dikbD2R:modality>ncit:negative</dikbD2R:modality>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:FBA60B3A-004D-4687-B7EC-56E7B9D4A78B"/>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:AA24DC3C-1B9F-4AFC-BD77-237EC620A97C">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/518C4EF2-C804-4CF7-9CBD-9075D385C990"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/73909726-6159-4FE8-9D74-430BABED53E4"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:AFC84332-4270-4613-97A1-CFC4BE857816">
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <dikbD2R:modality>ncit:negative</dikbD2R:modality>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:844F447A-D83F-4BF1-A0FE-F99E548B8383"/>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:859E1AF5-02AF-407E-8AFD-7DE7B211AB48">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/A5BD11F1-3771-4A48-8EB4-641010611616"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/9C092694-B2C7-4517-AE2B-2F29437C3E14"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N5d60867c76f34dcdacacfaeac1c9d1f8">
    <permissions:accessType>urn:domeo:access:public</permissions:accessType>
    <permissions:isLocked>false</permissions:isLocked>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Ne53c3da88e0547958da74d3efa70fb52">
    <domeo:sets rdf:resource="urn:pddi:uuid:31B6ED7E-D003-4C21-A285-EBE6FB28E552"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:D4F68DB2-7686-4E60-9A9D-F764E3A0DF93">
    <ao:exact>fluconazole</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix>xsd:String</ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-23.txt.html</ao:hasSource>
    <pav:createdOn>2014-07-16 15:40:17 -0700</pav:createdOn>
    <ao:suffix> AUC of 13% ± 11% (range: -3.4 to -31%) and Cmax decreased 19% ± 14% (range: -5 to -40%). However, the administration of cimetidine 600 mg to 900 mg intravenously over a four-hour period (from one hour before to 3 hours after a single oral dose of flucon</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:D4F68DB2-7686-4E60-9A9D-F764E3A0DF93"/>
    <domeo:uuid></domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>D4F68DB2-7686-4E60-9A9D-F764E3A0DF93</domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/F995B9BA-3282-4734-8DF3-ADABDFFE80DD">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <rdfs:label>rifampin</rdfs:label>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/9384</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/14706E71-7D17-4340-9C53-D35DEA1F60E7">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdfs:label>risperidone</rdfs:label>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/35636</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N6d4d7d940f4c4c0dbe72e196ae29e74b">
    <permissions:accessType>urn:domeo:access:public</permissions:accessType>
    <permissions:isLocked>false</permissions:isLocked>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/5D96455B-66E9-4C54-AEED-0EA46BBFE77A">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/679314</dailymed:activeMoietyRxCUI>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <rdfs:label>9-hydroxyrisperidone</rdfs:label>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N5dcde12194d54b40bca8e29a1aaf1884">
    <domeo:sets rdf:resource="urn:pddi:uuid:9DE6AF1A-97A2-486C-8C39-E06C073F68E4"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/F4596278-DB6D-4D84-BE8A-5A41F37ACB1F">
    <rdfs:label>9-hydroxyrisperidone</rdfs:label>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/679314</dailymed:activeMoietyRxCUI>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/metabolite"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:661B4601-2894-4F1C-AF15-9A8877C53253">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/E9F8DA0B-E7E6-4545-B4F7-E4DF1CE97D9F"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/82CCB5FE-D88E-4927-8E8E-50DF768746E6"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:person:uuid:080e143046812afe0146812ce85a0000">
    <foafx:lastname>1</foafx:lastname>
    <foafx:email>ningyifan1212@163.com</foafx:email>
    <rdfs:label>expert1</rdfs:label>
    <foafx:title>expert1</foafx:title>
    <rdf:type rdf:resource="http://xmlns.com/foaf/0.1/Person"/>
    <foafx:middlename></foafx:middlename>
    <foafx:firstname>expert</foafx:firstname>
    <foafx:homepage></foafx:homepage>
    <foafx:name>expert1</foafx:name>
    <foafx:picture>http://www.hcklab.org/images/me/paolo%20ciccarese-boston.jpg</foafx:picture>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:590959F7-F15A-4306-BE23-1D37D8B0C281">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/52C813E5-0F7C-4C85-B289-60F729DEBDA0"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/F42BBCFB-733A-404A-8BEB-B260F9A5A30B"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/8A564946-B312-4E79-B2E9-FDBA2D36B979">
    <rdfs:label>sildenafil</rdfs:label>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/136411</dailymed:activeMoietyRxCUI>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Nf8561cb33604467ea02ef2ac6183824e">
    <permissions:isLocked>false</permissions:isLocked>
    <permissions:accessType>urn:domeo:access:public</permissions:accessType>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Nda06508f885044a7aabb745504400d31">
    <permissions:accessType>urn:domeo:access:public</permissions:accessType>
    <permissions:isLocked>false</permissions:isLocked>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N59972b213fde4f518c1ad1b27b750240">
    <domeo:sets rdf:resource="urn:pddi:uuid:F906594B-BBC1-48AF-8F3D-C4A2E2A96B54"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/A1BA9036-F53C-4EFD-BBA8-76308D7248BA">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdfs:label>carbamazepine</rdfs:label>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/2002</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:2C83F977-3681-48B0-B3C1-D84A60204AF3">
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:9C571DAA-DD40-49B9-9828-24A46A158061"/>
    <dikbD2R:modality>ncit:negative</dikbD2R:modality>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/D5AC44EF-FF16-4090-BC49-DC5AF84EFD85">
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdfs:label>9-hydroxyrisperidone</rdfs:label>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/679314</dailymed:activeMoietyRxCUI>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/metabolite"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Ne57d03d49ada45caaa0b15b5b8bf770a">
    <domeo:sets rdf:resource="urn:pddi:uuid:53C6241F-D757-403E-842E-927E95B2B792"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:005571AF-9B7B-4186-B036-1D92080F00CA">
    <ao:prefix>Administration of a single oral 200 mg dose of </ao:prefix>
    <ao:suffix> after 15 days of rifampin administered as 600 mg daily in eight healthy male volunteers resulted in a significant decrease in fluconazole AUC and a significant increase in apparent oral clearance of fluconazole. There was a mean ± SD reduction in flucon</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:005571AF-9B7B-4186-B036-1D92080F00CA"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2014-07-18 13:43:09 -0700</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-24.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>fluconazole</ao:exact>
    <domeo:uuid>005571AF-9B7B-4186-B036-1D92080F00CA</domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:8E283C96-F95C-4194-BC61-D0686F57EA11">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/F284651A-2CF1-43FE-A8FB-93C6E543AD6F"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/431D7F17-E533-4D99-B4EB-F68A78736463"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/0A391966-16D3-4D0D-ACE8-794D85C254DC">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <rdfs:label>bosentan</rdfs:label>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/75207</dailymed:activeMoietyRxCUI>
    <dct:description>Referred to the drug in the interaction.</dct:description>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/7C97C366-586A-4E79-A103-59807877BA4D">
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <rdfs:label>risperidone</rdfs:label>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/35636</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/84F0BF77-BE8B-434E-9DD7-38ABB593D8D4">
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/679314</dailymed:activeMoietyRxCUI>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/metabolite"/>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdfs:label>9-hydroxyrisperidone</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Nded6cab7b2cb4cf1baa747a776609218">
    <domeo:sets rdf:resource="urn:pddi:uuid:06D83359-3B18-4014-8D41-6A116B0BED04"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:5E2AECBE-2BC8-474F-A9DF-7464B1923A05">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/A7E56081-CD67-4A16-A78C-32BEED516AE5"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/80952517-1424-4D02-AC72-0FF70FEA2BCA"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N847ff6f9e2fe47dba0a178753931d455">
    <domeo:sets rdf:resource="urn:pddi:uuid:9A1D2CFB-D308-4756-8AAA-6F32083CC598"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/F18B18E9-19FE-4C8D-BEE4-1C59CA30430D">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <rdfs:label>lithium</rdfs:label>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/</dailymed:activeMoietyRxCUI>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <dct:description>Referred to the drug in the interaction.</dct:description>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N7becc7d2e945433299294dfe825ef7c5">
    <permissions:isLocked>false</permissions:isLocked>
    <permissions:accessType>urn:domeo:access:public</permissions:accessType>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Nd1d6288ba30f4599bb8bf4eb2f6211c1">
    <permissions:isLocked>false</permissions:isLocked>
    <permissions:accessType>urn:domeo:access:public</permissions:accessType>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:D74FB459-7D36-43C5-A6D6-15F309939817">
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:C1E678B1-4206-4A5F-822D-FE021ECEB12D"/>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Nedc4ff23db304cd084af415e92951fd4">
    <permissions:accessType>urn:domeo:access:public</permissions:accessType>
    <permissions:isLocked>false</permissions:isLocked>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/53C53ABF-54FF-48FB-8A92-C02082DDB82F">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <rdfs:label>risperidone</rdfs:label>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/35636</dailymed:activeMoietyRxCUI>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:47F91319-FBBC-4D96-B4A4-0705F95D9E7C">
    <domeo:uuid>47F91319-FBBC-4D96-B4A4-0705F95D9E7C</domeo:uuid>
    <ao:exact>risperidone</ao:exact>
    <ao:suffix> and 9-hydroxyrisperidone [see 7 DRUG INTERACTIONS]. It would also be possible for risperidone to interfere with metabolism of other drugs metabolized by CYP 2D6. Relatively weak binding of risperidone to the enzyme suggests this is unlikely [see 7 DRUG </ao:suffix>
    <ao:prefix> may cause a decrease in the combined plasma concentrations of </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid></domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <pav:createdOn>2014-07-15 14:16:36 -0700</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:47F91319-FBBC-4D96-B4A4-0705F95D9E7C"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:ED25013C-406F-45E7-817A-38F31C1C84A1">
    <domeo:uuid></domeo:uuid>
    <ao:prefix>xsd:String</ao:prefix>
    <ao:exact>carbamazepine (10 mcg/mL) caused only a slight increase in the free fraction of risperidone at 10 ng/mL and 9-hydroxyrisperidone at 50 ng/mL</ao:exact>
    <pav:createdOn>2014-07-15 14:27:09 -0700</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid>ED25013C-406F-45E7-817A-38F31C1C84A1</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:ED25013C-406F-45E7-817A-38F31C1C84A1"/>
    <ao:suffix>xsd:String</ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Ne3169e6abd4c4208b5e22c4cf166dca5">
    <permissions:accessType>urn:domeo:access:public</permissions:accessType>
    <permissions:isLocked>false</permissions:isLocked>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N26aa2427cb2d40bd9d3bae25ca2f6013">
    <domeo:sets rdf:resource="urn:pddi:uuid:C98CE18F-F7E6-4A0B-9E8F-722C99D1E7A6"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:0D248DC0-8452-431C-B6AC-BAE6D8DD90A8">
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:1CA929CF-E1E3-4FA4-8B7E-65CF662A40DA"/>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:52DE006C-2A48-4A64-83D4-EE312E42B8E6">
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:4E844D74-03C0-41B6-B571-7703666D11BA"/>
    <dikbD2R:modality>ncit:negative</dikbD2R:modality>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:14470CEA-E989-4566-A704-AC9CEFD39B6E">
    <ao:prefix>, whereas poor CYP 2D6 metabolizers convert it much more slowly. Although extensive metabolizers have lower </ao:prefix>
    <ao:suffix>and higher 9-hydroxyrisperidone concentrations than poor metabolizers, the pharmacokinetics of risperidone and 9-hydroxyrisperidone combined, after single and multiple doses, are similar in extensive and poor metabolizers.</ao:suffix>
    <ao:exact>risperidone </ao:exact>
    <domeo:uuid>14470CEA-E989-4566-A704-AC9CEFD39B6E</domeo:uuid>
    <pav:createdOn>2014-07-15 14:14:54 -0700</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid></domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:14470CEA-E989-4566-A704-AC9CEFD39B6E"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/A241CF77-D66D-4D63-803F-85B041DD2240">
    <rdfs:label>9-hydroxyrisperidone</rdfs:label>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/679314</dailymed:activeMoietyRxCUI>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/metabolite"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:C1E678B1-4206-4A5F-822D-FE021ECEB12D">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/8AE718F6-37B9-4BDF-AFE7-EDA5106A59F7"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/7C97C366-586A-4E79-A103-59807877BA4D"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N37196c6fde0647afbdd2b7777de1e363">
    <permissions:isLocked>false</permissions:isLocked>
    <permissions:accessType>urn:domeo:access:public</permissions:accessType>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:97C614D7-82D7-4EE5-956C-6F6E2BA9A886">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/971F6D08-1DD4-4857-AFE6-8AC2A827166E"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/80039273-3912-42BE-B7A9-ACED668AB27A"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N0e293d4a0ce740aba23ee8a5d99cc68e">
    <domeo:sets rdf:resource="urn:pddi:uuid:DC0B1C38-224C-4FD8-BC2A-B7D2AE11EBF8"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:7A0B21EC-9B42-45A6-939E-5702AED058B8">
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:41F53CFC-A1D1-4460-AD5B-0F44E9396C8A"/>
    <dikbD2R:modality>ncit:negative</dikbD2R:modality>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/276A1818-8600-415C-BF4E-E95E1BB0E0CC">
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/4450</dailymed:activeMoietyRxCUI>
    <rdfs:label>fluconazole</rdfs:label>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N2d8480186c6e4c128872bfe67884f461">
    <domeo:sets rdf:resource="urn:pddi:uuid:9C0615DE-8C02-4011-9E8F-285A1438818F"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:AD5B7089-9702-4769-81CE-C27334ABF991">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/A5A1C319-789D-4E34-9D41-8E64F0B79D55"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/0E178A5B-0ACA-4567-B955-2FBD97EA282B"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N3f501a665880439c80efc0356eaced0c">
    <permissions:accessType>urn:domeo:access:public</permissions:accessType>
    <permissions:isLocked>false</permissions:isLocked>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/14DF06A5-FE87-442F-A9ED-BDE176C70C7C">
    <rdfs:label>9-hydroxyrisperidone</rdfs:label>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/679314</dailymed:activeMoietyRxCUI>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/metabolite"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N8d07473393e54f2c91da3ddf7f612957">
    <domeo:sets rdf:resource="urn:pddi:uuid:18F0C730-DDF2-4F8F-842E-A969F966577E"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:D5A340B0-D3A4-41A6-BBFF-E7008548903E">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/CC9456BB-F2F5-4CE1-B12B-11D10CE387AE"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/A02C8A1F-1E5C-43D8-ABEA-D88CAF3D8A03"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:2BE90FDD-0DF8-4A0A-9B1E-B84B43D68582">
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:0409A564-F79B-4C83-9844-E9D65A082622"/>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:91F1D915-0F2B-4B98-A86E-D0E424CBADC1">
    <ao:suffix>, is 77%. Neither risperidone nor 9-hydroxyrisperidone displaces each other from plasma binding sites. High therapeutic concentrations of sulfamethazine (100 mcg/mL), warfarin (10 mcg/mL), and carbamazepine (10 mcg/mL) caused only a slight increase in th</ao:suffix>
    <ao:prefix> is 90%, and that of its major metabolite, </ao:prefix>
    <domeo:uuid></domeo:uuid>
    <pav:createdOn>2014-07-15 14:08:40 -0700</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:91F1D915-0F2B-4B98-A86E-D0E424CBADC1"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>91F1D915-0F2B-4B98-A86E-D0E424CBADC1</domeo:uuid>
    <ao:exact>9-hydroxyrisperidone</ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/AnnoStudy/package-insert-section-8.txt.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Nb2b03e5f5afb44e9aa000e94df07b912">
    <permissions:isLocked>false</permissions:isLocked>
    <permissions:accessType>urn:domeo:access:public</permissions:accessType>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Nca1d22992ec443e29ab296850be1ce8a">
    <domeo:sets rdf:resource="urn:pddi:uuid:A7956964-620D-495E-B0B0-1B54C6188D1C"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:7A9FA12F-6FE2-4EA8-B4AC-E3B6A73BE8C6">
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <dikbD2R:modality>ncit:negative</dikbD2R:modality>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:9DDF1E26-0943-47B1-807E-9B8D4B5EBA05"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N788e9911c5f942cea64b0f7331acf157">
    <domeo:sets rdf:resource="urn:pddi:uuid:7A0B21EC-9B42-45A6-939E-5702AED058B8"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:8495478D-931C-477B-8658-0378929F1BAF">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/D5AC44EF-FF16-4090-BC49-DC5AF84EFD85"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/838C89BB-67FF-4BA3-AE73-A11A7721AFAE"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:0F2A01F7-5870-48E8-B927-577A7FEDC2E6">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/3B58FCCA-E6B2-45AE-ACE1-19D3FE8C36CD"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/2902A8BF-91ED-45A1-915C-39CB68D197C6"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:B3A2FE9F-B6D1-4F2D-8EB2-E8EA69DEC037">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/FE3925A8-8E3B-4F19-B5AB-889AF933932B"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/A04865E8-787E-4761-9CCC-B05D3C433330"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N8be54a2e5a6146bd9129189a355b882d">
    <domeo:sets rdf:resource="urn:pddi:uuid:0F043D82-C59E-477B-8CC6-ED534D6C8664"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/D3E8CE76-944F-40F2-AF66-51EBF76481A9">
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/2002</dailymed:activeMoietyRxCUI>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <rdfs:label>carbamazepine</rdfs:label>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <dct:description>Referred to the drug in the interaction.</dct:description>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:3E222580-6163-4407-B0C4-D0FC6BC85172">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/D3C6A443-5788-4C8E-B4F0-D1A386132459"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/5D96455B-66E9-4C54-AEED-0EA46BBFE77A"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/68169CA6-EEA6-4C01-BAD6-EB46996FEBC2">
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <rdfs:label>zidovudine</rdfs:label>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/11413</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/608E1DA9-C778-41BB-AF19-BEB866893872">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <rdfs:label>fluconazole</rdfs:label>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/4450</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N1949cbd8fdd0465383c1405253457dc9">
    <domeo:sets rdf:resource="urn:pddi:uuid:52DE006C-2A48-4A64-83D4-EE312E42B8E6"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N38ce0769c3e6448788fb649cd2cfa456">
    <permissions:isLocked>false</permissions:isLocked>
    <permissions:accessType>urn:domeo:access:public</permissions:accessType>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/2A063602-BECD-4E27-881B-DF86652CE970">
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/11289</dailymed:activeMoietyRxCUI>
    <rdfs:label>warfarin</rdfs:label>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <dct:description>Referred to the drug in the interaction.</dct:description>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Nd38c8439574849118ab636eefec731ef">
    <permissions:isLocked>false</permissions:isLocked>
    <permissions:accessType>urn:domeo:access:public</permissions:accessType>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N7603ab6d050d4a819ee99357e7ac3fd6">
    <permissions:isLocked>false</permissions:isLocked>
    <permissions:accessType>urn:domeo:access:public</permissions:accessType>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N28a19dd2e0fe4529b1e00a3cd0eb7374">
    <domeo:sets rdf:resource="urn:pddi:uuid:FC5E2AEC-F9BE-4E70-A265-19B20FB3E3D2"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N0c3808b9ed5843e9a43ee26b718ac1af">
    <domeo:sets rdf:resource="urn:pddi:uuid:1EFF2490-0B61-41C8-834C-DB6A557BD8F0"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N326e95db960f4c31ae0919fc8806e9dc">
    <domeo:sets rdf:resource="urn:pddi:uuid:B8206C01-73E3-49C2-B300-B5B0DE6FBC1B"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/EA846F11-F8CD-42D1-8BB5-6033431D84BF">
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/35636</dailymed:activeMoietyRxCUI>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <rdfs:label>risperidone</rdfs:label>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N6c201c50ed164a088486a4794032ccb0">
    <permissions:isLocked>false</permissions:isLocked>
    <permissions:accessType>urn:domeo:access:public</permissions:accessType>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Na984382f798044a29d8988e44a3cba1b">
    <domeo:sets rdf:resource="urn:pddi:uuid:1AF9FCBE-D690-435E-848A-C035A391B132"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/A854A7DE-A8FE-498F-9B31-F34790052689">
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/679314</dailymed:activeMoietyRxCUI>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/metabolite"/>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdfs:label>9-hydroxyrisperidone</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N8fb8323cb79b415abac0facb0ea9b004">
    <domeo:sets rdf:resource="urn:pddi:uuid:BEAE7606-F223-4295-A5D4-C1A750C28439"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Ndfe970a841f44bb49bd85d8289505fc0">
    <permissions:isLocked>false</permissions:isLocked>
    <permissions:accessType>urn:domeo:access:public</permissions:accessType>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Nf7e6bddc379949799259f7378c641905">
    <domeo:sets rdf:resource="urn:pddi:uuid:E4704CA0-5730-4A9D-9D0B-72695CA1CAC6"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N58f3fc48b9604820936f995003155bb8">
    <permissions:accessType>urn:domeo:access:public</permissions:accessType>
    <permissions:isLocked>false</permissions:isLocked>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/175C780B-E011-4DC0-94B4-BBEC5EDDC82A">
    <rdfs:label>risperidone</rdfs:label>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/35636</dailymed:activeMoietyRxCUI>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dct:description>Referred to the drug in the interaction.</dct:description>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:DD1D98FB-026A-4A63-A3CE-F2CF57FA0D72">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/134A6837-6F9F-4758-AAC4-3A4B621B5D17"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/DCAE7BE5-CA2D-42DE-AD2F-DA9E269EF211"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/5DE2E202-6D4F-4F94-96E7-9AC3DF505EFC">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/32937</dailymed:activeMoietyRxCUI>
    <rdfs:label>paroxetine</rdfs:label>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:22D7536B-F2C3-4847-A116-46A6B05916F0">
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:AD5B7089-9702-4769-81CE-C27334ABF991"/>
    <dikbD2R:modality>ncit:negative</dikbD2R:modality>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:742BAEF2-5B32-4F05-87AD-ACC7F302B35E">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/F5B727AA-1FE7-4EF4-9422-5C712EBAD08C"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/A3473ECA-4411-4CF5-A4E8-ABE5F8CA6A53"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Nde005fba6b0542c8a71e07e71f5a3232">
    <domeo:sets rdf:resource="urn:pddi:uuid:22D7536B-F2C3-4847-A116-46A6B05916F0"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:C54C358E-1731-4D93-820E-2F87B9D286FE">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/D2062C41-A719-4900-9B45-2632D5CEE604"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/2CB7BD6B-AF06-43CD-9905-C06E37B34FC9"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Nc84da17ee4cb445e87f9708b8ff44a30">
    <domeo:sets rdf:resource="urn:pddi:uuid:5A10196D-612D-427F-A010-CCF56DACBAEA"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:AE0CC832-EE7D-4E19-8731-01D46C24AA3D">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/E6B9269E-0F1E-4EA7-9B11-2B410071D56E"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/4512FD1D-26DF-4608-92A5-E0B5D3388329"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N85089624aa664b80b60b53d56d87cc39">
    <domeo:sets rdf:resource="urn:pddi:uuid:2BE90FDD-0DF8-4A0A-9B1E-B84B43D68582"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N6f77e491b4c042cfb1923d40cdb14b9a">
    <permissions:accessType>urn:domeo:access:public</permissions:accessType>
    <permissions:isLocked>false</permissions:isLocked>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:A1F526CA-6030-4127-9BB6-6D4E1719252E">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/5E972E60-CC16-43FB-B91B-88EDC51512DD"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/3C160E2B-4E7F-4651-8C33-B715669F67D7"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N77d0f1c1a62043cf858346777fcbe67b">
    <domeo:sets rdf:resource="urn:pddi:uuid:4E5794FD-667C-4031-AE7A-DDDC905400BE"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N29dad09cc6c54a5992be671bb14c4002">
    <domeo:sets rdf:resource="urn:pddi:uuid:3BD41FAC-162E-4141-B15C-C7AD0CAF56A0"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Nc0a8a6ffd9aa40c8954f3d400a804dc0">
    <permissions:isLocked>false</permissions:isLocked>
    <permissions:accessType>urn:domeo:access:public</permissions:accessType>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N1bf593e39ea8472e8e6263957c1a0cd9">
    <permissions:isLocked>false</permissions:isLocked>
    <permissions:accessType>urn:domeo:access:public</permissions:accessType>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:F0AE4B90-85AC-42C7-B80E-8A27A4B6E455">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/595576F3-EC50-44DE-92FC-A9FC2111AFB6"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/F0D97621-1E50-45F0-BAA1-F81268B95E28"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N07254ea8d76c49b29d7bad60b95d19e6">
    <domeo:sets rdf:resource="urn:pddi:uuid:44695E00-3FB6-4D5F-B815-8E3CED70A3F6"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Nae05c13f18064a84ac606c8afc944091">
    <domeo:sets rdf:resource="urn:pddi:uuid:7B416A74-DC20-4C40-8395-6E603CABC003"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N5ce09eba37984fe9b6ab275a17e31b77">
    <domeo:sets rdf:resource="urn:pddi:uuid:21985ECB-619E-48CC-8AB3-93723B535D1F"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N6be5e5a7447c475695953a4666d8ca69">
    <permissions:accessType>urn:domeo:access:public</permissions:accessType>
    <permissions:isLocked>false</permissions:isLocked>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N0f1ed5582b544732b7e7ced219fa898e">
    <domeo:sets rdf:resource="urn:pddi:uuid:F68205D1-C26C-4CDF-8BC6-B801BDEFE695"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/426B0374-C8D4-4202-B915-8FB41FCE1E34">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/679314</dailymed:activeMoietyRxCUI>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <rdfs:label>9-hydroxyrisperidone</rdfs:label>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/metabolite"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:A7956964-620D-495E-B0B0-1B54C6188D1C">
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:97C614D7-82D7-4EE5-956C-6F6E2BA9A886"/>
    <dikbD2R:modality>ncit:negative</dikbD2R:modality>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N37844053ae7d48518c7d2eafb1991533">
    <permissions:accessType>urn:domeo:access:public</permissions:accessType>
    <permissions:isLocked>false</permissions:isLocked>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Ndea203f3f0f341ffa9558d67b3e517b9">
    <domeo:sets rdf:resource="urn:pddi:uuid:7A6A4F43-E19F-4F5E-BBA6-D0937A988F58"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Nccb0c3ea034845dd966c4f33629f76a6">
    <permissions:accessType>urn:domeo:access:public</permissions:accessType>
    <permissions:isLocked>false</permissions:isLocked>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N854c8cbe91074eea8f4227a25349bddf">
    <domeo:sets rdf:resource="urn:pddi:uuid:A0073BE0-0C00-42AF-8C67-EADDD1F4519E"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Nc967c2be66e740bca26f01bce73d1370">
    <domeo:sets rdf:resource="urn:pddi:uuid:EC8E54B5-0BA4-4BDD-B164-66B9C1417149"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N1fd5325f3fff46beaeb1c3ec92e92735">
    <domeo:sets rdf:resource="urn:pddi:uuid:2BE39456-0995-441E-9B43-639B42929C06"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Nd41b5f39f8fb4b7ca07b1f290f829794">
    <domeo:sets rdf:resource="urn:pddi:uuid:DC11109C-477E-45E9-8790-252CE45CAC57"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Nfc0f1cf71b11466da2955618ef16e15d">
    <domeo:sets rdf:resource="urn:pddi:uuid:523A8E6B-6F7F-4807-9852-CFA0940BB6CC"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N39c1e0a97b1b424898b19d13b50b7326">
    <domeo:sets rdf:resource="urn:pddi:uuid:61CB1DA8-A104-4CBC-A3C7-E8898B001ECF"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Ne933c0da3ead40b9b3a77fbee9d05c9d">
    <domeo:sets rdf:resource="urn:pddi:uuid:580A3551-8F22-418F-831B-419485D8F711"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:8237D894-48AB-40ED-BA0C-2A88EF2D9CC4">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/1AE17014-4CEE-4452-A8DB-A7AD795E46A5"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/E2C33A26-EBDB-4674-BEC1-C76A9750E5F7"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:D0B55215-1EBF-494D-B824-11B81E6480B8">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/C47A2842-C13E-4BAB-8DB6-578609EBC0CA"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/F4596278-DB6D-4D84-BE8A-5A41F37ACB1F"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N8531c33fb2ab4ab19f30030cf770160f">
    <domeo:sets rdf:resource="urn:pddi:uuid:1C1206FB-FFE6-4216-8FC7-016E9D7B0A16"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Nef75cde762c443a3858c1527ba433e17">
    <domeo:sets rdf:resource="urn:pddi:uuid:2500769A-71A4-43D8-8E3E-130085DACC0D"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Nad12fcfe73cf48d88f8563a744c2f25d">
    <domeo:sets rdf:resource="urn:pddi:uuid:CC8EDBDD-A7A3-41E7-8775-C12B2FD8C92B"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N7e3f621adfe64aa792e6f3f20ad0f31c">
    <domeo:sets rdf:resource="urn:pddi:uuid:E5374C47-F6BA-4C76-BA79-A45CBC597A4C"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Ncfd0b85462e544fb81b6acda79f74fc4">
    <domeo:sets rdf:resource="urn:pddi:uuid:74592674-5629-4C4B-8931-FFAA6830CB3B"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N82b3173fd9584f64a005d9e4746a9788">
    <domeo:sets rdf:resource="urn:pddi:uuid:6FE3E0C7-BFF1-4C33-8E1B-DDF1CDB00784"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Nc8b0c1d6706e4e9e8e24456dcf776ca9">
    <domeo:sets rdf:resource="urn:pddi:uuid:D74FA7C5-5531-44B7-99F1-8D9CCAA862A7"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N124af162555645ef80c102558d0822ea">
    <permissions:isLocked>false</permissions:isLocked>
    <permissions:accessType>urn:domeo:access:public</permissions:accessType>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N126b3162582e4f75b30cc7724bc26472">
    <domeo:sets rdf:resource="urn:pddi:uuid:438EE2CD-205C-4FF7-85D9-5CA19DA48F3F"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N96e9e9e77eb543b19ba44ef505150dd6">
    <domeo:sets rdf:resource="urn:pddi:uuid:98211317-4C78-4697-963F-262D8DC874A6"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N789347a8eb994eeaaae16cbf6eb02d59">
    <domeo:sets rdf:resource="urn:pddi:uuid:8B60173A-DE13-439C-A9A3-32C58F0F5E08"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Ne3f71507c6784f1b9c4c02bffffdf912">
    <domeo:sets rdf:resource="urn:pddi:uuid:2A85543D-D428-4598-B706-98C5E81EE7F2"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Nea6a65c660354023a6f2662072a91800">
    <domeo:sets rdf:resource="urn:pddi:uuid:F6BE9E0C-96F1-4A3F-BE0A-413829714A90"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N8f897fbf9a454608b5eab177a117b9d5">
    <domeo:sets rdf:resource="urn:pddi:uuid:1B280A2A-5A01-45FD-BA8D-9F6D2D706E50"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N90eccee110fe4b1ab9a2d69527543e98">
    <domeo:sets rdf:resource="urn:pddi:uuid:2F4ED2A9-99ED-44E0-8D7A-82BB231F6DBB"/>
  </rdf:Description>
</rdf:RDF>
